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PREFACE	This	 portfolio	 of	 competence	 demonstrates	 the	 development	 of	 a	 trainee	 health	psychologist	working	 in	 an	 acquired	 brain	 injury	 centre	 over	 the	 three	 years	 of	supervised	 practice,	 and	 more	 recently	 in	 a	 hospital	 stroke	 unit	 and	 neuro-rehabilitation	department.		Completing	this	training	has	given	the	trainee	the	skills,	knowledge	 and	 confidence	 to	 promote	 health	 psychology	 theory	 and	 implement	health	psychology-based	interventions	in	their	work	with	people	with	neurological	conditions.		
Section	B	–	Research	
Thesis	The	author	was	exploring	mindfulness-based	 interventions	 for	people	with	 long-term	conditions	when	they	were	invited	to	become	involved	in	a	pilot	randomised	controlled	trial,	assessing	the	feasibility	of	improving	the	non-motor	symptoms	of	people	with	Parkinson’s	disease	through	an	adapted,	remote-delivery	mindfulness	cognitive	behavioural	therapy.		Being	part	of	an	experienced	research	team	at	the	protocol	discussion	stage	was	an	excellent	opportunity	 for	a	researcher	who	had	only	previously	been	involved	in	student	studies	and	allowed	them	to	contribute	a	novel	 putative	 mediating	 construct	 to	 the	 doctoral	 study,	 which	 focused	 on	 the	possible	 mediators	 and	 moderators	 in	 the	 relationship	 between	 trial	 arm	 and	psychological	outcomes.				The	trainee’s	recent	multi-disciplinary	team	working	experience	with	people	with	Parkinson’s	 disease	 has	 been	 an	 invaluable	 resource	 in	 understanding	 the	 non-motor	symptoms	and	distress	in	this	population,	and	when	considering	suggestions	for	future,	larger-scale	trials	of	this	intervention.		Understanding	the	reality	of	living	with	both	non-motor	and	motor	symptoms,	only	partially	controlled	by	medication,	and	 with	 an	 uncertain	 and	 unpredictable	 disease	 trajectory,	 has	 provided	 the	motivation	to	complete	a	study	that	required	learning	challenging	new	quantitative	statistical	skills.		Being	able	to	offer	a	person	who	has	been	newly	diagnosed	with	Parkinson’s	disease,	and	who	has	yet	to	experience	any	cognitive	impairment,	a	non-pharmacological	pathway	that	may	help	them	cope	better	with	symptoms,	including	
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anxiety	 and	 depression,	 increase	 the	 patients’	 ability	 to	 manage	 more	 severe	symptoms	 as	 the	 disease	 progresses.	 	 Understanding	 which	 of	 the	 mediating	constructs	 may	 most	 influence	 successful	 outcome	 will	 enable	 targeted	interventions,	that	could	not	only	reduce	the	skill-learning	burden	for	the	patient	with	 Parkinson’s	 disease,	 but	 would	 improve	 cost-effectiveness	 in	 delivery.		Parkinson’s	 disease	 clinical	 nurse	 specialists	 are	 often	 the	 prime	 contact	 for	outpatients	and	frequently	deal	with	concerns	about	the	uncertainty	of	the	disease.		Being	 able	 to	 improve	 patient	 self-efficacy	 in	 self-management	 of	 anxiety	 and	depression	 symptoms	will	 enable	 the	 clinical	 staff	 to	 guide	 the	 patient	 to	 better	manage	their	other	symptoms.		
Supplementary	research	Three	papers	have	been	devised	and	submitted,	but	without	publication	success	at	the	time	of	writing.		A	paper	on	a	systematic	review,	on	which	the	author	acted	as	a	consultant,	describing	the	lack	of	inclusion	of	people	with	severe	mental	illness	in	trials	of	education	interventions	for	type	II	diabetes	mellitus,	has	been	submitted	twice,	 but	 on	 each	 occasion,	 they	 have	 been	 rejected.	 	 A	 third	 attempt	 will	 be	undertaken	after	revision.		A	paper	reporting	a	systematic	review	of	the	literature	on	 the	utility	of	 illness	perceptions	 in	 the	management	of	people	with	 functional	neurological	 symptom	 disorder	 has	 also	 been	 submitted	 and	 rejected	 following	review.	Each	opportunity	for	review	has	contributed	to	improving	the	articles,	and	both	will,	after	further	revision	and	careful	consideration	of	appropriate	journals,	be	resubmitted.		A	third	article	describing	the	trainee’s	application	of	health	psychology	theory	and	practice	 within	 neurological	 settings	 and	 decrying	 the	 lack	 of	 access	 for	 health	psychologists	 to	 neuropsychology	 training,	 has	 been	 submitted	 to	 the	 Health	Psychology	Update	and	is	awaiting	review.							
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Section	C	-	Professional	Practice	
Teaching	and	training	of	health	professionals	Following	the	completion	of	a	successful	behaviour	change	intervention	case	study	with	a	functional	neurological	symptoms	(FNSD)	patient,	it	became	clear	that	other	members	of	the	multidisciplinary	team	were	not	as	confident	when	treating	patients	with	this	diagnosis.		People	with	FNSD	often	present	with	stroke-like	symptoms,	and	while	 no	 brain	 pathology	 is	 noted	 on	 imaging,	 inconsistencies	 with	 stroke	presentation	can	be	detected	on	clinical	examination.		While	the	aetiology	is	often	complex,	 and	 is	probably	best	 explained	 in	biopsychosocial	 terms,	 the	 treatment	includes	physiotherapy	and	psychology,	with	occupational	therapy	where	available,	and	 follows	a	 similar	pathway	 to	 stroke	 rehabilitation.	 Successful	 reversal	of	 the	symptoms	(which	may	be	cognitive	and	sensory	as	well	as	physical)	is	achievable	with	early	intervention	and	good	rapport	with	the	patient.		However,	this	approach	is	reasonably	novel,	and	despite	the	prevalence	of	this	condition	(between	10	and	20%	 at	 the	 brain	 injury	 centre),	 and	 the	 NICE	 recommendations,	 there	 remains	controversy	within	health	care	professions	as	to	how	to	manage	people	with	FNSD,	with	many	still	believing	that	people	with	FNSD	are	not	as	“deserving”	as	people	with	recognised	brain	pathology.		Three	 teaching	 sessions	 lasting	 1-1.30	 hours	 were	 organised	 so	 that	 everyone	within	 the	 team	 who	 wished	 to	 attend	 could	 access	 a	 session.	 	 The	 staff	 were	engaged	by	inviting	them	to	discuss	the	emotions	elicited	when	working	with	this	population,	including	the	feelings	of	low	self-efficacy.		After	interactive	teaching	of	the	 theory-based	 explanations	 of	 symptom	 perception,	 assessment	 and	maintenance,	and	a	description	of	the	successful	case	study,	all	but	one	participant	reported	greater	confidence	in	dealing	with	this	patient	group.				
Teaching	and	training	of	general	population	A	 seminar	was	 planned	 and	 delivered	 to	 a	 group	 of	 Health	 Psychology	Master’s	students	on	“medically	unexplained	symptoms”	(a	term	that	is	no	longer	used,	with	functional	or	persistent	physical	symptoms	being	preferred).		The	students	had	no	health	care	working	experience,	and	the	first	half	of	the	seminar	was	more	general	
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and	 included	 teaching	 on	 health	 psychology	 models,	 illustrated	 with	 studies	 on	functional	 conditions	 such	 as	 irritable	 bowel	 syndrome	 and	 chronic	 fatigue.	 	 An	early	 slide	warned	 the	 small	 group	 that	 these	 subjects	 often	 aroused	 conflicting	thoughts	 and	 emotions,	 and	 indeed,	 one	 participant	 did	 share	 that	 they	 had	experienced	 disbelief	 and	 poor	 treatment	 for	 their	 own	 functional	 symptoms.		Teaching	a	small,	intimate,	but	very	diverse	group	of	students,	some	of	whom	felt	mandated	 to	 be	 there,	 was	 challenging,	 but	 the	 experience	 and	 the	 supervisor’s	observations	of	the	session	were	extremely	useful,	and	the	author	has	since	taken	more	opportunities	to	expand	their	teaching	and	training	practice.		
Consultancy	For	this	competency,	the	author	was	asked	to	contribute	to	a	systematic	review	of	the	 exclusion	 of	 people	 with	 severe	 mental	 illness	 in	 trials	 of	 self-management	education	for	people	with	type	II	diabetes	mellitus,	for	which	the	client,	a	research	group	based	at	the	university,	had	already	started	the	preliminary	searches.	 	The	task	 involved	 assessing	 1245	 study	 abstracts,	 reading	 the	 full	 papers	 if	 needed,	contacting	 the	 authors	 if	 the	 exclusion	 criteria	 were	 not	 explicit,	 collating	 and	cataloguing	 the	 data,	 and	 finally,	 writing	 two	 versions	 of	 the	 paper	 for	 journal	submission.	 	 The	 first	 contract	 underestimated	 the	 time	 involved	 and	 was	renegotiated	so	that	some	of	the	hours	were	included	in	supervised	practice	for	the	doctorate.	 	 This	 consultancy	 experience	 provided	 the	 trainee	 with	 a	 greater	understanding	of	working	collaboratively	in	an	academic	field.	
	
Behaviour	change	intervention	Therapeutic	 interventions	 for	 people	 who	 have	 an	 acquired	 brain	 injury	 or	neurological	symptoms,	require	motivating	them	to	change	behaviours	that	may	be	hindering	rehabilitation.		People	with	FNSD	may	not	have	the	same	brain	pathology	as	people	with	neurological	conditions	but	do	have	similar	symptoms.	Many	display	pre-morbid	 “boom	 and	 bust”	 behaviours	 that	 may	 have	 contributed	 to	 both	symptom	development	 and	 symptom	maintenance.	 	 Learning	 to	 self-regulate,	 as	well	 as	 exploring	 their	 emotional	 state	 during	 therapy,	 can	 help	 reverse	 FNSD	symptoms.	 	 The	Common-Sense	Model	 (Leventhal	&	Diefenbach,	 1991)	 can	help	
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explain	how	emotional	and	cognitive	interpretation	of	physical	symptoms	leads	to	maladaptive	 coping	 behaviours.	 Cognitive	 behavioural	 therapy,	 including	 third-wave	 compassion	 focused	 therapy,	 and	 motivational	 interviewing,	 and	 joint	working	 with	 physiotherapy	 and	 occupational	 therapy,	 have	 been	 shown	 to	 be	effective	in	a	few	studies	with	small	samples.	The	case	study	of	an	FNSD	patient	in	this	competency	illustrated	how	all	these	techniques	could	be	used	to	support	the	return	to	full	function.			
	
Section	D	–	Systematic	review	Researching	 interventions	 for	 people	 with	 FNSD	 revealed	 very	 few	 examples	 of	successful	outpatient	cases.		As	illness	perceptions	have	been	shown	to	help	people	with	long-term	conditions,	and	as	FNSD	will,	in	most	cases,	lead	to	similar	disability	and	distress,	there	was	a	need	to	explore	whether	using	the	Common-Sense	Model	and	the	illness	perception	scales	had	been	effective	in	managing	this	condition.		A	comprehensive	 review	 was	 conducted	 generating	 a	 total	 of	 233	 papers,	 and	eventually,	 including	updating	at	a	 later	date,	nine	met	 the	 inclusion	criteria	and	were	included	in	the	review.		This	systematic	review	revealed	a	paucity	of	studies,	conducted	mostly	by	a	very	small	 group	 of	 researchers,	 and	 with	 very	 few	 utilising	 the	 full	 IPQ-R	 and	 thus	neglecting	 to	 examine	 the	 participant’s	 the	 emotional	 perceptions.	 Nevertheless,	illness	perceptions	were	shown	to	be	associated	with	psychological	outcome	and	symptom	improvement,	to	be	predictive	of	outcome,	and	to	differentiate	between	functional	 patients	 and	 patients	 with	 neurological	 disease.	 This	 review	 has	demonstrated	that	illness	perceptions	warrant	further	exploration	in	this	group	of	complex	patients,	and	the	measures	could	be	useful	 in	helping	to	understand	the	patient’s	beliefs	and	willingness	to	engage	in	therapy.		
Conclusion	The	competencies	demonstrated	in	this	portfolio	have	contributed	to	the	author’s	working	as	a	reflective	scientist	practitioner	in	neurological	settings,	a	health	care	area	 that	 straddles	mental	 and	 physical	 health.	 	Working	 alongside	many	 other	
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therapies,	 as	 a	 trainee	 health	 psychologist,	 has	 led	 to	 reflection	 on	 how	 health	psychology	 theory	 contributes	 to	 the	 understanding	 of	 complex	 long-term	conditions,	and	how	further	work	is	needed	to	enable	health	psychologists	to	devise	and	implement	interventions	for	people	with	neurological	conditions.																				 	
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Exploring	mechanisms	of	change	in	a	pilot	randomised	
trial	of	a	distant	delivery	mindfulness	intervention	for	
people	with	Parkinson’s	disease.	
Abstract	People	 with	 Parkinson’s	 disease	 report	 high	 levels	 of	 non-motor	 symptoms,	including	 anxiety	 and	 depression,	 that	 are	 difficult	 to	 treat	 pharmacologically.	Mindfulness-based	interventions	have	been	shown	to	be	effective	in	other	long-term	conditions.	 	This	pilot	study	explored	how	a	mindfulness-based	intervention	may	have	had	an	effect	and	for	whom,	with	a	view	to	informing	future	studies.	Volunteers	were	 randomised	 to	 a	 remote	 delivery,	 eight-week	 mindfulness	 cognitive	behavioural	group	therapy	intervention	(n=40)	or	wait-list	(n=38),	and	measures	for	psychological	outcomes	and	putative	mediators	were	taken	at	baseline,	4	weeks,	8	weeks	and	20-week	follow-up.		The	study	showed	that	all	the	outcome	measures	changed	in	a	positive	health	direction	in	the	intervention	group.	The	intervention	had	 a	 small	 effect	 on	 decentering	 (d=.36)	 and	 acceptance	 (d=.27)	 by	mid-point,	before	depression	at	8	weeks	(d=-.28)	and	anxiety	at	follow-up	(d=-.29),	indicating	an	indirect	effect	between	trial	arm	and	levels	of	distress.	Mediation	and	moderation	analysis	were	conducted	using	PROCESS,	time-lagging	the	mediators	to	the	outcome	variables,	but	no	combined	or	 individual	 indirect	effects	had	confidence	intervals	entirely	above	or	below	zero,	thus	mediation	cannot	be	confirmed.	When	the	end	of	intervention	 mediators	 were	 analysed	 with	 the	 follow-up	 levels	 of	 anxiety	 and	depression,	 there	 is	 evidence	 of	 inconsistent	mediation,	 or	 possible	 suppression	effects.	 Moderation	 analysis	 revealed	 that	 the	 effect	 on	 anxiety	 levels	 was	moderated	 by	 gender,	 with	 women	 benefitting	 more	 from	 the	 mindfulness	intervention.		Moderated	mediation	analysis	also	indicated	that	the	effect	of	the	trial	arm	on	levels	of	acceptance	was	conditional	by	age	and	time	since	diagnosis,	and	the	effect	 of	 trial	 arm	 on	 levels	 of	mindfulness	 skills	 by	 age,	meaning	 that	 younger,	newly-diagnosed	 patients	 were	 more	 able	 to	 increase	 mindfulness	 skills	 and	acceptance.			
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1 Introduction:	
 
1.1 Parkinson’s	disease	
 First	described	in	1817	by	Dr	James	Parkinson	in	his	“Essay	on	the	Shaking	Palsy”	(Parkinson,	 2002),	 Parkinson’s	 disease	 (PD)	 is	 a	 chronic	 and	 progressive	neurological	disease	affecting	around	127,000	people	 in	 the	UK	 (Parkinson’s	UK,	2017),	or	around	1	person	in	500.		PD	is	more	common	in	men	than	women	(1.5:1),	the	mean	age	of	onset	 is	65	(Connelly	&	Lang,	2014)	and	the	 incidence	 increases	with	age	(De	Lau	&	Breteler,	2006).					It	is	usually	diagnosed	when	the	substantia	nigra	(within	the	basal	ganglia)	starts	losing	 the	 cells	 that	 produce	 dopamine,	 a	 neurotransmitter	 responsible	 for	 the	regulation	 of	 voluntary	 movement,	 resulting	 in	 the	 motor	 symptoms	 becoming	evident.	 	 Motor	 symptoms	 only	 become	 evident	 after	 70-80%	 of	 striatal	dopaminergic	content	is	lost,	presumably	because	of	the	remaining	neurons	acting	to	 compensate	 (Hemmerle,	 Herman	 &	 Seroogy,	 2012).	 Motor	 symptoms	 include	tremors,	freezing,	stiffness	and	slowness	of	movement.		Other	specific	neurochemical	disruption	may	also	be	involved	and	is	also	implicated	in	the	development	of	non-motor	symptoms,	such	as	low	mood,	anxiety,	depression,	sleep	dysfunction,	fatigue	and	central	pain,	and	which	may	precede	any	PD	motor	signs	(Marras	&	Chaudhuri,	2016).			The	combined	effect	of	motor	and	non-motor	symptoms	has	been	shown	to	reduce	health-related	 quality	 of	 life	 (Soh,	 Morris,	 &	 McGinley,	 2010),	 and	 non-motor	symptoms	(anxiety	and	depression)	have	been	demonstrated	to	have	more	effect	on	health	status	than	motor	symptoms	(Hinnell,	Hurt,	Landau,	Brown	&	Samuel,	2011).			Drug	treatment	for	PD	is	aimed	at	modifying	dopamine	levels	in	the	brain	to	stabilise	motor	symptoms,	but	as	the	disease	progresses	and	treatment	time	lengthens,	the	effectiveness	of	the	drugs	declines.		There	may	be	daily	fluctuations	of	symptoms	(as	medication	dose	wears	off	and	symptom	return)	as	well	as	increasing	delay	in	the	dose	showing	benefit	to	symptoms.	Dopaminergic	treatment	for	motor	symptoms	
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may	 also	 have	 an	 iatrogenic	 effect	 on	 non-motor	 symptoms	 (Chaudhuri,	 Odin,	Antonini,	 &	 Martinez-Martin,	 2011),	 and	 may	 cause	 serious	 side	 effects	 like	hallucinations,	which	are	also	a	potential	symptom	of	Parkinson’s	(Connelly	&	Lang,	2014).		
 Non-motor	symptoms	in	Parkinson’s	disease	Recognition	of	the	non-motor	symptoms’	contribution	to	burden	in	PD	patients	is	growing	amongst	health	care	providers	(Pfeiffer,	2016).	In	an	Italian	multi-centred	survey	 (n=1072),	 non-motor	 symptoms	were	 reported	 by	 98.6%	of	 PD	 patients,	with	fatigue	as	the	most	common	(58%),	followed	by	anxiety	(56%),	pain	(38%)	and	insomnia	(37%)	(Barone	et	al,	2009).	A	recent	systematic	review	and	meta-analysis	of	non-motor	symptomology	prevalence	in	PD	literature	found	significant	clinical	heterogeneity	 among	 the	 included	 studies	 and	 reported	 the	 prevalence	 of	depression	at	51.7%	and	of	anxiety	at	46.7%	(Tagliati,	Chaudhuri	&	Pagano,	2014).	Some	 non-motor	 symptoms	 of	 Parkinson’s	 disease	 are	 also	 commonly	 found	 in	people	 as	 they	 age,	 but	 Parkinson’s	 disease	 patients	 report	 a	 greater	 number	 of	symptoms,	 and	with	 greater	 frequency	 and	 severity	 (Krishnan,	 Sarma,	 Sarma,	 &	Kishore,	2011;	Khoo	et	al,	2013).	Chaudhuri	et	al	(2011)	list	48	different	non-motor	symptoms	 in	 PD	 and	 report	 that	 a	 typical	 patient	 describes	 10-12	 non-motor	symptoms	(Chaudhuri	et	al,	2006).			Cognitive	impairment	is	a	common	feature	in	people	with	PD	and	has	been	shown	to	predict	reduced	coping,	lower	quality	of	life	and	higher	anxiety	and	depression	in	people	with	PD	(Hurt	et	al,	2012).		Depression	and	anxiety	have	both	been	reported	as	the	most	prevalent	non-motor	symptoms	in	PD	even	when	the	disease	is	not	at	an	advanced	stage	and	depression	may	be	present	even	before	motor	symptoms	are	evident	(Barone	et	al,	2009).	
 Depression	in	PD	has	frequently	been	explained	by	biological	mechanisms,	such	as	disruption	to	brain	chemistry	(Burn	et	al,	2012).	However,	a	bio-psychosocial	model	is	 gaining	 traction	 in	 explorations	 of	 the	 causal	 and	 maintenance	 factors	 of	depression,	 which	 in	 turn	 informs	 management	 of	 depressive	 symptoms	 in	
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Parkinson’s	 disease	 (Hurt,	 Weinman,	 Lee,	 &	 Brown,	 2012;	 Hurt,	 Burn,	 Hindle,	Samuel,	Wilson,	&	Brown,	2014).				Depression	 in	 PD	 has	 been	 associated	 with	 higher	 functional	 disability	 (Brown,	McCarthy,	Gotham	et	al,	1988),	with	a	reduction	in	motor	function	and	daily	living	measures	(Riedel	et	al,	2010)	and	higher	mortality	(Hughes,	Ross,	Mindham,	et	al,	2004).	Many	symptoms	of	depression	are	difficult	to	differentiate	from	those	of	PD	(including	 psychomotor	 retardation)	 which	 makes	 the	 diagnosis	 of	 depression	challenging	 (Lieberman,	 2006),	 however	 two	 distinct	 clinical	 phenotypes,	 one	“anxious–depressed”	 and	 the	 other	 “depressed”	 have	 been	 identified	 (Brown,	Landau	et	al,	2011).		
 Anxiety	also	shares	somatic	symptoms	with	PD,	making	diagnosis	difficult,	and	has	until	 recently	 not	 been	 the	 subject	 of	 as	 much	 research	 as	 depressive	 mood	 in	Parkinson	 patients	 (Dissanayaka	 et	 al,	 2016).	 Anxiety	 has	 been	 shown	 to	 be	prevalent	 in	 25-40%	 of	 people	 with	 PD	 (Simuni	 &	 Fernandez,	 2013),	 and	 the	incidence	of	anxiety	independent	of	depression	has	been	demonstrated	by	Brown,	Landau	et	al	(2011)	using	latent	class	analysis	(22%	of	n=	513	patients	with	PD).	The	same	participants	were	examined	4	years	later	(with	64.1%	of	the	sample	still	participating)	 and	 showed	 stable	 class	membership	 in	 the	 anxious	 and	 anxious-depression	groups	and	high	resilience	in	the	psychologically	healthy	group.		Higher	baseline	 depression,	 psychiatric	 history	 and	 younger	 age	 onset	 of	 PD	 predicted	whether	distress	was	stable	over	the	4-year	period,	which	the	authors	suggest	may	indicate	vulnerability	factors	(Landau	et	al,	2016).		The	authors	also	noted	that	over	25%	of	people	in	the	“moderate	anxiety”	class	at	year	1	were	classed	as	one	of	the	two	anxiety	and	depression	classes	a	year	later,	and	a	third	of	participants	moved	in	the	other	direction,	 indicating	 that	 remission	 from	depressive	 symptoms	did	not	lead	to	a	reduction	in	significant	anxiety.		Anxiety	may	also	be	masking	depression	and	Landau	and	colleagues	make	the	point	that	there	continues	to	be	little	research	in	anxiety	and	its	treatment,	despite	a	clear	case	for	further	management	direction	(Deane	et	al,	2014).						
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Anxiety	has	also	been	shown	to	be	associated	with	freezing	of	gait	in	PD,	a	major	cause	of	falls,	and	may	be	implicated,	through	the	attentional	demands	that	anxiety	provokes,	in	the	development	of	freezing	(Martens,	Hall,	Gilat,	Georgiades,	Walton,	&	Lewis,	2016).	These	authors	conclude	that	early	treatment	of	anxiety	may	prevent	the	onset	of	freezing,	thus	reducing	the	potential	impact	on	quality	of	life	and	apathy	(Perez-Lloret	et	al,	2014).		
 Treatments	for	non-motor	symptoms	Little	 evidence	 base	 exists	 of	 effective	 treatments	 for	 non-motor	 symptoms	(Connolly	&	Lang,	2014)	and	a	recent	report	stated	that	non-treatment	of	non-motor	symptoms	is	common	–	only	28%	of	those	with	moderate	to	severe	depression	were	being	 prescribed	 pharmacological	 treatment	 and	 only	 2%	 of	 people	 were	 being	treated	 for	 REM	 sleep	 behaviour	 disorder	 despite	 screening	 positive	 (Pfeiffer,	2016).				The	 lack	 of	 treatment	 of	 non-motor	 symptoms	 is	 partly	 due	 to	 barriers	 to	 help-seeking	which	 include	 lack	 of	 awareness	 that	 symptoms	 are	 associated	with	PD,	embarrassment	at	discussing	sexual,	urinary	and	bowel	problems,	and	medical	staff	focus	on	motor	symptoms	(Hurt,	Rixon,	Chaudhuri,	Moss-Morris,	Samuel,	&	Brown,	2016).		Furthermore,	anxiety	and	depression	symptoms	in	Parkinson’s	disease	have	been	found	to	be	unrecognised	by	neurologists	in	routine	clinics	(Shulman,	Gruber-Baldini,	Anderson,	Fishman,	Reich,	&	Weiner,	2002),	and	low	mental	health	literacy,	lack	of	referral	and	transport	access	have	been	found	to	be	barriers	to	help-seeking	in	mood	 disorders	 in	 people	with	 PD	 (Dobkin,	 Rubino,	 Friedman,	 Allen,	 Gara,	 &	Menza,	2013).				Further,	the	lack	of	treatment	of	the	non-motor	symptoms	in	PD	is	also	due	to	the	lack	of	 effective	pharmacological	 treatment.	This	 is	 especially	 true	 in	 the	 case	of	depression	in	PD	(Pfeiffer,	2016;	Frisina,	Borod,	Foldi,	&	Tenenbaum,	2008)	and	it	has	 been	 shown	 that	 people	 with	 depression	 and	 PD	 report	 less	 benefit	 from	antidepressants	 than	 people	 without	 PD	 (Weintraub	 et	 al,	 2005).	 	 A	 systematic	review	and	meta-analysis	of	anti-depressant	use	and	effectiveness	in	PD	concluded	
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that	there	were	too	few	included	trials	and	too	many	methodological	drawbacks	to	establish	 that	 antidepressant	 medications	 were	 effective	 long-term	 or	 with	tolerable	 side	 effects	 (Rocha,	 Murad,	 Stumpf,	 Hara	 &	 Fuzikawa,	 2013).	 More	recently,	a	systematic	review	examining	all	anti-depressive	treatments	for	PD	found	a	significant	positive	effect	with	selective	serotonin	reuptake	inhibitors	(SSRI)	as	a	treatment	for	depression	but	also	noted	that	SSRIs	are	associated	with	PD	motor	symptom	 changes	 and	 with	 interactions	 with	 motor	 symptom	 pharmacologic	treatments	(Dobkin	et	al,	2011).				Standard	pharmacological	treatment	for	anxiety	is	also	not	effective	in	people	with	PD	(Weintraub	et	al,	2005)	or	has	been	found	to	exacerbate	cognitive	and	motor	symptoms	(Hanagasi	&	Emrie,	2005;	Wermuth	&	Bech,	2006;	Mueller	et	al,	2018).		Treatment	of	acute	anxiety	with	benzodiazepines	has	been	shown	to	be	associated	with	a	significant	increase	in	falls	(Martinez-Ramirez	et	al,	2015).			There	 is	 increasing	 interest	 in	 empowering	 people	 who	 live	 with	 chronic,	degenerative	disease	to	self-manage	their	symptoms	(De	Ridder,	Geenen,	Kuijer,	&	van	Middendorp,	 2008;	 Challis,	 Hughes,	 Berzins,	 Reilly,	 Abell,	 &	 Stewart,	 2010).	People	 with	 Parkinson’s	 disease	 have	 been	 participating	 in	 self-management	programmes	for	several	decades,	with	goal-setting,	education	and	guided	problem-solving	 being	 shown	 to	 contribute	 to	 outcome	 (Kessler	 &	 Liddy,	 2017).	 	 The	psychosocial	 benefits	 of	meeting	 other	 people	with	 PD	was	 demonstrated	 to	 be	another	 important	 ingredient	 in	 encouraging	patient	 engagement,	 emerging	 as	 a	dominant	 theme	 in	 a	 qualitative	 study	 of	 participants’	 experiences	 of	 a	 self-help	programme	(Mulligan,	Arps,	Bancroft,	Mountfort,	&	Polkinghorne,	2011).					Specialist	 nurses,	 Expert	 Patient	 Groups,	 access	 to	 group	 education	 and	 support	have	all	been	part	of	 the	drive	 to	promote	self-management	 in	people	with	 long-term	 conditions	 under	 the	 framework	 of	 the	 House	 of	 Care,	 a	model	 developed	within	the	5	Year	Forward	View	(NHS	England,	2014).	 	This	model	promotes	the	patient	and	carer	as	being	engaged,	informed	and	pro-active	in	self-managing	their	long-term	 condition,	 with	 the	 health	 professionals	 being	 highly	 committed	 to	
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collaborative	care	(Coulter,	Roberts,	&	Dixon,	2013).		Learning	new	coping	skills	to	help	people	self-manage	their	long-term	conditions	is	fundamental	to	this	model.					There	 is	growing	 interest	 in	non-pharmacological	 interventions	 for	mood-related	symptoms	 in	 PD,	 including	 a	 systematic	 review	 and	 meta-analysis	 that	 found	 a	significant	effect	of	CBT	for	treating	depression	in	CBT	(Bomasang-Layno,	Fadlon,	Murray,	&	Himelhoch,	2015).		Other	non-pharmacological	interventions,	including	dance	 therapy,	 physiotherapy,	 and	 voice	 training	 have	 been	 studied,	 but	 with	limited	effect	sizes,	heterogeneity	of	participants,	disease	stage	and	small	sample	sizes,	clinical	effectiveness	cannot	be	rated	(Bloem,	de	Vries,	&	Ebersbach	(2015).					Mindfulness	 training	has	been	shown	to	reduce	distress	 in	health	conditions	 like	cancer,	type	two	diabetes,	chronic	pain	and	multiple	sclerosis	as	well	as	to	promote	more	 adaptive	 ways	 of	 coping	 when	 faced	 with	 challenging	 health	 situations	(Bogosian	et	al,	2015;	Grossman,	Niemann,	Schmidt,	&	Wallach,	2004;	Van	Son	et	al,	2013).	 	 An	 underpowered,	 non-controlled	 pilot	 study	 assessing	 an	 8-week	mindfulness-based	intervention	in	groups	of	people	with	PD	and	their	caregivers,	found	a	very	small	effect	(h2=.3)	in	reducing	levels	of	self-report	depression	(Cash,	Ekouevi,	Kilbourn	&	Lageman,	 2015),	 none	 the	 less,	 suggesting	 that	mindfulness	training	may	be	helpful	in	improving	psychological	well-being	in	this	population.			
1.2 Intervention:	Mindfulness	Training		Mindfulness-based	therapy	is	rooted	in	Buddhist	tradition	and	aims	to	develop	self-regulation	 of	 awareness	 and	 attention	 towards	 the	 present	 moment,	 and	 to	becoming	more	open	and	accepting	of	experiences,	however	painful	they	may	be.	The	goal	of	mindfulness-based	training	is	not	to	change	the	experience	of	a	person,	but	 to	change	 the	way	 in	which	a	person	responds	 to	experiences.	 	Mindfulness-based	 training	 has	 been	 shown	 in	 many	 studies	 and	 reviews	 to	 be	 positively	associated	with	changes	in	self-reported	levels	of	mindfulness	skills,	which	in	turn	have	predicted	better	clinical	outcomes	(Chiesa	et	al,	2014;	Alsubaie	et	al,	2017).			
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Different	 sorts	 of	 mindfulness-training	 have	 evolved	 –	 Jon	 Kabat-Zinn	 (1990)	developed	mindfulness-based	 stress	 reduction	 (MBSR)	 targeting	 chronic	 pain	 or	anxiety	disorders,	using	secular	meditation	 techniques	and	gentle	yoga	exercises	within	 a	 collaborative	 group	 setting.	 The	 facilitator	 encourages	 mindfulness	attitudes	 of	 non-judgement,	 acceptance,	 beginner’s	 mind,	 curiosity	 and	nonattachment	 amongst	 others,	 aiming	 at	 developing	 skills	 of	 noticing	 physical	sensations,	 experiences,	 thoughts	 or	 feelings.	 	 A	 systematic	 review	 found	 that	meditation	 studies	 for	 psychological	 stress	 and	well-being	 had	 small	 to	medium	effects	on	anxiety,	depression	and	pain	(Goyal	et	al,	2014).		Mindfulness-based	 cognitive	 therapy	 (MBCT)	 was	 developed	 for	 people	 with	relapsing	 depressive	 symptoms	 by	 CBT	 experts	 interested	 in	 helping	 people	develop	 resilience	 (Segal	 et	 al,	 2002;	 Kuyken	 et	 al,	 2008).	 	 This	 training	 is	 also	delivered	over	an	8-week	period,	usually	in	2	hour-long	sessions	and	in	groups	of	up	to	12	people,	and	shares	many	of	the	practices	of	MBSR,	including	a	body	scan	and	 sitting	 and	 walking	 meditations,	 but	 focusing	 on	 understanding	 depression	rather	 than	 stress.	 Participants	 are	 encouraged	 to	 identify	 automatic	 thinking	patterns	and	to	acknowledge	them	as	just	thoughts,	allowing	them	to	come	and	go,	and	not	to	ruminate.		Unlike	in	traditional	CBT,	participants	are	gently	directed	to	not	challenge	or	replace	thoughts	but	to	see	them	as	impermanent,	and	to	practice	activities	that	promote	wellbeing	and	pleasure.	Mindfulness-based	training	requires	considerable	commitment	-	participants	are	expected	to	practice	for	approximately	an	hour	a	day	during	the	course	and	day	retreats	are	recommended	during	and	after	the	 course	 ends,	 and	 each	 of	 the	 8	weekly	 sessions	 includes	 an	 opportunity	 for	participants	to	share	their	practice	experience	(Shapiro	&	Carlson,	2009).				
 Mindfulness-based	interventions	in	clinical	populations	(physical	
health)	
 Mindfulness-based	 interventions	were	 first	 implemented	 in	 people	with	 chronic	pain	 syndromes	 and	 it	 was	 found	 that	 following	 a	 MBSR	 intervention,	 levels	 of	reported	pain	and	mood	had	improved	(Kabat-Zinn,	1982;	Chiesa	&	Serretti,	2010).	Cancer	 patients	 have	 also	 reported	 significant	 gains	 in	 psychological	 well-being	
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following	 mindfulness	 training	 (Bränström	 et	 al,	 2010)	 and	 there	 is	 promising	evidence	 of	 mindfulness	 being	 positively	 correlated	 to	 cardiovascular	 health	outcomes	(Loucks	et	al,	2015).		Mediation	studies	of	mechanisms	of	mindfulness	in	interventions	for	people	with	physical	health	conditions	have	also	contributed	to	conceptualising	how	the	process	effects	change	in	psychological	outcomes:	Bogosian	et	al’s	(2016)	pilot	RCT	study	of	a	mindfulness	intervention	for	people	with	multiple	sclerosis	used	mixed	methods	to	explore	putative	mediators,	and	found	that	decentring	had	the	largest	mediating	effect	on	distress	and	that	self-compassion	increased,	but	at	a	slower	rate.		
 Mindfulness-based	interventions	for	people	with	Parkinson’s	disease	
 While	mindfulness	training	has	been	shown	to	improve	the	psychological	well-being	of	 people	with	mental	 health	 problems,	 stress,	 cancer,	 as	well	 as	 of	 people	with	chronic,	progressive	diseases	 like	multiple	sclerosis	(Bohlmeijer,	Prenger,	Taal,	&	Cuijpers,	2010;	Bogosian	et	al,	2015),	there	have	been	very	few	studies	that	have	examined	if	people	with	PD	benefit	from	MBIs.	A	pilot	study	of	a	mindfulness-based	stress	 reduction	 group	 therapy	 intervention	 including	 people	 with	 Parkinson’s	disease	and	their	care-givers	demonstrated	significant	improvements	in	depression	symptoms	and	self-reported	everyday	cognitive	functioning,	as	well	as	mindfulness	levels,	for	all	participants	(Cash	et	al,	2016).			The	experiences	of	people	with	PD	who	participated	in	another	mindfulness-based	cognitive	 therapy	 course	 were	 examined	 qualitatively	 and	 revealed	 that	 the	intervention	enabled	better	coping	through	changing	ways	of	coping	and	adapting	existing	coping	skills,	 including	reducing	social	avoidance.	 	This	study	also	 found	that	mindfulness	meditation	enabled	 the	participant	 to	 temporarily	 experience	a	freedom	from	the	physical	constraints	of	their	PD	(e.g.	a	reduction	in	tremor	when	meditating).		The	participants	(n=12,	with	11	completers)	reported	that	they	found	the	 intervention	 both	 acceptable	 and	 beneficial	 (Fitzpatrick,	 Simpson	 &	 Smith,	2010).		
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	Alternative	treatments	appear	to	be	welcomed	by	people	with	PD,	but	they	remain	under-researched	 (Frisina	 et	 al,	 2008).	 	 Mindfulness	 training	 has	 been	demonstrated	 to	 improve	 psychological	 and	 physical	 well-being	 in	 a	 variety	 of	health	 conditions,	 and	 has	 shown	 promising	 benefit	 to	 people	with	 neurological	conditions	 including	 some	 pilot	 studies	 in	 people	 with	 PD.	 	 Examining	 which	mechanisms	 of	MBIs	 have	 the	most	 effect	 in	 this	 population	would	 enable	more	targeted	and	effective	interventions.		
 	Theories	of	Mindfulness	Whilst	empirical	evidence	of	 the	benefits	of	mindfulness-based	 interventions	has	been	demonstrated,	there	is	a	lack	of	theoretical	consensus	as	to	how	mindfulness	practice	effects	these	changes	or	how	best	to	measure	the	constructs	within	those	theories.	Metacognitions,	attentional	focus,	emotion	regulation	and	neurobiological	processes	 have	 all	 been	 hypothesised	 to	 mediate	 in	 the	 relationship	 between	mindfulness	 training	 and	 well-being	 outcomes.	 There	 is	 also	 an	 increasing	contribution	from	neuroscientists,	examining	structural	and	functional	differences	and	changes	in	people	who	are	expert	meditators	and	naïve	participants	undergoing	mindfulness	 training.	 	Each	study	adds	 to	 the	understanding	of	how	mindfulness	interventions	may	be	effective	in	promoting	well-being,	but	at	the	same	time,	the	wide-ranging	concepts	and	neural	correlates	implicated	highlight	the	complexity	of	the	effect	of	this	seemingly	outwardly	simple	practice.				Meditation	 practice	 is	 frequently	 described	 as	 paying	 attention	 purposely	 and	without	judgement	in	the	present	moment	(Kabat-Zinn,	1990),	and	attention	plays	a	 central	 role	 in	many	 explanatory	 frameworks	 (Table	 1):	 for	 instance,	 Shapiro,	Carlson,	Astin,	&	Freedman,	(2006)	posit	that	attention,	intention	and	attitude	are	the	umbrella	components	of	mindfulness,	and		while	there	is	no	definitive	model	of	mindfulness	processes,	there	are	common	constructs	that	are	theorised	to	be	key	ingredients	 (Table	 2)	 and	 semantic	 differences	 require	 that	 their	 fundamental	characteristics	are	made	explicit.	 	This	present	study	will	 focus	on	Shapiro	et	al’s	2006	 model	 of	 mindfulness	 process,	 which	 includes	 five	 distinct	 psychological	constructs	 which	 predict	 psychological	 health	 outcomes:	 decentring,	 or	 re-
 26 
perceiving,	 being	 the	 meta-mechanism	 which	 in	 turn	 predicts	 four	 further	mechanisms:	 values	 clarification,	 self-regulation,	 cognitive/behavioural	 flexibility	and	exposure	(Figure	1).								 	 	 	 	 	 	 				 	 	 	 	
		 		 	 	 	 	 	 				
Figure	1.	Shapiro	et	al’s	(2006)	theoretical	model	of	mindfulness	mechanisms		In	this	model,	reperceiving	or	decentering,	is	described	as	the	shift	in	perspective	that	distances	oneself	 from	thoughts	and	feelings,	which	 in	turn	 is	posited	as	 the	mechanism	that	mobilises	the	other	four.		Values	clarification	has	been	suggested	as	leading	to	increased	value-led	behaviour,	through	changing	from	acting	reflexively	to	reflectively	(acting	impulsively	to	acting	thoughtfully)	and	with	self-compassion.		Self-regulation	 refers	 to	 the	 monitoring	 and	 adaption	 of	 behaviour,	 including	reduction	in	avoidance	behaviours,	to	achieve	goals.		Having	flexibility	in	cognitive	and	 behavioural	 functioning	 involves	 being	 aware	 of	 the	 environment	 and	responding	appropriately.	 	Exposure	implies	the	ability	to	manage	uncomfortable	and	negative	emotional	states	and	is	associated	with	distress	 intolerance	and	the	intolerance	of	uncertainty	(Dugas,	Gosselin,	&	Ladouceur,	2001;	Shapiro	et	al,	2006;	Simons	&	Gaher,	 2005).	 	Decentring	has	been	 shown	 to	 increase	more	 following	mindfulness	 training	 than	 after	 two	 other	 relaxation	 techniques	 (progressive	muscle	relaxation	and	loving	kindness	meditation)	(Feldman,	Greeson,	&	Senville,	
Trait	Mindfulness		 Decentering	or	Reperceiving	
Values	Clarification	
Self-Regulation/	Management	
Cognitive/	Behavioural	Flexibility	
Exposure	
Positive	Health	Outcomes	
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2010),	and	mindfulness	and	decentring	scores	were	shown	to	be	strongly	correlated	and	predictive	of	psychological	symptom	change	in	a	MBSR	intervention	(Carmody,	Baer,	 Lykins,	 &	 Olendzki,	 2009).	 This	 last	 study	 demonstrated	 that	 values	clarification	 and	 cognitive/behavioural	 flexibility	 mediated	 the	 relationship	between	 the	 combined	 mindfulness	 and	 decentring	 scores,	 and	 psychological	distress	scores,	but	not	levels	of	self-regulation	and	experiential	avoidance.		There	is	a	proliferation	of	models	that	have	been	posited	to	describe	the	constructs	included	 in	 possible	mechanisms	 of	 change,	 some	 of	 them	 described	 in	 Table	 1.	While	there	is	no	definitive	theory	of	how	mindfulness	affects	change,	authors	have	suggested	different	constructs	that	may	play	a	part	in	the	process.		With	reference	to	 the	 original	 description	 of	 the	 state	 of	mindfulness	 as	 of	 being	 in	 the	 present	moment,	 with	 an	 attitude	 of	 non-judgement,	 attention	 is	 considered	 to	 be	 a	fundamental	 mechanism	 which	 is	 developed	 by	 changes	 to	 trait	 mindfulness	through	training.	Paying	attention	to	the	present	moment,	both	reduces	rumination	on	 past	 events,	 and	 reduces	 worry	 about	 future	 events.	 Increased	 emotional	regulation,	or	non-reactivity,	 is	another	construct	widely	held	to	be	an	important	outcome	 of	MBIs	 and	 is	 closely	 associated	with	 acceptance.	 Exposure	 is	 another	construct	 that	 is	 included	 in	 both	 Shapiro	 et	 al’s	 2006	model	 and	 that	 of	Hölzel,	Lazar,	Gard,	Schuman-Olivier,	Vago,	&	Ott	(2011),	and	has	been	linked	to	intolerance	of	uncertainty,	a	construct	that	is	increasingly	examined	in	psychopathology.	Neuro-imaging	 studies,	 particularly	 those	 using	 functional	magnetic	 resonance	 imaging	(fMRI),	can	contribute	to	our	understanding	of	the	mechanisms	of	MBIs	by	adding	to	 evidence	 that	 had	 previously	 been	 exclusively	 self-report,	 however,	 there	remains	much	heterogeneity	in	samples	and	methodology	(Young	et	al,	2017).	
 28 
	
TABLE	1.	MODELS	OF	MECHANISMS	OF	MINDFULNESS	
	
Model	 Authors	 Key	constructs		 Empirical	evidence		
Psychological			 Shapiro,	Carlson,	Astin,	&	Freedman	(2006)		 Attention,	intention	and	attitude.				Decentering	is	meta-mediator	between	mindfulness	and	symptom	change,	with	values	clarification,	self-regulation,	cognitive/behavioural	flexibility,	exposure.	(see	figure	1.)	
Carmody,	Baer,	Lykins,	&	Olendzki	(2007).		Found	that	values	clarification	and	flexibility	were	mediators,	but	not	self-regulation	and	experiential	avoidance.		Brown,	Bravo,	Roos,	&	Pearson	(2014).	Tested	the	Shapiro	et	al	model	of	mediation	in	a	college	student	sample	using	the	Five	Facets	of	Mindfulness	measure	(Baer,	Smith,	Hopkins,	Krietemeyer,	&	Tony,	2006).	Four	out	of	five	of	their	facets	predicted	higher	decentering	which	in	turn	predicted	the	mediators	and	the	psychological	outcomes.			 Lindsay	&	Creswell	(2015,	2016)	 	Monitoring	and	Acceptance	Theory:	Training	increases	attention	and	acceptance.		 Baer,	Carmody	&	Hunsinger,	(2012)	-evidence	that	monitoring	skills	(part	of	attention)	are	cultivated	faster	than	acceptance	skills.			
Neuroscience					
Hölzel	et	al,	2011	 The	enhanced	self-regulation	
model	Reappraisal,	exposure,	extinction,	reconsolidation.	Reperceiving	or	decentering.	
Farb	et	al	(2007)	–	brain	activity	study	showed	mindfulness	group	had	changes	in	medial	prefrontal	cortex	interpreted	as	higher	body	awareness	and	greater	detachment	from	self.	Hölzel	et	al,	2011.	Structural	changes	in	grey	matter	after	mindfulness	training.		
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	 Tang,	Hölzel	&	Posner	(2015)		 Emotion	regulation	Mindfulness	training	equivalent	to	exposure	therapy,	mindfulness	enhances	ability	to	extinguish	conditioned	fear.		Attention,	emotional	processing	and	regulation,	exposure,	self-awareness.		
Pickut	et	al,	2013.		Grey	matter	density	increased	in	MBI	group,	example	of	neuro-plastic	changes	in	structure	and	function	of	brain	areas	involved	in	attention,	emotion	and	self-awareness	regulation.	
	 Young	et	al,	2017	 The	insula,	a	region	of	the	frontal	lobe,	is	associated	with	enhanced	present	moment	awareness.		
fMRI	images	have	shown	increased	activity	in	insula	following	mindfulness	training.	
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Table	2.	Constructs	included	in	this	study,	with	evidence	of	mediation	role	
	
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Construct	and	
equivalent	in	
Shapiro’s	model	
Shown	to	be	a	mediator	between	MBI	and	
psychological	outcomes	Acceptance	-	flexibility	 Bogosian,	Hughes,	Norton,	Silber,	&	Moss-Morris,	2016	Lin,	Klatt,	Mccracken,	&	Baumeister,	2018		Decentering	-	reperceiving	 Bogosian,	Hughes,	Norton,	Silber,	&	Moss-Morris,	2016	McCracken,	Barker,	&	Chilcot,	2014	Brown,	Bravo,	Roos,	&	Pearson,	2015	Franquesa	et	al,	2017		Self-compassion	-	values	clarification	 Bogosian,	Hughes,	Norton,	Silber,	&	Moss-Morris,	2016	Gu,	Cavanagh,	&	Strauss,	2017		Mindfulness	-	self-regulation	and	attention	 Lau,	Leung,	Wing,	&	Lee,	2017	Gu,	Cavanagh,	&	Strauss,	2017	Bränström,	Kvillemo,	Brandberg,	&	Moskovitz,	2010	Franquesa	et	al,	2017		Exposure	-	intolerance	of	uncertainty	 NONE	–	except	Brown,	Bravo,	Roos,	&	Pearson,	2015	used	distress	tolerance	scale	(Simons	&	Gaher,	2005).		
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2 MEDIATION	ANALYSIS		Mediation	 analysis	 aims	 to	 discover	 the	 active	 therapeutic	 ingredients	 of	 a	treatment	 for	 a	 particular	 population	 –	 in	 this	 case	 through	 examining	 which	particular	elements	of	the	mindfulness	intervention	and	process	effect	changes	in	the	psychological	outcomes	of	people	with	PD.		The	focus	of	the	analysis	should	be	informed	by	theory,	supported	in	the	literature,	and	also	be	plausible	in	the	target	population	 (Kazdin,	 2007).	 Temporal	 differences	 in	 change,	 with	 the	 mediator	showing	an	effect	before	the	outcome,	strengthens	any	causal	chain	claim	(Kraemer,	Wilson,	 Fairburn,	 &	 Agras,	 2002),	 and	 mediation	 can	 be	 inferred	 without	 a	statistically	significant	main	effect	(Hayes	&	Rockwood,	2017).		Key	ingredients	are	important	 as	 traditional	 mindfulness	 is	 a	 broad	 instrument,	 and	 there	 may	 be	aspects	of	the	therapeutic	process	that	work	better,	while	others	may	be	iatrogenic,	or	may	suppress	the	benefits	of	others	(Johnson	&	Wade,	2017).				This	study	will	examine	five	potential	mediators	–	four	included	because	they	have	been	 demonstrated	 in	 a	 similar	 neurological	 or	 long-term	 condition	 to	 mediate	between	trial	arm	and	psychological	well-being	outcomes,	and	one	a	construct	that	has	 been	 theoretically	 and	 empirically	 demonstrated	 to	 be	 associated	 with	psychological	distress	and	with	people	with	Parkinson’s	disease.		
2.1 Putative	Mediators	in	the	Present	Study:	A	randomised	controlled	pilot	trial	of	a	mindfulness	cognitive	behavioural	therapy-based	 intervention	 on	 several	 common	 non-motor	 symptoms	 in	 people	 with	Parkinson’s	 disease	 (protocol	 in	 Bogosian	 et	 al,	 2017),	 included	 depression	 and	anxiety	as	primary	outcomes	and	fatigue,	pain	and	insomnia	as	secondary	outcomes.		These	 symptoms	 are	 commonly	 reported	 by	 people	 with	 Parkinson’s	 disease	(Barone,	 2009;	 Tagliati	 et	 al,	 2015)	 and	 have	 been	 shown	 to	 be	 potentially	modifiable	 with	 non-pharmacological	 interventions	 (Harrison,	 McCracken,	Bogosian	 &	 Moss-Morris,	 2014;	 Bogosian	 et	 al,	 2015;	 Romenets	 et	 al,	 2013;	Videnovic,	2017).		This	secondary	analysis	will	explore	some	putative	mediators	in	the	 relationship	 between	 a	 mindfulness-based	 intervention	 and	 the	 primary	
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outcomes,	depression	and	anxiety	scores,	in	people	with	Parkinson’s	disease,	aiming	to	understand	the	mechanisms	of	any	intervention	effect,	and	to	inform	any	future	large-scale	 study.	 	 Exploring	 the	 mechanism	 of	 therapeutic	 change	 involves	exploring	mediation,	moderation	and	mediated	moderation	analyses,	to	understand	the	processes	that	lead	from	intervention	to	outcome	(Kazdin,	2007).		Each	of	these	processes	will	be	examined	in	turn.		Mechanisms	of	mindfulness	that	have	previously	been	demonstrated	to	mediate	the	intervention	effect	on	distress	in	people	with	other	chronic,	and	incurable	diseases,	(decentering,	acceptance,	self-compassion	and	mindfulness	levels)	are	included	(eg:	Bränström	et	al,	2010;	Bogosian	et	al,	2016).	Bogosian	et	al	(2016)	suggested	that	there	were	unmeasured	mediators	in	their	study	of	the	effects	of	an	MBI	on	people	with	 MS,	 as	 three	 out	 of	 the	 four	 mediators	 only	 explained	 a	 small	 amount	 of	variance	 in	 the	 outcomes.	 	 To	 explore	 further	 possible	mediators,	 intolerance	 of	uncertainty,	a	construct	that	is	relevant	both	theoretically	in	mindfulness	literature	(Kraemer,	O’Bryan	&	McLeish,	2016),	and	clinically	in	Parkinson’s	disease	studies	(Brown	&	Fernie,	2015),	but	which	has	not	been	explored	as	a	putative	mediator	in	mindfulness-based	interventions	for	people	with	PD	with	psychological	outcomes,	is	introduced.			Each	included	mediator	will	be	described	in	detail	–	and	is	shown	in	Figure	2.			
 Acceptance			Mindfulness	research	defines	acceptance	differently	to	coping	literature	–	wherein	worse	outcomes	may	follow	acceptance	or	relinquishment	(Reed,	Kemeny,	Taylor	1994).	 	 	 In	 mindfulness,	 acceptance	 is	 likened	 to	 willingness,	 and	 increasing	acceptance	of	conditions/symptoms	has	been	shown	to	be	effective	 in	 improving	adjustment	to	chronic	pain	(McCracken,	1998).		Lindsay	&	Creswell	(2016)	describe	acceptance	as	being	the	lens	through	which	monitoring	of	experience	takes	place,	a	perspective	in	how	monitoring	is	undertaken.			
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In	PD,	like	other	chronic	illnesses,	acceptance	may	be	an	important	part	of	better	adjustment,	 but	 it	 may	 have	 to	 follow	 changes	 in	 other	 mindfulness	 processes.		Bogosian	et	al	(2016)	found	that	people	with	MS	took	longer	to	develop	acceptance	than	decentering.					
 Decentering		Decentering	 can	 be	 described	 as	 not	 becoming	 caught	 up	 with	 thoughts	 –	 but	acknowledging	 them	and	 responding	 consciously,	 not	 reacting	or	 avoiding	 them.	Decentring	 has	 been	 shown	 to	 be	 an	 important	 mediator	 between	 mindfulness	training	 and	 emotional	 distress	 in	 people	 with	 chronic,	 progressive	 illness	(Bogosian	 et	 al,	 2016).	 	 	 Shapiro	 et	 al’s	 2006	 model	 of	 the	 mechanisms	 of	mindfulness	proposes	that	reperceiving	(or	decentering,	Safran	&	Segal,	1990)	is	the	meta-mechanism	of	action:	it	is	through	this	process	that	the	other	mechanisms	lead	to	 change	 in	 outcomes.	 They	 argue	 that	 decentring	 is	 part	 of	 the	 developmental	process,	and	that	mindfulness	practice	further	develops	the	ability	to	detach	from	one’s	personal	internal	experience,	strengthening	the	observing	self,	experiencing	without	judgement	(Shapiro	&	Carlson,	2009).			Shifting	 perspective	 enables	 people	 with	 chronic	 illness	 to	 maintain	 an	 identity	beyond	their	health	condition:	being	able	to	acknowledge	thoughts	and	emotions	about	the	illness	but	being	able	to	maintain	a	distance	that	allows	more	choice	in	how	to	pursue	those	emotions	and	thoughts.		A	study	including	people	with	multiple	sclerosis	 (MS)	 (Bogosian	 et	 al,	 2016)	 suggested	 that	decentring	was	 a	mediating	mechanism	that	acted	before	acceptance,	and	that	decentring	was	the	largest	change	and	largest	mediating	effect	between	the	mindfulness	intervention	and	anxiety	and	depression	 scores,	 both	 immediately	 after	 the	 intervention	 and	 at	 the	 3-month	follow-up.				
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 Self-compassion		Self-compassion	has	been	defined	as	“an	orientation	of	mind	that	recognizes	pain	and	the	universality	of	pain	in	human	experience	and	the	capacity	to	meet	that	pain	with	kindness,	empathy,	equanimity	and	patience.	While	self-compassion	orients	to	our	 own	 experience,	 compassion	 extends	 this	 orientation	 to	 others’	 experience”	(Feldman	&	Kuyken,	2011,	p145).	Kirstin	Neff	describes	three	components	of	self-compassion:	self-kindness,	common	humanity,	and	mindfulness,	and	considers	the	construct	to	be	closely	related	to	self-regulation	(Neff	2003a).		Self-compassion	has	
Mediators:	
Acceptance	
Decentering	
Self-compassion	
Mindfulness		
Intolerance	of	Uncertainty	
	
Random	
allocation:	
Mindfulness	training	
Waiting	List	
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Baseline	anxiety	and	depression	
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(a)	
(b)	
(c’)	
Figure	2.	Diagram	showing	the	expected	associations	between	random	
allocation	and	outcome,	between	putative	mediators	and	outcome,	and	
measured	covariates.	(c’)	represents	the	direct	effect,	and	(a)	and	(b)	
represent	the	indirect	effect.		The	moderators	have	an	effect	on	both	the	
mediators	and	the	outcomes. 
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been	shown	to	be	positively	correlated	with	age,	to	psychological	well-being	and	to	be	 a	moderator	 of	 the	 relationship	 of	 self-rated	 health	 and	 depression	 (Homan,	2016).		Randomised	controlled	 trials	of	mindfulness-based	 interventions	 for	people	with	depression	 (Kuyken	 et	 al,	 2010)	 and	 chronic	 fatigue	 (Rimes	&	Wingrove,	 2011),	showed	increases	 in	both	mindfulness	 levels	and	 levels	of	self-compassion	which	mediated	 the	 effects	 of	 the	 MBCT	 intervention	 on	 outcomes,	 and	 which	 were	maintained	at	follow-up	of	15	months	and	6	months	respectively.				The	association	between	mindfulness	and	self-compassion	was	also	shown	to	have	long-term	effects	in	other	studies,	with	mindfulness	predicting	significant	increases	in	 self-compassion	 in	 an	 RCT	 of	 an	MBCT	 intervention	 for	 chronic	 fatigue	 being	maintained	at	6	months	(Rimes	&	Wingrove,	2011)	and	both	mindfulness	levels	and	self-compassion	mediating	the	effect	of	an	MBCT	intervention	at	15-month	follow-up	(Kuyken	et	al,	2010).			However,	Chiesa,	Anselmi,	&	Serretti	(2014)	suggest	that	more	studies	are	needed	to	 investigate	 the	relationship	between	mindfulness,	 self-compassion	and	clinical	outcomes,	to	determine	if	self-compassion	is	a	mediator	or	if	it	has	a	direct	effect	on	clinical	outcomes.		The	temporal	ordering	of	self-compassion	may	be	significant	in	determining	 whether	 it	 is	 a	 mediator	 -	 Bogosian	 et	 al	 (2016)	 found	 that	 self-compassion	had	a	small	effect	after	an	8-week	mindfulness	intervention	for	people	with	MS,	but	 a	moderate	effect	 at	 follow	up	 (12	weeks)	 and	 concluded	 that	 self-compassion	 takes	 longer	 to	 develop	 than	 other	 mediating	 mechanisms,	 such	 as	decentring	and	acceptance.		
 Mindfulness	skills		Self-reported	trait	mindfulness	levels	have	been	shown	to	be	higher	in	people	who	are	 expert	 meditators	 (Brown,	 Ryan,	 &	 Creswell,	 2007).	 	 Increases	 in	 levels	 of	mindfulness	 skills	 are	 correlated	 to	 increases	 in	 self-compassion,	 as	 well	 as	 to	decreases	in	rumination	and	trait	anxiety	(Shapiro,	Brown	&	Biegel,	2007),	in	mental	
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health	 populations	 (Dobkin,	 2008)	 and	 improvement	 in	 symptoms	 in	 physical	health	populations	including	people	with	breast	cancer	(Dobkin,	2008),	chronic	pain	(McCracken	&	Gutierrez-Martinez,	2011),	and	irritable	bowel	syndrome	(Ljotsson,	Hedman,	 Lindfors	 et	 al,	 2011).	 A	 systematic	 review	 of	 mindfulness-based	interventions	 in	people	with	physical	and/or	psychological	conditions	 found	that	changes	 to	 mindfulness	 levels	 were	 associated	 with	 better	 outcomes	 (Alsubaie,	2017).			It	 has	 been	 suggested	 that	 increases	 in	 levels	 of	 mindfulness	 are	 specific	 to	mindfulness-based	 interventions	 and	 that	 active	 control	 groups	 undergoing	therapies	 (such	as	progressive	muscle	 relaxation)	do	not	experience	 this	 level	of	benefit	 (Kuyken	 et	 al,	 2010).	 	 Many	 measures	 have	 been	 produced	 to	 evaluate	baseline	and	changes	in	mindfulness	levels	and	skill	acquisition	–	all	are	self-report	with	the	additional	difficulty	that	mindfulness	as	a	concept	is	highly	subjective	and	tends	to	higher	social	desirability	bias	(Jensen,	2012).		Assessing	mindfulness	skills	indirectly	 by	 evaluating	 changes	 in	 attention	 skills	 has	 only	 demonstrated	 small	effects	(Jha	et	al,	2007).			
 Intolerance	of	Uncertainty	The	construct	of	intolerance	of	uncertainty	(IU)	has	been	defined	as	the	tendency	of	an	 individual	 to	 consider	 the	 possibility	 of	 a	 negative	 event	 as	 unacceptable	(Carleton,	 Sharpe,	 &	 Amundson,	 2007)	 and	 has	 been	 demonstrated	 to	 be	 a	dispositional	 risk	 factor	 for	developing	and	maintaining	significant	 levels	of	both	anxiety	and	depression	(McEvoy	&	Mahoney,	2011;	Boswell,	Thompson-Hollands,	Farchione,	&	Barlow,	2013).		Most	recently	IU	has	been	a	focus	in	General	Anxiety	Disorder	 studies,	 being	 the	 target	 of	 some	 effective	 therapeutic	 interventions	(Robichaud,	2013),	but	it	has	also	been	found	to	be	trans-diagnostic	across	mental	health	conditions	–	Talkovsky	&	Norton	(2016)	demonstrated	that	a	reduction	in	IU	was	predictive	of	clinical	improvement	across	a	variety	of	mental	health	diagnoses.			Uncertainty	about	future	events	has	been	associated	with	worry	and	anxiety,	whilst	the	 feelings	 of	 uncontrollability	 about	 the	 future	 are	 associated	with	depression.		
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However,	 the	 high	 comorbidity	 of	 anxiety	 and	depression	 indicates	 that	 the	 two	mechanisms	are	closely	associated	(Grupe	&	Nitschke,	2013).	Functional	Magnetic	Resonance	Imaging	(FMRI)	has	demonstrated	that	the	Anterior	Insula,	implicated	in	subjective	 emotional	 awareness,	 becomes	 overactive	 when	 presented	 with	uncertain	negative	threats.		Grupe	and	Nitschke	report	that	this	over-activation	is	one	of	the	most	frequent	neuroimaging	findings	in	common	anxiety	disorders	like	social	 anxiety	 and	 fear	 conditioning	 and	 leads	 to	 avoidant	 behaviours	 and	maladaptive	decision-making.			A	 mediation	 analysis	 found	 that	 IU	 mediated	 the	 association	 between	 distress	intolerance	and	worry	(Kertz,	Stevens,	McHugh	&	Björgvinsson,	2014),	and	distress	intolerance	 significantly	 mediated	 the	 relationship	 between	 decentering	 and	psychological	outcomes	in	a	college	student	sample	(Brown,	Bravo,	et	al,	2015).				As	IU	is	frequently	included	in	modern	anxiety	disorder	models,	representing	a	fear	of	the	unknown	(Carleton,	2012)	it	may	be	particularly	salient	to	people	who	have	a	chronic	disease.		Parkinson’s	disease	is	progressive	and	has	an	unpredictable	and	uneven	course:		some	people	may	eventually	have	cognitive	deterioration,	some	not;	some	of	the	motor	symptoms	make	social	interaction	very	difficult,	and	this	can	be	exacerbated	by	non-motor	symptoms	which	may	be	embarrassing	and	debilitating	(Maffoni,	Giardini,	Pierobon,	Ferrazzoli,	&	Frazzitta,	2017).	There	is	an	increasing	lack	 of	 agency	 as	 the	 disease	 progresses	 and	 drug	 treatment	 becomes	 more	refractory	which	adds	to	the	uncertainty	experienced	by	people	with	PD.	
	IU	 has	 been	 found	 to	 be	 related	 to	 motor	 fluctuations	 in	 PD,	 along	 with	metacognitions,	anxiety	and	distress	(Brown	&	Fernie,	2015).		As	drug	interventions	gradually	 lose	 effectiveness	 in	 people	 with	 PD,	 both	 motor	 and	 non-motor	symptoms	 fluctuate	 in	 severity	 and	 occur	 unpredictably.	 	 The	 impact	 of	 the	uncertain	 trajectory	 of	 this	 disease	 was	 illustrated	 by	 the	 autobiographical	narratives	of	23	people	with	PD,	which	when	qualitatively	examined	suggested	that	uncertainty	was	related	to	trust,	specifically	in	trust	in	their	bodies	(they	may	fall,	symptoms	 are	 unpredictable),	 in	 their	 identity	 (no	 longer	 comfortable	 driving,	
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lacking	 self-confidence)	 and	 in	 the	 outside	 world	 (outside	 home	 is	 no	 longer	familiar)	(Nijhof,	1999).			Buddhist	 tradition	 teaches	 that	 impermanence	 is	 central	 to	 life,	 that	 every	experience	 and	 emotion	 eventually	 passes,	 whether	 painful	 or	 pleasurable,	 and	becoming	aware	of	this	ephemeral	nature	of	all	experience	can	lead	to	freedom	from	the	Western	 concerns	 over	 controlling	 future	 events	 (Shapiro	 &	 Carlson,	 2009).		Shapiro’s	model	of	mindfulness	processes	includes	exposure,	which	is	described	as	learning	 to	 live	 with	 emotions	 and	 body	 sensations,	 to	 accept	 them	 as	 being	transitory.		Psychopathology	literature	defines	exposure	as	an	increasing	tolerance	of	fear	stimuli,	or	the	extinction	of	fear	response	and	avoidance	behaviour,	with	the	growing	 awareness	 of	 the	 lack	 of	 catastrophic	 consequences	 (Baer,	 2003).	 	 This	process	 is	 also	 part	 of	 emotion	 regulation,	 in	 the	 way	 that	 reperceiving	 body	sensations	and	emotions	from	a	less	threatening	perspective	increases	tolerance.		A	systematic	 review	 and	 meta-analysis	 of	 mediation	 studies	 of	 MBIs	 designed	 to	improve	mental	health	 and	well-being	described	 six	mindfulness	models,	 four	of	which	included	exposure	as	a	possible	mechanism	(Baer,	2003;	Brown	et	al,	2007;	Shapiro	et	al,	2006;	Hölzel	et	al,	2011),	however,	none	of	the	20	included	studies	tested	exposure	as	a	mediator	(Gu,	Strauss,	Bond	&	Cavanagh,	2015).			Distress	 tolerance	 has	 been	 posited	 as	 a	 close	 proxy	 for	 exposure	 (Brown	 et	 al,	2015);	 a	 college	 student	 sample	 study	 examining	 the	 relationship	 of	 a	 multi-dimensional	model	of	the	five	facets	of	mindfulness	(Baer	et	al,	2006)	with	Shapiro’s	model	of	mindfulness	mechanisms	 found	 that	decentring	only	partially	mediated	between	the	associations	among	the	facets	and	psychological	health	outcomes,	and	that	distress	tolerance	was	a	significant	mediator.				The	authors	reported	that	non-judging	of	inner	experience,	one	of	the	five	facets	of	mindfulness,	was	most	strongly	related	 to	 exposure,	 as	 measured	 by	 distress	 tolerance,	 which	 in	 turn	 was	substantially	related	to	both	stress	and	anxiety	symptoms.							Distress	 tolerance	 has	 been	 theorised	 to	 include	 five	 lower-order	 constructs	 –	uncertainty,	 ambiguity,	 physical	 discomfort,	 frustration	 and	 negative	 emotion	
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(Zvolensky,	Vujanovic,	Bernstein,	&	Leyro,	2010;	Bebane,	Flower	&	Maltby,	2015).		When	 the	 relationship	 between	 four	 cognitive	 constructs,	 including	 anxiety	sensitivity,	 distress	 tolerance	 and	 discomfort	 tolerance,	 and	 anxiety	psychopathology,	 were	 investigated	 in	 two	 non-clinical	 samples,	 intolerance	 of	uncertainty	was	consistently,	and	significantly	more	robustly,	associated	with	the	symptoms	(Norr,	Oglesby,	Capron,	Raines,	Korte	&	Schmidt,	2013).				The	utility	of	the	 IU	construct	as	a	 trans-diagnostic	maintaining	risk	 factor	 in	psychopathology	has	been	supported	by	a	clinical	review	by	Vander	Haegen	&	Etienne	(2016)	with	the	 recommendation	 that	 IU	 be	 incorporated	 both	 in	 research	 and	 as	 a	 specific	treatment	target.						More	recently	IU	has	been	shown	to	be	a	mediator	 in	the	relationship	between	a	mindfulness-based	intervention	and	health	anxiety	in	a	student	sample	(Kraemer	et	al,	2016),	suggesting	that	increased	levels	of	mindfulness	lead	to	physical	symptoms	of	anxiety	being	perceived	as	less	threatening.			IU	has	also	been	shown	to	explain	unique	 variance	 in	 social	 anxiety,	 obsessive	 compulsive	 disorder	 and	 worry	symptoms	(McEvoy	&	Mahoney,	2011).		As	IU	is	associated	with	both	the	development	and	maintenance	of	worry	(Buhr	&	Dugas,	 2002;	 Buhr	 &	 Dugas,	 2006)	 and	 rumination	 (Julien	 et	 al,	 2016),	 and	mindfulness-based	training	has	been	shown	to	reduce	levels	of	worry	(Fisak	&	von	Lehe,	2012)	and	rumination	at	follow-up	(Philippot	et	al,	2012),	it	is	hypothesised	that	mindfulness	interventions	would	have	a	similar	association	with	reduction	in	IU,	as	mindfulness	training	includes	attending	to	the	present	moment	rather	than	worrying	about	the	future.		
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People	with	Parkinson’s	live	with	an	uncertain	future;	their	disease	progression	and	pharmacological	treatment	effects	are	unpredictable.		A	Priority-Setting	Partnership	between	people	with	PD,	their	families	and	caregivers,	and	professionals	clinically	involved	with	people	with	PD,	identified	management	of	stress	and	anxiety	as	the	second	most	pressing	research	area	(the	first	was	management	of	balance	and	falls,	another	area	that	provokes	anxiety	and	uncertainty).		These	were	ranked	higher	as	areas	 of	 research	 aspiration	 than	 dementia,	mild	 cognitive	 problems,	 fine	motor	skills	and	urinary	difficulties	(Deane	et	al,	2014).		
	
	
	
Rumination		 Worry	
Intolerance	
of	
Uncertainty	
Distress		
tolerance	
Figure	3.		Simple	model	showing	associations	of	constructs	associated	
with	intolerance	of	uncertainty	and	exposure	as	a	potential	mindfulness	
process	of	change		
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2.2 Moderators	
 Possible	 moderators	 of	 the	 relationship	 between	 the	 trial	 arm	 and	 anxiety	 and	depression	 in	people	with	PD	will	 also	be	 examined	 (see	Figure	2).	 	Moderation	analysis	examines	whether	the	intensity	of	the	response	to	the	intervention	differs	between	 different	 people	 in	 the	 trial	 and	 helps	 to	 establish	 which	 subsets	 of	 a	population	may	be	more	or	less	susceptible	to	the	therapeutic	effects.	Moderated	mediation	examines	whether	any	of	the	constructs	proposed	as	mediators	are	more	or	less	responsive	to	the	intervention,	thus	identifying	whether	certain	mediators,	or	 elements	 of	 mindfulness,	 may	 be	 better	 intervention	 targets	 for	 people	 with	certain	clinical	or	demographic	 features.	 	For	 instance,	a	correlation	analysis	of	a	student	sample	MBI	found	gender	differences:	only	women	had	greater	reduction	in	negative	 affect	 and	 this	 was	 significantly	 associated	 with	 increases	 in	 levels	 of	mindfulness	and	self-compassion	(Rojiani,	Santoyo,	Rahrig,	Roth,	&	Britton,	2017),	and	this	gender	effect	was	also	replicated	in	an	RCT	at	15-month	follow-up	(Kuyken	et	al,	2010).				In	 this	study,	age,	gender,	disease	severity	(self-report),	 time	since	diagnosis	and	mood	medication	use	were	chosen	as	possible	moderators	to	explore	if	any	of	these	factors	influenced	the	effect	of	the	intervention	on	anxiety	and	depression	directly,	or	the	effect	of	the	trial	arm	on	the	putative	mediating	variables,	which	would	help	identify	who	would	most	benefit	from	aspects	of	the	MBI.		Age	of	the	person	with	PD,	 their	disease	severity	and	 level	of	disability,	and	disease	duration,	have	been	found	to	be	important	factors	in	health-related	quality	of	life	in	people	with	PD	(Soh	et	al,	2010),	and	women	with	PD	have	reported	more	mood	pathology	 than	men	(Martinez-Martin	et	al,	2012).	 	Psychogenic	medication	use	was	also	 included,	 to	explore	for	possible	moderation	on	either	the	direct	effect	of	the	intervention	on	the	psychological	outcomes	or	the	indirect	pathway	to	any	of	the	mediator	variables.		There	is	an	indisputable	need	for	effective	interventions	to	reduce	the	non-motor	symptoms	 of	 people	 with	 PD,	 including	 psychological	 distress,	 and	 MBIs	 are	beginning	to	be	explored	as	training	for	people	with	long-term	conditions	to	better	manage	their	symptoms	and	improve	well-being.		However,	there	is	little	evidence	
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of	moderation	analysis	within	the	MBI	literature;	a	recent	systematic	review	that	included	 18	 studies	 that	 examined	 mediators	 in	 MBIs	 with	 people	 with	 either	comorbid	psychological	and	physical	health	problems,	or	psychological	conditions,	did	not	report	on	any	moderating	variables	(Alsubaie	et	al,	2016).		Yet	traditional	mindfulness	 courses	 are	 cognitively,	 emotionally	 and	 sometimes	 physically,	arduous	 for	 people	 with	 health	 conditions,	 and	 tailored,	 disease-specific	interventions	may	improve	outcomes	and	retain	more	participants.		Mediation	and	moderation	analyses	explore	the	how	and	for	whom	interventions	have	an	effect	–	and	this	exploratory	study	of	pilot	trial	data	will	examine	the	implications	of	those	analyses.		
 Research	questions		
	1. Do	 the	 putative	 mediators	 (acceptance,	 decentering,	 self-compassion,	mindfulness	skills	and	intolerance	of	uncertainty	change	significantly	at	mid	intervention	 (4-weeks),	 post	 intervention	 (8-weeks)	 and	 follow-up	 (20	weeks)	for	the	mindfulness	and	the	waiting	list	control	groups	and	are	the	changes	 in	 these	putative	mediators	associated	with	changes	 in	 treatment	effect?		2. Can	the	changes	in	the	putative	mediators	at	the	end	of	the	treatment	predict	change	in	distress	at	final	follow-up	(i.e.	change	in	mediator	precedes	change	in	 distress)	 or	 is	 change	 in	 mediators	 and	 anxiety	 and	 depression	concurrent?	3. Are	there	sub-sets	of	people	with	PD	for	whom	the	mindfulness	intervention	may	be	more	effective?			
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3 METHODS	
	
3.1 Design	The	present	study	aimed	to	explore	putative	mediators	of	the	relationship	between	a	 mindfulness	 intervention	 and	 changes	 to	 levels	 of	 distress	 in	 people	 with	Parkinson’s	 disease.	 The	 mediators	 included	 decentering,	 acceptance,	 self-compassion,	mindfulness	skills	and	intolerance	of	uncertainty	based	on	the	analysis	of	past	literature	on	MBIs.	Possible	moderators	of	the	main	and	indirect	effects	of	trial	 arm	 on	 psychological	 outcome	were	 also	 explored,	 and	 included	 time	 since	diagnosis,	age	of	participant,	gender,	mood	medication	use	and	self-report	levels	of	disability	at	baseline.			Ethics	 approval	 was	 granted	 by	 the	 psychology	 committee,	 City,	 University	 of	London,	before	the	start	of	the	study	(ethics	reference	number	PSYETH	(S/F)	15/16	112).		
 Participants	
 Recruitment	of	participants	was	through	advertisements	placed	in	spring	2016	on	the	Parkinson’s	UK	and	the	Michael	J.	Fox	Foundation	websites.		Inclusion	criteria	required	a	PD	diagnosis	by	a	neurologist	or	geriatrician	(according	to	UK	PD	Brain	Bank	Criteria	(Hughes,	Ben-shlomo,	Daniel,	&	Lees,	1992;	Gibb	&	Lees,	1988);	having	home	 internet	 access;	being	able	 to	 communicate	 fluently	 in	English;	 and	 to	 report	 having	 been	 on	 a	 stable	 dose	 of	 PD	medication	 or	mood	medication	for	at	least	a	month.		Participants	 were	 excluded	 after	 the	 initial	 telephone	 contact	 with	 the	 trial	coordinator	if	they	had	severe	cognitive	impairments,	indicated	by	a	score	of	20	or	lower	in	a	Telephone	Interview	for	Cognitive	Status	instrument	(modified	version,	TICS-M	 (Brandt,	 Spencer,	 &	 Feldstein,	 1993))	 or	 if	 they	 had	 a	 severe	 hearing	impairment	which	would	make	participation	difficult.		Participants	who	had	serious	psychiatric	 conditions	 (e.g.	 psychosis)	 or	 who	 had	 current	 drug	 and	 or	 alcohol	
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abuse,	were	also	excluded.	People	who	were	participating	in	psychological	therapy,	or	who	had	previously	participated	in	formal	mindfulness	training,	or	who	currently	practiced	meditation,	were	also	excluded,	to	avoid	any	contaminating	effects	of	past	experiences.		
 Procedures	
 Information	about	the	trial,	both	in	written	(postal)	and	verbal	form,	was	shared	and	discussed	with	the	participants,	who	were	invited	to	consult	with	friends	and	family,	and	the	trial	researchers	if	required,	before	signing	the	consent	form.		Baseline	measures	were	obtained	before	randomisation	via	online	questionnaires,	and	 further	 online	 measures	 were	 taken	 from	 both	 groups	 at	 4	 weeks	 (mid	intervention),	8	weeks	(end	of	intervention),	and	20	weeks	(follow-up).			
 Randomisation	
 Each	participant	was	randomly	allocated	to	a	single	treatment	group	(mindfulness-based	intervention	(MBI)	group	versus	waiting	list	control	(WLC)	group)	by	using	a	computer-generated	 randomly	 permuted	 blocks	 scheme.	 The	 randomisation	scheme	 was	 generated	 using	 the	 randomization.com	 website	(http://www.randomization.com).	 Since	 this	 project	 aimed	 to	 recruit	 60	participants	with	fixed	balanced	groups	of	10	participants	for	each	treatment	group	(MBI	versus	WLC),	60	participants	were	randomised	to	6	blocks	of	10	participants.	This	plan	was	generated	using	the	following	parameters:	10	participants	per	block,	6	blocks	and	MBI	and	WLC	as	the	treatment	labels.	The	seed	to	reproduce	this	plan	is	 19033.	 This	 randomisation	 scheme	 allowed	 for	 keeping	 the	 groups	 in	 similar	sizes,	 ensuring	 that	 the	 number	 of	 participants	 on	 each	 treatment	 group	 was	roughly	equal	at	any	time	during	the	trial.			Because	there	was	a	very	positive	response	to	the	call	for	participants,	an	extra	20	participants	were	 later	recruited	 for	 the	study	 following	the	same	randomisation	plan	as	described	above,	bringing	the	total	number	of	participants	to	78	(MBI	n	=	
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38,	WLC	n	=	40).	To	generate	this	randomisation	plan,	the	number	of	participants	entered	 per	 block	 was	 10	 and	 the	 number	 of	 blocks	 entered	 was	 2	 using	 the	treatment	labels	MBI	and	WLC.	The	seed	to	reproduce	this	plan	is	15391.				
 Intervention	
 The	MBI	 consisted	 of	 8	 one-hour-long	 sessions	 on	 a	 weekly	 basis,	 delivered	 by	videoconference	(via	Skype)	to	groups	of	5	participants.	The	same	facilitator,	AB,	who	ran	all	the	groups,	had	experience	of	delivering	such	courses	for	people	with	long-term	neurological	conditions.	 	Participants	were	given	support	 in	setting	up	Skype	and	the	group	sessions	were	arranged	for	a	mutually	convenient	time	and	day	of	the	week.			
 Further	details	of	the	intervention	protocol	are	reported	elsewhere	(Bogosian,	Hurt,	Vasconselos	e	Sa,	Hindle,	McCracken	&	Cubi-Molla,	2017). 	
3.2 MEASURES	
	All	 participants	 were	 invited	 to	 complete	 online	 questionnaires	 measuring	 self-reported	 psychosocial	 outcomes	 and	 putative	 process	 or	 mechanisms	 of	mindfulness	measures.		All	questionnaires	were	completed	at	baseline,	4	weeks,	8	weeks	and	20	weeks	(T1,	T2,	T3,	T4),	apart	from	the	demographics	questionnaire	and	 the	 Parkinson’s	 Activities	 of	 Daily	 Living	 Scale	 (PADLS)	 that	 were	 only	completed	at	T1.	Included	measures	were	selected	to	evaluate	mechanisms	that	had	already	been	shown	to	be	mediators	 in	similar	 intervention	studies	with	chronic	illness	 participants	 (eg:	 Bogosian	 et	 al,	 2016),	 or	 were	 theorised	 to	 measure	constructs	relevant	to	people	with	Parkinson’s	disease	and	which	may	be	part	of	any	causal	chain	between	a	mindfulness	intervention	and	improved	levels	of	distress,	as	discussed	in	introduction.		Where	appropriate,	Cronbach’s	alpha	was	calculated	to	assess	internal	consistency	in	the	measures	(following	reversal	of	appropriate	items	per	scale),	with	0.70	and	above	 considered	 adequate,	 and	 below	 0.70	 considered	 questionable	 (DeVellis,	
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2012).		Scales	with	fewer	items	will	have	a	lower	Cronbach’s	alpha,	and	alphas	that	are	over	0.95	 could	 indicated	 redundant	 and	overlapping	 scale	 items	 (Cronbach,	1951;	Tavakol	&	Dennick,	2011).	If	 the	baseline	Cronbach	alpha	score	was	below	0.70,	removal	of	questionnaire	items	was	examined	to	see	if	there	was	any	impact	on	the	consistency	score	(Appendix	B1).		
 Baseline	self-report	disability	
 
Parkinson’s	Disease	Activities	of	Daily	Living	Scale	(PADLS)	(Hobson,	Edwards,	&	
Meara,	2001)	A	 very	 brief	 (1	 minute	 approximately),	 self-report,	 five-item	 scale	 that	 assesses	patients’	perceptions	of	how	difficult	they	are	finding	activities	of	daily	living	in	the	previous	month	whilst	living	with	PD,	was	completed	at	baseline	only.		It	has	been	used	in	this	study	to	evaluate	homogeneity	in	the	groups’	perceptions	of	disability	and	as	a	predictor	of	treatment	outcome.	This	scale	gives	an	indication	of	disease	severity	level	and	can	be	used	as	a	proxy	for	total	motor	and	non-motor	symptom	burden	 (Hobson	 et	 al,	 2001;	 Jonasson,	Hagell,	Hariz,	 Iwarsson,	&	Nilsson,	 2017).	Participants	 are	 asked	 to	 tick	 one	box	 that	 best	 describes	 how	 their	 Parkinson’s	disease	has	affected	their	day-to-day	activities	in	the	last	month	with	five	options	ranging	 from	 no	 difficulties	 to	 extreme	 difficulties	 with	 day-to-day	 life.	 	 Ticking	number	 3,	 “moderate	 difficulties	 with	 day-to-day	 activities”,	 also	 includes	 the	description:	“your	Parkinson’s	disease	 is	 interfering	with	your	daily	activities.	 	 It	 is	
increasingly	difficult	to	do	simple	activities	without	some	help	such	as	rising	from	a	
chair,	 washing,	 dressing,	 shopping,	 housework.	 	 You	 may	 have	 some	 difficulties	
walking	and	may	 require	assistance.	 	Difficulties	with	 recreational	activities	or	 the	
ability	 to	 drive	 a	 car.	 The	medication	 is	 now	 less	 effective”.	 	The	 PADLS	 has	 been	shown	 to	 correlate	with	 clinical	 ratings	 of	 disease	 severity	 (r=0.68)	 and	 disease	duration	(r=0.39)	(Hobson,	2001).		As	this	is	a	single	item	scale	(with	five	possible	answers),	Cronbach’s	alpha	cannot	be	calculated.						
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 Primary	outcome	measure	
 
Hospital	Anxiety	and	Depression	Scale	(HADS)	(Zigmond	&	Snaith,	1983)	
 A	 fourteen-item	 self-report	 scale	 that	 measures	 anxiety	 and	 depression	 and	 is	extensively	 used	 in	 both	 primary	 and	 secondary	 medical	 settings	 (Wilkinson	 &	Barczak,	1988).		Anxiety	and	depression	can	be	rated	separately,	each	measured	by	7	items,	and	the	HADS	has	been	shown	to	be	effective	in	assessing	the	severity	of	anxiety	and	depression	(Herrman,	1997).	 	One	of	four	possible	responses	to	each	item	gives	a	score	from	0	to	3,	with	0	as	no	impact	and	3	indicating	the	most	severe	level.	An	example	of	a	depression	item	is	“5.		I	have	lost	interest	in	my	appearance,	
with	possible	answers	–	Definitely;	I	don’t	take	as	much	care	as	I	should;	I	may	not	take	
quite	as	much	care;	 I	 take	 just	as	much	care	as	ever”.	The	anxiety	and	depression	subscales	scores	each	range	from	0-21	with	higher	scores	indicated	higher	levels	of	anxiety	or	depression.	A	cut-off	of	8	or	more	on	each	subscale	indicates	clinical	levels	and	11	is	considered	the	cut-off	for	caseness	(Crawford,	Henry,	Crombie,	&	Taylor,	2001;	Snaith,	2003).		Internal	reliability	for	the	anxiety	and	depression	scales	have	been	reported	as	good	(Cronbach	alphas	were	0.83	and	0.82	respectively	(Bjelland,	Dahl,	Haug	&	Neckelmann,	2002)).		In	the	present	study	the	Cronbach	alpha	for	the	anxiety	 scale	 was	 0.83	 and	 for	 the	 depression	 scale	 0.76,	 within	 the	 acceptable	range.	
	
 Putative	process	measures	
 
Experiences	Questionnaire	(EQ)	(Fresco,	Moore,	van	Dulmen,	Segal,	Ma,	Teasdale,	
&	Williams,2007)		
 The	Experiences	Questionnaire	was	designed	to	measure	decentering	–	the	ability	to	 observe	 one’s	 thoughts	 and	 emotions	 as	 temporary,	 and	 as	 just	 thoughts	 and	feelings,	and	not	necessarily	true	(Safran	&	Segal,	1990).		This	skill	is	central	to	many	of	 the	 facets	 of	 mindfulness,	 awareness	 and	 non-reactivity	 and	 is	 negatively	correlated	 with	 the	 maintenance	 of	 depressive	 symptoms,	 including	 rumination	(Watkins,	Teasdale,	&	Williams,	2000).	 	Twenty	statements	(e.g.	“I	remind	myself	that	these	thoughts	aren’t	facts”)	are	rated	using	a	5-point	Likert	scale	of	1	“Never”	to	5	“All	the	time”.		Six	of	the	items	are	reverse	scored,	and	the	possible	range	is	from	
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20	to	100,	higher	scores	representing	better	decentering	ability.		Initial	validation	reported	a	Cronbach	alpha	score	of	0.90	(Fresco	et	al,	2007).	 	The	present	study	found	a	good	level	of	reliability	(Cronbach	alpha	=0.85).		
Acceptance-Action	Questionnaire	(AAQ-II)	(Bond,	Hayes,	Baer,	Carpenter,	
Guenole,	Orcutt,	….	&	Zettle,	2011)	
 This	10-item	scale	assesses	acceptance,	experiential	avoidance	and	psychological	inflexibility.	 	Statements	such	as	 “2.	My	painful	experiences	and	memories	make	 it	
difficult	for	me	to	live	a	life	that	I	would	value”	are	scored	with	a	7-point	Likert	scale	(1,	“never	true”;	7,	“always	true”).	Seven	of	the	items	are	reverse	scored,	the	possible	range	 is	 10	 to	70,	with	higher	 scores	 indicating	better	 levels	 of	 acceptance.	This	second	version	of	the	widely-used	scale	has	been	demonstrated	to	have	more	stable	internal	reliability	(Cronbach	alpha	mean	=0.84,	Bond	et	al,	2011).		In	this	present	study	the	Cronbach	alpha	value	was	very	good	(0.90).	
	
Self-Compassion	Scale	–	Short	Form	(SCS-SF)	(Raes,	Pommier,	Neff,	&	Van	Gucht,	
2011)		
 This	12-item	self-report	questionnaire	evaluates	the	levels	of	trait	self-compassion,	defined	by	Neff	(2003;	2015)	as	the	way	in	which	people	respond	emotionally	to	pain	and	failure,	awareness	of	being	part	of	human	experience,	and	the	way	in	which	suffering	is	attended	to.	Responders	are	asked	to	use	a	5-point	Likert	scale	where	1	is	“almost	never”	and	5	is	“almost	always”	to	rate	statements	such	as	“2.	I	try	to	be	
understanding	 and	 patient	 towards	 those	 aspects	 of	 my	 personality	 I	 don’t	 like”.		Scores	 range	 from	 12	 to	 60,	 with	 higher	 scores	 indicating	 better	 levels	 of	 self-compassion.	Internal	reliability	of	the	short-form	of	the	scale	has	been	shown	to	be	good	 (Cronbach	 alpha	 =	 0.86	 (Raes	 et	 al,	 2011)	 and	 in	 this	 present	 study	 the	Cronbach	alpha	score	was	an	acceptable	0.89.		Self-compassion	was	also	demonstrated	to	be	a	better	predictor	of	improvement	in	symptoms	 than	 mindfulness	 levels	 in	 a	 study	 (N=505,	 people	 with	 anxiety	 and	depression)	comparing	the	Mindful	Awareness	Attention	Scale	(MAAS)	to	the	Self-compassion	Scale	(Neff,	2003a),	indicating	that	there	is	overlap	between	these	two	
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scales	and	also	that	measuring	mindfulness	with	a	single	scale	is	problematic		(Van	Dam,	Shepperd,	Forsyth,	&	Earleywine,	2011).	
	
Philadelphia	Mindfulness	Scale	(PHLMS)	(Cardaciotto,	Herbert,	Forman,	Moitra,	&	
Farrow,	2008)		
 Present-moment	awareness	and	acceptance,	which	the	authors	describe	as	the	two	most	integral	key	components	of	mindfulness,	are	measured	in	a	20-item	scale	using	a	five-point	Likert	scale	(1	“Never”,	5	“Very	Often”).		Even-numbered	statements	are	reverse-scored	to	produce	the	acceptance	sub-scale,	for	instance,	2.	“I	try	to	distract	
myself	when	I	feel	unpleasant	emotions”.		The	awareness	sub-scale	comprises	the	odd	numbered	items	such	as	“11	When	someone	asks	how	I	am	feeling,	I	can	identify	my	
emotions	easily”.		The	range	of	scores	is	from	20	to	100,	with	a	higher	total	indicating	higher	awareness	and	acceptance	levels.		Good	reliability	has	been	demonstrated	at	0.86	in	student	samples	(Cardaciotto	et	al,	2008),	however	in	this	present	study,	the	reliability	at	baseline	was	below	the	acceptable	level	(0.70,	Cronbach,	1951),	with	a	Cronbach	alpha	at	0.61.		Removing	items	would	not	have	improved	the	alpha	level	to	 an	 acceptable	 level,	 so	 the	 reliability	 of	 the	 scale	 at	 4	weeks	 (mid-trial),	 eight	weeks	 (end	 of	 trial)	 and	 20	 weeks	 (follow-up)	 were	 calculated,	 and	 Cronbach’s	alphas	was	found	to	be	0.69,	0.74	and	0.77	respectively.		The	mean	Cronbach	alpha	over	the	four	time	points	was	0.70,	and	therefore	within	the	acceptable	level.		Previous	 research	 had	 reported	 mindfulness	 skills	 as	 a	 similar	 construct	 to	decentering,	as	both	are	theorised	to	influence	non-reactivity	(Carmody,	2009),	but	Hoge	et	al	 (2015)	has	differentiated	 them	–	 identifying	mindfulness	as	enhanced	awareness	with	non-judgemental	attitude,	while	clarifying	decentering	as	a	stance	of	psychological	distance.			
Intolerance	of	Uncertainty	Scale-Short	Version	(IUS-12)	(Carleton,	Norton,	&	
Asmundson,	2007)	
 This	 scale	 measures	 the	 tendency	 to	 find	 the	 possibility	 of	 a	 negative	 event	happening	 unacceptable,	 a	 psychological	 state	 which	 has	 been	 associated	 with	worry	 and	 anxiety.	 	 This	 short	 form	 of	 the	 original	 27-item	 Intolerance	 of	
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Uncertainty	 Scale	 (Freeston,	Rheume,	 Letarte,	Dugas	&	Ladouceur,	 1994)	has	12	items	that	are	rated	by	a	five-point	Likert	scale	(1	is	“not	at	all	characteristic	of	me”,	5	is	“entirely	characteristic	of	me”)	and	contains	statements	such	as	“7.	When	I	am	
uncertain	I	can’t	function	very	well”.	No	items	are	reverse	scored,	the	scores	range	is	12	 to	 60,	 and	 a	 higher	 score	 indicates	 higher	 intolerance	 of	 uncertainty.	 	 Good	reliability	has	been	described	–	with	a	Cronbach	alpha	of	0.91	(Carleton	et	al,	2007a)	and	replicated	in	the	present	study	(Cronbach	alpha	0.89).		Two	subscales	have	been	proposed:	the	prospective	IU	which	is	described	as	the	desire	for	predictability	and	active	engagement	in	seeking	certainty,	and	the	inhibitory	IU	which	is	the	paralysis	of	 cognition	 and	 lack	of	 action	when	 faced	with	uncertainty	 (Birrell	 et	 al,	 2011),	however,	in	this	present	exploratory	study,	the	whole	scale	has	been	used.		
3.3 Statistical	Analyses	
	All	 analyses	were	 undertaken	 in	 IBM	 SPSS	 Statistics	 Version	 23.0.	 The	 PROCESS	plug-in	 for	SPSS	(Release	2.16.3)	was	used	 to	run	 the	mediation	and	moderation	analyses.			
3.4 Descriptive	statistics		
 Sample	size	
 As	this	is	a	pilot	trial,	aiming	to	assess	the	feasibility	of	a	full-size	RCT,	it	is	assumed	that	 the	 trial	 will	 not	 have	 sufficient	 power	 to	 formally	 test	 for	 efficacy	 of	 the	intervention	 (Eldridge,	 Chan,	 Campbell,	 Bond,	 Hopewell,	 Thabane,	 &	 Lancaster,	2016),	despite	exceeding	the	traditional	pilot	sample	size	of	n=30	(Browne,	1995).			
 Missing	data	analyses	
 To	 check	 for	 any	 systematic	 differences	 between	 the	 missing	 values	 and	 the	observed	values,	Little’s	test	of	Missing	Completely	at	Random	(MCAR,	Little,	1988)	was	undertaken	and	was	found	to	be	significant	for	the	entire	data	set	across	time	frames	(Chi-square=346.91,	DF=289,	p=0.011)	meaning	that	the	assumption	that	all	
	 51 
the	missingness	in	this	study	was	completely	at	random	cannot	be	supported.		It	is	likely	 that	 the	 participants’	 non-motor	 symptoms	 (e.g.	 depression,	 fatigue)	 may	have	contributed	to	non-completion	of	all	the	questionnaires	or	to	dropping-out	of	the	 trial.	However,	 after	 running	 t-tests,	 no	 significant	 (p<0.05)	 relationship	was	found	between	missingness	 in	 those	variables	with	 a	minimum	5%	missing,	 and	gender,	 ethnicity,	 marital	 status,	 years	 since	 diagnosis,	 baseline	 disability,	 or	baseline	 anxiety	 and	 depression.	 The	 reason	 for	 missingness	 may	 be	 related	 to	unobserved	participant	 characteristics	 (Missing	Not	 at	Random,	MNAR)	 or	more	probably	Missing	at	Random	(MAR)	where	the	presence	of	the	data	is	conditional	on	an	observed	patient	characteristic	(Tabachnik	&	Fidell,	2007).		The	results	of	any	of	the	analyses	should	therefore	be	interpreted	with	caution.		Some	data	were	missing	at	baseline:	participants	were	prompted	if	they	omitted	to		answer	any	of	 the	online	questionnaire	 items,	but	 they	were	not	prevented	 from	continuing	without	answering.		Two	items	in	the	Exposure	Questionnaire	at	T1	were	omitted	by	two	participants	(0.0006%	of	the	baseline	data	set).	In	the	full	data	set,	another	21	items	within	scales	were	missing.	Items	missing	within	questionnaires	can	be	assumed	to	be	MCAR,	as	the	participant	has	probably	skipped	forward.				Three	 participants	 (two	 of	 whom	 dropped	 out	 by	 T2)	 omitted	 some	 of	 the	questionnaires	at	baseline	which	totalled	2%	of	the	entire	baseline	data	set.		Over	the	four	measurement	occasions,	29.49%	of	cases	had	missing	values,	with	a	total	loss	of	13.76%	of	data	(see	Table	3).		
Table	3.		Missing	data		
Item	Level	 21	items		 0.07%	of	data	base	
Scale	Level	 4	entire	scales		 0.23%	of	data	base	
Time	Point	Level	 42	time	points		 13.46%	of	data	base		The	groups	differed	in	the	amount	of	total	missing	scales	(Table	4)	with	a	far	greater		number	of	people	in	the	intervention	group	missing	scales	or	whole	time	points	(6.6	times	greater	than	in	the	control	group).		
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	SPSS	defaults	to	using	listwise	deletion	where	there	is	missing	data,	which	reduces	the	number	of	participants’	observations	included	in	the	analyses	and	thus	reduces	the	 power	 of	 the	 study.	 Eliminating	 the	 cases	 that	 have	 missing	 data	 also	contravenes	the	intention-to-treat	principle	(White	and	Thompson,	2005).				
	Listwise	deletion	 is	 the	most	 inefficient	way	of	 conducting	analysis,	 especially	 in	small	 samples	with	 a	 large	percent	 of	missing	data	 (Rubin,	Witkiewitz,	Andre,	&	Reilly,	 2007).	 The	 popular	 missing-indicator	 method	 (using	 a	 dummy	 variable	where	 there	 is	 a	 missing	 value)	 is	 often	 used	 to	 comply	 with	 the	 principle	 of	intention-to-treat	but	has	been	shown	to	introduce	bias	even	if	the	missing	data	is	MCAR	(Donders,	van	der	Heijden,	Stijnen,	&	Moons,	2006).			The	last	observation	carried	forward	(LOCF)	method,	assumes	that	values	are	MCAR	–	when	 there	may	well	 be	 reasons	 for	 dropping	 out,	 such	 as	 disease	 severity	 or	cognitive	or	emotional	burden	and	it	has	been	shown	to	create	unnecessary	risk	of	bias,	 in	particular	with	trials	 involving	people	with	chronic	progressive	disorders	(Molnar,	Hutton,	&	Fergusson,	2008).				Maximum	Likelihood	(ML)	and	Multiple	Imputation	(MI)	are	preferred	methods	but	are	 unsuitable	 for	 small	 samples	 (ML)	 or	 too	 complex	 to	 be	 accessible	 to	 most	researchers	 (MI)	 (Rubin	 et	 al,	 2007),	 and	mean	 substitution	or	 regression-based	methods	are	recommended.			
Table	4.	Missing	scales	by	time	point	and	group	
Time	 Control	group		 MBI	group	
T1	 7	missing	 1	missing	
T2	 8	missing	 26	missing	
T3	 6	missing	 29	missing	
T4	 6	regained	 43	missing	
Total	missing	scales	 15	 99	
	 53 
In	the	present	study,	if	there	were	missing	values	at	item	level,	and	more	than	80%	of	 that	 scale	was	 complete,	 the	mean	of	 the	 completed	 items	was	 calculated	and	imputed	 for	 the	missing	 items.	 	Where	 less	 than	80%	of	 the	questionnaire	 items	were	completed,	or	entire	scales	or	time-points	were	missing,	no	data	imputation	was	made	(Allison,	2002).			
 Normality	and	outliers	
 Distribution	of	questionnaire	scores	were	examined	using	histograms,	normal	Q-Q	plots	and	by	the	Shapiro-Wilk	test	for	normality	(a	significant	value	(p<	or	equal	to	0.05)	 indicates	a	deviation	from	normality).	All	of	the	variables	were	found	to	be	acceptable	in	distribution.		Outliers	were	identified	by	box-plots,	then	the	cases	examined	in	the	data	set,	to	see	if	 the	 scores	 were	 within	 questionnaire	 ranges.	 The	 5%	 trimmed	 mean	 was	compared	to	the	mean,	and	lastly,	z	scores	were	calculated	to	see	if	any	were	over	3.29	 (Tabachnik	 &	 Fidell	 2006).	 	 Homogeneity	 of	 variance	 can	 be	 assumed	 as	Levene’s	test	was	not	significant	for	any	of	the	variables	at	any	of	the	time	points.		All	 of	 the	 outliers	 were	 retained,	 and	 no	 data	 trimming	 or	 transformation	 was	undertaken.	
	
 Intention-to-treat	analysis	
 This	 randomised	 pilot	 trial	 was	 conducted	 within	 an	 intention-to-treat	 (ITT)	approach,	 as	 recommended	 in	 the	 Consolidated	 Standards	 of	 Reporting	 Trials	(CONSORT)	guidelines,	whereby	every	participant	who	is	randomised	to	a	trial	arm	is	 included	 in	 the	 analyses,	 even	 when	 non-compliant,	 or	 if	 they	 contributed	incomplete	 data	 or	 dropped-out.	 	 By	 not	 excluding	 cases	 of	 non-compliance,	 the	estimated	treatment	effect	is	generally	more	conservative	but	also	more	reflective	of	real-life	clinical	delivery.		However,	because	the	statistical	analysis	of	this	study	examines	 data	 from	 an	 underpowered	 pilot	 trial,	 and	 is	 exploratory,	 those	participants	with	missing	data	have	been	lost.		A	future	fully-powered	randomised	controlled	 trial	 would	 be	 able	 to	 compensate	 for	 the	 inevitable	 missing	 data	 in	
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studies	involving	human	participants	with	chronic	diseases,	by	using	sophisticated	imputation	methods.		
 Significance	level	
 A	 minimum	 significance	 level	 of	 p<0.05	 was	 used.	 	 Significance	 levels	 in	 an	underpowered	 pilot	 study	 are	 not	 as	 interpretable	 as	 trends	 or	 effect	 sizes	 in	measuring	 differences	 between	 trial	 arm	 groups,	 and	 confidence	 intervals	 are	preferred	 in	 estimating	 effects	 (Eldridge	 et	 al,	 2016;	 Lee,	Whitehead,	 Jacques,	 &	Julious,	2014).		
 Comparison	between	trial	arms	at	baseline		
	Normally	 distributed	 continuous	 variables	 were	 examined	 with	 independent	samples	 t-tests,	 to	 assess	 baseline	 differences	 between	 the	 intervention	 and	 the	control	group	(see	Table	5).				
 Primary	outcome	variables	
 Anxiety	and	depression	levels	at	baseline	were	examined	for	differences	between	the	groups.	 	The	HADS	can	be	 interpreted	as	normal	at	≤7,	between	8	and	10	as	suggestive	 of	 a	 disorder,	 and	 11	 or	 higher	 (maximum	 21)	 as	 being	 probable	“caseness”	of	clinical	anxiety	or	depression	(Snaith,	2003).		Almost	three	quarters	of	the	 total	 sample	had	anxiety	 levels	below	11,	and	80.8%	of	 the	 total	 sample	had	levels	of	depression	below	the	level	of	caseness.			Because	 of	 the	 small	 number	 of	 participants	 falling	 into	 the	 severe	 range,	 the	intervention	and	control	groups’	distress	levels	were	compared	by	forming	two	sets	of	severity	levels	in	both	anxiety	and	depression.		Normal	and	mild	anxiety	levels	were	combined	to	form	“low	anxiety”	and	moderate	and	 severe	 levels	 combined	 to	 form	 “high	 anxiety”.	 A	 chi-square	 test	 for	independence	indicated	no	significant	association	between	the	groups	and	baseline	
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low	anxiety	levels	and	high	anxiety	levels	(c2(2,	n=78)	=1.025,	p=0.599;	Cramer’s	V=0.115	which	is	a	small	effect	(Appendix	B2).		Normal	and	mild,	and	moderate	and	severe	depression	levels	were	also	combined	in	the	same	way	to	form	“low	depression”	and	“high	depression”	levels.	A	chi-square	test	for	independence	showed	no	significant	association	between	the	groups	and	the	proportion	 of	 low	 and	 high	 levels	 of	 depression	 (c2(2,	 n=78)	 =1.632,	 p=0.442;	Cramer’s	V	=	0.145,	small	effect	(Appendix	B3).		
 Attendance		
 A	 hierarchical	 regression	 was	 used	 to	 assess	 if	 MBI	 participants’	 attendance	 at	sessions	(maximum	8)	was	predicted	by	baseline	disability,	and	by	baseline	anxiety	and	 depression.	 Preliminary	 analyses	 checked	 that	 assumptions	 of	 normality,	linearity,	 multicollinearity	 and	 homoscedasticity	 had	 not	 been	 violated,	 through	acceptable	Normal	P-P	Plots,	residuals	and	Tolerance	Values.		Baseline	disability	levels	(measured	by	PADLS,	Parkinson’s	Activities	of	Daily	Living	Scale	 (Hobson	 et	 al,	 2001),	 and	 mean	 baseline	 anxiety	 and	 depression	 scores	(measured	by	the	Hospital	Anxiety	and	Depression	Scale	(Zigmond	&	Snaith,	1983)	were	introduced	to	the	regression	at	stage	1	and	stage	2	respectively.								
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Table	5.	Demographics	and	clinical	characteristics	of	participants	
Variable	 Mindfulness	
(n=40	except	ethnicity	n=39)	
Waiting	list	
(n=38)	
Statistical	test	Stats,		 df	 p	 ES	Gender,	female	(n,	%)	 17(44%)	 22(56%)	 c2	=1.283		 (1,	n=78)	 p=.26	 f=-.15	Age,	in	years	(M,	SD)	 60.30(10.30)	 62.74(8.81)	 t	=1.12	 (76)	 p=.266	 h=.02	Living	status	–	with	spouse/partner	(n,	%)	 30(78.9)	 30(75)	 	 	 p=0.825a	 	Education,	College	or	higher	(n,	%)	 36(95)	 34(85)	 	 	 p=0.264a	 	Ethnicity,	White	(n,	%)	 38(97.4)	 37(97.4)	 	 	 p=1.00a	 	Years	since	diagnosis	(M,	SD)	 5.47(3.95)	 6.33(4.08)	 U=663,	z=-.97	 	 p=.333	 h=.11	Use	of	anti-anxiety/depression	medication	(Yes,	%)	 	12(30)	 	12(31)	 c2=.00	 (1,	n=78)			 p=1.0	 f=-.02	PADLS			disease	severity	(n,	%)										-		no	difficulties												-		mild	difficulties						-		moderate											-		high	level						-		extreme	
		6(15)	26(65)	6(15)	2(5)	0	
		5(13.2)	22(57)	9(23.7)	2(5.3)	0	
	 	 p=0.826a	 	
aFisher’s	exact	probability	test	as	the	expected	frequency	assumption	was	violated
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 Associations	between	outcome	measures,	putative	mediators	and	
moderators	
 Pearson	product-moment	correlation	analysis	was	undertaken	to	examine	if	there	were	 any	 patterns	 of	 association	 between	 the	 two	 outcome	 measures,	 the	 five	candidate	mediators	and	the	five	potential	moderating	variables,	at	each	of	the	four	time	points.		Analysis	of	the	whole	sample,	followed	by	analysis	of	the	two	groups,	were	 compared	 for	 any	 differences	 in	 associations	 which	 may	 indicate	 an	intervention	 effect.	 	 Correlations	 at	 each	 time	 point	 were	 then	 examined	 to	determine	any	change	over	time.		Standard	regression	analysis	of	the	potential	mediating	variables	as	predictors	of	anxiety	 and	 depression	 at	 baseline	 were	 conducted	 to	 examine	 what	 unique	variance	they	each	contributed	to	total	outcome	variance,	while	controlling	for	the	other	variables.				
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3.5 Inferential	statistics	
 
 Effect	of	time	
 Although	trial	effectiveness	is	not	a	main	aim	of	this	present	study,	examining	when	outcome	scores	 changed	over	 time	may	 indicate	which	processes	of	mindfulness	occur	before	others,	thus	establishing	mediation.	 	As	this	study	is	underpowered,	any	statistical	results	should	be	treated	with	caution.		A	2x4	mixed	ANOVA	was	 conducted	 to	 test	whether	 there	was	 a	main	 effect	 for	group	(the	between-subjects	factor,	MBI	or	WL)	or	main	effect	of	time	(the	within-subjects	factor,	T1,	T2,	T3,	T4).		This	also	examined	whether	time	interacts	with	trial	arm.		These	analyse	were	computed	twice,	once	for	anxiety	and	once	for	depression.				
 MEDIATION	Analysis	
	A	 mediator	 is	 a	 third,	 or	 intervening,	 variable	 in	 the	 causal	 chain	 between	 an	independent	variable	and	the	outcome.		As	 the	 main	 research	 aim	 of	 this	 study	 is	 to	 explore	 possible	 mediators	 and	mechanisms	of	change	in	levels	of	anxiety	and	depression	during	and	following	a	mindfulness	intervention,	exploratory	analyses	were	undertaken	to	examine	if	any	of	 the	 proposed	 mediating	 variables’	 indirect	 effects	 on	 the	 outcome	 could	 be	identified,	thus	suggesting	that	they	are	important	elements	in	the	causal	chain.				
 Background	to	mediation	analysis	
 Baron	 and	 Kenny’s	 seminal	 paper	 (1986;	 Kenny,	 1998)	 proposed	 four	 steps	 to	establish	 mediation,	 through	 a	 series	 of	 regressions:	 firstly,	 the	 effect	 of	 the		intervention	 variable	 on	 the	 outcome	 should	 be	 significant	 (X®Y),	 secondly,	 the	effect	of	the	intervention	variable	the	mediator	should	be	significant	(X®M),	thirdly,	when	 the	outcome	variable	 is	 regressed	on	 the	 intervention	variable	 (Y®X),	 the	significance	of	c’	is	reduced	when	the	effect	on	M	is	controlled	for	(Fourth	step)	(see	Figure	4)		
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However,	the	method	has	been	criticised	because	of	it	stipulates	that	there	must	be	evidence	of	a	statistically	significant	relationship	between	the	trial	arm	(X)	and	the	outcome	(Y),	between	X	and	the	putative	mediator	(M),	and	between	M	and	Y	when	X	is	controlled	for,	thus	ignoring	any	possible	suppression	effect	(where	the	direct	and	 indirect	 effects	 are	 opposite)	 (Elmsley,	 Dunn,	 &	 White,	 2010;	 Windgassen,		Goldsmith,	Moss-Morris,	&	Chalder,	2016)	or	un-modelled	interactions	which	may	compromise	the	direct	effect	(Hayes,	2009;	Fairchild	&	McDaniel,	2017)																		
																																																																						c					Further	criticisms	include	not	directly	measuring	pathway	b,	between	M	and	Y,	bias	from	not	including	confounding	variables,	and	lower	power	in	detecting	mediation	than	other	methods	(Hayes,	2009;	Preacher	&	Hayes,	2008).		The	traditional	Sobel	test	for	significance	is	less	powerful	and	assumes	normal	distribution,	while	ab	 is	usually	 not	 normally	 distributed	 (Hayes	 and	 Sharkow,	 2013),	 thus	 bootstrap	
Figure	4.	A	simple	mediation	model.	X	represents	the	independent	variable	 (trial	 arm),	 Y	 the	 dependent	 variable	 (anxiety,	 depression),	M	 the	mediator	variable	(e.g.	acceptance,	decentering,	self-compassion,	mindfulness	skills	and	intolerance	of	uncertainty).		c	represents	the	direct	effect	of	X	on	Y.		
c	represents	the	total	effect	of	X	on	Y	(a+b+c’).		
a b 
c’	
 
X	
M	
Y	
X	 Y	
 60 
confidence	intervals	which	support	a	claim	of	indirect	effect	if	it	does	not	straddle	0,	are	preferred.				Inferring	mediation	is	now	acknowledged	to	be	far	more	complex	than	the	Baron	&	Kenny	method	 (Bullock,	 Green,	&	Ha,	 2010),	 and	 examining	 all	 putative	 indirect	paths	 simultaneously	 is	 	 recommended	 rather	 than	 a	 series	 of	 simple	mediation	models,	when	theory	suggests	that	there	are	multiple	mediators,	to	maximise	the	correspondence	between	theory	and	the	mathematical	model,	and	to	compare	the	size	of	indirect	effects	through	different	mediators	(Hayes	&	Rockwood,	2017).		
 Mediation	analysis	using	Ordinary	Least	Squares	Regression	
 One	 of	 the	 preferred	 modern	 methods	 of	 analysing	 mechanisms	 of	 change	 is	PROCESS,	a	macro	developed	 for	use	with	SPSS	(Hayes,	2013).	 It	 is	a	conditional	process	 modelling	 programme	 that	 uses	 an	 ordinary	 least-squares-based	 path	analytical	framework.		PROCESS	conducts	a	series	of	multiple	regression	analyses	to	estimate	the	total	(the	relationship	of	X	to	Y,	c),	direct	(c’)	and	indirect	effect	(ab).		The	 indirect	 effect	 is	 the	 product	 of	 the	 path	 coefficient	 a	 (X®M)	 and	 the	 path	coefficient	b	(M®Y)	(Hayes,	2013)	(Figure	4).	Rejection	of	the	null	hypothesis	that	the	indirect	effect	is	zero	(or	the	confidence	intervals	don’t	include	zero)	supports	the	claim	that	there	is	a	mediation	effect	of	X	on	Y	through	M.		Significance	of	a	and	
b,	 or	 even	 c	 is	 not	 essential	 when	 inferring	 mediation	 -	 Hayes	 and	 Rockwood	recommend	that	inference	about	an	indirect	effect	of	X	on	Y	should	be	based	on	ab	rather	than	individual	paths.				Hayes	(2013)	also	recommends	that	unstandardised	variables	should	be	used,	and	that	centering	to	the	mean	is	not	required	if	the	aim	of	the	analysis	is	to	examine	mediation	and	not	compare	direct	effects.		
 
 Mediation	analyses	in	this	present	study	
 The	current	model	(Figure	5)	estimates	the	mindfulness	processes	that	may	mediate	the	relationship	between	the	trial	arm	(X)	and	levels	of	anxiety	and	depression	(Y).	Two	 separate	 analyses	 were	 undertaken	 for	 each	 outcome,	 using	 data	 from	 2	
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different	time	points.	The	effect	of	a	mindfulness	therapy	group	(MBI)	relative	to	a	wait	list	control	group	(WL)	on	anxiety	and	depression	levels,	at	both	end	of	therapy	(T3,	8	weeks),	and	at	20-week	follow-up	(T4).	Participants	were	randomly	assigned	to	MBI	or	WL,	coded	1	and	0	respectively,	in	a	variable	named	trial	arm	(X).	Putative	mediator	 variables	 were,	 M1:	 levels	 of	 decentering,	 M2:	 acceptance,	 M3:	 self-compassion,	M4:	mindfulness	skills,	and	M5:	intolerance	of	uncertainty,	selected	on	the	 basis	 of	 evidence	 of	 mediator	 roles	 in	 previous	mindfulness	 studies.	 Higher	scores	indicate	better	outcome	for	all	mediator	variables	except	for	intolerance	of	uncertainty,	 and	 for	 primary	 outcomes	 anxiety	 and	 depression	 levels,	 for	which	higher	scores	represented	greater	distress.	Baseline	measures	of	outcomes	(Y)	and	mediators	 (Ms)	were	also	 included	 in	 the	model	as	covariates	 to	control	 for	pre-existing	group	differences.		Bootstrap	 confidence	 intervals	 (bias-corrected)	 for	 the	 indirect	 effect	 were	constructed	in	PROCESS	by	randomly	resampling	10,000	cases	from	the	data	with	replacement,	 where	 n	 is	 the	 original	 sample	 size.	 Bootstrapping	 uses	 listwise	deletion	 (as	 does	 PROCESS)	 so	 missing	 data	 is	 not	 analysed.	 If	 the	 confidence	interval	straddles	zero,	the	claim	that	mediation	is	present	is	not	supported	(Shrout	&	Bolger,	2002).					
 Multiple	mediation		
Temporal	ordering	of	the	mediation	model	
 Mediator	variables	measured	at	4	weeks	(T2)	and	8	weeks	(T3)	were	examined	with	outcome	measures	taken	at	T3	and	T4	(20-week	follow-up)	in	order	to	explore	any	temporal	ordering,	thus	strengthening	any	chain	of	causality	claim,	and	to	compare	sizes	 of	 indirect	 effects	 of	 each	 mediator	 (Cole	 &	 Maxwell,	 2003;	 Kazdin,	 2007;	Windgassen	et	al,	2016).						
Power	
 Power	to	detect	mediation	and	moderation	effects	depends	on	the	effect	sizes	of	the	
a	and	b	parameters	in	the	model,	and	the	total	n,	however,	multiple	mediator	models	
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have	been	demonstrated	to	require	a	minimum	of	n=377	(Fritz	&	MacKinnon,	2007).		This	present	exploratory	study	of	an	underpowered	pilot	trial	cannot	confidently	detect	 any	mediation	 effect	 but	 can	 only	 highlight	 potential	 relationships	 among	variables	that	may	be	interesting	to	pursue	in	a	future	fully-powered	trial.						
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Figure	5.		Parallel	multiple	mediator	model,	showing	5	potential	mediators	(acceptance,	decentering,	self-compassion,	mindfulness	skills	and	intolerance	of	uncertainty	(M1	–	M5)),	direct	effect	c’,	indirect	effect	
a1b1	etc.,	total	effect	c.				
Covariates:	Baseline	(T1)	Acceptance,	Decentering,	Self-compassion,	Mindfulness,	Intolerance	of	Uncertainty,	Depression	and	Anxiety.	
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Procedure	for	mediation	analyses		
 Two	 separate	 parallel	 mediation	 analyses	 were	 undertaken	 for	 each	 outcome	variable.	 	 The	 first	 model	 estimated	 the	 indirect	 effect	 of	 the	 trial	 arm	 via	 the	mediator	 variables	 at	 T2	 on	 the	 outcome	 variables	 at	 T3,	 whilst	 controlling	 for	baseline	outcome	variable,	and	baseline	mediator	variables.	 	The	second	analysis	examined	mediator	variables	at	T3,	and	outcome	variables	at	T4,	again	controlling	for	 baseline.	 	 In	 both	 cases,	 time-lagging	 the	mediator	 variables	 to	 the	 outcome	variables	as	the	indirect	effect	should	occur	earlier	than	the	direct	effect	(Kazdin,	2007).			
Data	loss	
 The	analyses	using	PROCESS	eliminate	cases	with	missing	data	listwise,	and	in	this	present	study	there	was	a	loss	of	between	18-20	cases	out	of	a	total	of	78	(23-25%),	further	reducing	power.		
	
3.6 MODERATION	analysis	
	
 Methodological	rationale	
 The	strength	of	the	effect	of	the	trial	arm	on	anxiety	and	depression	levels	may	be	dependent	 on	 moderator	 variables,	 such	 as	 age,	 gender,	 baseline	 disability,	medication	 and	 time	 since	 diagnosis.	 The	 choice	 of	 moderating	 variables	 was	influenced	 by	 both	 previous	mindfulness	 literature	 (Kuyken	 et	 al,	 2010;	 Arch	 &	Ayers,	 2013;	 Nyklíček,	 van	 Son,	 Pop,	 Denollet,	 &	 Pouwer,	 2016;	 Bogosian	 et	 al,	2016),	and	exploratory	hypothesis,	that	people	with	a	deteriorating	disease	that	is	more	prevalent	with	age	and	that	has	 impact	on	cognitive	 functioning,	may	react	differently	according	to	their	age,	time	since	diagnosis	and	baseline	disability	levels.		To	explore	the	moderating	effects	 in	more	depth,	 the	Johnson-Neyman	technique	(Johnson	&	Neyman,	1936;	Hayes	&	Matthes,	2009)	defines	the	significant	regions	of	the	moderator	(only	if	non-dichotomous)	where	the	trial	arm	was	significantly	related	to	the	outcome,	for	instance,	certain	age	groups	may	respond	differently	to	
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the	 intervention	 (Hayes	&	Rockwood,	2017).	 	As	 an	 example,	mean	age	may	not	show	any	overall	amplification	or	weakening	effect	on	the	relationship	between	trial	arm	and	depression,	but	 there	may	be	differences	 in	how	younger	or	older	 ages	moderate	that	relationship.		
 Simple	moderation	
 In	 this	 study,	 a	 simple	moderator	model	 (PROCESS	 template	Model	 1,	 Figure	 6)	analysis	was	applied	to	see	if	the	strength	and	direction	of	the	relationships	of	trial	arm	to	levels	of	anxiety	and	depression	at	both	T3	and	T4,	were	dependent	on	age,	gender,	baseline	disability,	medication	and	time	since	diagnosis,	and	if	any	levels	of	these	moderators	were	significant.		Baseline	anxiety	and	depression	were	included	as	covariates.																Each	 possible	 moderator	 was	 entered	 in	 single	 analyses	 of	 the	 relationships	between	the	trial	arm	(control	or	MBI)	and	each	primary	outcome	measure	taken	at	T3	and	at	T4	(anxiety	or	depression).		Significant	 moderation	 is	 indicated	 by	 bias-corrected	 bootstrap	 confidence	intervals,	and	the	Johnson-Neyman	technique	identifies	the	regions	of	significance	in	the	moderator	variable.					
W 
X Y 
Figure	6.		Simple	moderation	model	-	W	represents	the	moderator	(i.e.	age),	X	 is	 the	 trial	 arm,	 and	 Y	 represents	 the	 outcome	 variable	 (anxiety	 or	depression	at	T3	and	T4).	
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 Moderated	mediation	
 The	 mediational	 mechanism	may	 be	 different	 for	 different	 subgroups	 who	 may	respond	to	aspects	of	mindfulness	in	different	ways,	for	instance,	age	may	moderate	how	well	a	person	develops	acceptance,	or	self-reported	baseline	disability	could	influence	 the	 strength	 of	 the	 relationship	 between	 the	 intervention	 and	 self-compassion.	Results	from	such	analyses,	may	lead	to	greater	understanding	of	the	barriers	to	therapeutic	change	in	subsets	of	people	with	PD.				Simple	models	 in	PROCESS	 (template	model	1)	analysed	any	moderation	by	age,	gender,	baseline	disability,	medication	and	time	since	diagnosis,	individually,	of	the	indirect	 effect	 –	 the	 relationships	 between	 trial	 arm	 and	 the	 putative	 mediator	variables	(T3	and	T4).														The	moderated	mediation,	 or	 conditional	 effect,	 of	X	 (trial	 arm)	on	 the	mediator	variable	 (either	 acceptance,	 decentering,	 self-compassion,	 mindfulness	 skills	 or	intolerance	of	uncertainty)	 is	 calculated	by	PROCESS;	again,	using	bias-corrected	bootstrap	confidence	intervals	(10,000,	95%)	to	support	the	effect,	and	with	regions	of	significance	identified	through	the	Johnson-Neyman	technique.	
	
	
	
a	
W	=	moderator	
X	Trial	
Arm	
Mediator		
Figure	7.	Moderated	mediation	model,	where	the	indirect	effect	of	X®M	(trial	arm	on	mediator	variable,	path	a)	moderated	by	(or	conditional	on)	another	variable	(W,	moderator	variable).	
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4 RESULTS	
 Ninety-seven	people	were	assessed	for	eligibility,	thirteen	of	whom	were	excluded	because	they	did	not	meet	the	inclusion	criteria,	and	six	who	dropped	out	before	or	during	baseline	measurement.		Therefore	78	participants	were	randomly	assigned	to	either	 the	mindfulness-based	 intervention	(MBI)	group	(n=40)	or	 the	wait-list	(WL)	control	group	(n=38)	(Figure	8).			
4.1 Missing	Data	
 Baseline	 questionnaires	 had	 been	 completed	 online	 before	 participants	 were	informed	of	which	group	they	had	been	randomised	to.	One	participant	in	the	MBI	group	 failed	 to	complete	 the	Philadelphia	Mindfulness	Scale	 (PHLMS)	at	baseline	and	 then	 dropped	 out	 of	 the	 trial,	 and	 one	 of	 the	WL	 group	 failed	 to	 complete	baseline	Acceptance	 and	Action	Questionnaire	 (AAQ),	 Experiences	Questionnaire	(decentering)	 (EQ),	 Philadelphia	 Mindfulness	 Scale	 (PHLMS),	 and	 Intolerance	 of	Uncertainty	 Scale	 (IUS),	 but	 completed	 measures	 at	 all	 three	 subsequent	 time	points.		Another	WL	participant	missed	baseline	PHLMS,	AAQ,	EQ	and	dropped	out	of	the	study.			Nine	participants	in	the	MBI	who	dropped	out	of	the	study	(22.5%)	gave	a	variety	of	reasons:	two	stated	that	they	had	too	many	work	commitments,	one	was	too	ill	to	begin	the	course	and	one	too	ill	to	continue,	one	had	a	bereavement	before	the	start	of	the	course,	one	declared	they	did	not	have	time,	another	that	they	did	not	 like	Skype	 and	 another	 that	 they	 did	 not	 like	 mindfulness	 after	 taking	 part	 in	 two	sessions.		A	further	participant	did	not	state	a	reason	for	dropping-out	after	three	sessions.	In	the	present	study	it	can	be	shown	that	despite	dropping	out	from	the	intervention,	participants	were	encouraged	to	complete	the	outcome	and	process	questionnaires	within	their	treatment	arm,	and	55%	of	the	MBI	group	who	dropped	out	contributed	data	to	at	least	two	of	the	four	time	points.	In	particular,	two	of	the	participants	who	did	drop	out	completed	the	mid-course	(4	weeks)	questionnaires,	two	participants	were	able	to	complete	the	measures	on	three	occasions	and	one	on	all	four.		Their	data	therefore	was	included	in	the	analyses.	
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 Missingness	
	T	tests	were	run	to	see	if	missingness	in	any	of	the	variables	with	more	than	5%	missing	values	was	related	to	gender,	ethnicity,	marital	status,	years	since	diagnosis,	medication	or	baseline	disability.		No	significant	relationships	were	found.	As	shown	in	Table	1,	both	groups	were	well-matched	 in	 terms	of	demographic	and	disease	severity	characteristics.			
	
6.1.2	Attendance		Out	of	the	27	MBI	participants	who	attended	more	than	50%	of	the	eight	sessions,	33%	attended	all	sessions	and	another	26%	attended	7	sessions	(Table	6).		
Table	6.	Participants’	attendance	at	MBI	sessions	
	
	MBI	participants	(total	n=40)	 	 %	of	
total	n	
Drop-
outs	No	of	MBI	participants	attending	8	sessions	 9	 22.50	 -	No	of	MBI	participants	attending	7	sessions	 7	 17.50	 -	No	of	MBI	participants	attending	6	sessions	 8	 20	 -	No	of	MBI	participants	attending	5	sessions	 2	 5	 -	No	of	MBI	participants	attending	4	sessions	 3	 7.5	 -	No.	of	MBI	participants	attending	3	sessions	 3	 7.5	 2	No.	of	MBI	participants	attending	2	sessions	 4	 10	 3	No.	of	MBI	participants	attending	1	session	 1	 2.5	 1	No.	of	MBI	participants	attending	0	sessions	 3	 7.5	 3		
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Figure 8. CONSORT flowchart of MindPD trial 
 
 
 
 
 
 
 
	
 
 
 
 
 
 
 
 
 
 
 
 
 
 
5 	 	 	
	 	
 
 
 
 
 
 
 
 						P				 		PHLMS:	Philadelphia	Mindfulness	Scale;	IUS:	Intolerance	of	Uncertainty;	AAQ	II:	Acceptance-Action	Questionnaire;	EQ:	Experiences	Questionnaire	(decentering);		SCS:	Self-Compassion	Scale.
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6.1.3	Self-reported	levels	of	disability,	baseline	anxiety	and	depression,	and	
attendance	at	MBI	sessions		To	determine	if	the	number	of	sessions	attended	could	be	predicted	by	the	level	of	participant	 self-report	 disability,	 a	 hierarchical	 regression	 analysis	 of	 baseline	disability	levels	(Stage	1)),	and	mean	baseline	anxiety	and	depression	scores	(Stage	2)	on	number	of	sessions	attended	was	undertaken	(see	Table	7).		There	was	a	negative	relationship	between	the	level	of	disability	at	baseline	(higher	score	in	disability	equalling	worse	status)	and	the	number	of	sessions	attended	by	MBI	participants	(F(1,38)=4.85,	p=0.03),	but	there	was	no	significant	relationship	(F(3,36)=1.79,	p=0.167)	between	mood	levels	and	number	of	sessions	attended.						
	
Table	7.	Linear	model	of	predictors	of	number	of	sessions		
	 b	(CI,	SE)	 SE	B	 b	 p	
Step	1	 	 	 	 	
				Constant	 7.54	 0.95	 	 <0.001	
	 (5.71,	8.93)	 	 	 	
				
			PADLS*	
	-1.15	 	0.44	 	-.336	 	0.034	
	 (-1.93,	0.02)	 	 	 	
Step	2	 	 	 	 	
				Constant	 7.65	 1.06	 	 <0.001	
	 (5.59,	9.00)	 	 	 	
			
		PADLS	
	-1.25	 	0.59	 	-.336	 	0.049	
	 (-2.54,	0.06)	 	 	 	
				
		Baseline	Anxiety	
	-0.53	 	0.71	 	-.129	 	0.45	
	 (-1.99,	1.31)	 	 	 	
			
		Baseline	Depression	
	0.74	 	1.0	 	.156	 	0.45	
	 (-1.30,	2.74)	 	 	 	Note.	R2=0.13	for	Step	1(p=0.03);	D	R2=	(p=0.016)	Step	2(p=0.715)	*PADLS=Parkinson’s	Disease	Activities	of	Daily	Living	Scale	(Hobson	et	al,	2001)	95%	bias	corrected	and	accelerated	confidence	intervals	reported	in	parentheses.		Confidence	intervals	and	standard	errors	based	on	10,000	bootstrap	samples				
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 Change	in	outcomes	and	putative	mediators	
 Descriptive	statistics	for	the	primary	outcomes	and	for	the	candidate	mediators	at	all	 four	 time	 points	 are	 reported	 in	 Table	 8.	 Independent	 samples	 t-tests	 were	conducted	to	compare	the	baseline	primary	outcome	and	baseline	putative	mediator	scores	for	both	groups.		There	were	no	significant	differences	 in	baseline	variables:	 the	magnitude	of	 the	differences	in	the	means	were	very	small,	apart	from	baseline	depression	scores	that	were	higher	for	the	mindfulness	group	(h2=0.2,	Cohen’s	d=-0.25,	small	effect),	and	self-compassion	 scores	 that	were	higher	 for	 the	 control	 group	 (h2=0.01,	 Cohen’s	d=0.22,	small	effect).				All	confidence	intervals	(95%)	for	the	mean	differences	straddled	zero,	except	for	the	 mean	 differences	 in	 decentering	 at	 post-intervention	 and	 follow-up,	 and	 in	mindfulness	 skills	 at	 post-intervention,	 indicating	 confidence	 in	 the	 differences	between	these	two	constructs	at	these	time	points.			To	 examine	 for	 temporal	 ordering	 of	 any	 change,	 the	 means	 of	 	 the	 primary	outcomes		(anxiety	and	depression)	and	of	the	five	putative	mediators	(acceptance,	decentering,	 self-compassion,	mindfulness	 skills,	 and	 intolerance	 of	 uncertainty)	were	plotted	over	the	four	time	periods	to	examine	if	any	of	the	mediators	showed	change	 before	 the	 primary	 outcomes,	 indicating	 an	 indirect	 effect.	 	 Visual	examination	of	graphs	showing	change	over	the	four	time	points	(see	Figures	9	and	10)	suggested	T3	to	be	the	point	of	greatest	difference	between	the	trial	arms	in	all	the	putative	mediators	and	depression	scores,	whilst	the	other	dependent	variable,	anxiety,	 continued	 to	diverge	at	T4.	The	moderator	variables	 showed	changes	 in	positive	directions	in	the	MBI	group,	from	baseline	to	T3,	but	little	change	from	T3	to	follow-up	(T4).		
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Table	8:	descriptive	statistics	for	primary	
outcomes	and	putative	mediators	
	
	
	 Control	 Mindfulness	 	 	 	n	 mean	 SD	 n	 mean	 SD	 Mean	difference	 Confidence	Intervals	 Effect	Size	Cohen’s	d	
Statistical	test	
Anxiety	 	baseline	 						38	 	1.15	 	0.54	 	40	 	1.19	 	0.60	 	0.04	 	-.299,	.214	 	-0.07	 	t	(76)=-.33,	p=0.742,	
h2=.001		 mid-intervention	 36	 0.99	 0.60	 37	 0.95	 0.62	 -0.04	 -.246,	.315	 -0.06	 	post-intervention	 36	 0.93	 0.58	 32	 0.89	 0.49	 -0.04	 -.227,	.299	 -0.07	 	follow-up	 36	 0.99	 0.59	 26	 0.83	 0.51	 -0.15	 -.130,	.447	 -0.29	 	
Depression	 	baseline	 	38	 	0.85	 	0.46	 	40	 	0.98	 	0.51	 	0.13	 	-.346,	.092	 	0.25	 	t	(76)=-1.16,	p=.252,	
h2=.02		 mid-intervention	 36	 0.87	 0.50	 37	 0.87	 0.55	 0	 -.249,	.245	 	0	 	post-intervention	 36	 0.86	 0.51	 32	 0.73	 0.42	 -.013	 -.096,	.358	 -0.28	 	follow-up	 36	 0.91	 0.50	 26	 0.84	 0.53	 -0.07	 -.196,	.333	 -0.15	 		
Acceptance	
	baseline	 	36	 	4.78	 	0.94	 	40	 	4.82	 	1.14	 	0.04		 	-.527,	.437	 	0.04	 	t	(74)=.186,	p=.853,	h2=0.001		 mid-intervention	 36	 4.83	 1.01	 36	 5.11	 0.95	 0.28	 -.747,	.174	 0.27	 	post-intervention	 35	 4.98	 0.96	 32	 5.28	 0.82	 0.30	 -.744,	.135	 0.34	 	follow-up	 36	 4.86	 1.05	 26	 5.25	 0.81	 0.39	 -.881,	.101	 0.42	 	
Decentering	 	Baseline	 	36	 	2.96	 	0.46	 	40	 	2.96	 	0.51	 	0		 	-.224,	.221	 		0	 	t	(74)=-.12,	p=.991,	h2=0.0001		 mid-intervention	 36	 3.12	 0.39	 36	 3.26	 0.42	 0.13	 -.334,	.047	 0.36	 	post-intervention	follow-up	 35		36	 3.10		3.09	 0.43		0.35	 32		26	 3.34		3.29	 0.33		0.43	 0.24		0.20	 -.440,	-.059		-.405,	-.006	 0.65		0.54	 	
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Self-
compassion	
	Baseline	 	 38	 	3.25	 	0.85	 	40	 	3.08	 	0.73	 	-0.17	 	-.185,	.527	 				-0.22	 	t	(76)=.955,	p=.343,	
h2=0.01		 mid-intervention	 36	 3.35	 0.89	 36	 3.44	 0.77	 	0.09	 -.487,	.297	 0.12	 	post-intervention	 35	 3.39	 0.80	 32	 3.49	 0.68	 0.10	 -.603,	.278	 0.32	 	follow-up	 36	 3.31	 0.92	 26	 3.47	 0.76	 0.16	 -.603,	.278	 0.40	 	
Mindfulness	
	skills	
	Baseline	 	36	 	3.24	 	0.38	 	39	 	3.17	 	0.32	 	-0.07	 	-.095,	.227	 	-0.19	 	t	(73)=0.817,	p.416,	
h2=0.007		 mid-intervention	 36	 3.29	 0.42	 35	 3.28	 0.34	 -0.01	 -.174,	.186	 -0.02	 	post-intervention	 35	 3.20	 0.40	 32	 3.40	 0.39	 							0.20	 -.390,	-.006	 	0.51	 	follow-up	 36	 3.23	 0.42	 26	 3.37	 0.42	 								0.14	 -.362,	.069	 	0.36	 	
Intolerance	
of	
uncertainty	
	Baseline	 	37	 	2.29	 	0.73	 	40	 	2.44	 	0.93	 		0.15	 	-.501,	.207	 		0.18	 	t	(75)=-.828,	p=.411,	
h2=0.009		 mid-intervention	 36	 2.11	 0.73	 36	 2.20	 0.68	 	0.09	 -.418,	.242	 	0.13	 	post-intervention	 35	 2.08	 0.65	 32	 2.04	 0.52	 -0.04	 -.250,	.329	 	-0.06	 	follow-up	 36	 2.12	 0.69	 25	 2.12	 0.50	 0	 -.321,	.324	 			0	 	
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 Effect	sizes			At	 T2,	 mid-point	 of	 the	 intervention,	 only	 acceptance	 (d=.27)	 and	 decentering	(d=.36)	 had	 small	 effect	 sizes	 (Cohen,	 1988),	 indicating	 that	 these	 potential	mediators	 were	 showing	 changes	 before	 the	 outcome	 measures	 of	 anxiety	 and	depression,	 suggesting	 an	 indirect	 effect.	 	 At	 T3,	 the	 end	 of	 the	 intervention,	depression	showed	a	small	effect	size	(d=-.28)	as	did	acceptance	(d=.34)	and	self-compassion	 (d=.32),	 but	 not	 anxiety.	 	 Moderate	 effect	 sizes	 were	 shown	 in	decentering	(d=.65)	and	mindfulness	skills	(d=.51).		Only	decentering	continued	to	have	 a	 moderate	 effect	 (d=.54)	 at	 follow-up,	 while	 anxiety	 (d=-.29),	 acceptance	(d=.42),	self-compassion	(d=.40)	and	mindfulness	skills	(d=.36)	were	all	in	the	small	effect	range.	Intolerance	of	uncertainty	had	no	reportable	effects	(d>.20)	at	any	of	the	time	points.		
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Figure	9.	Mean	primary	outcomes	and	mediators	over	four	time	points.		
 
(a)	
 
	
	
(b)	
                                     		T1:	Baseline;	T2:	4	weeks,	mid-intervention;  T3:	8	weeks,	end	of	intervention;	T4:	20	weeks, follow-up.	(a)	Hospital	Anxiety	and	Depression	Scale	(HADS)	anxiety	and	(b)	HADS	depression	(range	0-21,	normal	range	0-7).		Mean	mediator	scores	over	four	time	points(	(c)	acceptance,	(d)	decentering,	(e)	self-compassion,	(f)	mindfulness	skills,	(g)	intolerance	of	uncertainty.		
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(c)	Acceptance-Action	Questionnaire	II:	7-70.	
(d)	Experiences	Questionnaire:	20-100.	
(e)	Self-compassion	Scale:	range	12-60.	
(f)	Philadelphia	Mindfulness	Scale:	20-100	
(g)	Intolerance	of	Uncertainty	Scale	–	Short	Form:	12-60	
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5.2 CORRELATION	ANALYSES	
 
 Total	sample	
 To	 examine	 associations	 between	 the	 variables,	 bivariate	 correlations	 were	calculated	 between	 all	 the	 outcome	 measures	 (anxiety	 and	 depression),	 the	candidate	mediators	(acceptance,	decentering,	self-compassion,	mindfulness	skills	and	 intolerance	 of	 uncertainty)	 and	 the	 five	 potential	moderator	 variables	 (age,	gender,	years	since	diagnosis,	mood	medication	and	self-report	disability)	on	the	full	sample,	at	each	of	the	four	time	points	(see	Tables	9	(T1	and	T2)	and	10	(T3	and	T4)).				Correlation	 strength	 between	 variables	was	 interpreted	 as	 small	 if	 r	=.10	 to	 .29,	medium	if	r	=.30	to	.49,	and	large	if	r=.50	to	1.00	(Cohen,	1988;	Cohen,	1992).		These	relate	to	R2	values	of	1%	to	8%,	9%	to	24%,	25%	to	100%	of	variance	explained	and	are	colour-coded	 in	 the	 tables	 (9	 and	10	 for	 total	 sample	 correlations,	 and	 for	 trial	 arm	correlations	in	Appendix	B4,	5,	6	and	7	as	small,	medium,	and	large.		Anxiety	and	depression	scores	were	positively	and	strongly	correlated	with	each	other	 at	 each	 of	 the	 four	 time	 points,	 and	 at	 strong	 to	 medium	 strength	 with	intolerance	 of	 uncertainty;	 strongly	 and	 negatively	 with	 acceptance;	 medium	strength	 and	 negatively	 with	 decentering	 and	 strongly	 with	 self-compassion.	Anxiety	 was	 positively	 and	 moderately	 correlated	 with	 self-reported	 baseline	disability	levels,	at	T1,	T2	and	T3,	but	not	at	T4.		Mindfulness	 skills	 were	 only	 negatively	 and	 of	 medium	 strength	 related	 with	depression		at	T1.	At	T2,	mindfulness	skills’	correlation	strength	was	medium	with	acceptance,	 decentering,	 self-compassion	 and	 strong	 with	 intolerance	 of	uncertainty.	 	At	T3,	 correlations	were	medium	with	depression,	 acceptance,	 self-compassion	and	 intolerance	of	uncertainty,	while	 strong	with	decentering.	At	T4	mindfulness	 skills	 correlated	 in	 the	 medium	 strength	 range	 with	 all	 the	 other	mediators	and	with	anxiety	and	was	strongly	correlated	to	depression.		
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Intolerance	of	uncertainty	 strongly	correlated	 to	anxiety,	depression,	acceptance,	decentering	and	self-compassion	at		T1,	with	only	small	strength	correlation	with	mindfulness	skills.		However,	at	every	time	point	the	strength	of	the	relationships	between	 intolerance	 of	 uncertainty	 and	 	 anxiety,	 depression,	 and	 the	 other	mediators	 (except	with	mindfulness	 skills,	which	 strengthened)	 became	weaker,	until	 at	 T4	 only	 acceptance	was	 strongly	 correlated	with	 all	 others	 being	 in	 the	medium	range.	There	was	a	medium	strength	relationship	between	intolerance	of	uncertainty	and	baseline	levels	of	disability	at	all	time	points.			Gender	did	not	correlate	at	medium	or	strong	strength	with	any	variable	except	with	anxiety	 at	 T3.	 Age	 of	 participant	 had	 a	 medium	 strength	 association	 only	 with	anxiety	and	self-compassion	at	T2.				Years	since	diagnosis	was	only	correlated	with	medium	strength	with	depression.	Mood	medication	 correlated	 at	medium	 strength	 only	with	 levels	 of	 depression,	mindfulness	skills	and	years	since	diagnosis	at	T4.			Self-reported	 disability	 at	 baseline,	 measured	 by	 the	 PADLS,	 was	 strongly	 and	positively	 correlated	 with	 years	 since	 diagnosis.	 	 At	 T1,	 self-reported	 disability	correlated	 strongly	 with	 depression,	 and	 at	medium	 strength	with	 anxiety,	 self-compassion,	 and	 intolerance	 of	 uncertainty.	 	 At	 T2	 and	 T3	 acceptance,	 self-compassion	 and	 intolerance	 of	 uncertainty	 remained	 in	 the	medium	 range,	with	anxiety	and	mood	medication	at	T3.		At	T4	depression	was	in	the	medium	range,	and	anxiety,	acceptance	and	decentering	only	in	the	small	effect	range.		
 Correlations	within	trial	arm	groups	
 Correlations	were	also	calculated	for	each	trial	arm,	to	examine	if	any	of	the	patterns	shown	in	the	total	sample	correlations	differed	between	the	groups	(Appendix	B4,	5,	6	and	7).			At	 T3,	 the	 completion	 of	 the	 8-week	 course,	 the	 intervention	 group’s	 levels	 of	anxiety	 and	 depression,	 were	 no	 longer	 strongly	 correlated	 with	 levels	 of	
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acceptance,	 decentering	 and	 self-compassion	 in	 contrast	 to	 the	wait	 list	 group’s	correlations.	At	T4,	12	weeks	later,	the	strength	of	correlation	between	anxiety	and	depression	 and	 the	 mediator	 variables	 in	 the	 MBI	 group	 had	 returned	 to	medium/strong.			Mindfulness	 skills	 in	 the	MBI	 group	were	 significantly	 correlated	 to	 anxiety	 and	depression	 by	 T4	 but	 not	 in	 the	wait	 list	 control	 group.	Mindfulness	 skills	were	strongly	associated	with	acceptance,	decentering	and	self-compassion	at	T2	and	T4	in	the	MBI	group,	but	not	in	the	waiting	list	group,	(at	T3	both	groups	showed	strong	correlations	between	mindfulness	skills	and	decentering).			Self-reported	disability	at	baseline	was	strongly	correlated	with	depression	scores	at	T4	 for	 the	MBI	group	 	but	only	correlated	at	medium	strength	 for	 the	waitlist	group.			
5.2.2.1 Multicollinearity	
 The	inter-correlation	between	the	putative	mediators	and	the	outcome	variables	was	not	excessively	high	(r>.90),	Tolerance	values	and	Variance	inflation	factors	were	at	acceptable	levels,	so	multicollinearity	can	be	discounted	. 		
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Table	9	-	Bivariate	correlations	–	associations	between	outcomes,	putative	mediators	and	possible	moderators	-		
Whole	sample	–	T1	 1	 2	 3	 4	 5	 6	 7	 8	 9	 10	 11	 12	1.			Anxiety		 (.83)	 34%	 49%	 27%	 35%	 4% 40% 1% 6% <1% <1% 12% 2.			Depression	 .58**	 (.76)	 26%	 16%	 33%	 11%	 29% 2% <1% 8% 6% 30% 3.			Acceptance	 -.70**	 -.51**	 (.90)	 58%	 53%	 8%	 44%	 <1%	 4%	 <1%	 <1%	 7%	4.			Decentering	 -.52**	 -.40**	 .76**	 (.85)	 52%	 5%	 38%	 <1%	 4%	 <1%	 <1%	 4%	5				Self-compassion	 -.59**	 -.57**	 .73**	 .72**	 (.89)	 4%	 36%	 <1%	 7%	 <1%	 <1%	 10%	6.			Mindfulness	Skills	 -.19	 -.33**	 .28*	 .23*	 .20	 (.61)	 4%	 2%	 <1%	 1%	 <1%	 <1%	7.			Intol.	of	Uncertainty	 .63**	 .54**	 -.66**	 -.62*	 -.60**	 -.21	 (.89)	 1%	 3%	 3%	 <1%	 22%	8.			Gender	 .11	 -.14	 .08	 -.06	 .04	 .14	 .12	 -	 3%	 5%	 5%	 <1%	9.			Age	 -.24*	 -.05	 .21	 .19	 .26*	 -.003	 -.18	 .16	 -	 6%	 <1%	 <1%	10.	Years	since	diagnosis	 .03	 .29*	 .007	 -.03	 .05	 .11	 .17	 .22*	 .25*	 -	 4%	 31%	11.	Mood	medication	 .07	 .25*	 -.04	 .01	 -.06	 .05	 -.04	 -.22	 .09	 .20	 -	 6%	12.	Self-report	disability	 .35**	 .55**	 -.26*	 -.21	 -.32**	 -.06	 .47**	 .04	 .04	 .56**	 .24*	 	
																																						n=	 78	 78	 76	 76	 78	 75	 77	 78	 78	 78	 78	 	
Whole	sample	–	T2	 1	 2	 3	 4	 5	 6	 7	 8	 9	 10	 11	 12	1.			Anxiety		 (.81)	 46%	 35%	 23%	 35%	 2% 30% 5% 9% 4% 3% 2% 2.			Depression	 .68**	 (.86)	 33%	 26%	 35%	 4%	 22% 5% 3% 16% 7% 49% 3.			Acceptance	 -.59**	 -.57**	 (.89)	 52%	 56%	 20%	 36%	 1%	 2%	 2%	 3%	 13%	4.			Decentering	 -.48**	 -.51**	 .72**	 (.78)	 56%	 19%	 24%	 3%	 5%	 <1%	 <1%	 6%	5				Self-compassion	 -.59**	 -.59**	 .75*	 .75**	 (.90)	 12%	 27%	 <1%	 10%	 1%	 <1%	 16%	6.			Mindfulness	Skills	 -.13	 -.19	 .45*	 .43**	 .34**	 (.69)	 6%	 1%	 <1%	 <1%	 2%	 <1%	7.			Intol.	of	Uncertainty	 .55**	 .47**	 -.60**	 -.49**	 -.52**	 -.25*	 (.89)	 1%	 1%	 4%	 1%	 13%	8.			Gender	 .23	 -.04	 -.10	 -.17	 -.03	 .12	 .10	 -	 3%	 5%	 5%	 <1%	9.			Age	 -.30**	 -.17	 .14	 .22	 .31**	 .08	 -.12	 .16	 -	 6%	 <1%	 <1%	10.	Years	since	diagnosis	 .19	 -.34**	 -.14	 -.07	 -.12	 -.003	 .21	 .22*	 .25*	 -	 4%	 31%	11.	Mood	medication	 .17	 .26*	 -.16	 .04	 -.08	 -.13	 .10	 -.22	 .09	 .20	 -	 6%	12.	Self-report	disability	 .44**	 .67**	 -.36**	 -.24*	 -.40**	 -.05	 .36**	 .04	 .04	 .56**	 .24*	 	
n=	 73	 73	 72	 72	 72	 71	 72	 78	 78	 78	 78	 	**	Correlation	is	significant	at	the	0.01	level	(2-tailed).		*	Correlation	is	significant	at	the	0.05	level	(2-tailed).		Note:	Cronbach	alphas	are	provided	in	parentheses	on	the	diagonal.	R2	reported	as	a	percentage,	indicating	variance	explained. R2	values	of	1%	to	8%:	small;	9%	to	24%:	medium;	25%	to	100%:	large	
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Table	10	-	Bivariate	correlations	
Whole	sample	–	T3	 1	 2	 3	 4	 5	 6	 7	 8	 9	 10	 11	 12	1.					Anxiety		 (.75)	 27%	 14%	 17%	 15%	 7%	 20%	 13%	 2%	 <1%	 <1%	 13%	2. Depression	 .52**	 (.85)	 21%	 19%	 26%	 13%	 24%	 <1%	 <1%	 8%	 6%	 37%	3. Acceptance	 -.38**	 -.46**	 (.88)	 53%	 49%	 24%	 31%	 <1%	 3%	 <1%	 <1%	 10%	4. Decentering	 -.41**	 -.43**	 .73**	 (.79)	 48%	 35%	 25%	 1%	 <1%	 4%	 1%	 13%	5.				Self-compassion	 -.39**	 -.51**	 .70**	 .69**	 (.87)	 14%	 21%	 <1%	 3%	 <1%	 <1%	 16%	6.				Mindfulness	Skills	 -.27*	 -.36**	 .49**	 .59**	 .38**	 (.74)	 12%	 <1%	 <1%	 <1%	 4%	 4%	7. Intol.	of	Uncertainty	 .45**	 .49**	 -.56**	 -.50**	 -.46**	 -.35**	 (.86)	 <1%	 <1%	 5%	 <1%	 19%	8. Gender	 .36**	 .07	 .04	 -.1	 -.03	 .04	 .03	 -	 3%	 5%	 5%	 <1%	9. Age		 -.13	 .02	 .18	 -.09	 .17	 -.07	 -.07	 .16	 -	 6%	 <1%	 <1%	10. Years	since	diagnosis		 .10	 .28*	 -.07	 -.19	 -.09	 -.06	 .22	 .22*	 .25*	 -	 4%	 31%	11. Mood	medication		 .08	 .25*	 .03	 -.10	 -.06	 -.20	 .06	 -.22	 .09	 .20	 -	 6%	12. Self-report	disability		 .36**	 .61**	 -.32**	 -.36**	 -.40**	 -.19	 .43**	 .04	 .04	 .56**	 .24*	 	
n=	 68	 68	 67	 67	 67	 67	 67	 78	 78	 78	 78	 	
Whole	sample	–	T4	 1	 2	 3	 4	 5	 6	 7	 8	 9	 10	 11	 12	1.				Anxiety	 (.80)	 44%	 24%	 20%	 35%	 14%	 14%	 8%	 2%	 <1%	 7%	 5%	2. Depression	 .66**	 (.85)	 14%	 21%	 20%	 35%	 14%	 2%	 <1%	 6%	 11%	 18%	3. Acceptance	 -.49**	 -.37**	 (.91)	 44%	 45%	 17%	 42%	 <1%	 2%	 <1%	 1%	 7%	4. Decentering	 -.45**	 -.46**	 .66**	 (.79)	 45%	 17%	 18%	 <1%	 <1%	 2%	 4%	 7%	5.				Self-compassion	 -.59**	 -.63**	 .67**	 .67**	 (.92)	 14%	 22%	 <1%	 3%	 <1%	 4%	 14%	6. Mindfulness	Skills	 -.37**	 -.30**	 .41**	 .41**	 .37**	 (0.77)	 9%	 <1%	 <1%	 <1%	 8%	 <1%	7. Intol.	of	Uncertainty	 .38**	 .35**	 -.65**	 -.42**	 -.47**	 -.30*	 (.85)	 <1%	 <1%	 2%	 3%	 18%	8. Gender	 .28*	 .14	 .06	 -.09	 -.09	 .07	 -.02	 -	 3%	 5%	 5%	 <1%	9. Age	 -.14	 .03	 .14	 .05	 .17	 -.02	 .03	 .16	 -	 6%	 <1%	 <1%	10. Years	since	diagnosis	 -.002	 .24	 .04	 -.19	 -.09	 .05	 .14	 .22*	 .25*	 -	 4%	 31%	11. Mood	medication	 .16	 .33**	 -.11	 -.21	 -.20	 -.29*	 .16	 -.22	 .09	 .20	 -	 6%	12. Self-report	disability	 .22	 .42**	 -.26*	 -.27*	 -.38**	 -.07	 .42**	 .04	 .04	 .56**	 .24*	 	
n=	 62	 62	 62	 62	 62	 62	 61	 78	 78	 78	 78	 	**	Correlation	is	significant	at	the	0.01	level	(2-tailed).		*	Correlation	is	significant	at	the	0.05	level	(2-tailed).	Note:	Cronbach	alphas	are	provided	in	parentheses	on	the	diagonal.	R2	reported	as	a	percentage,	indicating	variance	explained.	R2	values	of	1%	to	8%:	small;	9%	to	24%:	medium;	25%	to	100%:	large.	
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 Contribution	of	putative	mediators	to	variability	in	baseline	primary	
outcome	measures	
 Standard	 multiple	 regressions	 were	 used	 to	 assess	 the	 ability	 of	 the	 mediator	variables	 and	 the	 dependent	 variables	 to	 predict	 levels	 of	 anxiety	 and	 levels	 of	depression	at	baseline	and	to	examine	what	unique	variance	is	contributed	by	each	of	these	predictor	variables	to	the	total	variance	of	anxiety	and	depression	levels.			
Anxiety	
 This	model	explains	55%	of	the	variance	in	levels	of	anxiety	at	baseline	(adjusted	R2=.55);	acceptance	made	the	most	significant	unique	contribution	to	the	prediction	of	anxiety	after	controlling	for	the	variance	explained	by	all	the	other	variables	in	the	 model	 (b	 =	 -.49,	 p=.001,	 semi-partial	 correlation	 co-efficient=-.271	 giving	 a	unique	contribution	by	acceptance	of	7.6%),	followed	by	depression	scores	(b	=.27,	
p=.012,	semi-partial	correlation	co-efficient=.199,	giving	a	unique	contribution	by	depression	 of	 3%).	 	 None	 of	 the	 other	 mediator	 variables’	 contributions	 were	significant	(see	Table	11).	
	
Table	11.	Linear	model	of	predictors	of	anxiety	levels	at	Baseline		
	 b	
[LLCI,	ULCI]	
SE	B	 b	 p	
Constant	 1.19	[-.13,	2.51]	 .66	 	 .076	
M	Depression	T1	 .32	
[.04,	.56]	
.12	 .25	 .022	
M	Acceptance	T1	 -.26	
[-.42,	-.13]	
.07	 -.49	 .001	M	Decentering	T1	 .11	[-.23,	.47]	 .18	 .10	 .465	M	Self-compassion	T1	 -.03	[-.23,	.18]	 .11	 .05	 .738	M	Mindfulness	skills	T1	 .11	[-.15,	.37]	 .13	 .06	 .466	M	Intol.	of	uncertainty	T1	 .16	[-.001,	.35]	 .09	 .22	 .055	Note:	adjusted	R2	=	.55,	p<.001;	95%	bias	corrected	and	accelerated	confidence	intervals	reported	in	parentheses.		CI	and	SE	based	on	1000	bootstrap	samples.		
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Depression	
	This	model	explained	45%	(adjusted	R2=.45)	of	the	variance	in	depression,	with	self-compassion	making	a	statistically	significant	unique	contribution	of	6%	(b=-.40,	p<.01	semi-partial	correlation	co-efficient=-.248).		Anxiety	contributed	4%,	(b	=.30,	p<.05,	semi-partial	correlation	co-efficient=.202)	and	mindfulness	skills	3.8%	(b	=-.21,	p<.05,	semi-partial	correlation	co-efficient=-.197),	when	all	the	other	variables	were	controlled	for.		None	of	the	other	variables’	contributions	were	statistically	significant	(see	Table	12).	
	
Table	12.	Linear	model	of	predictors	of	depression	levels	at	baseline	
	
	 b	
[LLCI,	ULCI]	
SE	B	 b	 p	
Constant	 1.26	[.014,	2.50]	 .62	 	 .072	
M	Anxiety	T1	 .26	
[.04,	.48]	
.11	 .30	 .022	M	Acceptance	T1	 .02	[-.13,	.18]	 .08	 .05	 .760	M	Decentering	T1	 .20	[-.09,	.50]	 .15	 .20	 .173	
M	Self-compassion	T1	 -.25	
[-.42,	-.08]	
.09	 -.40	 .005	
M	Mindfulness	skills	T1	 -.29	
[-.54,	-.04]	
.13	 -.21	 .025	M	Intol.	of	uncertainty	T1	 .14	[-.01,	.30]	 .08	 .23	 .07	Note:	adjusted	R2	=	.45,	p<.001;	,	with	95%	bias	corrected	and	accelerated	confidence	intervals	reported	in	parentheses.		CI	and	SE	based	on	1000	bootstrap	samples.	
	
	
 Examining	the	Effect	of	Time	
	Although	trial	effectiveness	is	not	a	main	aim	for	this	present	study,	examining	how	outcome	scores	changed	over	time	may	indicate	when	change	occurred.		A	2x4	mixed	ANOVA	was	 conducted	 to	 test	whether	 there	was	 a	main	 effect	 for	group	(the	between-subjects	factor,	MBI	or	WL)	or	main	effect	of	time	(the	within-
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subjects	factor:	T1,	T2,	T3,	T4).		This	also	examined	whether	time	interacts	with	trial	arm.		These	analyse	were	computed	twice,	once	for	anxiety	and	once	for	depression.			Normal	distributions	were	checked	through	histograms	and	box-plots,	and	the	5%	trimmed	means	of	any	identified	outliers	were	within	acceptable	limits.		Linearity	was	examined	through	scatterplots.		Mauchly’s	test	of	Sphericity	was	not	significant,	so	it	can	be	assumed	that	the	variance	of	the	differences	between	all	possible	pairs	of	 within-subject	 condition	 (in	 this	 case,	 time)	 is	 equal.	 Levene’s	 Test	 was	 non-significant	thus	the	assumption	of	homogeneity	of	variances	was	not	violated,	and	as	Box’s	M	was	not	significant,	homogeneity	of	 intercorrelations	can	be	assumed	(Tabachnick	&	Fidell,	2013).			
	
Anxiety	
 There	 was	 no	 significant	 interaction	 between	 trial	 arm	 and	 time,	 Wilks’	Lambda=0.94,	F(3,	55)=1.05,	p=0.38,	partial	eta	squared=0.54	 	(Wilks’	Lambda	is	equivalent	to	the	interaction	effect).		There	was	a	substantial	and	significant	main	effect	for	time,	Wilks’	Lambda=0.65,	F(3,	 55)=9.79,	 p<0.001,	 partial	 eta	 squared=0.35,	 the	 MBI	 group	 showing	 a	reduction	in	mean	anxiety	scores	over	all	time	periods	except	at	T3	(see	Table	13).				
Table	13.	Mean	anxiety	scores	for	the	WL	and	MBI	groups	across	four	time	
periods		 Wait	List	Control	 Mindfulness	Based	
Intervention	
Time	 n	 M	 SD	 n	 	M	 SD	T1	-	Baseline	 34	 1.16	 0.56	 25	 1.10	 0.56	T2	-	4	weeks	 34	 0.98	 0.60	 25	 0.90	 0.61	T3	-	8	weeks	 34	 0.93	 0.60	 25	 0.93	 0.50	T4	–	20	weeks	 34	 1.01	 0.59	 25	 0.82	 0.52	
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The	main	effect	 comparing	 the	 two	 trial	 arms	was	not	 significant,	 F(1,	57)=0.36,	p=0.55,	partial	eta	squared=0.006	(partial	eta	squared	guidelines	(Cohen	1988)	is	.01=small	effect,	.06=moderate	effect,	.14=large	effect).				Post-hoc	analysis	with	a	Bonferroni	adjustment	revealed	that	anxiety	 levels	were	significantly	 decreased	 from	 pre-intervention	 to	 4	 weeks	 (T2)	 (M=0.19,	 95%	CI[0.08-0.31],	 p<.001,	 and	 from	 pre-intervention	 to	 8	weeks	 (T3)	 (M=0.20,	 95%	CI[0.08,	0.32],	p<.001,	and	from	pre-intervention	to	20	weeks	(T4)	(M=0.22,	95%	CI[0.07,	0.36],	p<.001.	There	were	no	significant	differences	between	the	other	time	levels	(see	Figure	9	(a)).		
Depression:		
 There	 was	 no	 significant	 interaction	 between	 trial	 arm	 and	 time,	 Wilks’	Lambda=0.87,	F(3,	55)=2.64,	p=0.06,	partial	eta	squared=0.13.				There	was	a	substantial	main	effect	 for	 time,	Wilks’	Lambda=0.84,	F(3,	55)=3.54,	p=0.02,	partial	eta	squared=0.16,	with	the	MBI	group	showing	a	reduction	in	mean	depression	scores	across	the	four	time	periods	(see	table	14).			
Table	14.	Mean	depression	scores	for	the	WL	and	MBI	groups	across	four	
time	periods		 Wait	List	Control	 Mindfulness	Based	
Intervention	
Time	 n	 M	 SD	 n	 	M	 SD	T1	-	Baseline	 34	 0.85	 0.48	 25	 0.99	 0.50	T2	-	4	weeks	 34	 0.85	 0.51	 25	 0.93	 0.53	T3	-	8	weeks	 34	 0.83	 0.50	 25	 0.79	 0.44	T4	–	20	weeks	 34	 0.93	 0.52	 25	 0.86	 0.54		The	main	effect	 comparing	 the	 two	 trial	 arms	was	not	 significant,	 F(1,	57)=0.06,	p=0.79,	partial	eta	squared=0.001.				
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	Post	 hoc	 analysis	with	 a	 Bonferroni	 adjustment	 revealed	 that	 depression	 levels	were	statistically	significantly	decreased	between	T1	(pre-intervention)	and	T3	(8	weeks)	 (M=0.11,	 95%	 CI	 [0.00-0.22],	 p=0.049.	 	 Levels	 of	 depression	 were	 not	significantly	decreased	between	T1	and	T2,	M=0.03,	95%	CI[-0.10-0.16],	p=1.000,		or	between	T1	and	T4	M=0.03,	95%	CI[-0.12-0.18]	(see	Figure	9	(b)).	
	
6 MECHANISMS	OF	CHANGE	
	
6.1 Mediation	Analysis	
 Mediation	 analysis	 was	 undertaken	 with	 the	 PROCESS	 macro	 to	 explore	 if	 the	relationships	between	the	dependent	variable,	trial	arm	(X:	intervention	or	control),	and	the	primary	outcomes,	anxiety	and	depression	(Y),	are	influenced	through	the	putative	mediators,	or	process	variables	(M),	(see	Figure	4	from	methods	chapter,	showing	path	X®M	(	a),	M®Y	(b),	direct	effect	of	X®Y	(c’)).				The	first	analysis	examined	both	outcome	variables	at	T4	(20	weeks’	follow	up)	with	mediator	 variables	 at	 T3	 (8	 weeks	 –	 end	 of	 intervention),	 controlling	 for	 T1	(baseline)	outcome	and	mediator	variables.	A	second	analysis	of	outcome	variables	at	T3	with	mediator	variables	at	T2	(4	weeks,	mid-point	of	intervention)	was	also	carried	out	(Appendices	B8,	B9,	B10	and	B11).		
 Anxiety	
 
Anxiety	levels	at	follow	up	(T4:	20	weeks)	predicted	by	mediator	levels	at	end	
of	intervention	(T3:	8	weeks)	(Figure	10	below;	Appendix	B8	)	
 Results	 from	a	 regression	 analysis	 including	T3	mediators	 and	T4	 anxiety	 levels	indicated	that	trial	arm	was	a	significant	predictor	of	levels	of	decentering	(a=.31,	SE=.07,	p<0.001,	CI=.16,	.46)	and	mindfulness	skills	(a=.27,	SE=.07,	p=.0005,	CI=.12,	.41).			However,	 the	 only	 mediator	 variable	 that	 predicted	 anxiety	 levels	 at	 T4	 was	intolerance	 of	 uncertainty	 at	 T3	 (b=.39,	 SE=.14,	 p=.007,	 CI=.11,	 .66).	 	 No	 other	
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mediators	showed	significant	indirect	effects	of	trial	arm	on	anxiety	levels.		There	was	no	significant	direct	effect	of	trial	arm	on	anxiety	levels	(c’=.20,	SE=.14,	p=.14,	CI=-.47,	.07).			Approximately	64%	of	the	variance	in	levels	of	anxiety	at	T4	is	explained	by	both	the	mediator	variables	at	T3	and	the	trial	arm.
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								Figure	10.	Model	of	putative	parallel	mediation	of	acceptance,	decentering,	self-compassion,	mindfulness	and	
								intolerance	of	uncertainty	(all	at	T3)	on	levels	of	ANXIETY	at	T4.	
 										 	 		 					
0.15	
-0.20	
0.24	
Mindfulness	T3	 0.03	0.39**	
Intolerance	of	Uncertainty	T3	
Anxiety	T4	(Y)	
Acceptance	T3	
Self-Compassion	T3	
Decentering	T3	
Trial	Arm	(X)	
0.31**	
0.27**	-0.08	
0.35	-.10	
	*p=<0.05	**p=<0.01	R2	=	0.64	F(12,	45)	=	6.58,	p	<	0.001		
0.04	
Covariates:	Baseline	(T1)	Acceptance,	Decentering,	Self-compassion,	Mindfulness,	Intolerance	of	Uncertainty,	Anxiety,	controlled	for	in	this	model.	
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Anxiety	levels	at	end	of	intervention	(T3:	8	weeks)	predicted	by	mediator	levels	
at	mid	intervention	(T2:	4	weeks)	(Figure	11	below;	Appendix	B9)		Results	 from	a	 regression	 analysis	 including	T2	mediators	 and	T3	 anxiety	 levels	indicated	 that	 trial	 arm	 was	 not	 a	 significant	 predictor	 of	 any	 of	 the	 mediating	variables.		Levels	of	acceptance	at	T2	predicted	levels	of	anxiety	at	T3	(b=.20,	SE=.09,	
p=.035,	CI=-.38,	-.01).	There	was	no	significant	direct	effect	of	trial	arm	on	anxiety	levels	(c’=.02,	SE=.09,	p=.83,	CI=-.16,	.20).		Approximately	66%	of	the	variance	in	levels	of	anxiety	at	T3	is	explained	by	both	the	mediator	variables	at	T2	and	the	trial	arm.		
Mediation	effects	of	relationship	of	trial	arm		on	anxiety	levels	(see	Table	15):	At	the	end	of	the	intervention	(T3),	the	total	effect	of	mindfulness	training	on	anxiety	levels	 was	 -.0414,	 (SE=.0873,	 CI=-.2161,	 .1334),	 meaning	 that	 being	 in	 the	intervention	 group	 lead	 to	 lower	 levels	 of	 anxiety,	 although	 the	 95%	 bootstrap	confidence	 interval	 straddles	 zero	 so	 the	 result	 cannot	 be	 said	 to	 be	 definitely	different	 from	 zero.	 The	 direct	 effect	 (path	 c’)	 was	 .0186	 (SE=.0879,	 CI=-.1579,	.1950),	but	again	the	confidence	intervals	straddle	zero.		None	of	the	specific	indirect	effects	 of	 the	 mediators	 (measured	 at	 mid-point	 in	 the	 intervention)	 were	significant,	but	as	the	total	effect	was	greater	than	the	direct	effect	it	can	be	assumed	that	there	was	no	inconsistent	mediation	(or	evidence	of	suppression	in	the	indirect	effects,	 Mackinnon,	 Fairchild,	 &	 Fritz,	 2007).	 	 By	 follow-up,	 there	 appears	 to	 an	inconsistent	mediation	 effect:	 the	 total	 effect	 of	 trial	 arm	 on	 anxiety	was	 -.1220	(SE=.117,	CI=-.3462,	.1023)	and	direct	effect	-.2013,	(SE=.1347,	CI=-.4725,	.0699).		The	individual	indirect	effects	of	the	mediating	variables	showed	that	acceptance,	decentering,	mindfulness	skills	no	longer	had	negative	signs,	but	positive,	resulting	in	a	total	 indirect	effect	of	 .0794	(SE=.1005,	CI=-.1006,	 .3034),	 indicating	that	the	mediators	at	T3	did	not	predict	a	reduction	in	anxiety	levels	at	follow-up.						
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			Figure	11.	Model	of	putative	parallel	mediation	of	acceptance,	decentering,	self-compassion,	mindfulness	and	intolerance	of	uncertainty	
				(all	at	T2)	on	levels	of	ANXIETY	at	T3.	
 
 																
0.06	
0.02	
0.20	
Mindfulness	T2	 0.26	0.04	
Intolerance	of	Uncertainty	T2	
Anxiety	T3	(Y)	
Acceptance	T2	
Self-Compassion	T2	
Decentering	T2	
Trial	Arm	(X)	
0.11	
-.02	0.06	
-0.22	0.07	
	*p=<0.05	**p=<0.01	R2=0.71	F(12,	52)	=	10.50,	p	<	0.001				
-0.20*	
Covariates:	Baseline	(T1)	Acceptance,	Decentering,	Self-compassion,	Mindfulness,	Intolerance	of	Uncertainty,	Anxiety,	controlled	for	in	this	model.	
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 Depression	
 
Depression	levels	at	follow	up	(T4:	20	weeks)	predicted	by	mediator	levels	at	
end	of	intervention	T3:	8	weeks)(	(Figure	12	below;	Appendix	B10)			Results	 from	 the	 regression	 analysis	 including	 T3	mediators	 and	 T4	 depression	levels	 indicated	that	 trial	arm	was	a	significant	predictor	of	 levels	of	decentering	(a=.31,	SE=.07,	p<0.01,	CI=.16,	 .46)	and	mindfulness	skills	(a=.29,	SE=.07,	p<.001,	CI=.14,	.43).	Intolerance	of	uncertainty	and	self-compassion	at	T3	predicted	levels	of	depression	at	T4	(b=.29,	SE=.13,	p<.05,	CI=.02,	.56;	b=.27,	SE=.13,	p<.05,	CI=-.53,	-.004).	 	There	was	no	significant	direct	effect	of	 trial	arm	on	 levels	of	depression	(c’=.21,	SE=.13,	p=.1313,	CI=-.47,	0.64).				Approximately	55%	of	the	variance	in	levels	of	depression	at	T4	is	explained	by	both	the	mediator	variables	at	T3	and	the	trial	arm.			
Depression	levels	at	follow	up	(T3:	8	weeks)	predicted	by	mediator	levels	at	
mid-point	of	intervention	T2:	4	weeks)(	(Figure	13	below;	Appendix	B11)		
	Results	 from	 the	 regression	 analysis	 including	 T2	mediators	 and	 T3	 depression	levels	indicated	that	trial	arm	was	not	a	significant	predictor	of	levels	of	any	of	the	mediator	 variables	 at	 4	 weeks,	 and	 none	 of	 the	mediator	 variables	 significantly	predicted	depression	levels	at	T3.			However,	there	was	a	significant	total	effect	of	trial	arm	on	levels	of	depression	at	T3	(c=-.1977,	SE=.07,	p=.0091,	CI=-.34,	 -.05)	with	participants	 in	the	mindfulness	group	experiencing	a	small	reduction	in	anxiety	levels.			Approximately	73%	of	the	variance	in	levels	of	depression	at	T3	is	explained	by	both	the	mediator	values	and	the	trial	arm.		
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Figure	12.	Model	of	putative	parallel	mediation	of	acceptance,	decentering,	self-compassion,	mindfulness	and	intolerance	of	uncertainty	(all	
at	T3)	on	levels	of	DEPRESSION	at	T4																		
0.21	
0.16	
-0.21	
0.04	
Acceptance	T3	
Decentering		T3	
Self-Compassion	T3	
Depression	T4	(Y)	Trial	Arm	(X)	
0.31**	
0.08	0.35	-0.27*	
0.29*	
Intolerance	of	Uncertainty	T3	
Mindfulness	T3	0.29**	-0.10	 	*p=<0.05	**p=<0.01	R2=0.55	F(12,	45)=4.59,	p	<	0.001			
Covariates:	Baseline	(T1)	Acceptance,	Decentering,	Self-compassion,	Mindfulness,	Intolerance	of	Uncertainty,	Depression,	controlled	for	in	this	model.	
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Figure	13.	Model	of	putative	parallel	mediation	of	acceptance,	decentering,	self-compassion,	mindfulness	and	intolerance	of	uncertainty	(all	
at	T2)	on	levels	of	DEPRESSION	at	T3
Mindfulness	T2	
0.21	
0.07	
-0.15	
0.19	
-0.01	Intolerance	of	Uncertainty	T2	
Depression	T3	(Y)	
Acceptance	T2	
Self-Compassion	T2	
Decentering	T2	
Trial	Arm	(X)	
0.11	
-0.007	0.04	
-0.11	-0.18	-0.11	
	*p=<0.05	**p=<0.01	R2=.73	F(12,	52)	=	11.55,	p	<	0.001		
Covariates:	Baseline	(T1)	Acceptance,	Decentering,	Self-compassion,	Mindfulness,	Intolerance	of	Uncertainty,	Depression,	controlled	for	in	this	model.	
	 93 
Mediation	effects	in	relationship	between	trial	arm		on	depression	levels	
(see	Table	15):	At	the	end	of	the	intervention	(T3),	the	total	effect	of	trial	arm	on	depression	levels	was	 significant	 (supported	by	 the	bootstrap	 confidence	 intervals,	with	95%	confidence)	 and	was	equal	 to	 -.1997	 (SE=.0733,	CI=-.3444,	 -.0510).	The	direct	 effect	 of	 trial	 arm	on	depression	was	 smaller	 (=-.1457,	 SE=.0730,	 CI=-.2922,	 .0008)	 and	 very	 close	 to	 significance.	 	 All	 the	 indirect	 effects	 of	 the	individual	mediators	 (measured	 at	 T2)	were	 negative,	 indicating	 that	 (apart	from	 intolerance	 of	 uncertainty)	 they	 contributed	 to	 reducing	 levels	 of	depression,	but	none	of	these	effects	were	supported	by	the	confidence	levels.		The	total	indirect	effect	of	the	trial	arm	on	depression	was	-.0520	(SE=.0477,	CI	-.1561,	.0319).				At	follow-up,	neither	the	total	effect	(-.1404,	SE=.1093,	CI=.3600,	.0792)	or	the	direct	effect	of	the	trial	arm	on	levels	of	depression	(-.2056,	SE=.1338,	CI=-.4751,	.0638)	had	confidence	intervals		entirely	above	or	below	zero.		The	direct	effect	is	again	larger	than	the	total	effect	indicating	some	suppression	effect.		The	total	indirect	effect	(.0652,	SE=.0949,	CI=-.1249,	.2515)	indicated	that	the	combined	mediators	no	longer	contributed	to	the	reduction	in	depression	levels.		Only	self-compassion	showed	a	non-significant	but	negative	effect.		The	 total	 variance	 	 explained	 in	 both	 anxiety	 and	 depression	 at	 T4	 by	 the	mediation	models,	including	the	time-lagged	mediators	at	T3,	shows	that	there	is	 a	 reduction	 compared	 to	 the	models	of	 anxiety	 and	depression	at	T3	with	mediators	 at	 T2,	 indicating	 that	 there	 is	 unaccounted	mediation	 either	 from	missing	mediators,	overlapping	mediators,	suppression	between	mediators	or	that	moderation	of	the	mediators	has	had	an	increased	effect.		It	may	also	be	an	effect	of	reduced	power	as	 the	sample	size	 included	at	 the	 later	stages	of	 the	mediation	analysis	reduced	(T3	n=65,	T4	n=58).	
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Table	15.	Total,	direct	and	indirect	effects	of	trial	arm	on	anxiety	and	depression.	
	
	 Anxiety	T3	(LLCI,	ULCI)	 Anxiety	T4	(LLCI,	ULCI)	 Depression	T3	(LLCI,	ULCI)	 Depression	T4	(LLCI,	ULCI)	
Total	effect	 -.0414	-.2161,	.1334	 -.1220*	-.3462,	.1023	 -.1977	-.3444,	-.0510	 -.1404*	-.3600,	.0792	
Direct	effect	 -.0186	-.1579,	.1950	 -.2013	-.4725,	0.699	 -.1457	-.2922,	.0008	 -.2056	-.4751,	.0638	
Total	indirect	effect	 -.0600	-.1943,	.0254	 .0794	-.1006,	.3034	 -.0520	-.1561,	.0319	 .0652	-.1249,	.2515	
Indirect	effect	of	acceptance		 -.0389	-.1816,	0.142	 .0092	-.0330,	.1073	 -.0223	-.1210,	.0073	 .0175	-.0193,	.1375	
Indirect	effect	of	decentering		 -.0234	-.1479,	.0154	 .1060	-.0658,	.3492	 -.0206	-.1284,	.0166	 .1068		-.0667,	.3229	
Indirect	effect	of	self-compassion		 .0041	-.0201,	.0872	 -.0151	-.1623,	.0242	 -.0072	-.0911,	.0135	 -.0418	-.2179,	.0243	
Indirect	effect	of	mindfulness	skills		 -.0038	-.0727,	.0327	 .0085	-.1179,	.1226	 -.0014	-.0548,	.0315	 .0118	-.1450,	.1533	
Indirect	effect	of	intolerance	of	uncertainty		 .0020	-.0238,	.0542	 -.0292	-.1586,	.0551	 -.0005	-.0347,	.0249	 -.0291	-.1672,	.0194	Note:	mediators	measured	at	T	preceding	outcome	T.		*inconsistent	mediation,	where	total	effect	smaller	than	direct	effects
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6.2 MODERATION	ANALYSIS	
 The	strength	and	direction	of	the	relationship	between	the	trial	arm	(X)	and	the	outcomes	(Y,	anxiety	and	depression)	was	examined	for	moderation	effects	by	clinical	 factors,	 including	 participant	 age,	 gender,	 years	 since	 diagnosis,	 self-report	baseline	disability	and	psychogenic	medication	use	in	individual	analyses	(Figure	14).			Both	 outcomes	 at	 T3	 and	 T4	 were	 analysed	 with	 baseline	 anxiety	 and	depression	included	as	covariates.		
Figure	 14.	 Simple	model	 of	 moderation	 of	 the	 effect	 of	 trial	 arm	 on	 levels	 of	
anxiety	and	depression		
		
	
	
	
	
	
																								
	
	
										
Anxiety	T4	
 The	only	significant	moderator	of	anxiety	 (T4,	at	 follow-up)	was	gender	 (b=-3.61,	 SE=1.29,	 t=-2.78,	 p=.0074,	 CI=-6.204,	 -1.006;	 R2	 change=.0509,	 F1,57	 =	7.7149,	 p=.0074).	 	 When	 the	 	 MBI	 participant	 was	 female,	 the	 relationship	between	 the	 trial	 arm	 and	 levels	 of	 anxiety	 was	 negative	 and	 statistically	significant	(b	=-2.42,	SE=.13,	t=-2.71,	p=.009,	CI=-4.2055,	-.62),	indicating	that	females	randomised	to	the	intervention	group	had	lower	levels	of	anxiety	than	females	randomised	to	the	waiting	list.		When	the	MBI	participant	was	male,	the	
					
				Trial	Arm	(X)	 Outcome	(Y):		anxiety	(T3	or	T4)	or	depression	(T3	or	T4)	
 
Moderators	(W):	Age	or	gender	or	years	since	diagnosis	or	self-report	disability	or	medication	use,	and	T1	anxiety	or	depression	
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relationship	between	the	trial	arm	and	levels	of	anxiety	was	positive,	but	non-significant	(b=1.18,	SE=.14,	t=1.26,	p=.212,	CI=-.6966,	3.07)	(Figure	15).				
Figure	15.		Moderating	effect	of	gender	on	levels	of	anxiety	
	
Anxiety	T3	
 There	was	no	moderating	effect	of	gender	on	the	relationship	between	the	trial	arm	and	anxiety	immediately	following	the	intervention	(T3).		Age,	years	since	diagnosis,	baseline	disability	and	medication	use	did	not	moderate	 the	direct	effect.		
Depression	T4	&	T3	
 No	statistically	significant	interaction	effects	were	found	for	any	of	the	proposed	clinical	moderators	between	the	trial	arm	and	depression	at	T4	or	T3.			
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6.3 Moderated	Mediation	
 This	 occurs	 when	 the	 relationship	 between	 trial	 arm	 	 and	 moderator	 is	moderated	by,	 or	 the	 strength	 of	 that	 relationship	 is	 conditional	 on,	 another	variable	(W).		In	this	study,	the	putative	mediators	(acceptance,	decentering,	self-compassion,	mindfulness	 skills	 and	 intolerance	 of	 uncertainty	 at	 T3	 and	 T4)	were	 singly	entered	into	a	simple	conditional	model	in	PROCESS	(template	model	1,	Hayes,	2013)	 as	 the	dependent	 variable	 (Y)	 and	 the	 relationship	with	 each	possible	moderator	 (age,	 gender,	 years	 since	 diagnosis,	 baseline	 disability	 and	medication	 use)	 was	 tested	 for	 significance	 by	 bias-corrected	 bootstrap	confidence	intervals.				
Figure	16.	A	simple	model	of	moderated	mediation					
	
	
	
	
 
 
 
 
 
 
 
	
	
	
Years	since	diagnosis	moderating	acceptance	T3	and	T4	
 Years	since	diagnosis	moderated	the	relationship	between	trial	arm	and	levels	of	 acceptance	 at	 T4	 (a=-.79,	 SE=.38,	 t=-2.11,	 p=.0397,	 CI=-1.55,	 -.039;	 R2	change=0.02,	F1,56=4.431,	p=.0397)(Figure	17).		This	suggests	that	as	years	since	
Trial	Arm	(X):	
WL	or	MBI	
Moderators	(W):	Age	or	gender	or	years	since	diagnosis	or	self-report	disability	or	medication	use.	Control:	T1	Mediator		
 
Mediators	(M):	acceptance,	decentering,	self-compassion,	mindfulness	skills	and	intolerance	of	uncertainty	(a)	(horizontal	line	as	on	fig.	6)	
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diagnosis	change	by	one	unit,	 in	the	MBI	group,	the	overall	effect	on	levels	in	acceptance	differs	by	a	coefficient	of	-.79.		Probing	the	interaction	with	the	Johnson-Neyman	(JN)	technique	indicated	that	there	was	a	significant	and	positive	effect	of	trial	arm	on	acceptance	levels	when	MBI	participants’	time	since	diagnosis	was	less	than	1.8	years	(a=3.85,	SE=1.92,	t=2.003,	p=0.05,	CI=.00,	7.70),	meaning	that	acceptance	levels	in	a	participant	randomised	 to	 the	 intervention	 arm	were	 higher	 if	 the	 participant	 had	 been	diagnosed	 within	 1.8	 years	 (8.2%	 of	 participants).	 Participants	 diagnosed	within	6	months	had	an	effect	size	of	4.911,	(SE=2.29,	t=2.14,	p=0.039,	CI	.3090	–	9.51).	There	was	also	a	negative	effect	if	the	diagnosis	was	more	than	7.1	years,	but	this	was	not	statistically	significant.		
Figure	17.		Moderating	effect	of	years	since	diagnosis	on	acceptance	at	T4	
	
	Years	 since	 diagnosis	 also	moderated	 acceptance	 at	 T3,	 (a=-1.07,	 SE=.40,	 t=-2.65,	p=.0102,	CI=-1.88,	-.26;	R2	change=0.06,	F1,61=7.04,	p=.0102)(Figure	18).	
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The	significant	values	identified	by	JN	suggest	that	immediately	after	the	MBI,		people	in	the	intervention	group	who	were	within	2.69	years	of	diagnosis	had	a	significant	and	positive	relationship	with	levels	of	acceptance	(a=4.23,	SE=2.12,	t=1.99,	p=.05,	CI=.00,	8.45;	24%	of	the	sample).		However,	for	people	in	the	MBI	who	 had	 been	 diagnosed	more	 than	 12.5	 years,	 there	 was	 a	 significant	 and	negative	relationship	with	levels	of	acceptance	(a=-6.37,	SE=3.19,	t=-1.99,	p=.05,	CI=-12.75,	0.00;	10.6%	of	the	sample).				
Figure	18.		Moderating	effect	of	years	since	diagnosis	on	acceptance	T3		
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Years	since	diagnosis	and	mindfulness	skills	T3	
 Years	since	diagnosis	significantly	moderated	the	relationship	between	the	trial	arm	and	mindfulness	skills	at	T3	(a=-.6857,	SE=.34,	t=-2.02,	p=.0482,	CI=-1.365,	-.0057;	 R2	 change=0.03,	 F1,61=4.07,	 p=.0482)	 (figure	 19).	 	 Probing	 the	interaction,	the	significant	region	was	for	people	in	the	MBI	diagnosed	within	7.5	 years,	 	 who	 benefitted	 from	 greater	mindfulness	 skills	 (a=2.99,	 SE=1,50,	t=1.99,	p<.05,	CI=.00,	5.99;	67%	of	the	sample).		
Figure	19.		Moderating	effect	of	years	since	diagnosis	on	mindfulness	skills	T3		
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Age	of	participant	and	acceptance	T4	
 Age	 significantly	 moderated	 the	 relationship	 of	 trial	 arm	 and	 acceptance	 at	T4(a=-.45,	 SE=.16,	 t=-2.80,	 p=.0071,	 CI=-.7772,	 -.1268;	 R2	 change=0.04,	F1,56=7.82,	p=.0071)(Figure	20).		For	people	in	the	MBI	who	were	younger	than	57.7	years,	 there	was	a	significant	and	positive	effect	of	age	of	participant	on	levels	 of	 acceptance	 (a=3.01,	 SE=1.50,	 t=2.00,	 p=.05,	 CI=.0000,	 6.01).	 	 This	accounted	for	26%	of	the	sample.	
	
Figure	20.		Moderating	effect	of	age	on	acceptance	at	T4		
  
Other	moderation	effects		
 There	 were	 no	 significant	 moderation	 effects	 of	 disability	 levels,	 gender	 or	medication	use	on	any	of	the	relationships	between	trial	arm	and	acceptance,	decentering,	self-compassion,	mindfulness	skills	and	intolerance	of	uncertainty.	 	
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7 DISCUSSION	
 This	 paper	 set	 out	 to	 explore	 if	 acceptance,	 decentring,	 self-compassion,	mindfulness	 skills	 and	 intolerance	of	uncertainty	 levels	 	 changed	 	during	 the	intervention	 and	 at	 follow-up,	 and	 if	 these	 changes	 were	 associated	 with	changes	in	treatment	effect	on	anxiety	and	depression.		The	temporal	order	of	change	was	examined	to	see	if	any	putative	mediator	change	preceded	change	in	psychological	outcome	measures,	and	the	association	between	changes	was	analysed.	Analysis	using	the	PROCESS	plug-in	examined	whether	there	was	any	significant		mediation	of	the	effects	of	the	intervention	on	levels	of	anxiety	and	depression.	Potential	process	pathways	were	also	examined	for	any	moderation	of	 the	direct	or	 indirect	effects,	 to	see	 if	any	subsets	of	 the	sample	benefitted	more.		
7.1 PRIMARY	FINDINGS	
 The	 findings	 revealed	 that	 levels	 of	 all	 the	 mediator	 variables	 in	 people	randomised	to	the	intervention	changed	in	a	positive	health	outcome	direction.		Immediately	 following	 the	 8-week	 course,	 the	 MBI	 group	 had	 statistically	significant	 improvements	 in	 levels	of	depression,	decentring	and	mindfulness	skills.		All	other	outcomes	showed	greater	improvement	in	the	intervention	arm	than	in	the	wait	list,	but	the	differences	were	not	statistically	significant.			Being	 in	 the	 intervention	 group	 significantly	 predicted	 higher	 levels	 of	decentering	and	mindfulness	skills,	but	these	putative	mediators	did	not	then	significantly	predict	the	outcomes	anxiety	or	depression.		However,	lower	levels	of	 intolerance	 of	 uncertainty,	 and	 higher	 levels	 of	 acceptance	 in	 the	MBI	 did	predict	lower	anxiety	levels,	and		lower	intolerance	of	uncertainty	and	higher	self-compassion	predicted	lower	levels	of	depression.		No	complete	mediation	path	 (ab)	 was	 significant,	 but	 all	 the	 included	 candidate	 mediators	 were	significant	in	at	least	one	area	of	each	of	the	causal	paths	at	one	of	the	time	points	for	one	of	the	outcome	variables,	indicating	that	they	have	some	influence	over	either	 the	mediator	or	 the	psychological	 outcome	 following	 the	 intervention.	
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There	were	 also	 suggestions	 of	 suppression	 effects	 in	 the	multiple	mediator	models	that	examined	the	effect	of	the	intervention	on	anxiety	and	depression	levels	at	follow-up	(T4),	by	mediators	measured	at	week	eight	(T3).	
 Even	though	there	were	no	significant	differences	in	levels	of	anxiety	between	men	and	women	at	baseline,	at	the	3-month	follow-up	(T4)	anxiety	levels	were	moderated	by	gender,	with	females	having	lower	scores;	however,	gender	did	not	 moderate	 levels	 of	 depression	 at	 either	 point.	 	 People	 who	 were	 more	recently	 diagnosis	 and	who	were	 younger,	 showed	 greater	 increase	 in	 their	levels	of	acceptance	at	the	end	of	the	intervention.		This	 pilot	 study	 was	 exploratory,	 and	 in	 accordance	 with	 CONSORT	recommendations,	 does	 not	 aim	 to	 report	 significant	 trial	 efficacy	 but	 to	examine	areas	of	uncertainty	in	a	future	trial.	 	This	study	set	out	to	explore	if	relationships	between	 the	 intervention	and	 the	psychological	outcomes	were	mediated	 by	 constructs	 that	 are	 theorised	 to	 contribute	 to	 process	 or	mechanisms	 of	 therapeutic	 change,	 and	 also	 to	 examine	 if	 any	 of	 these	relationships	were	conditional	on	moderating	clinical	variables	(Thabane	et	al,	2010;	Leon,	Davis,	&	Kraemer,	2011;	Eldridge	et	al,	2016).		Shapiro’s	 theoretical	 model	 of	 mindfulness	 (2006,	 Figure	 1)	 includes	decentering,	 values	 clarification,	 self-regulation,	 cognitive	 flexibility	 and	exposure	 as	 psychological	 constructs,	 which	 broadly	 compare	 to	 the	instruments	 used	 in	 this	 paper	which	 evaluate	 decentering,	 self-compassion,	mindfulness	skills,	acceptance	and	intolerance	of	uncertainty.					Intolerance	 of	 uncertainty	 (IU)	 has	 been	 introduced	 as	 a	 novel	 putative	mediator	in		mindfulness	training	and	PD;	IU	has	previously	been	demonstrated	to	have	a	role	in	transdiagnostic	psychological	disorders	(McEvoy	&	Mahoney,	2010;	Vander	Haegen	&	Etienne,	2016),	and	to	be	responsive	to	CBT	(Talkovsky	&	Norton,	2016),	to	be	associated	with	panic	disorders	(Carleton,	Duranceau	et	
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al,	2014),		and	to	be	predictive	of	anxiety	in	people	with	PD	(Brown	&	Fernie,	2014).		Robust	 design	 is	 important	 even	 in	 a	 pilot	 study	 to	 ensure	 that	 process	mechanisms	 can	be	 identified	 (Kazdin,	 2007;	Gu,	 Strauss,	Bond,	&	Cavanagh,	2015;	van	der	Velden	et	al,	2015)	and	this	study	examined	a	self-selected	sample	randomised	 to	 either	 the	 MBI	 or	 a	 WL	 control.	 	 While	 WL	 groups	 are	 not	comparable	to	active	control	groups,	because	they	cannot	control	for	the	group	placebo	effects	or	positive	 treatment	expectancies,	active	control	groups	also	generate	expectancies	of	change	that	equate	to	an	intervention	effect	and	which	can	also	confound	outcome	(Kazdin,	2014).			
 Kazdin	 (2007,	2014)	 	 also	 recommends	 that	 	 in	order	 to	establish	mediation	change	 all	 the	 constructs	 should	 be	 measured	 not	 just	 pre-	 and	 post-intervention,	but	also	during	 the	 intervention.	 	This	present	study	 included	a	mid-intervention	 point	 as	 well	 as	 a	 follow-up	 time	 point	 of	 20	 weeks,	 eight	weeks	longer	than	a	similar	study	(Bogosian	et	al,	2016).				Mediator	 variables	 represent	 constructs	 that	 are	 part	 of	 the	 mechanism	 or	processes	of	change,	so	examining	mediation	is	just	a	first	step	to	understanding	how	change	is	effected	(Kazdin,	2009;	Windgassen	et	al,	2016).		Demonstrating	mediators	and	mechanisms	of	change	requires	evidence	of	strong	associations	between	 the	 intervention	 and	 the	 mediator	 and	 the	 mediator	 and	 the	therapeutic	 change.	 	 In	 this	 pilot	 study,	 	 correlation	 analysis	 was	 used	 to	establish	that	there	were	associations,	in	the	expected	directions,	between	the	outcome	variables	and	the	putative	mediator	variables.		Analysis	of	the	changes	over	time	should	also	include	time-lagging	the	mediator	variable	 to	 the	 outcome	 variable,	 as	 significant	 change	 then	 indicates	 the	direction	of	process,	and	strengthens	the	mediation	and	thus	causal	chain	claim.		This	 study	 found	some	expected	relationships,	 for	 instance,	 that	mindfulness	skills	were	not	significantly	correlated	to	psychological	outcomes	until	later	on,	as	 the	 naive	 participants	 underwent	 training.	 	 On	 the	 other	 hand,	 the	
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correlations	between	outcomes	and	mediator	variables	at	T3	(8	weeks)	were	mostly	non-significant	for	the	intervention	group	yet	were	significant	at	T2	and	T4.		This	may	indicate	that	responses	to	questionnaires	immediately	following	the	end	of	an	intense	and	supportive	therapeutic	period	may	be	moderated	by	some	 emotional	 process	 that	 could	 be	 revealed	 through	 qualitative	 research	undertaken	concurrently	and	which	will	be	reported	elsewhere.		The	effect	of	time	on	change	in	primary	outcomes	was	examined,	and	anxiety	levels	 were	 significantly	 lower	 at	 all	 levels	 when	 compared	 to	 baseline,	 but	depression	levels	were	only	significantly	lower	at	the	end	of	the	intervention.		Effect	sizes	at	each	time	point	indicate	that	acceptance	and	decentering	had	an	effect	 at	 T2	 before	 both	 depression	 and	 anxiety,	 and	 self-compassion	 and	mindfulness	skills	had	a	small	effect	at	T3	before	anxiety	showed	a	small	effect	at	T4	(Figure	9	a-g).				Kazdin	 (2014)	 describes	 the	 lack	 of	 evidence	 base	 for	 psychotherapeutic	interventions	in	clinical	practice,	in	particular	the	need	for	treatments	that	have	reach,	 scalability,	 and	 affordability	 to	 meet	 the	 increasing	 demand	 for	 non-pharmaceutical	interventions	for	people	with	chronic	and	degenerative	disease.		Because	there	is	some	evidence	that	certain	broad	characteristics	in	populations	and	core	processes	 in	mindfulness	may	explain	how	different	patient	groups	have	benefitted	from	an	intervention,	it	has	been	described	as	a	transdiagnostic	treatment	(Chiesa	and	Serreti,	2010;	McEvoy	and	Mahoney,	2012).	 	However,	there	 is	 still	much	 to	 discover	 about	 how	 the	 potential	 processes	work,	 and	which	 particular	 patients	 would	 benefit	 from	 treatment.	 	 Studies	 examining	mechanisms	 in	 	 MBI	 studies	 in	 people	 with	 physical	 disease	 are	 limited:		Alsubaie	 et	 al	 (2017)	 only	 found	 four	 mediation	 studies	 of	 mindfulness	interventions	for	people	with	physical	disease	and	mood	disorders,	three	were	in	cancer	populations	and	one	in	coronary	heart	disease	patients.	A	review	of	16	mediation	studies	in	cancer	populations	found	promising	potential	mediators	in	cognitions,	 self-efficacy	 and	 self-esteem	 (Stanton,	 Luecken,	 Mackinnon,	 &	
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Thompson,	2013).			A	later	publication	Bogosian	et	al	(2016)	examined	possible	mediation	in	a	remote	delivery	MBI	for	people	with	multiple	sclerosis.			
7.2 Associations	between	variables	
 The	whole	sample	bivariate	correlations	showed	strong	associations	between	all	the	variables	purported	to	be	mediators	or	outcomes,	except	for	mindfulness	skills	 at	 baseline,	 which,	 as	 would	 be	 expected	 from	 naïve	 participants	embarking	 on	 mindfulness	 training,	 became	 more	 strongly	 and	 significantly	correlated	with	 time,	 and	on	examining	 the	 separate	 group	 correlations,	 this	was	 clearly	 focused	 within	 the	 MBI	 group.	 	 Associations	 between	 the	intervention	and	putative	mediators,	and	the	mediators	and	change	variables	were	therefore	demonstrated.			Furthermore,	 standard	 regression	 analysis	 explored	 the	 associations	 at	baseline	between	mediator	variables	and	either	outcome,	whilst	controlling		for	the	remaining	variables,	and	demonstrated	that	the	models	explained	55%	and	45%	of	the	variance	in	levels	of	anxiety	and	depression	respectively,	both	within	moderate	 levels.	 	 Statistical	 significance	 was	 only	 achieved	 in	 one	 mediator	variable	(acceptance)	 in	anxiety,	and	two	 in	depression	(self-compassion	and	mindfulness	skills);	baseline	decentering,	which	by	T3	is	significantly	increased	in	the	MBI	group,	did	not	significantly	predict	baseline	anxiety	or	depression,	and	this	is	reflected	in	subsequent	mediation	analysis.			
Acceptance	
 This	 study	 has	 demonstrated	 that	 acceptance	 is	 likely	 to	 mediate	 the	relationship	 between	 mindfulness	 training	 and	 anxiety	 and	 depression	 in	people	with	PD,	despite	the	non-significance	of	the	multiple	mediation	study	in	all	 the	 pathways	 except	 when	 mid-intervention	 levels	 of	 acceptance	 were	regressed	on	levels	of	anxiety	at	the	end	of	the	intervention	(T4).	 	Treatment	effects	were	small,	but	increased	at	every	time	point,	including	follow-up,	and	before	any	effects	were	evident	in	the	treatment	outcomes.	This	steady	growth	
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pattern	 replicates	 the	 change	 in	 acceptance	 levels	 found	 in	 an	 intensive	Acceptance	 and	 Commitment	 Therapy	 (Hayes,	 Stroshal,	 &	 Wilson,	 1999)		intervention	for		chronic	pain	(which	included	substantial	mindfulness	training)	(McCracken	&	Gutiérrez-Martínez,	 2011).	 	 As	 previously	mentioned,	 another	remote	 delivery	 MBI	 for	 people	 with	 MS	 found	 little	 change	 in	 levels	 of	acceptance	 until	 the	 3-month	 follow-up,	 and	 supporting	 qualitative	 evidence	described	the	participants’	struggle	in	increasing	their	acceptance	of	the	daily	challenges	of	their	chronic	illness	(Bogosian	et	al,	2016).			
	In	this	study,	acceptance	was	shown	to	be	conditional	on	the	participant’s	age,	with	people	in	the	intervention	arm	younger	than	57.7	benefitting	from	higher	levels	of	acceptance.	 	Time	since	diagnosis	also	moderated	whether	 trial	arm	would	have	an	effect	on	acceptance,	as	midway	during	the	 	 intervention,	MBI	participants	 diagnosed	 within	 2.7	 years	 were	 more	 likely	 to	 have	 higher	acceptance	levels,	and	within	1.8	years	at	the	end	of	the	intervention.		As	age	of	patient	 and	onset	 of	 PD	 are	 correlated	 (Pringsheim,	 Jette,	 Frolkis,	&	 Steeves,	2014),	it	is	unsurprising	that	they	both	moderate	this	mediator.		Baseline	levels	of	acceptance	predicted	baseline	levels	of	anxiety,	with	a	unique	contribution	of	7.6%	 to	 the	 variance,	 but	 baseline	 acceptance	 did	 not	 predict	 baseline	depression.		These	results	contrast	to	community	sample	evidence	that	greater	acceptance	is	 associated	with	 older	 age,	 and	 that	 acceptance	mediates	 between	 age	 and	negative	effect	(in	particular,	levels	of	anxiety	and	not	sadness)		and	that	older	people	in	general	report	higher	emotional	well-being,	(Shallcross,	Ford,	Floerke,	&	Mauss,	2013;	Butler	&	Ciarrochi,	2007).	The	majority	of	participants	in	this	present	 sample	 reported	mild	 Parkinson’s	 symptoms,	 were	 approximately	 6	years	 since	 diagnosis,	 and	were	mostly	 in	 their	 early	 60s,	 so	 it	 is	 somewhat	surprising	that	this	moderation	analysis	of	the	mediation	effect	of	acceptance	defined	such	a	narrow	window	of	positive	change.		
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While	 a	 ceiling	 effect	 of	 acceptance	 in	 older	 people	 has	 been	 reported	 in	mindfulness	 levels	 in	 a	 review	 by	 Geiger	 et	 al	 (2016),	 	 it	 is	more	 likely	 that	acceptance	is	a	skill	that	requires	practice,	and	that	the	daily	challenges	people	with	 PD	 face	 increase	 with	 age	 and	 disease	 progression,	 including	 cognitive	decline,		may	make	some	of	the	processes	involved	in	mindfulness	training	more	difficult,	thus	giving	patients	only	a	limited	time	opportunity	in	which	to	acquire	these	new	skills.		
Decentering	
 Acceptance	has	been	shown	to	be	closely	linked	to	decentering	(McCracken	et	al,	2014);	without	being	able	to	decenter	from	frightening	thoughts,	there	is	no	possibility	of	acceptance	of	that	thought,	and	in	turn,	acceptance,	by	increasing	engagement,	enhances	decentering.		This	present	study	found	that	acceptance	and	decentering	were	strongly	correlated	at	all	time	points	for	both	groups,	but	decentering	 showed	 a	 larger	 effect	 size	 at	 mid-point	 and	 end	 of	 treatment.		Bogosian	et	al	 (2016)	also	 found	that	decentering	had	the	greatest	change	at	follow-up	and	had	greater	(although	still	small)	effect	size	than	acceptance	and	self-compassion	 at	 post-intervention,	 and	 considered	 decentering	 the	 most	likely	mediator	of	change	in	distress	in	an	MBI	study	of	people	with	MS.	
 Decentering	 has	 been	 described	 as	 “the	 ability	 to	 step	 outside	 of	 one’s	immediate	 experience,	 thereby	 changing	 the	 very	 nature	 of	 that	 experience”	(Safran	&	Segal,	1990,	p.	117).	In	a	physical	disease	like	PD,	many	frightening	and	persistent	thoughts	can	dominate,	influencing	behaviour	and	psychosocial	outcomes	 (Julien,	 Rimes	 &	 Brown,	 2016).	 	 Certainly,	 some	 of	 the	 motor	symptoms	of	PD	can	be	dramatic	and	frightening	and	can	lead	to	worries	about	the	future	that	are	realistic	(Wright,	Hurt,	Gorniak,	&	Brown,	2015).		Despite	the	theoretical	 and	 plausible	 central	 role	 of	 decentering	 as	 a	 mechanism	 in	mindfulness	 interventions,	 it	 was	 not	 included	 as	 a	 construct	 in	 any	 of	 the	studies	examining	mindfulness	interventions	for	people	with	physical	disease	in	a	recent	review	(Alsubaie	et	al,	2017)	and	only	Bogosian	et	al	(2016)	have	been	able	 to	demonstrate	 that	decentering	may	be	an	 important	mediator	 in	
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chronic	 progressive	 illness	 and	 thus	 an	 important	 target	 for	 therapeutic	intervention.		
 Although	 Shapiro’s	 model	 of	 mindfulness	 includes	 decentering	 as	 the	 meta-mediator	between	mindfulness	and	psychological	outcomes,	this	present	study	examined	 a	 parallel	 model	 of	 mediation	 with	 all	 five	 mediators	 measured	simultaneously.			Graphs	of	means	over	the	four	time	points	(Figure	9)	show	that	there	was	more	change	in	decentering	between	baseline	and	mid-point	than	at	any	other	 time,	and	 this	was	confirmed	by	effect	 size	 in	descriptive	statistics	(Table	8),	suggesting		that	changes	in	decentering	levels	did	occur	earlier	than	in	other	mediators	or	outcomes,	adding	to	support	that	it	is	a	meta-mediator.	This	sequential	placement	in	the	causal	chain	was	challenged	by	Carmody	et	al	(2009),	who	used	some	of	the	FFMQ	to	measure	mindfulness	and	who	found	a	strong	 correlation	 between	 mindfulness	 levels	 and	 decentering,	 and	subsequently	 combined	 the	 two	 concepts.	 	 However,	 another	 student	 study	supported	 two	 separate	 constructs,	 and	 demonstrated	 that	 decentering	mediated	between	mindfulness	 levels	and	depressive	 symptoms	 (Gecht	et	al,	2014).			
	This	 present	 study	 has	 shown	 that	 decentering	 should	 be	 included	 in	 future	studies	 as	 a	 plausible	 mediator:	 participants	 randomised	 to	 MBI	 did	 have	increases	in	decentering	at	mid-point	that,	when	regressed	on	end	of	treatment	anxiety	 and	 depression	 levels,	 showed	 a	 mediating	 effect,	 although	 not	statistically	significantly,	however,	including	decentering	in	a	serial	mediation	model	would	examine	any	meta-mediation	role.		
	
Mindfulness	Skills	Assessing	 levels	 of	 mindfulness	 skills	 through	 self-report	 measures	 is		challenging	as	there	are	difficulties	with	shared	semantic	meaning	in	describing	mindfulness,	 as	well	 as	 social	 desirability	 bias	 (Grossman	&	Van	Dam,	 2011;	Jensen,	2012)	and	this	may	contribute	to	why	only	45%	of	MBIs	included	in	a	meta-analysis	 measured	mindfulness	 levels	 (Khoury	 et	 al,	 2013).	 	 However,	there	is		evidence	that	mindfulness	skills	are	an	important	link	within	the	causal	
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chain:	 self-report	mindfulness	 increased	 following	 an	MBI	 (Visted,	 Vøllestad,	Nielsen,	&	Nielsen,	2015),	mindfulness	skills	have	been	demonstrated	to	be	a	mediating	variable	between	 the	MBI	and	psychological	outcomes	 (Baer	et	 al,	2012;	Bränström	et	al,	2010;	Chiesa	et	al,	2014;	Gu,	Strauss,	Crane,	Barnhofer,	Karl,	Cavanagh,	&	Kuyken,	2016),	and	lower	levels	of	mindfulness	are	associated	with	people	high	in	GAD	(Roemer	et	al,	2009).	An	MBI	with	people	with	PD	and	their	carers	found	significant	increases	in	mindfulness	levels	(using	the	FFMQ)	for	both	types	of	participant,	and	the	PD	participants	reported	fewer	symptoms	of	 apathy	 and	 anxiety,	 as	well	 as	 improvements	 in	 PD	 related	 quality	 of	 life	(Cash,	Ekouevi,	Kilbourn,	&	Lageman,	2016).		However,	the	“observe”	construct	from	 the	 FFMQ,	which	 has	 been	 defined	 as	 noticing	 or	 attending	 to	 internal	experiences	and	is	a	proxy	for	attention,	was	the	only	facet	from	this	measure	of	mindfulness	skills	to	significantly	increase	eight	weeks	following	a	small-scale	trial	MBI	for	people	with	PD.					In	the	present	study	mindfulness	skills	became	more	strongly	correlated	with	anxiety	and	depression	in	the	MBI	group,	and	levels	of	mindfulness	increased	throughout	the	training,	as	expected,	showing	a	medium	strength	effect	size	at	the	end	of	the	intervention;	however,	by	follow-up,	there	was	a	small	reversal	in	trend,	 indicating	 that	 trait	 mindfulness	 may	 not	 be	 maintained	 without	intervention.				While	mindfulness	levels	have	been	shown	to	mediate	the	relationship	between	an	MBI		and	both	anxiety	and	depression	(Vøllestad,	Nielsen	&	Nielsen,	2012),	this	was	not	immediately	evident	in	this	present	study,	where	at	T2	mindfulness	levels’	 effects	 on	T3	 anxiety	 and	depression	were	 not	 beneficial,	 but	 implied	increased	 psychopathology.	 	 	 By	 T4	 (for	 outcomes),	mindfulness	 levels	were	showing	an	increased	positive	effect	from	the	trial	arm,	and	the	negative	effect	on	T4	distress	levels	had	decreased	to	very	small	levels.	Baseline	mindfulness	skills	 did	 not	 predict	 baseline	 anxiety	 but	 did	 predict	 baseline	 depression,	uniquely	 contributing	 3.8%	 to	 the	 variance,	 however,	 the	 overall	 levels	 of	anxiety	and	depression	in	this	sample	were	not	at	case	levels,	and	indeed	were	
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very	close	to	normal	levels,	meaning	there	could	have	been	a	floor	effect,	and	this,	as	well	as	time-lagging,	may	have	contributed	to	this	unexpected	mediation	effect.		Other	studies	have	also	reported	no	mediation	effect	of	mindfulness	skills	(for	instance	Labelle,	Campbell,	Faris,	&	Carlson	(2015)	in	a	cancer	study):	only	two	out	 of	 the	 four	mediation	 analyses	 of	 the	 effects	 of	mindfulness	 for	 physical	illnesses	 identified	 in	 Alsubaie	 et	 al’s	 (2017)	 review	 found	 that	mindfulness	levels	mediated	 the	 effects	 of	 the	MBI	 on	 stress,	 depression	 and	 anxiety	 and	psychosocial	adjustment	in	breast	cancer	and	cardiology	(Bränström	et	al,	2010;	O’Doherty	et	 al,	 2015).	Heterogeneity	 in	mindfulness	measures	and	 concepts	have	been	suggested	to	be	factors	in	these	inconsistent	effects	(Alsubaie	et	al,	2017),	 and	 this	 present	 study’s	 inclusion	 of	 the	 rarely	 used	 Philadelphia	Mindfulness	Scale	limits	comparison	with	previous	studies	(Visted	et	al,	2015).	The	PHLMS	also	focuses	on	present	moment	awareness	(and		acceptance)	and	in	 this	 present	 study	 is	 intended	 to	measure	 the	 self-regulation	 construct	 in	Shapiro’s	model,	and	is	a	representation	of	emotional	regulation.				Emotional	 regulation	 in	 people	with	PD	has	 been	 an	 area	 of	 recent	 research	growth	(Sotgiu	&	Rusconi,	2013),	and	studies	have	demonstrated	that	some	PD	patients	 without	 dementia	 or	 depression	 have	 dysfunction	 in	 angry	 faces	recognition	and	anger	control,	and	that	this	is	associated	with	disease	duration	(Ille	et	al,	2016).		Alexithymia	has	also	been	significantly	associated	with	disease	stage	 in	 PD	 patients,	 including	 a	 difficulty	 in	 externally	 oriented	 thinking	(Bogdanova	 &	 Cronin-Golomb,	 2013).	 These	 difficulties	 with	 emotional	regulation,	 which	 increase	 with	 disease	 progression,	 may	 contribute	 to	explaining	 the	present	 study’s	 	 findings	of	moderation	of	 the	mediation	path	between	trial	arm	and	mindfulness	skills	by	years	since	diagnosis.	Mindfulness	skills,	 as	measured	by	 the	PHLMS,	 are	 theorised	 to	 include	 awareness	 in	 the	present	moment,	conducted	non-judgementally,	which	must	include	being	able	to	regulate	emotions	associated	with	distressing	experiences	or	cognitions,	thus	an	 increase	 in	mindfulness	 skills	would	 lead	 to	enhanced	emotion	regulation	
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(Hayes	&	Feldman,	2004).			If	emotional	processing	is	compromised,	it	follows	that	augmenting	mindfulness	skills,	which	include	being	non-judgemental,	and	regulating	the	emotional	response,	are	also	compromised.		Assessing	whether	taking	part	 in	an	MBI	 increases	specific	mindfulness	skills	and	whether	 certain	 skills	were	more	 accessible	 to	 people	with	 Parkinson’s,	would	 enable	 improved	 future	 intervention	 design.	 	 However,	 this	 seems	unlikely	without	 consensus	 on	mindfulness	 concepts,	 and	measures,	 and	 the	development	 of	 interventions	 that	 combine	 more	 accessible	 and	 palatable	neuro-functional	 imaging	 with	 self-report	 findings	 as	 suggested	 by	 Kazdin	(2011).		The	challenge	of	defining	mindfulness	levels,	in	all	its	complexity,	has	been	 aptly	 described	 as	 “the	 integration	 of	 Western	 evidence-based	psychological	tradition	with	a	Buddhist	phenomenological	orientation”	(Chiesa,	2012).		
Self-compassion	
	While	mindfulness	 skills	 and	 self-compassion	 have	 been	 shown	 to	 be	 highly	correlated,	with	self-compassion	to	be	the	stronger	predictor	of	psychological	health	 (Chiesa	 et	 al,	 2010;	 Van	 Dam	 et	 al,	 2010),	 in	 this	 present	 study,	mindfulness	levels	only	became	strongly	correlated	with	self-compassion	in	the	MBI	group	as	the	intervention	ended,	and	the	correlation	strength	continued	at	follow-up,	and	both	self-compassion	and	mindfulness	skills	were	predictive	of	depression	at	baseline	but	not	predictive	of	anxiety.	This	contrasts	with	findings	from	Hoge	et	al	(2013)	who	found	that	both	mindfulness	and	self-compassion	were	associated	with	generalised	anxiety	disorder	and	concluded	that	higher	self-compassion	 indicates	 better	 acceptance	 of	 limitations	 imposed	 by	 the	disorder.			
	This	 present	 mediation	 analysis	 showed	 that	 self-compassion	 at	 T2	 and	 T3	predicted	 lower	 levels	of	depression	at	T3	and	T4,	 and	only	predicted	 lower	levels	of	anxiety	at	T4.		As	in	Bogosian’s	et	al	(2016)	study	of	MS	patients,	levels	of	 self-compassion	 continued	 to	 increase	 throughout	 the	 intervention	 and	 at	
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follow-up,	 showing	 a	 small	 effect,	 reflecting	 the	 slow	 development	 of	 self-compassion.			Mediation	analysis	demonstrated	that	the	indirect	effect	of	self-compassion	 	at	 the	end	of	 the	 intervention	was	the	only	mediator	 to	have	an	effect	 in	 a	 positive	 direction,	 that	 is	 in	 predicting	 reduced	 depression	 and	anxiety	 at	 follow-up,	 however,	 the	 confidence	 intervals	 for	 these	 effects	straddled	zero.		While	this	study	was	followed	up	at	20	weeks,	self-compassion	has	been	found	to	continue	to	be	a	significant	mediator	(along	with	mindfulness	levels)	between	an	MBI	and	depressive	symptomology	at	15	months	(Kuyken	et	al,	 2015),	 raising	 the	 possibility	 of	 even	 greater	 effect	 when	 follow-ups	 are	extended.				
 Older	people	are	more	likely	to	have	developed	self-compassion	and	this	may	buffer	against	adverse	events	(Neff,	2009)	and	self-compassion	has	been	shown	to	moderate	the	relationship	between	physical	health	and	subjective	well-being	in	 older	 adults,	 and	 high	 self-compassion	 to	 be	 associated	 with	 better	adjustment	to	disability	(Allen	&	Leary,	2010)	in	a	cross-sectional	study	of	older	people	 with	 self-compassion	 moderating	 the	 relationship	 between	 overall	health	 and	 depression.	 However,	 the	 older	 people	 in	 those	 studies	were	 not	reported	 to	 have	 chronic	 disease,	 	 which	 may	 explain	 why,	 in	 this	 present	research,		in	a	sample	of	older	people	living	with	PD,	age		did	not	moderate	the	relationship	of	trial	arm	and	self-compassion.			Higher	levels	of	self-compassion	are	also	associated	with	lower	stress	and	more	engagement	in	health	promoting	behaviours,	which	in	turn	had	a	positive	effect	on	physical	health	(Homan	&	Sirois,	2017).		Further	evidence	of	the	role	of	self-compassion	in		adjustment	to	chronic	illness	has	been	demonstrated	in	women	with	 IBS	 or	 arthritis,	 those	with	 higher	 self-compassion	were	 found	 to	 have	more	 adaptive	 coping	 styles	 (Sirois,	 Molnar,	 &	 Hirsch,	 2015).	 A	 similar	association	was	found	in	people	with	HIV	and	higher	self-compassion,	who	were	more	willing	 to	adopt	 safer	health	practices	and	 reported	 less	 shame	 (Brion,	Leary	&	Drabkin,	2014).			
 
 114 
High	levels	of	shame	and	perceptions	of	stigma	are	prevalent	in	people	with	PD,	with	both	motor	symptoms	and	non-motor	symptoms	causing	embarrassment	and	social	 isolation	 (Nijhoff,	1995;	Simpson,	Macmillan,	&	Reeve,	2013),	 thus	developing	 self-compassion	 could	 increase	 positive	 adaption,	 and	 could	enhance	quality	of	life	and	reduce	distress.		While	there	is		a	lack	of	statistical	significance	in	the	test	of	mediation	by	self-compassion	 reported	 here,	 there	 is	 evidence	 of	 a	 positive	 trend	 in	 self-compassion	 slowly	 developing	 and	maintaining	 stability	 after	 the	 end	 of	 the	intervention,	 making	 self-compassion	 a	 compelling	 construct	 within	 the	mindfulness	 intervention	process.	 	However,	 the	dearth	of	evidence	that	self-compassion	 is	 a	 significant	 mediator	 in	 MBIs	 (Gu	 et	 al,	 2015)	 has	 led	 to	recommendations	that	different	roles	should	be	explored	for	this	construct,	and	it	has	been	suggested	as	a	moderating	variable	(Homan,	2016),	who	found	that	self-compassion	 moderated	 between	 self-report	 health	 and	 depression.		Another	possible	mechanism	of	self-compassion	may	be	that	it	has	a	direct	effect	on	psychological	outcomes;	in	a	study	of	the	effect	of	self-compassion	in	people	with	multiple	sclerosis	on	health-related	quality	of	life,	the	effect	was	both	direct	and	also	indirect	through	resilience	levels	(Nery,	Hurwit,	Yun,	&	Ebbeck,	2018).			
 
Intolerance	of	Uncertainty	
 In	health	settings,	the	IU	construct	broadly	describes	how	people		cope	with	not	knowing	what	the	future	holds,	whether	in	diagnosis,	symptomology,	treatment,	disability,	social	environment,	and	even	mortality.		Technological	advances	and	mass	media	have	increased	treatment	choices	and	access	to	information,	while	at	 the	 same	 time	 the	 patient	 faces	 a	 growing	 burden	 of	 decision-making.		Uncertainty	has	been	shown	to	provoke	greater	anxiety	and	fear	and	decision-avoidance	and	is	conceptualised	as	a	dispositional	fear	of	the	unknown	(Dugas,	Gagnon,	 Ladouceur,	 &	 Freeston,	 1998;	 Buhr	 &	 Dugas,	 2006;	 Carleton,	 2012;	Carleton	2016).		In	line	with	IU’s	relationship	with	distress	intolerance,	Carlson	(2012)	 suggests	 that	 exposure	 to,	 or	 increasing	 tolerance	 to,	 symptoms	 or	feelings	that	are	avoided	because	of	the	uncomfortable	feelings	they	provoke,	
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could	be	a	mechanism	of	change	that	could	be	targeted	in	interventions.			It	has	been	suggested	that	increased	mindfulness,	through	interventions,	reduces	the	perceived	threat	of	physical	symptoms	of	anxiety,		and	that	this	relationship	is	mediated	 by	 reductions	 in	 intolerance	 of	 uncertainty	 (Kraemer	 et	 al,	 2016).		Many	 of	 the	motor	 and	 non-motor	 symptoms	 of	 PD	 are	 transitory,	 yet	 very	frightening,	including	freezing	of	gait	and	hallucinations,	and	being	able	to	target	and	 reduce	 the	 impact	 of	 the	 	 perception	 of	 these	 symptoms	 would	 reduce	patients’	distress.		Most	 studies	 examining	 the	 role	 of	 IU	 have	 been	 conducted	 on	 non-clinical	populations,	 or	 with	 participants	 with	 anxiety	 and	 depression	 disorder.		Following	 a	 chronic	 illness	 diagnosis,	 patients	 experience	 disruption	 to	certainty	 and	 control,	 which	 may	 be	 moderated	 by	 coherent	 information,	accurate	 prognosis,	 and	 effective	 talking	 therapy	 (Grupe	 &	 Nitschke,	 2013).			Uncertainty	pervades	all	of	the	experience	of	living	with	PD,	both	for	the	patient	and	 for	 family	 members.	 Ravenek,	 Rudman,	 Jenkins,	 &	 Spaulding	 (2017)	qualitatively	 examined	 39	 people	with	 young-onset	 PD	 and	 found	 two	 areas	where	uncertainty	was	problematic:		the	change	in	identity	caused	by	having	the	disease,	and	the	uncertainty	of	charting	disease	progression	and	therefore	life	goals.		
 Intolerance	of	uncertainty	has	been	shown	to	be	a	transdiagnostic	feature	across	both	anxiety	and	depression	(McEvoy	&	Mahoney,	2011;	Carleton	et	al,	2012;	Kertz	et	al,	2015)	as	well	as	a	 transdiagnostic	risk	 factor	maintaining	anxiety	and	depression	(Vander	Haegen	&	Etienne,	2016).		In	people	with	PD,	IU	along	with	activities	of	daily	living,	positive	beliefs	about	worry,	metacognitions	about	uncontrollability,	 and	 lack	of	 cognitive	 confidence	were	predictive	 of	 anxiety	(Brown	&	Fernie,	2014).			The	treatment	effect	on	IU	in	this	present	study	was	small	and	positive	at	mid-intervention,	 meaning	 that	 being	 in	 the	 intervention	 group	 led	 to	 worse	intolerance,	 but	 very	 slightly	 negative	 at	 post-intervention	 and	 negligible	 at	follow-up,	 thus	 no	 effect	 by	 trial	 arm	 can	 be	 claimed.	 However,	 this	 present	
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study	also	suggests	that	IU	is	associated	with	and	predictive	of	both	anxiety	and	depression:	a	linear	multiple	regression	revealed	that	when	all	other	variables	were	controlled	 for,	 IU	at	T1	narrowly	missed	being	a	statistically	significant	predictor	of	both	baseline	anxiety	and	baseline	depression,	and	IU	measured	at	T3	significantly	predicted	both	anxiety	and	depression	at	follow-up,	but	as	there	was	little	effect	on	IU	levels	by	trial	arm,	mediation	by	IU	cannot	be	assumed.			This	present	study	has	also	demonstrated	a	relationship	between		mindfulness	skills	 and	 intolerance	 of	 uncertainty;	 correlations	 showed	 associations	 that	were	 weak	 and	 not	 significant	 at	 T1,	 but	 which	 increased	 in	 strength,	 in	particular	in	the	MBI	group,	until	moderate	and	significant	at	T4,	suggesting	that	acquiring	mindfulness	skills	may	increase	tolerance	of	uncertainty.		A	mediation	study	that	measured	the	exposure	element	of	Shapiro’s	model	with	the	Distress	Tolerance	Scale	(Simons	&	Gaher,	2005),	found	significant	mediation	between	mindfulness	facets	and	anxiety,	depression	and	stress	(Brown,	Bravo,	Roos	et	al,	2015).	 	 These	 authors	 also	 reported	 that	non-judgement	of	 inner	 experience	was	the	facet	of	the	FFMQ	that	was	most	closely	associated	with	exposure,	and	this	adds	support	to	the	inclusion	of	IU	in	this	present	study,	as	the	construct	representing	exposure,	as	non-judgement	of	whether	a	situation	is	threatening	or	not	could	also	be	interpreted	as	tolerating	an	unknown	future.					However,	the	role	of	IU	in	psychopathology	models	remains	unclear:	mediation	analyses	have	 shown	 that	 IU	mediates	 the	effects	of	distress	 intolerance	and	worry	 in	 an	 undergraduate	 sample	 (Kertz	 et	 al,	 2015),	 but	 IU	 has	 also	 been	identified	 as	 a	 moderator	 of	 the	 relationship	 between	 catastrophic	 health	appraisals	 and	 health	 anxiety	 outcomes	 in	 a	 student	 sample	 (Fergus	 &	Valentiner,	 2011),	 and	 in	 a	 PD	 sample,	 metacognitions	 concerning	uncontrollability	 and	 danger	 were	 predictive	 of	 off-period	 distress	 after	controlling	for	disease	parameters,	IU	and	predictability,	suggesting	that	IU	may	be	 a	moderator	 of	 the	 cognitive	 response	 rather	 than	 a	mediator	 (Brown	&	Fernie,	2015).		
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Never	 the	 less,	 levels	 of	 intolerance	 of	 uncertainty	 have	 been	 shown	 to	 be	adaptable:	 	 a	 CBT	 intervention	 for	 people	 with	 panic	 disorder,	 generalised	anxiety	disorder	and	social	anxiety	disorder,	and	a	third	of	whom	had	secondary	depressive	disorder,	demonstrated	that	all	diagnostic	groups	showed	lower	IU	following	 treatment,	and	greater	reduction	 in	 IU	was	associated	with	greater	treatment	 gains	 (Talkovsky	 &	 Norton,	 2016).	 	 	 A	 recent	 review	 of	 tolerance	measures	recommends	that	there	is	a	need	to	operationalise	uncertainty	as	a	more	umbrella	construct	than	ambiguity	–	as	a	metacognitive	state	of	conscious	awareness	of	 ignorance,	with	ambiguity	as	a	subordinate	phenomenon	and	a	feature	 of	 information	 (Hillen,	 Gutheil,	 Stout,	 Smets,	 &	 Han,	 2017).	 	 These	authors	have	recommended	that	uncertainty	tolerance	measures	are	specified	for	particular	populations	to	encompass	the	complexity	of	healthcare,	and		to	be	person-specific,	 however	 there	 has	 yet	 to	 be	 any	 new	metrics	 advanced,	 let	alone	any	for	neurological	conditions		like	PD.		While	this	study	has	only	shown	a	very	small	effect	of	trial	arm	on	IU	levels	at	T3,	and	there	is	no	treatment	effect	at	T4,	the	role	of	IU	as	a	mediator	between	mindfulness	interventions	and	psychological	outcomes	cannot	be	supported	–	however,	this	study	has	demonstrated	that	IU	plays	some	role	in	reducing	both	anxiety	and	depression	levels	in	people	with	PD,	and	that	it	is	associated	with	trait	mindfulness.	 	 IU	remains	a	plausible	and	potentially	 important	 factor	 in	distress	in	people	with	PD.		
7.3 Study	limitations	
 The	 self-selected	 sample	 included	 in	 this	 present	 study	 had	 low	 levels	 of	baseline	distress,	with	most	participants	being	below	case	level	(HADS	³11)	at	leaving	little	scope	for	significant	improvement.		A	moderating	effect	of	baseline	depression	levels	on	the	treatment	effect	of	an	MBI	on	levels	of	anxiety	has	been	demonstrated	 in	 a	 study	 of	 people	 with	 anxiety	 disorder,	 with	 those	 with	significant	 levels	 of	 baseline	 depression	 benefitted	more	 from	 a	mindfulness	intervention	than	from	a	comparator	CBT	intervention,	while	the	reverse	was	true	 for	people	with	 low	 levels	of	baseline	depression	 (Arch	&	Ayers,	 2013).	
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Recruiting	future	participants	in	future	trials	with	clinical	levels	of	anxiety	and	depression	would	improve	ecological	validity	and	would	increase	the	possibility	of	significant	results.				
7.4 Future	considerations		It	is	interesting	to	note	that	the	direct	effect	of	the	trial	arm	on	anxiety	at	T3	was	very	slightly	positive	but	not	statistically	significant	(c’=.02,	SE=.09,	p=.83,	CI=-.16,	.20),	while	the	total	effect	of	the	trial	arm	on	anxiety	levels	showed	change	in	the	expected	direction	(c=-.04,	SE=.09,	p=.64,	CI=-.22,	.13),	suggesting	that	the	reduction	 in	 anxiety	 levels	were	 fully	mediated	 by	 the	moderating	 variables	(T2),	 and	 on	 closer	 inspection	 of	 the	 indirect	 effects,	 these	were	 acceptance,	decentering,	and	mindfulness	levels	(although	none	of	the	confidence	intervals	straddled	zero),	but	not	self-compassion	or	intolerance	of	uncertainty.	 	These	five	mediators,	however,	showed	a	reverse	pattern	at	T4	for	both	anxiety	and	depression,	 with	 only	 self-compassion	 and	 intolerance	 of	 uncertainty	contributing	to	reducing	levels	of	the	outcomes.		It	may	be	inferred	that		without	active,	organised	mindfulness	intervention,	any	improvements	in	distress	levels	may	not	be	maintained	by	acceptance,	decentering	and	mindfulness	skills,	and	that	 self-compassion	 and	 intolerance	 of	 uncertainty	 continue	 to	 develop	 and	influence	 distress.	 	 Any	 qualitative	 data	 collected	 as	 this	 present	 study	 was	conducted,	as	well	as	practice	diaries,		could	contribute	to	understanding	why	these	changes	occurred	between	end	of	intervention	and	follow-up.				Self-compassion	 may	 be	 a	 promising	 target	 construct	 for	 interventions:	 an	eight-week	 intervention,	 Mindful	 Self-Compassion,	 similar	 to	 MBIs	 but	 with	greater	 emphasis	 on	 developing	 self-compassion,	 found	 a	 large	 effect	 post-intervention	 in	 self-compassion	 (measured	 by	 SCS)	 (d=1.67)	 which	 was	associated	with	reductions	in	anxiety,	depression	and	stress.	Significantly,		levels	of	self-compassion	remained	high	at	6	months	and	1-year	follow-ups	(Neff	&	 Germer,	 2013).	 As	 the	 results	 of	 the	 present	 study	 indicate	 that	 self-compassion	was	 slow	 to	 cultivate,	 but	 that,	 unlike	 three	 other	 constructs,	 it	
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continued	to	contribute	to	reducing	distress	at	the	20-week	time-point,	it	may	play	 an	 important	 role	 in	 effective	 treatment	 in	 people	 with	 PD.	 	 Further	longitudinal	 trials	 examining	 the	 role	 of	 intolerance	 of	 uncertainty	 in	mindfulness-based	 interventions	 are	 also	 warranted,	 as	 this	 too	 may	demonstrate	 greater	 stability	 following	 intervention	 than	 acceptance,	decentering	and	mindfulness	skills.		Future	 large-scale	 studies	may	aim	 to	 recruit	participants	who	may	be	more	responsive	to	this	 intervention.	 	While	 in	this	study,	moderation	of	the	direct	effect	 by	 gender	 was	 demonstrated,	 and	 women	 in	 the	 intervention	 group	benefitted	very	slightly	more	from	the	intervention,	replicating	an	effect	found	in	 an	 MBI	 study	 including	 people	 with	 diabetes	 (Nyklicek,	 van	 Son,	 Pop,	Denollet,	 &	 Pouwer,	 2016)	 and	 students	 (Rojiani	 et	 al,	 2017),	 there	 is	 no	suggestion	that	men	should	be	excluded	from	further	interventions.			However,	moderation	 of	 the	mediators	 themselves	 indicate	 that	 there	may	 be	 specific	subsets	 within	 this	 sample	 who	 are	 more	 likely	 to	 develop	 acceptance	 and	mindfulness	skills.		Positive	changes	to	acceptance	were	shown	to	be	conditional	on	participants	 in	 the	 intervention	 arm	being	under	57.7	 years	old,	 and	 also	conditional	on	participants	being	within	2.7	years	of	diagnosis,	and	people	who	had	 been	 diagnosed	 over	 12.5	 years	 before	 were	 significantly	 less	 likely	 to	acquire	 	 higher	 acceptance.	 Improvements	 in	 mindfulness	 skills	 were	 also	conditional	on	how	long	the	participant	in	the	intervention	had	been	diagnosed,	with	under	7.5	years	being	the	optimal	period.				There	is	evidence	that	both	age	and	time	since	diagnosis	correlate	with	decline	in	cognitive	functioning	in	people	with	PD	(Pedersen	et	al,	2017),	in	particular	with	 decline	 in	 executive	 functioning	 which	 is	 not	 always	 evident	 in	 daily	functioning	(Papagno	&	Trojano,	2017;	Kudlicka,	Clare	&	Hindle,	2012;	Miller,	Neargarder,	Risi	&	Cronin-Golomb,	2013).		PD	mild	cognitive	impairment	(PD-MCI)(Litvan	et	al,	2012)	has	been	suggested	to	affect	up	to	57%	of	people	with	PD	within	3-5	years	of	diagnosis	(Williams-Gray,	Foltynie,	Brayne,	Robbins,	&	Barker,	2007).		In	our	sample,	over	half	the	participants	had	been	diagnosed	for	
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over	 five	 years	 (54%),	 and	 only	 33%	 were	 under	 60,	 with	 19%	 over	 70.		Undertaking	mindfulness	training	requires	commitment,	time	and	is	cognitively	challenging	 (Segal	 et	 al,	 2002)	 and	 in	 particular,	 it	 has	 been	 suggested	 that	changing	metacognitions	can	be	particularly	challenging	for	some	people	with	PD	 (Brown	 &	 Fernie,	 2014).	 	 Identifying	 MCI	 prior	 to	 intervention	 should	include	measures	of	executive	functioning	and	speed	of	processing,	which	are	lacking	 in	 the	 screen	used	 in	 this	present	 study	 (TICS-M,	Brandt	 et	 al,	 1988)	(Crooks,	 Petitti,	 &	 Buckwalter,	 2006).	 	 A	 telephone	 version	 of	 the	 Montreal	Cognitive	Assessment	(MoCA)	(Pendlebury,	Welch,	Cuthbertson,	Mariz,	Mehta,	&	Rothwell,	2013)	has	been	developed,	and	the	original	test	has	been	endorsed	in	PD	populations	(Dalrymple-Alford,	2010)	as	sensitive	to	PD-MCI.		Improved	screening	 would	 increase	 the	 likelihood	 of	 participants	 showing	 greater	treatment	 effects,	 but	 may	 also	 contribute	 to	 better	 trial	 retention,	 as	 the	participant	may	also	be	able	to	engage	better	with	the	standard	MBI	course.		It	 should	 also	 be	 noted	 however,	 that	 MBIs	 	 have	 been	 found	 to	 improve	cognitive	function	in	older	people	(Smoski,	McClintock	&	Keeling,	2016)	and	in	people	with	PD	(Cash	et	al,	2015;	Dissanayaka	et	al,	2016;	Paris	et	al,	2011),	and	there	 is	 brain	 imaging	 evidence	 to	 support	 increased	 grey	 matter	 following	interventions	(Pickut	et	al,	2013).	Stricter	screening	for	cognitive	impairment	may	also	exclude	some	people	who	may	benefit	from	participation. 	Engagement	with	MBIs	for	people	with	PD	may	also	depend	on	their	perceptions	of	how	much	 their	condition	affects	 their	activities	of	daily	 living.	While	self-report	baseline	disability	levels	did	not	moderate	either	the	direct	or	indirect	effects	of	 the	 trial	 arm	on	 levels	of	 anxiety	 and	depression,	participants	who	reported	 worse	 levels	 of	 disability	 at	 baseline	 were	 found	 to	 attend	 fewer	sessions	 	 in	 this	MBI,	 and,	 some	 of	 their	 data	 was	 then	 lost	 to	 the	 analysis.	Understanding	what	 barriers	 people	with	 PD	 have	 in	 engaging	with	MBIs	 is	important,	 whether	 they	 be	 the	 motor-symptoms	 themselves,	 cognitive	 and	emotional	 processing	 challenges	 because	 of	 age	 and	 	 disease	 progression,	 in	
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order	 to	 ensure	 that	 more	 PD	 patients	 who	 can	 benefit	 from	 a	 non-pharmacological	treatment	are	able	to	access	training	at	the	right	time.	
 	
 
8 CONCLUSION	
 This	exploratory	study	of	data	selected	from	a	randomised,	controlled	pilot	trial	of	an	MBCT	intervention	for	people	with	PD,	has	shown	that	evaluations	of	the	mechanisms	 of	 mindfulness	 interventions	 in	 this	 population	 should	 include	acceptance,	 decentering,	 self-compassion.	 These	 constructs	 have	 been	demonstrated	to	be	responsive	to	the	MBCT	intervention,	to	be	associated	with	the	 psychological	 outcomes,	 and	 simple	 analyses	 suggest	 that	 they	 may	 be	plausible	mediating	variables	between	the	MBI	and	the	outcomes,	although	no	statistically	significant	mediation	effects	were	observed.		There	was	a	medium-sized	 treatment	 effect	 on	mindfulness	 skills	 at	 the	 end	 of	 the	 trial,	 however,	mediation	 analysis	 only	 showed	 a	 very	 small	 indirect	 effects,	 the	 role	 of	mindfulness	 skills	 in	 the	 causal	 chain	 remains	 unclear.	 Also,	 intolerance	 of	uncertainty	demonstrated	only	a	very	small	treatment	effect	at	the	end	of	the	intervention,	 	 but	 did	 show	 	 an	 association	with	mindfulness	 levels	 and	 the	psychological	outcomes,	and	remains	a	plausible	target	for	interventions	aiming	at	 reducing	 distress	 in	 people	with	 PD.	 	 However,	 further	 exploration	 of	 the	mediation	 and	moderation	paths	 through	 Structural	 Equation	Modelling	 in	 a	future	 full-size	 trial	 would	 increase	 understanding	 of	 these	 complex	relationships	to	enable	tailored	interventions	for	different	health	populations,	including	people	with	PD.		This	 study	 has	 also	 examined	 the	 moderation	 of	 the	 effect	 of	 trial	 arm	 on	outcomes	 and	 found	 that	 the	 trial	 arm’s	 direct	 effect	 on	 anxiety	 levels	 was	moderated	by	gender	–	women	randomised	to	the	intervention	reported	lower	levels	of	anxiety.		The	trial	arm’s	effect	on	acceptance	levels	was	moderated	by	time	since	diagnosis	and	also	by	the	age	of	the	participant,	with	younger,	newly	diagnosed	people	with	PD	having	greater	gains	in	acceptance.		Alongside	this,	
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people	in	the	intervention	arm	who	had	more	recently	been	diagnosed	were	also	more	likely	to	have	higher	levels	of	mindfulness	skills.	 	These	results	indicate	that	an	MBI	may	be	more	effective	in	the	early	stages	of	PD,	and	that	cognitive	decline,	 a	 feature	 of	 both	 aging	 and	 disease	 progression,	may	 play	 a	 part	 in	participants’	ability	to	benefit	from	and	indeed	to	participate	in	and	complete,	this	type	of	therapy.			This	 study	has	 contributed	 towards	understanding	how	people	with	PD	may	benefit	from	a	mindfulness	intervention	but	has	only	examined	a	small	part	of	the	 collected	 data	 which,	 when	 all	 qualitative	 and	 quantitative	 analyses	 are	synthesised,	 will	 provide	 deeper	 insight	 into	 how	 this	 form	 of	 therapy	 may	improve	non-motor	symptoms		in	Parkinson’s	disease.		26511	words	
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B1.	Internal	reliability	of	outcome	and	putative	mediator	measures	
	
		
HADS	A	Hospital	Anxiety	and	Depression	Scale	 a	=	0.83		Bjelland,	Dahl,	Haug,	&	Neckelmann,	2002	 a	=	0.83	good	HADS	D	Hospital	Anxiety	and	Depression	Scale	 a	=	0.82		Bjelland,	Dahl,	Haug,	&	Neckelmann,	2002	 a	=	0.76	acceptable	AAQ	II	Acceptance	Action	Questionnaire	II	 a	=	0.84	Bond	et	al,	2011.		 a	=	0.90	very	good	EQ	Experiences	Questionnaire	 a	=	0.90	Fresco	et	al,	2007.		 a	=	0.85	good	PHLMS		The	Philadelphia	Mindfulness	Scale	 a	=	0.86	Cardaciotto,	Herbert,	Forman,	Moitra,	Farrow,	2008.		
Time	1	a	=	0.61	Time	2	a	=	0.69	Time	3	a	=	0.74	Time	4	a	=	0.77		Time	3	and	4	acceptable	SCS	Self-Compassion	Scale	 a	=	0.86	Raes,	Pommier,	Neff	&	Van	Gucht,	2011.	 a=	0.89	very	good	IU-12	Intolerance	of	Uncertainty	Scale	–	short	form		 a	=	0.91	Carleton,	Norton	&	Asmundson,	2007.	 a	=	0.89	very	good	
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B2	–	Proportion	of	sample	with	normal,	mild,	moderate	and	
severe	levels	of	anxiety	at	baseline	
	
HADS		
anxiety	level	
Total		
(n=78,	%)	
MBI		
(n=40,	%)	
WLC		
(n=38,	%)	Normal	≤7	 37						47.5%	 15							37.5%	 22								58%	Mild	8-10	 21							27%	 16							40%	 5											13%	Moderate	11-14	 15							19%	 6										15%	 9											24%	Severe	15-21		 5											6.5%	 3												7.5%	 2												5%	
	
	
B3	–	Proportion	of	sample	with	normal,	mild,	moderate	and		
severe	levels	of	depression	at	baseline	
	
HADS		
depression	level	
Total		
(n=78,	%)	
MBI		
(n=40,	%)	
WLC		
(n=38,	%)	Normal	≤7	 52						66.5%	 23								57.5%	 29									76%	Mild	8-10	 14								18%	 8											20%	 6										15.5%	Moderate	11-14	 10									13%	 8												20%	 2													5%	Severe	15-21		 2												2.5%	 1													2.5%	 1													2.5%			
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Appendix	B4	-Correlations		Groups	T1	
WL	control	 1	 2	 3	 4	 5	 6	 7	 8	 9	 10	 11	 12	1.				Anxiety		 	 33%	 61%	 41%	 55%	 2% 49% 2% 7% 1% 2% 12% 2. Depression	 .58**	 	 25%	 18%	 40%	 10%	 36% <1% <1% 12% 19% 43% 3. Acceptance	 -.78**	 -.50**	 	 53%	 50%	 3%	 46%	 <1%	 5%	 1%	 1%	 9%	4. Decentering	 -.64**	 -.42*	 .73**	 	 56%	 6%	 35%	 3%	 3%	 <1%	 <1%	 7%	5				Self-compassion	 -.74**	 -.63**	 .71**	 .75**	 	 4%	 45%	 <1%	 10%	 <1%	 2%	 12%	6. Mindfulness	Skills	 -.15	 -.32	 .17	 .25	 .20	 	 <1%	 4%	 <1%	 <1%	 2%	 2%	13. Intol.	of	Uncertainty	 .70**	 .60**	 -.68**	 -.59	 -.67**	 .09	 	 <1%	 1%	 <1%	 <1%	 17%	14. Gender	 .14	 .06	 .08	 -.17	 -.04	 .19	 -.03	 	 10%	 7%	 5%	 1%	15. Age	 -.27	 -.09	 .23	 .18	 .32*	 .09	 -.19	 .31	 	 12%	 <1%	 4%	16. Years	since	diagnosis	 -.12	 .35*	 .12	 .05	 .07	 -.09	 .09	 .26	 .35	 	 5%	 34%	17. Mood	medication	 -.13	 .44**	 -.12	 -.09	 -.14	 -.15	 .02	 -.22	 -.005	 .23	 	 12%	18. Self-report	disability	 .35*	 .66**	 -.30	 -.26	 -.35*	 -.15	 .41*	 .10	 .20	 .58**	 .34*	 		
MBI	intervention	 1	 2	 3	 4	 5	 6	 7	 8	 9	 10	 11	 12	1.				Anxiety		 	 35%	 42%	 19%	 21%	 5% 34% 1% 4% 3% <1% 13% 2. Depression	 .59*	 	 28%	 15%	 28%	 11%	 25% 7% <1% 8% 1% 24% 3. Acceptance	 -.65**	 -.53**	 	 61%	 62%	 16%	 43%	 <1%	 4%	 <1%	 <1%	 5%	4. Decentering	 -.44**	 -.39*	 .78**	 	 51%	 6%	 44%	 <1%	 4%	 <1%	 <1%	 3%	5					Self-compassion	 -.46**	 -.53**	 .79**	 .72**	 	 4%	 30%	 1%	 4%	 <1%	 <1%	 8%	6.				Mindfulness	Skills	 -.23	 -.33*	 .40*	 .24	 .20	 	 1%	 3%	 4%	 1%	 <1%	 <1%	7. Intol.	of	Uncertainty	 .58**	 .50**	 -.66**	 -.66**	 -.55**	 -.10	 	 1%	 5%	 6%	 <1%	 28%	8. Gender	 .10	 -.27	 .08	 .03	 0.10	 .17	 .12	 	 <1%	 3%	 5%	 <1%	9. Age	 -.21	 .003	 .21	 .21	 0.20	 -.20	 -.23	 .01	 	 2%	 3%	 1%	10. Years	since	diagnosis	 .17	 .28	 -.08	 -.09	 .002	 .12	 .25	 .16	 .14	 	 3%	 29%	11. Mood	medication	 .02	 .10	 .02	 .08	 .02	 .001	 -.09	 -.23	 .17	 .17	 	 2%	12. Self-report	disability	 .36*	 .49**	 -.23	 -.18	 -.28	 .01	 .53**	 -.05	 -.11	 .54**	 .14	 	**Correlation	is	significant	at	the	0.01	level	(2-tailed).		*	Correlation	is	significant	at	the	0.05	level	(2-tailed).	R2	reported	as	a	percentage,	indicating	variance	explained.	R2	values	of	1%	to	8%:	small;	9%	to	24%:	medium;	25%	to	100%:	large.	
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Appendix	B5	Correlations	Groups	T2	
WL	control	 1	 2	 3	 4	 5	 6	 7	 8	 9	 10	 11	 12	1.			Anxiety		 	 58%	 48%	 35%	 41%	 <1%	 27%	 8%	 3%	 <1%	 6%	 19%	2.			Depression	 .76**	 	 38%	 33%	 38%	 1%	 25%	 1%	 <1%	 5%	 33%	 58%	3.			Acceptance	 -.69**	 -.62**	 	 64%	 56%	 10%	 37%	 <1%	 1%	 <1%	 4%	 16%	4.			Decentering	 -.59**	 -.57**	 .80**	 	 62%	 11%	 23%	 4%	 4%	 <1%	 <1%	 8%	5.			Self-compassion	 -.64**	 -.62**	 .75**	 .79**	 	 2%	 19%	 1%	 12%	 <1%	 1%	 14%	6.			Mindfulness	Skills	 -.05	 -.12	 .32	 .33	 .15	 	 3%	 3%	 10%	 2%	 3%	 <1%	7.			Intol.	of	Uncertainty	 .52**	 .50**	 -.61**	 -.48**	 -.43**	 -.17	 	 2%	 <1%	 4%	 3%	 <1%	8.			Gender	 .28	 .01	 -.08	 -.21	 -.10	 .16	 .15	 	 10%	 7%	 5%	 1%	9.			Age	 -.17	 -.04	 .13	 .22	 .34*	 .31	 .02	 .31	 	 12%	 <1%	 4%	10.	Years	since	diagnosis	 .08	 .23	 .06	 .01	 .002	 .15	 .20	 .26	 .35*	 	 5%	 34%	11.	Mood	medication	 .24	 .57**	 -.19	 -.05	 -.10	 -.18	 .18	 -.22	 -.01	 .23	 	 12%	12.	Self-report	disability	 .44**	 .76**	 -.40*	 -.29	 -.38*	 .06	 .35*	 .10	 .20	 .58**	 .35*	 		
MBI	intervention	 1	 2	 3	 4	 5	 6	 7	 8	 9	 10	 11	 12	1.				Anxiety		 	 37%	 25%	 14%	 28%	 5%	 35%	 3%	 18%	 8%	 1%	 19%	2. Depression	 .61**	 	 30%	 21%	 34%	 8%	 20%	 <1%	 8%	 19%	 <1%	 55%	3. Acceptance	 -.50**	 -.55**	 	 38%	 56%	 41%	 40%	 <1%	 3%	 10%	 2%	 10%	4. Decentering	 -.38*	 -.46**	 .62**	 	 53%	 34%	 29%	 <1%	 7%	 1%	 1%	 3%	5. Self-compassion	 -.53**	 -.58**	 .75**	 .73**	 	 38%	 42%	 <1%	 8%	 6%	 <1%	 19%	6. Mindfulness	Skills	 -.22	 -.28	 .64**	 .58**	 .62**	 	 13%	 <1%	 4%	 4%	 <1%	 <1%	7. Intol.	of	Uncertainty	 .59**	 .45**	 -.63**	 -.54**	 -.65**	 -.36*	 	 <1%	 6%	 6%	 <1%	 15%	8. Gender	 .18	 -.09	 -.06	 -.08	 .07	 .08	 .07	 	 1%	 3%	 5%	 <1%	9. Age	 -.42**	 -.28	 .18	 .26	 .29	 -.19	 -.25	 .01	 	 2%	 3%	 1%	10. Years	since	diagnosis	 .28	 .43**	 -.31	 -.11	 -.24	 -.20	 .25	 .16	 .14	 	 3%	 29%	11. Mood	medication	 .11	 .00	 -.13	 .11	 -.07	 -.07	 .02	 -.23	 .17	 .17	 	 2%	12. Self-report	disability	 .44**	 .74**	 -.31	 -.18	 -.43**	 -.03	 .39*	 -.05	 -.11	 .54**	 .14	 	**Correlation	is	significant	at	the	0.01	level	(2-tailed).		*	Correlation	is	significant	at	the	0.05	level	(2-tailed).	R2	values	of	1%	to	8%:	small;	9%	to	24%:	medium;	25%	to	100%:	large.	
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Appendix	B6	-	Correlations	Groups	T3	
WL	control	 1	 2	 3	 4	 5	 6	 7	 8	 9	 10	 11	 12	1.		Anxiety		 	 40%	 23%	 29%	 25%	 5% 35% 9% 1% 1% 5% 20% 2.		Depression	 .63**	 	 37%	 37%	 44%	 10%	 33% 1% <1% 7% 19% 38% 3.		Acceptance	 -.48**	 -.61**	 	 59%	 50%	 19%	 41%	 4%	 11%	 3%	 3%	 18%	4.		Decentering	 -.54**	 -.61**	 .77**	 	 64%	 26%	 38%	 1%	 6%	 1%	 1%	 23%	5.		Self-compassion	 .50**	 -.66**	 .71**	 .80**	 	 10%	 19%	 <1%	 10%	 1%	 3%	 23%	6.		Mindfulness	Skills	 -.23	 -.32	 .44**	 .51**	 .31	 	 17%	 3%	 3%	 1%	 11%	 3%	7.		Intol.	of	Uncertainty	 .59**	 .57**	 -.64**	 -.62**	 -.44**	 -.41*	 	 <1%	 <1%	 3%	 2%	 23%	8.		Gender	 .30	 .11	 .20	 -.11	 -.04	 .18	 .02	 	 10%	 7%	 5%	 1%	9.			Age	 -.12	 -.08	 .33	 .24	 .32	 .16	 -.07	 .31	 	 12%	 <1%	 4%	10.	Years	since	diagnosis	 .11	 .27	 .16	 -.10	 .10	 .12	 .18	 .26	 .35*	 	 5%	 34%	11.	Mood	medication	 .23	 .44**	 -.18	 -.11	 -.16	 -.33	 .14.	 -.22	 -.01	 .23	 	 12%	12.	Self-report	disability	 .45**	 .62**	 -.42*	 -.48**	 -.48**	 -.18	 .48**	 .10	 .20	 .58**	 .35*	 		
MBI	intervention	 1	 2	 3	 4	 5	 6	 7	 8	 9	 10	 11	 12	1.		Anxiety		 	 12%	 5%	 5%	 5%	 12% 5% 19% 3% 1% 2% 4% 2.		Depression	 .35*	 	 5%	 <1%	 8%	 14%	 14% <1% 2% 7% <1% 34% 3.		Acceptance	 -.23	 -.23	 	 41%	 45%	 25%	 25%	 2%	 <1%	 10%	 7%	 2%	4.		Decentering	 -.22	 -.09	 .64**	 	 29%	 41%	 11%	 <1%	 <1%	 6%	 2%	 1%	5.		Self-compassion	 -.22	 -.28	 .67**	 .54**	 	 23%	 23%	 <1%	 <1%	 <1%	 <1%	 7%	6.		Mindfulness	Skills	 -.35	 -.38*	 .50**	 .64**	 .48**	 	 7%	 <1%	 9%	 4%	 <1%	 2%	7.		Intol.	of	Uncertainty	 .23	 .37*	 -.49*	 -.33	 -.48**	 -.26	 	 <1%	 <1%	 7%	 <1%	 14%	8.		Gender	 .43*	 -.03	 -.13	 -.02	 -.01	 -.06	 .03	 	 10%	 7%	 5%	 1%	9.	Age	 -.17	 .13	 .01	 -.04	 -.01	 -.30	 -.08	 .31	 	 12%	 <1%	 4%	10.	Years	since	diagnosis	 .10	 .26	 -.32	 -.25	 -.06	 -.21	 .26	 .26	 .35*	 	 5%	 29%	11.	Mood	medication	 .13	 .001	 .27	 -.13	 -.07	 -.08	 -.04	 -.22	 -.01	 .23	 	 2%	12.	Self-report	disability	 .21	 .58*	 -.13	 -.10	 -.27	 -.13	 .38*	 .10	 .20	 .54**	 .14	 	**Correlation	is	significant	at	the	0.01	level	(2-tailed).		*	Correlation	is	significant	at	the	0.05	level	(2-tailed).	R2	values	of	1%	to	8%:	small;	9%	to	24%:	medium;	25%	to	100%:	large.	
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Appendix	B7	-	Correlations	Groups	T4	
WL	control	 1	 2	 3	 4	 5	 6	 7	 8	 9	 10	 11	 12	1.		Anxiety		 	 56%	 14%	 12%	 33%	 5% 15% 18% 5% <1% 5% 4% 2.		Depression	 .75**	 	 11%	 14%	 40%	 5%	 13% 12% <1% 3% 19% 12% 3.		Acceptance	 -.37*	 -.33*	 	 41%	 45%	 6%	 49%	 2%	 10%	 3%	 3%	 5%	4.		Decentering	 -.34*	 -.38*	 .64**	 	 42%	 2%	 18%	 4%	 1%	 4%	 3%	 11%	5			Self-compassion	 -.57**	 -.63*	 .67**	 .65**	 	 7%	 17%	 7%	 8%	 <1%	 4%	 13%	6.		Mindfulness	Skills	 -.22	 -.22	 .25	 .13	 .26	 	 6%	 3%	 1%	 3%	 10%	 <1%	7.		Intol.	of	Uncertainty	 .39*	 .36*	 -.70**	 -.42*	 -.41*	 -.25	 	 <1%	 <1%	 2%	 9%	 22%	8.		Gender	 .42*	 .34*	 .14	 -.20	 -.26	 .18	 -.04	 	 10%	 7%	 5%	 1%	9.		Age	 -.23	 -.05	 .31	 .11	 .28	 .12	 .03	 .31	 	 12%	 <1%	 4%	10.	Years	since	diagnosis	 -.04	 .17	 .17	 -.20	 -.04	 .16	 .13	 .26	 .35*	 	 5%	 34%	11.	Mood	medication	 .23	 .43**	 -.18	 -.18	 -.20	 -.32	 .30	 -.22	 -.005	 .23	 	 12%	12.	Self-report	disability	 .20	 .34*	 -.23	 -.33	 -.36*	 -.04	 .47**	 .10	 .20	 .58**	 .35*	 		
MBI	intervention	 1	 2	 3	 4	 5	 6	 7	 8	 9	 10	 11	 12	1.		Anxiety		 	 18%	 48%	 31%	 37%	 35% 14% <1% <1% <1% <1% 6% 2.		Depression	 .52**	 	 19%	 29%	 40%	 15%	 12% 2% 2% 13% 4% 28% 3.		Acceptance	 -.69**	 .-43**	 	 49%	 42%	 44%	 35%	 <1%	 2%	 1%	 <1%	 8%	4.		Decentering	 -.56**	 -.54**	 .70**	 	 50%	 46%	 25%	 1%	 <1%	 <1%	 6%	 3%	5.		Self-compassion	 -.61**	 -.63**	 .65**	 .71**	 	 28%	 41%	 4%	 <1%	 2%	 4%	 15%	6.		Mindfulness	Skills	 -.59**	 -.39**	 .66**	 .68**	 .53**	 	 19%	 <1%	 3%	 <1%	 5%	 <1%	7.		Intol.	of	Uncertainty	 .38	 .35	 -.59**	 -.50**	 -.64**	 -.43*	 	 <1%	 <1%	 4%	 1%	 12%	8.		Gender	 .03	 -.15	 .02	 .10	 .21	 .07	 .02	 	 <1%	 3%	 3%	 <1%	9.		Age	 -.004	 .13	 -.14	 .03	 .02	 -.18	 .02	 .01	 	 2%	 3%	 1%	10.	Years	since	diagnosis	 -.012	 .36	 -.12	 -.07	 -.15	 -.03	 .19	 .16	 .14	 	 3%	 29%	11.	Mood	medication	 .03	 .19	 .07	 -.24	 -.19	 -.23	 -.12	 -.23	 .17	 .17	 	 2%	12.	Self-report	disability	 .24	 .53**	 -.28	 -.17	 -.39*	 -.06	 .35	 -.05	 -.11	 .54**	 .14	 	**Correlation	is	significant	at	the	0.01	level	(2-tailed).		*	Correlation	is	significant	at	the	0.05	level	(2-tailed).		R2	reported	as	a	percentage,	indicating	variance	explained.	R2	values	of	1%	to	8%:	small;	9%	to	24%:	medium;	25%	to	100%:	large.	
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Appendix	B8.	Regression		Coefficients,	Standard	Errors,	and	Model	Summary	Information	for	the	Anxiety	(T4)	Parallel	Multiple	Mediator	Model	depicted	in	Figure	11.	
	 	
Consequent	
	
	
	
	
M1	(Acceptance	T3)	
	
	
M2	(Decentering	T3)	
	
M3	(Self-compassion	
T3)	
	
M4	(Mindfulness	skills	
T3)	
	
M5	(Intolerance	of	
uncertainty	T3)	
	
Y	(Anxiety	T4)	
	
Antecedent	
		 	Coeff.	 	 SE	 	 p	 		 	Coeff.	 	SE	 	p	 	 	 Coeff.	 	SE	 	 p	 	 	Coeff.	 	SE	 	 p	 	 	Coeff.	 	SE	 	 p	 	 	Coeff.	 	SE	 	 p	
	
X	(trial	arm)	
		 	.24	 	.18	 	.200	 	 	.31	 	.07	 	<0.001	 	 	.15	 	.15	 	.334	 	 	.27	 	.07	 	<0.001	 		 	-.08	 	.12	 	.525	 	 	-.20	 	.14	 	.142	
	
M1	(Accep.)	
		 	-	 	-	 	-	 		 	-	 	-	 	-	 		 	-	 	-	 	-	 	 	-	 	-	 	-	 	 	-	 	-	 	-	 	 	.04	 	.10	 	.446	
	
M2	(Decen.)	
	 	-	 	-	 	-	 	 	-	 	-	 	-	 		 	-	 	-	 	-	 	 	-	 	-	 	-	 	 	-	 	-	 	-	 	 	.35	 	.10	 	.703	
	
M3	(Self-co.)	
	 	-	 	-	 	-	 		 	-	 	-	 	-	 		 	-	 	-	 	-	 	 	-	 	-	 	-	 	 	-	 	-	 	-	 	 	-.10	 	.14	 	.446	
	
M4	(Mind.	
sk.)	
	 	-	 	-	 	-	 	 	-	 	-	 	-	 		 	-	 	-	 	-	 		 	-	 	-	 	-	 	 	-	 	-	 	-	 	 	.03	 	.24	 	.895	
	
M5	(Int.	of	u.)	
	 	-	 	-	 	-	 	 	-	 	-	 	-	 		 	-	 	-	 	-	 	 	-	 	-	 	-	 	 	-	 	-	 	-	 	 	.39	 	.14	 	.007	
	
Constant	
	 	 1.86	 	1.34	 	.201	 	 	1.57	 	.54	 	.006	 	 	1.34	 	1.08	 	.224	 	 	.50	 	.53	 	.341	 	 	1.14	 	.59	 	.191	 	 	-.54	 	.88	 	.541	
	 	R2	=	0.52	F(7,	50)	=	7.70,		
p	<	0.001	
				 	R2	=	0.61	F(7,	50)	=	11.07,		
p	<	0.001		
	R2	=	0.52	F(7,	50)	=	7.78,							
p	<	0.001	
	 	R2	=	0.66	F(7,	50)	=	13.70,									
p	<	0.001	
	 	R2	=	0.59	F(7,	50)	=	10.32,		
p	<	0.001	
	R2	=	0.64	F(12,	45)	=	6.58,	
p	<	0.001		
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Appendix	B9.	Regression		Coefficients,	Standard	Errors,	and	Model	Summary	Information	for	the	Anxiety	(T3)	Parallel	Multiple	Mediator	Model	depicted	in	Figure	12.	
	 	
Consequent	
	
	
	
	
M1	(Acceptance	T2)	
	
	
M2	(Decentering	T2)	
	
M3	(Self-
compassion	T2)	
	
M4	(Mindfulness	skills	
T2)	
	
M5	(Intolerance	of	
uncertainty	T2)	
	
Y	(Anxiety	T3)	
	
Antecedent	
		 	Coeff.	 	SE	 	 p	 		 	Coeff.	 	SE	 	p	 	 	Coeff.	 	SE	 	 p	 	 	Coeff.	 	SE	 	 p	 	 	Coeff.	 	SE	 	 p	 	 	Coeff.	 	SE	 	 p	
	
X	(trial	
arm)	
		 	.20	 	.15	 	.20	 	 	.11	 	.07	 	.130	 	 	.06	 	.12	 	.61	 	 	-.02	 	.08	 	.849	 		 	.06	 	.12	 	.66	 	 	.02	 	.09	 	.834	
	
M1	(Accep.)	
		 	-	 	-	 	-	 		 	-	 	-	 	-	 		 	-	 	-	 	-	 	 	-	 	-	 	-	 	 	-	 	-	 	-	 	 	.20	 	.09	 	.035	
	
M2	(Decen.)	
	 	-	 	-	 	-	 	 	-	 	-	 	-	 		 	-	 	-	 	-	 	 	-	 	-	 	-	 	 	-	 	-	 	-	 	 	-.22	 	.22	 	.340	
	
M3	(Self-co.)	
	 	-	 	-	 	-	 		 	-	 	-	 	-	 		 	-	 	-	 	-	 	 	-	 	-	 	-	 	 	-	 	-	 	-	 	 	.07	 	.13	 	.702	
	
M4	(Mind.	
sk.)	
	 	-	 	-	 	-	 	 	-	 	-	 	-	 		 	-	 	-	 	-	 		 	-	 	-	 	-	 	 	-	 	-	 	-	 	 	.26	 	.17	 	.895	
	
M5	(Int.	of	
u.)	
	 	-	 	-	 	-	 	 	-	 	-	 	-	 		 	-	 	-	 	-	 	 	-	 	-	 	-	 	 	-	 	-	 	-	 	 	.04	 	.10	 	.702	
	
Constant	
	 	 1.20	 	1.1	 	.29	 	 	1.37	 	.52	 	.012	 	 	1.27	 	.92	 	.17	 	 	.06	 	.56	 	.917	 	 	1.27	 	.92	 	.17	 	 	.51	 	.68	 	.458	
	 	R2=0.63	F(7,	57)=13.66,		
p	<	0.001	
				 	R2=0.60	F(7,	57)=12.25,		
p	<		
	R2=0.71	F(7,	57)	=	19.47,							
p	<	0.001	
	 	R2=0.45	F(7,	57)=6.64,										
p	<	0.001	
	 	R2=0.51	F(7,	57)=8.41,		
p<0.001	
	R2=0.71	F(12,	52)	=	10.50,	
p	<	0.001	
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Appendix	B10.	Regression		Coefficients,	Standard	Errors,	and	Model	Summary	Information	for	the	Depression	(T4)	Parallel	Multiple	Mediator	Model	depicted	in	Figure	13.	
	 	
Consequent	
	
	
	
	
M1	(Acceptance	T3)	
	
	
M2	(Decentering	T3)	
	
M3	(Self-
compassion	T3)	
	
M4	(Mindfulness	skills	
T3)	
	
M5	(Intolerance	of	
uncertainty	T3)	
	
Y	(Depression	T4)	
	
Antecedent	
		 	Coeff.	 	SE	 	 p	 		 	Coeff.	 	SE	 	p	 	 	Coeff.	 	SE	 	 p	 	 	Coeff.	 	SE	 	 p	 	 	Coeff.	 	SE	 	 p	 	 	Coeff.	 	SE	 	 p	
	
X	(trial	arm)	
		 	.21	 	.19	 	.12	 	 	.31	 	.08	 	<0.01	 	 	.16	 	.15	 	.31	 	 	.29	 	.07	 	<0.01	 		 	-.10	 	.12	 	.40	 	 	-.21	 	.13	 	.131	
	
M1	(Accep.)	
		 	-	 	-	 	-	 		 	-	 	-	 	-	 		 	-	 	-	 	-	 	 	-	 	-	 	-	 	 	-	 	-	 	-	 	 	.08	 	.10	 	.400	
	
M2	(Decen.)	
	 	-	 	-	 	-	 	 	-	 	-	 	-	 		 	-	 	-	 	-	 	 	-	 	-	 	-	 	 	-	 	-	 	-	 	 	.35	 	.26	 	.217	
	
M3	(Self-co.)	
	 	-	 	-	 	-	 		 	-	 	-	 	-	 		 	-	 	-	 	-	 	 	-	 	-	 	-	 	 	-	 	-	 	-	 	 	-.27	 	.13	 	.047	
	
M4	(Mind.	
sk.)	
	 	-	 	-	 	-	 	 	-	 	-	 	-	 		 	-	 	-	 	-	 		 	-	 	-	 	-	 	 	-	 	-	 	-	 	 	.04	 	.24	 	.863	
	
M5	(Int.	of	
u.)	
	 	-	 	-	 	-	 	 	-	 	-	 	-	 		 	-	 	-	 	-	 	 	-	 	-	 	-	 	 	-	 	-	 	-	 	 	.29	 	.13	 	.034	
	
Constant	
	 	 2.04	 	1.3	 	.12	 	 	1.54	 	.52	 	.005	 	 	1.77	 	1.0	 	.10	 	 	.69	 	.49	 	.163	 	 	.96	 	.81	 	.24	 	 	-.36	 	.82	 	.658	
	 	R2=0.52	F(7,	50)=7.20,		
p	<	0.001	
				 	R2=0.61	F(7,	50)	=	11.06,		
p	<	0.001		
	R2=0.52	F(7,	50)	=	7.76,							
p	<	0.001	
	 	R2	=	0.67	F(7,	50)	=	14.77,									
p	<	0.001	
	 	R2=0.60	F(7,	50)	=	10.77,		
p	<	0.001	
	R2=0.55	F(12,	45)=4.59,	
p	<	0.001		
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Appendix	B11.	Regression		Coefficients,	Standard	Errors,	and	Model	Summary	Information	for	the	Depression	(T3)	Parallel	Multiple	Mediator	Model	depicted	in	Figure	13.	
	 Consequent	
	
	
	
	
M1	(Acceptance	
T2)	
	
	
M2	(Decentering	
T2)	
	
M3	(Self-
compassion	T2)	
	
M4	(Mindfulness	
skills	T2)	
	
M5	(Intolerance	
of	uncertainty	
T2)	
	
Y	(Depression	T3)	
	
Antecedent	
		 	Coeff.	 	SE	 	 p	 		 	Coeff.	 	 SE	 	p	 	 	Coeff.	 	SE	 	 p	 	 	Coeff.	 	SE	 	 p	 	 	Coef	 	SE	 	 p	 	 	Coeff.	 	SE	 	 p	
	
X	(trial	arm)	
		 	.21	 	.15	 	.17	 	 	.11	 	.07	 	.113	 	 	.07	 	.12	 	.58	 	 	-.007	 	.08	 	.923	 		 	.04	 	.12	 	.74	 	 	-.15	 	.07	 	.05	
	
M1	(Accep.)	
		 	-	 	-	 	-	 		 	-	 	-	 	-	 		 	-	 	-	 	-	 	 	-	 	-	 	-	 	 	-	 	-	 	-	 	 	-.11	 	.08	 	.159	
	
M2	(Decen.)	
	 	-	 	-	 	-	 	 	-	 	-	 	-	 		 	-	 	-	 	-	 	 	-	 	-	 	-	 	 	-	 	-	 	-	 	 	-.18	 	.18	 	.331	
	
M3	(Self-co.)	
	 	-	 	-	 	-	 		 	-	 	-	 	-	 		 	-	 	-	 	-	 	 	-	 	-	 	-	 	 	-	 	-	 	-	 	 	-.11	 	.10	 	.305	
	
M4	(Mind.	
sk.)	
	 	-	 	-	 	-	 	 	-	 	-	 	-	 		 	-	 	-	 	-	 		 	-	 	-	 	-	 	 	-	 	-	 	-	 	 	.19	 	.14	 	.167	
	
M5	(Int.	of	
u.)	
	 	-	 	-	 	-	 	 	-	 	-	 	-	 		 	-	 	-	 	-	 	 	-	 	-	 	-	 	 	-	 	-	 	-	 	 	-.01	 	.08	 	.883	
	
Constant	
	 	 1.48	 	1.1	 	.19	 	 	1.53	 	.52	 	.005	 	 	1.49	 	1.9	 	.10	 	 	.39	 	.56	 	.48	 	 	1.31	 	.91	 	.16	 	 	.64	 	.57	 	.264	
	 R2=0.63	F(7,	57)=13.83,		
															p	<	0.001	 R2=0.6						F(7,57)=12.43,			p	<	0.001		
R2=0.71	F(7,	57)=19.58,							
p	<	0.001	 	 R2=0.71	F(7,	57)=19.58,			p	<	0.001	 	 R2=0.59	F(7,	57)	=	8.41,														p	<	0.001	 R2=.73	F(12,	52)	=	11.55,	p	<	0.001	 	
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Inclusion	of	adults	with	severe	mental	illness	in	trials	of	type	2	diabetes	self-
management	education	programmes:	a	systematic	review.	
	Anne	 Coxon	 MSc1,	 Hayley	 McBain	 PhD	 CPsychol1,	 Reesha	 Solanki1,	 Kathleen	Mulligan	PhD	CPsychol1	2*		1	Centre	for	Health	Services	Research,	School	of	Health	Sciences,	City,	University	of	London,	UK		2	Community	Health	Newham,	East	London	NHS	Foundation	Trust,	UK	*Corresponding	author	
	
Abstract	
Background:	People	with	severe	mental	illnesses	(SMI),	such	as	schizophrenia	and	bipolar	disorder,	are	at	an	increased	risk	of	developing	type	2	diabetes.	 	Diabetes	self-management	 education	 programmes	 are	 effective	 in	 improving	 health	outcomes	 in	the	general	population	with	diabetes.	However,	people	with	SMI	are	often	 excluded	 from	 research	 and	 it	 is	 not	 known	 if	 they	 have	 been	 included	 in	evaluations	 of	 these	 programmes.	 	 The	 aim	 of	 this	 review	 was	 to	 examine	 if	evaluations	of	diabetes	 self-management	education	programmes	 included	people	with	SMI,	and	if	so,	whether	the	interventions	were	beneficial	for	this	population.	
Methods:	This	systematic	review	examined	the	inclusion	of	people	with	SMI	and	co-morbid	type	2	diabetes	in	randomised	controlled	trials	of	diabetes	self-management	education	 programmes.	 The	 following	 bibliographic	 databases	 were	 searched	 -	Cochrane	 Library,	 Medline,	 Embase,	 PsychINFO,	 Allied	 and	 Complimentary	Medicine	 Database,	 Health	 Technology	 Assessment,	 NHS	 Economic	 Evaluations	Database	and	CINAHL.	
Results:	A	total	of	282	trials	were	included.	At	least	39%	of	trials	did	not	recruit	any	participants	with	SMI.	Only	 five	confirmed	 inclusion	of	participants	with	SMI	but	they	included	a	very	small	number	of	participants	with	SMI	(of	the	three	trials	that	
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reported	details,	only	13	out	of	335	participants	had	SMI,	less	than	4%)	and	did	not	report	their	results	separately.			
Conclusions:	This	systematic	review	confirms	that	people	with	SMI	are	excluded,	whether	 purposely	 or	 not,	 from	 trials	 of	 diabetes	 self-management	 education,	resulting	 in	a	 lack	of	an	evidence	base	on	which	 to	base	 treatment	paths	 for	 this	vulnerable	population.		
	
Background	The	 estimated	 prevalence	 of	 diabetes	mellitus	 in	 people	with	 psychosis	 is	 13%,	which	is	between	two	and	five	times	higher	than	the	general	population	(Ward	&	Druss,	 2015).	 Several	 factors	 are	 thought	 to	 contribute	 to	 this	 increased	 risk,	including	 the	 effects	 of	 anti-psychotic	 medications,	 pathophysiology	 of	 SMI	 and	lifestyle	factors	such	as	poor	diet,	obesity	and	physical	inactivity	(Osborn,	Wright,	Levy,	King,	Deo,	&	Nazareth,	2008).	Among	people	with	diabetes	mellitus,	the	risk	of	acute	complications	and	mortality	is	also	greater	in	those	with	SMI	(Becker	&	Hux,	2011;	Vinogradova,	Coupland,	Hippisley-Cox,	Whyte,	&	Penny,	2010).			Self-management	of	type	2	diabetes	mellitus	(T2DM)	is	complex,	and	to	achieve	this	successfully,	diabetes	clinical	guidelines	(National	Institute	for	Health	and	Clinical	Excellence,	2015;	Powers	et	al,	2016;	SIGN,	2010;	IDF	CG,	2006;	Royal	Australian	College	 of	 General	 Practitioners,	 2017)	 recommend	 structured	 education	 for	 all	patients.	 	 A	 number	 of	 systematic	 reviews	 have	 reported	 the	 positive	 effects	 of	diabetes	 self-management	 education	 (DSME)	 programmes	 (Chrvala	 Sherr,	 &	Lipman,	 2016;	 Steinsbekk,	 Rygg,	 Lisulo,	 Rise,	 Fretheim,	 2012)	 such	 as	 better	glycaemic	 control,	 greater	 diabetes	 knowledge	 and	 self-management	 skills,	 and	higher	 self-efficacy	 ,	 but	 it	 is	 unclear	 if	 people	 with	 SMI	 also	 experience	 these	benefits.	 A	 recent	 Cochrane	 review	 of	 DSME	 specifically	 for	 people	 with	 SMI	(McBain,	Mulligan,	Haddad,	Flood,	Jones,	&	Simpson,	2016),	conducted	by	members	of	 the	 current	 authorship	 team,	 identified	 only	 one	 intervention	 (McKibbin,	Patterson,	et	al,	2006).	McKibben	et	al	recruited	people	aged	over	40	with	T2DM	and	either	 schizophrenia	 or	 schizoaffective	 disorder.	 The	 intervention	 used	 adapted	materials	and	reinforced	behaviour	change,	to	help	overcome	impaired	motivation	
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and	insight.		At	the	end	of	the	24-week	trial,	the	intervention	group	experienced	a	greater	 reduction	 in	 weight,	 body	 mass	 index	 (BMI),	 waist	 circumference	 and	plasma	 triglycerides	 than	controls,	 and	had	 significantly	 increased	 their	diabetes	knowledge,	diabetes	self-efficacy	and	self-reported	physical	activity.	The	effects	on	participants’	BMI,	waist	circumference	and	diabetes	knowledge	were	maintained	at	6-month	 follow-up	 (McKibbin,	 Golshan,	 Griver,	 Kitchen,	 &	Wykes,	 2010)	 .	 There	were	however	no	statistically	significant	changes	in	fasting	glucose	or	glycosylated	haemoglobin	(A1C)	levels.	This	suggests	that	where	interventions	are	developed	to	address	 the	 particular	 needs	 of	 people	 with	 SMI	 and	 T2DM,	 positive	 lifestyle	changes	can	be	achieved.			Given	 that	McKibbin	 et	 al’s	 intervention	 did	 not	 achieve	 a	 change	 in	HbA1c,	 this	suggests	a	need	for	further	research	to	identify	how	best	to	optimise	diabetes	self-management	 for	 people	with	 SMI.	 	 The	 recent	 and	 rapid	 growth	 of	DSME	 in	 the	general	population	may	help	 to	shed	 light	on	this	 issue	-	a	rapid	synthesis	of	 the	evidence	 on	 interventions	 supporting	 self-management	 (Taylor	 et	 al,	 2014)	identified	179	unique	randomised	controlled	trials	(RCTs)	of	DSME	in	the	general	diabetes	population.	This	plethora	of	data	may	provide	 insight	 into	whether	and	how	 DSME	 programmes	 for	 the	 general	 population	 have	 been	 implemented	 for	people	with	SMI,	and	if	they	have	been	successful.			The	aim	of	this	systematic	review	was	therefore	to	examine	if	evaluations	of	DSME	programmes	 included	 people	 with	 SMI	 (defined	 as	 psychosis,	 schizophrenia,	schizoaffective	disorder,	bipolar	disorder,	or	depression	with	psychotic	features),	and	if	so,	what	type	of	interventions	have	been	successfully	implemented	and	what	the	benefits	were	for	this	population.		
Method	A	systematic	literature	search	was	undertaken	in	the	following	databases:	Cochrane	Library,	 Medline,	 Embase,	 PsychINFO,	 Allied	 and	 Complimentary	 Medicine	Database,	Health	Technology	Assessment,	NHS	Economic	Evaluations	Database	and	CINAHL	from	January	2004	to	July	2014.	The	search	included	terms	for	diabetes,	patient	education/self-management	and	randomised	controlled	trials.	The	full	list	
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of	 terms	 is	 reported	 in	 Additional	 file	 1.	 Study	 selection	 was	 undertaken	independently	 by	 two	 researchers.	 Data	 were	 extracted	 systematically	 using	 an	adapted	 Cochrane	 data	 extraction	 form	 and	 authors	were	 contacted	 for	missing	data.		Randomised	 controlled	 trials	 (RCTs),	 published	 in	 English	 in	 peer-reviewed	journals,	were	included.	Participants	had	to	be	aged	18	or	over	and	diagnosed	with	T2DM.	Interventions	for	individuals	or	groups,	in	person	or	online,	and	which	were	targeted	at	improving	the	self-management	of	T2DM	were	included.	This	included	interventions	 aimed	at	 promoting	healthy	diet	 or	physical	 activity.	 Interventions	that	focused	solely	on	the	management	of	mental	illness	were	excluded.		Trials	that	recruited	only	people	with	SMI	were	also	excluded	as	the	recent	Cochrane	review	had12	already	reviewed	these.		
Results	From	 an	 initial	 22659	 titles,	 1245	 abstracts	 were	 screened	 and	 585	 full	 paper	studies	were	assessed	for	eligibility.		A	total	of	282	RCTs,	conducted	in	40	different	countries,	were	included	in	the	review.	(See	PRISMA	flowchart	shown	in	Figure	1).	Studies	conducted	in	the	USA	dominated	(37%),	whilst	8.5%	were	UK-based	trials.		Results	for	recruitment	of	people	with	SMI	are	reported	in	Table	1	and	Additional	file	2.	At	least	110	(39%)	RCTs	did	not	recruit	any	participants	with	SMI.	In	a	further	30	(11%)	RCTs,	the	authors	were	unaware	if	there	had	been	any	participants	with	a	SMI	diagnosis	as	this	data	was	not	collected.			Five	 (2%)RCTs	 (Hill-Briggs	 et	 al,	 2011;	 Mohamed,	 Al-Lenjawi,	 Amuna,	 Zotor,	 &	Elmahdi,	2013;	Pimazoni-Netto,	Rodbard,	&	Zanella,	2011;	Spencer	et	al,	2011;	Wolf	et	al,	2014)	confirmed	inclusion	of	people	with	SMI,	however	the	numbers	recruited	were	very	small	(n=13	in	the	three	trials	that	reported	details)	and	authors	did	not	report	their	results	separately.				For	136	(48%)	RCTs	it	was	not	possible	to	obtain	data	from	authors.		
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Discussion	The	key	finding	of	this	review	was	that	a	substantial	proportion	of	trials	of	DSME	have	not	included	people	with	SMI.	At	least	39%	of	identified	trials	of	DSME	did	not	include	any	participants	with	SMI.	Only	2%	of	included	trials	had	participants	with	a	known	diagnosis	of	SMI,	and	the	effect	of	DSME	programmes	on	this	sub-group	is	unknown	 as	 no	 analyses	 were	 performed.	 Given	 the	 increased	 risk	 of	 T2DM	 in	people	with	SMI	and	the	large	number	of	RCTs	of	DSME	that	have	been	conducted,	this	is	a	remarkable	omission.			Previous	research	has	found	that	people	with	SMI	are	often	excluded	from	clinical	trials.	 A	 study	 that	 examined	 400	 highly	 cited	 trials	 across	 20	 common	 chronic	health	conditions	published	between	2002	and	2010	found	that	55%	of	the	papers	that	 described	 diabetes	 research	 had	 psychiatric	 exclusion	 criteria	 (Humphreys,	Blodgett,	&	Roberts,	2015).	Humphreys	et	al	argued	that	excluding	this	population	results	 in	 knowledge	 gaps	 that	 may	 harm	 people	 with	 SMI	 when	 a	 treatment	becomes	generalised.				The	only	trial	specifically	aimed	at	promoting	health	lifestyle	choices	in	people	with	SMI	and	T2DM	(McKibbin	et	al,	2006,	2010),	included	64	people	(n=	32	in	each	arm)	randomised	 to	 either	 treatment	 as	 usual	 with	 education	 leaflets,	 or	 to	 Diabetes	Awareness	 and	 Rehabilitation	 Training	 (DART).	 	 This	 24	 week,	 group-based	intervention	was	delivered	by	a	mental	health	professional	and	was	tailored	for	the	middle-aged	participants	who	also	had	Schizophrenia	or	Schizoaffective	disorder.	Adaptations	for	this	group	included	limiting	the	number	of	new	topics	introduced	at	weekly	meetings	and	using	more	accessible	literature.		Topics	covered	nutrition,	exercise,	medication	and	communication	skills	and	were	reinforced	throughout	the	programme	to	compensate	for	lower	motivation	and	insight.			The	King’s	Fund	(Naylor,	Das,	Ross,	Honeyman,	Thompson,	&	Gilburt,	2016)	recently	recommended	that	people	with	SMI	should	be	seen	as	a	priority	target	group	for	public	 health	 interventions	 and	 the	 UK	National	 Health	 Service	 (NHS)	 Five	 Year	Forward	View	for	Mental	Health	(Mental	Health	Task	Force,	2016)		also	proposes	that	access	to	evidence-based	physical	care	interventions	should	be	expanded	for	
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people	 with	 SMI.	 However,	 our	 findings	 concur	 with	 other	 research	 that	 has	identified	 under-representation	 of	 people	with	 psychiatric	 disorders	 in	 research	and	highlighted	this	issue	as	an	example	of	health	inequity	(Humphreys	et	al,	2015).	It	is	unclear	to	what	extent	this	under-representation	in	research	on	DSME	is	also	borne	out	in	referral	to	these	programmes	in	clinical	care.	Research	in	the	US	has	found	that	people	with	SMI	are	less	likely	than	those	without	SMI	to	receive	diabetes	education	(Goldberg	et	al,	2007)	and	anecdotal	evidence	suggests	that	this	is	also	be	the	case	elsewhere	(Taylor	&	Siddiqi,	2016)	but	data	are	unavailable.			Thornicroft	(2013)	has	described	the	mortality	gap	between	people	with	SMI	and	the	non-SMI	population	as	“at	worst	a	form	of	lethal	discrimination”	and	calls	for	evidence-based	interventions	to	address	 it,	and	the	Royal	College	of	Psychiatrists	(O’Brien	 et	 al,	 2009)	 recommends	 that	 their	members	 should	 feel	 competent	 to	address	 the	 physical	 as	 well	 as	 the	 mental	 health	 needs	 of	 people	 with	 SMI.		However,	 the	 lack	of	research	into	the	effectiveness	of	DSME	programmes	in	this	vulnerable	group	leaves	clinicians	without	a	clear	pathway	for	intervention.			A	limitation	of	this	review	is	that,	in	spite	of	our	attempts	to	contact	all	authors,	we	were	unable	to	obtain	data	for	a	substantial	number	of	trials.	It	is	possible,	however,	that	our	findings	underestimate	the	proportion	of	trials	that	do	not	include	SMI.	We	received	responses	from	authors	of	73	RCTs	that	had	not	reported	data	in	the	trial	publication,	and	of	these,	38	(52%)	did	not	have	any	participants	with	SMI.		This	systematic	review	has	shown	that	people	with	SMI	are	often	excluded,	whether	purposely	or	not,	from	trials	of	DSME.	If	people	with	SMI	are	to	receive	appropriate	diabetes	care	 in	accordance	with	current	guidelines,	 it	 is	essential	 that	evidence-based	diabetes	education	is	available.	This	review	indicates	that	there	is	a	need	to	identify	how	best	to	provide	DSME	for	this	vulnerable	population.		
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Appendix	B12		Table	1.	Number	and	%	of	RCTs	that	included	or	excluded	participants	with	SMI		 Reported	in	paper	 Response	from	author		 Response	not	received	 Total			 n	 n	 n	 n	 %	RCTs	with	participants	with	SMI	diagnosis	 	 5	 	 5	 1.8	RCTs	with	no	participants	with	SMI	diagnosis:	 	 	 	 	 						Explicitly	excluded	SMI	 72	 28	 	 100	 35.6						Not	explicitly	excluded	but	no-one	with	SMI	recruited	 	 10	 	 10	 			3.6	RCTs	unaware	of	participants	with	SMI	diagnosis	 	 30	 	 30	 10.7	RCTs	with	no	data	 	 	 136	 136	 48.4	TOTAL	RCTs	 72	 73	 136	 281	 100.0																												
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Paper	2.	
	
The	contribution	of	health	psychology	theory	and	practice	to	the	treatment	of	
acute	and	long-term	neurology	patients		
ABSTRACT	Neurology	patients,	and	neuropsychology,	have	 long	been	the	domains	of	clinical	psychologists.	 	However,	 health	psychology	 theory	 and	practice	 can	help	 explain	patients’	 behaviour	 and	 inform	 interventions	 to	 alleviate	 psychological	 distress	following	traumatic	neurological	events	such	as	stroke	or	brain	injury,	or	diagnosis	of	 long-term	 neurological	 disease.	 	 This	 paper	 reflects	 on	 the	 author’s	 clinical	practice	in	both	a	stroke	unit	and	in	neurology	outpatient	services	while	completing	a	doctorate	in	health	psychology.		
BACKGROUND	I	had	been	working	in	a	post-acute,	community	acquired-brain	injury	centre	for	over	eight	 years	 when	 it	 became	 clear	 that	 to	 progress	 in	 my	 career	 and	 become	 a	chartered	psychologist	I	would	need	to	complete	a	doctorate.		I	had	already	gained	a	Master’s	in	Health	Psychology,	which	I	had	found	both	fascinating	and	relevant	to	my	area	of	work,	and	despite	neurology	and	neuropsychology	seemingly	dominated	by	 clinical	 psychologists,	 the	 biopsychosocial	 perspective	 offered	 by	 health	psychology	greatly	influenced	my	doctoral	route,	which	I	have	never	regretted.		Last	 year,	 I	 successfully	 applied	 as	 a	 trainee	 health	 psychologist	 for	 a	 clinical	psychologist	role,	in	a	general	hospital,	working	on	the	acute	stroke	unit	for	about	a	third	of	my	time,	and	as	part	of	a	neuro-rehab	team	for	the	remainder.		The	team	consists	of	a	clinical	psychologist	with	an	interest	in	neuropsychology,	an	assistant	psychologist,	 specialist	 neuro-physiotherapists,	 occupational	 therapists,	rehabilitation	assistants	and	a	brain	 injury	specialist	nurse.	 	The	out-patients	are	varied	in	both	diagnosis	and	length	of	illness	–	whether	newly-diagnosed	patients	with	multiple	sclerosis	or	Parkinson’s	disease	–	the	two	most	frequent	diagnoses	–	or	 patients	 living	 with	 these	 and	 similar	 diseases	 over	 many	 decades.	 Other	neurological	 disorders,	 encephalitis,	 traumatic	 brain	 injury,	 and	 more	 rarely,	
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Huntingdon’s	 disease,	motor	 neurone	 disease	 and	 post-polio	 syndrome,	 are	 also	treated	within	our	team.		Referrals	 to	 psychological	 services	 are	 made	 by	 consultants,	 GPs,	 clinical	 nurse	specialists,	 or	 other	 therapists	 if	 patients	 are	 considered	 to	 be	 struggling	 with	acceptance,	 treatment	 adherence,	 or	 social	 adjustment,	 and	 patients	 are	 also	referred	for	cognitive	assessment	both	to	inform	therapy	and	to	establish	baseline	and	outcomes	of	interventions.		An	increasing	(and	fascinating)	group	of	referred	patients	 includes	people	with	a	diagnosis	 of	 functional	 neurological	 symptoms,	 a	 complex	 disorder	 with	 a	biopsychosocial	 aetiology,	whose	 symptoms	 appear	 to	 be	 similar	 to	 people	with	neurological	deficits,	but	which	are	 in	 fact	potentially	 reversible	 following	multi-disciplinary,	including	psychological,	intervention.			Patients	on	the	stroke	unit	will	all	have	had	a	stroke	–	an	interruption	to	blood	flow	to	the	brain,	but	the	effects	of	the	stroke	and	their	recovery	will	vary	enormously,	depending	 on	 neuro-location,	 age	 and	 co-morbidities,	 with	 a	mean	 stay	 of	 eight	weeks.	 	The	patient’s	social	support	and	pre-morbid	psychological	resources	will	impact	 recovery,	 and	 the	psychologist’s	 role	 includes	building	 relationships	with	family	and	friends	in	order	to	gain	insight	into	the	patient’s	previous	personality,	lifestyle,	 cognitive	 and	 emotional	 status,	 hopes	 and	 motivations,	 while	 also	supporting	 the	 family	with	 their	own	adjustment	needs	 following	 this	 frequently	sudden	event	which	leads,	for	many,	to	loss	of	identity,	family	role,	financial	stability	and	shared	hopes	for	the	future.			
HEALTH	PSYCHOLOGY	–	CONTRIBUTIONS	TO	PRACTICE	Health	 psychologists	 train	 towards	 gaining	 competency	 in	 five	 broad	 areas:	preventing	 health-damaging	 behaviours,	 promoting	 behaviours	 that	 enhance	health,	 in	 understanding	 health	 cognitions	 that	 may	 predict	 and	 change	 health	outcomes,	improving	health	communication	between	patient	and	professionals,	and		finally,	understanding	the	psychological	impact	of	illness	on	patients	and	their	wider	social	 circle,	 and	 developing	 interventions	 to	 improve	 patients’	 ability	 to	
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rehabilitate,	live	with	chronic	illness	and	reduce	distress	and	disability.		Each	area	will	be	examined	within	the	context	of	working	in	a	neurological	setting,	both	acute	and	non-acute,	with	a	view	to	describing	the	relevance	of	health	psychology	theory	and	practice.		
Preventing	health	damaging	behaviours:		Strokes	are	primarily	caused	by	modifiable	 life-style	behaviours	 (Di	Legge,	Koch,	Diomedi,	Stanzione,	&	Sallustio,	2012;	Boehme,	Esenwa,	&	Elkind,	2017),	however,	in	the	acute	phase,	there	is	little	opportunity	for	these	behaviours	to	be	perpetuated.		This	presents	an	opportunity	to	discuss	self-management	skills	with	the	patient	and	their	family	and	friends,	for	instance	to	prepare	for	the	patient’s	return	to	a	smoke-free	home.		Post-acute	therapy	for	stroke	patients	and	for	patients	with	neurological	diagnoses	should	 also	 introduce	 and	 reinforce	 lifestyle	 changes,	 however	 the	 delivery	 of	information	has	to	account	for	patients	who	may	lack	insight	into	their	deficits,	or	who	may	lack	cognitive	skills,	presenting	with	memory	deficits,	slow	processing	(for	both	verbal	and	written	information),	weak	visuospatial	and	attentional	skills,	and	poor	executive	functioning.		In	post-stroke	patients,	limiting	the	development	of	depression	may	in	turn	reduce	levels	 of	 anxiety	 (Wright,	 Wu,	 Chun,	 &	 Mead,	 2017),	 and	 therapy	 targeting	depression,	including	behavioural	activation	and	motivational	interviewing	both	in	acute	and	non-acute	settings,	may	contribute	to	lower	mortality	rates	(Watkins	et	al,	2011;	Ayerbe,	Ayis,	Crichton,	Rudd	&	Wolfe,	2014).		
Promoting	and	protecting	healthy	behaviours:	Rehabilitation	 from	 the	 effects	 of	 stroke	 is	 sometimes	painful,	 often	difficult	 and	distressing	 -	 in	 the	 early	 stages	 the	 patient	 may	 find	 recognising	 their	 deficits	extremely	 upsetting,	 including	 coming	 to	 terms	with	 losses	 that	may	 be	 involve	identity,	careers,	financial	independence,	relationships,	and	even	their	homes.	In	the	later	stages,	adherence	to	rehabilitation	and	engaging	with	behavioural	changes	to	
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incorporate	healthy	behaviours	such	as	exercise	and	health	eating,	while	struggling	with	ongoing	physical,	cognitive	and	emotional	disruption,	can	feel	overwhelming.			Premorbid	behavioural	patterns	may	have	contributed	to	the	stroke,	or	if	continued,	may	 increase	 disability	 levels,	 including	 for	 instance,	 all-or-nothing	 behaviour.	Learning	to	identify	physical,	cognitive	and		stamina	limitations	while	dealing	with	neurological	fatigue,	and	structuring	a	meaningful,	value-led	rather	than	goal-led	life	is	optimised	by	multidisciplinary	team	input,	with	specialist	neuro-physiotherapy,	neuro-occupational	therapy	and	health	psychology	working	collaboratively	with	the	patient,	in	both	the	clinical	and	home	setting	(Taylor,	2015;	Rudd,	Bowen,	James	&	Young,	2016).		Engaging	 patients	 in	 self-management	 and	 peer-led	 support	 groups	 is	 another	important	 element	 of	 rehabilitation,	 in	many	 cases	 requiring	 patients	 to	 explore	their	new	identity,	regain	confidence,	and	move	towards	feeling	safe	as	their	identity	develops	to	encompass	the	changes	they	have	experienced	(Gracey,	Evans,	&	Malley,	2009).	 	 While	 the	 Y	 shaped	 model	 was	 developed	 to	 explain	 the	 way	 that	discrepancies	of	self	can	become	resolved	in	acquired	brain	injury,	it	also	works	well	in	 neurological	 disease.	 	 An	 overarching,	 biopsychosocial	 and	 holistic	 model	 of	adjustment	 to	 chronic	 illness	 is	 posited	 by	 Moss-Morris	 (2013),	 based	 on	 self-regulation	theory	(Leventhal	et	al,	1997),	and	which	allows	for	mapping	a	patient’s	unique	 experience	 of	 chronic	 illness,	 whether	 post-stroke,	 neurodegenerative	disease,	or	traumatic	brain	injury,	enabling	the	identification	of	areas	of	behaviour	that	are	maintaining	the	disequilibrium.	Collaborating	on	and	sharing	formulations	enable	 the	 patient	 to	 see	 therapy	 as	 an	 opportunity	 that	 they	 can	 use	 to	 move	forward.		 	
Health-related	cognitions:		Illness	perceptions	have	been	shown	to	predict	outcome	and	to	be	useful	targets	for	interventions	to	improve	health	outcomes	for	people	with	chronic	illness	(Hagger	&	Orbell,	 2003;	 Dempster,	 Howell,	 &	 McCorry,	 2015)	 and	 also	 with	 neurological	conditions:	 Huntingdon’s	 disease	 (Helder,	 Kaptein,	 Kempen,	 Weinman,	
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Houwelingen,	&	Roos,	2002),	multiple	sclerosis	(Jopson	&	Moss-Morris,	2003),	and	carers	of	people	with	stroke	(McClenahan,	&	Weinman,	1998).		According	to	Leventhal	(Leventhal,	Brisette,	&	Leventhal,	2003),	both	cognitive	and	emotional	 perceptions	 of	 the	 health	 threat	 are	 processed	 in	 parallel	 and	interactively,	and	there	 is	constant	and	dynamic	 inter-relation	between	appraisal	and	 coping.	 	 Deficits	 in	 patients’	 cognitive	 and	 emotional	 skills	 need	 to	 be	understood	before	attempting	 to	understand	 their	 illness	perceptions,	 to	explore	coping	strategies	and	to	identify	maladaptive	beliefs.			
Communication	between	professionals	and	patient/family/carer	Any	multi-disciplinary	team	needs	good	communication	for	effective	joint	working,	and	 in	 a	 stroke	 unit,	 the	 number	 of	 health	 professionals	 involved	 with	 a	 single	patient	during	their	hospital	stay	may	amount	to	20-30	people,	with	post-discharge	services	adding	maybe	another	10-15	staff	members.		These	professionals	belong	to	a	meta-team,	 ie	teams	within	teams,	and	sharing	professional	knowledge,	patient	history	and	goal-setting	is	essential	for	effective		patient	treatment	(Wade,	2016).		Communication	 includes	 regular	 teaching	 sessions,	 both	 attending	 in-service	teaching	by	medical	clinicians,	to	delivering	workshops	to	rehabilitation	assistants	on	grief	and	loss	following	diagnosis	or	stroke.		Communication	is	also	important	between	the	patient,	their	family	and	friends,	and	the	professional	 team.	 	However,	 prognosis	 in	 stroke	 and	 traumatic	 brain	 injury	recovery	 is	often	uncertain,	and	 it	may	be	weeks	before	a	clear	understanding	of	rehabilitation	potential	is	gained,	and	discharge	plans	can	be	discussed.	During	that	time	family	dynamics	change,	and	co-morbidity,	hospital	acquired	infection	and	low	mood,	 will	 also	 influence	 length	 of	 stay,	 increasing	 uncertainty,	 	 and	 delaying	progress.	 The	 psychology	 service	 can	 play	 a	 part	 not	 just	 within	 the	 multi-disciplinary	meetings,	but	also	 in	supporting	 families,	eliciting	patient	and	 family	hopes	and	expectations,	ensuring	that	treatment	is	coherent.		Families	can	be	both	helpful	and	obstructive:	 there	 is	a	 fine	 line	between	a	 loved	one	encouraging	 the	patient	 to	 engage	 in	 rehabilitation	 (for	 instance	 in	 persisting	 with	 drinking	
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thickened	fluids)	and	being	perceived	as	nagging.		Observing	how	families	relate	to	the	 patient	 is	 an	 important	 part	 of	 building	 an	 understanding	 of	 how	 the	 family	understands	the	effects	of	the	stroke	and	the	treatment	pathway,	and	how	they	may	support	that	patient’s	coping	both	in	hospital	and	once	discharged.		The	contribution	of	families	to	the	efficacy	of	post-stroke	self-management	programmes	has	also	been	recognised	(Warner,	Packer,	Villeneuve,	Audulv,	&	Versnel,	2015).				Families	 are	 also	 important	 in	 supporting	 self-management	 in	 people	 with	neurological	diagnoses:	 in	deteriorating	 conditions,	 family	members	are	 likely	 to	face	 taking	 over	 the	 health	 management	 decisions	 and	 tasks,	 and	 it	 may	 be	important	that	there	is	joint	understanding	with	the	patient	about	treatment	goals	and	wishes.		In	functional	neurological	symptoms	there	may	be	secondary	gains	for	the	patient’s	partner	or	families	that	cause	them	to	obstruct	rehabilitation	efforts.		However,	a	study	examining	the	illness	beliefs	of	both	family	members	and	patients	with	 functional	 symptoms	 found	 that	 family	 members	 endorsed	 psychological	factors	as	a	causation	more	than	the	patients,	suggesting	that	they	may	be	important	routes	 to	 engagement	 	 in	 psychological	 interventions	 for	 people	with	 functional	symptoms	(Whitehead	et	al,	2015).	Functional	neurological	symptom	disorder	is	a	condition	where	 the	wording	 of	 the	 diagnosis	 and	 the	 aetiological	 stance	 of	 the	professional,	 usually	 a	 neurologist,	 delivering	 the	 diagnosis	 is	 crucial	 to	 any	potential	rehabilitation	(Stone,	Carson,	&	Hallett,	2016).				
Psychological	 aspects	 of	 illness:	 impact	 on	 patient	 and	 family	 and	
interventions:	The	Royal	College	of	Physicians	recommends	that	patients	in	a	stroke	unit	should	have	 45minutes	 daily	 of	 each	 therapy,	 including	 psychology,	 if	 they	 are	 able	 to	engage	(Bowen,	James,	&	Young,	2016).		In	reality	most	patients	in	the	stroke	unit	are	extremely	 fatigued,	and	 in	order	 to	spend	any	 time	with	 them	a	psychologist	needs	 to	 work	 collaboratively	 with	 other	 therapies,	 for	 instance	 being	 with	 the	patient	while	they	are	having	physiotherapy	in	the	gym,	practicing	independence	skills	in	the	kitchen,	or	in	informal	groups,	where	conversations	can	be	easier	than	the	 bedside	 in	 a	 busy	 bay.	 	 Many	 patients	 have	 cognitive	 and	 communication	
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difficulties,	 especially	 soon	 after	 the	 stroke,	 and	 therapeutic	 interventions	 are	necessarily	brief.								A	 common	 cause	 of	 severe	 distress	 for	 patients	 is	 how	 to	 deal	 with	 what	 they	perceive	as	the	humiliation	of	having	to	have	personal	care	carried	out	by	young	nursing	staff,	frequently	of	the	opposite	sex.		Acknowledging	that	these	procedures	are	 difficult	 for	 the	 patient,	 assuring	 them	 of	 the	 professionalism	 of	 the	 staff,	normalising	 the	 procedures	 at	 this	 stage	 of	 their	 recovery,	 and	 occasionally	practicing	simple	visual	imagery	with	the	patient	can	help	them	cope.		While	the	stroke	patient	may	be	dealing	with		traumatic	and	sudden	changes	to	their	identities	and	 feelings	of	 locus	of	control,	 their	 families	are	also	coming	 to	 terms	with	the	possible	changes	in	personality,	physical	and	cognitive	functioning	of	their	relative,	 often	 without	 any	 confirmed	 medical	 prognosis	 especially	 early	 in	 the	patient’s	recovery,	and	their	own	identity	change	in	becoming	carers,	with	possible	financial	and	social	consequences.	Concern	about	uncertainty	is	high	on	the	list	for	people	with	stroke	and	their	carers,	particularly	around	recurrence	of	stroke,	and	psycho-education	 interventions	 are	 frequently	 welcomed	 (White,	 Barrientos,	 &	Dunn,	2014).		While	there	is	scant	evidence	that	psychotherapy	helps	stroke	anxiety	(Knapp	et	al,	2017),	 or	 that	 it	 significantly	 improves	 depression	 following	 stroke	 (Hackett,	Anderson,	 House	 &	 Xia,	 2008),	 a	 small	 but	 significant	 effect	 of	 psychological	interventions	on	preventing	depression	has	been	shown	(Hackett,	Anderson,	House,	&	Halteh,	2008),	indicating	that	early	treatment	may	be	important	in	preventing	low	mood	and	the	consequent	deleterious	effects	on	functioning.		Intolerance	 of	 uncertainty	 is	 a	 construct	 that	 is	 frequently	 included	 in	 modern	anxiety	disorder	models,	and	represents	a	fear	of	the	unknown	(Carleton,	Norton,	&	Asmundson,	 2007).	 	 Neurological	 conditions	 like	 Parkinson’s	 disease	 are	progressive	 and	 unpredictable:	 motor	 symptoms	 and	 non-motor	 symptoms,	including	cognitive	deterioration,	can	be	embarrassing	and	debilitating	,	and	make	
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social	 interaction	 very	 difficult	 (Parkinson’s	 UK,	 2017).	 	 Talking	 therapies	 that	include	 worry	 exposure,	 cognitive	 behavioural	 therapy	 and	 mindfulness-based	interventions	 can	 help	 patients	 build	 psychological	 flexibility	 and	 resilience	 by	increased	levels	of	acceptance,	decentering,	self-compassion,	mindfulness	skills	and	tolerance	of	uncertainty	(Kabat-Zinn,	1990;	Butler	&	Rouf,	2004;	Homan	&	Sirois,	2017).				However,	neurological	conditions,	most	of	which	are	inherently	neurodegenerative,	have	a	high	correlation	with	cognitive	 impairment,	which	 in	 turn	 is	predictive	of	disability	 (Bobholz	&	 Gleason,	 2005;	 Skandsen,	 Finnanger,	 Andersson,	 Lydersen,	Brunner,	 &	 Vik,	 2010;	 Aarsland,	 Brønnick,	 &	 Fladby,	 2011).	 Understanding	 a	patient’s	 level	 of	 cognitive	 functioning	 is	 fundamental	 to	 understanding	 their	behaviours,	 illness	 beliefs,	 emotional	 status	 and	 potential	 for	 rehabilitation	 or	adjustment	therapy.				In	an	acute	setting	like	a	stroke	unit,	understanding	the	patient’s	cognitive	abilities	can	inform	the	therapy	team	of	any	specific	deficits	the	patient	may	be	experiencing,	particularly	the	deficits	that	the	patient	may	lack	conscious	awareness	of,	such	as	unilateral	 neglect,	 or	 disinhibition,	 which	 can	 lead	 to	 falls	 and	 delays	 in	rehabilitation.	 These	 cognitive	 deficits	 also	 impact	 on	 the	 patient’s	 mood,	 with	communication	 difficulties	 in	 particular	 being	 predictive	 of	 low	mood	 following	stroke	(Humphreys,	Thomas,	Phillips,	&	Lincoln,	2015).			In	post-acute	settings,		cognitive	function	assessment	including	neuropsychological	testing	 if	 appropriate,	 contributes	 to	 understanding	 the	 emotional,	 cognitive,	 or	behavioural	 difficulties	 that	 the	 patient	 and	 their	 families	 are	 reporting.		Collaborating	with	the	patient	on	formulation	and	planning	tailored	interventions	can	only	be	conducted	once	the	patient’s	cognitive	context	has	been	assessed	and	incorporated	into	a	social	and	physical	assessment	of	the	patient	that	is	then	shared	with	other	professionals	in	the	multi-disciplinary	team	(Lezak,	Howieson,	&	Loring,	2004).				
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Baseline	cognitive	testing	in	stroke	units	is	frequently	carried	out	by	occupational	therapists,	with	input	from	a	psychologist	when	a	need	for	further	testing	of	higher-order	 skills	 is	 identified,	 	 assessing	 possible	 deficits	 that	 would	 impact	 on	 the	patient’s	 post-acute	 rehabilitation	 –	 such	 as	 apraxia	 (an	 inability	 to	 carry	 out	purposive	actions),	or	executive	dysfunction	(skills	required	in	mental	control	and	self-regulation).				In	 the	 outpatient	 department,	 cognitive	 assessment	 is	 required	 for	 brain	 injury	patients,	again	as	a	baseline	and	also	to	inform	placements	in	secondary	or	tertiary	rehabilitation	units.		Understanding	executive	dysfunction,	a	frequent	consequence	of	frontal	lobe	damage,	can	help	a	family	recognise	that	their	loved	one’s	behaviours,	which	may	include	disinhibition,	apathy,	poor	planning	and	decision-making,	are	a	result	of	their	brain	injury,	and	compensatory	strategies	and	extensive	occupational	therapy	can	help	retrain	some	of	these	skills.		Neurological	 settings	provide	many	opportunities	 for	health	psychologists	 to	use	their	theoretically-driven	assessments	and	interventions,	such	as	the	common	sense	model	(CSM,	Leventhal,	Meyer,	&	Nerenz,	1980),	but	assessment	of	patient	cognitive	and	emotional	functioning	can	help	establish	how	interventions	aimed	at	cognitive	or	emotional	 appraisals	and	of	 the	health	 threat	and	coping	 strategies	may	need	modification.			Neuropsychological	 assessment	 integrates	 cognitive	 testing	 with	 	 the	 patient’s	history	and	behaviour,	preferably	including	a	witness	account	from	a	close	relative	or	friend	to	provide	a	fuller	picture	of	that	patient’s	baseline	skills,	personality	and	motivation	(Evans,	2003)			Cognitive	testing	should	be	undertaken	when	there	is	uncertainty	about	the	level	of	deficit	 caused	 by	 the	 neurological	 condition,	 when	 there	 is	 a	 need	 to	 measure	cognitive	 function	 to	 assess	 intervention	 effectiveness,	 to	 assess	 the	 patient’s	readiness	to	return	to	work,	independent	living,	and	education,	and	there	is	also	a	justification	 in	 some	cases,	 including	 functional	 cases,	 for	 testing	 to	demonstrate	
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normal	 functioning	 to	 the	 underconfident	 patient.	 	 Understanding	 the	 neurology	patient’s	level	of	cognitive	function	should	be	an	essential	part	of	assessment,	should	feature	in	the	formulation,	and	should	inform	the	choice	of	therapy,	which	may	need	adaption	to	compensate	for	deficits.			An	 example	 of	 a	 therapeutic	 intervention	 would	 be	 cognitive	 restructuring	 and	disputation,	 which	 may	 be	 too	 challenging	 for	 people	 who	 have	 difficulty	 with	abstract	reasoning,	or	with	language	processing.	Post-stroke	patients	may	benefit	more	 from	behavioural	 interventions	–	disputation	of	 thoughts	of	being	hopeless	and	helpless	may	not	be	possible,	but	working	on	demonstrating	what	strengths	the	patient	may	still	have,	reinforcing	small	progressions	in	rehabilitation	using	visual	aids	 including	 video,	 and	 motivating	 families	 to	 reinforce	 simple	 relaxation	strategies	and	coping	self-statements,	can	be	beneficial	(Kneebone,	2016).			Similarly,	mindfulness	interventions	require	attentional	and	executive	functioning	skills,	particularly	mental	manipulation,	which	again	may	be	 too	 taxing	 for	 some	patients.	In	one	study	of	people	with	Parkinson’s	disease,	57%	were	shown	to	have	mild	cognitive	impairment	within	3-5	years	of	diagnosis	(Williams-Gray,	Foltynie,	Brayne,	Robbins,	&	Barker,	 2007)	 indicating	 that	 timing	of	 the	 intervention	may	impact	on	the	effectiveness	of	learning	new	skills.				Adjustment	to	living	with	the	chronic	and	long-term	effects	of	stroke,	or	traumatic	brain	 injury,	or	a	 functional	neurological	symptom	disorder,	may	mean	having	to	follow	a	more	structured	lifestyle,	which	for	people	with	memory	difficulties	may	require	compensatory	strategies	and	support	to	carry	out.		Without	a	clear	picture	of	 the	 extent	 of	 the	memory	 or	 speed	 of	 processing	 deficits,	 a	multi-disciplinary	approach	 to	 rehabilitation	 may	 lack	 coherence	 and	 may	 not	 be	 pitched	 at	 an	achievable	 level	 to	maximise	 	 the	 patient’s	 potential	 (Prakash,	 Janssen,	 &	Derry,	2016).				Neuro-psychometric	tests	have	been	validated	for	specific	use	in	many	neurological	diseases,		and	care	should	be	taken	that	testing	is	undertaken	in	optimal	conditions	
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with	consideration	for	the	patient’s	particular	health	conditions,	such	as	pain	and	fatigue,	 mood	 levels	 or	 medication	 dose	 and	 timing,	 which	 may	 all	 impact	performance.	 	 Equally,	 consideration	 as	 to	 the	 specific	 cognitive	 domains	 that	accompany	 different	 neurological	 diseases	 should	 enable	 the	 patient	 to	 only	undertake	tests	that	target	assessment	of	those	particular	cognitive	deficits,	so	as	to	minimise	patient	burden	and	potential	distress.				However,	 many	 neuropsychological	 test	 materials	 remain	 available	 only	 to	qualified,	 Health	 and	 Care	 Professions	 Council	 registered,	 clinical,	 forensic,	 or	counselling	psychologists,	and	health	psychologists	are	specifically	excluded.	The	route	 to	 further	 training	 in	 clinical	 neuropsychology	 is	 only	 open	 to	 clinical	 or	educational	psychologists	in	the	UK,	with	the	possibility	of	counselling	psychologists	becoming	 eligible	 in	 the	 near	 future	 (personal	 communication,	 April	 2018,	Qualification	in	Clinical	Neuropsychology	(QiCN)).			Health	 psychologists,	 whose	 theory	 and	 practice	 emphasise	 a	 biopsychosocial	aetiology	 of	 illness	 and	 holistic	 treatment	 of	 long-term	 conditions,	 are	 useful	members	of	multi-disciplinary	teams	working	in	neurological	conditions.		However,	the	barriers	to	formal	training	in	neuropsychological	testing	are	preventing	health	psychologists	from	independently	contributing	to	complete	understanding	of	how	these	complex	patients	perceive	their	difficulties	and	how	best	to	help	them	self-manage	their	condition,	thus	maximising	their	potential.		3235	words		
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Case	Study:	Teaching	and	Training	Part	I	–	Health	Professionals		
Understanding	Functional	Neurological	Symptom	Disorder	–	
Training	for	Multi-disciplinary	Staff	at	a	Brain	Injury	
Rehabilitation	Centre		
Background	I	have	worked	at	a	post-acute,	outpatient	brain	injury	centre	for	the	past	six	years,	more	 recently	 as	 a	 trainee	 health	 psychologist.	 	 The	 centre	 assesses	 and	 treats	around	110	adult	clients	a	year	who	have	either	had	a	stroke	or	a	traumatic	brain	injury	and	who	are	expected	to	make	further	recovery.				
Plan	 and	 design	 training	 programmes	 that	 enable	 students	 to	 learn	 about	
psychological	knowledge,	skills,	and	practices.	Training	 needs	 within	 the	 clinical	 team	 for	 better	 understanding	 of	 Functional	Neurological	Symptom	Disorder	(FNSD)	were	recently	identified	as	more	research	is	 published	 about	 the	 disorder	 and	 more	 clients	 with	 predominantly	 FNSD	 or	functional	symptoms	comorbid	with	organic	disease	are	referred.				Many	members	of	the	team	had	expressed	dismay,	apprehension	and	concern	about	their	 competency	 to	 provide	 treatment	 for	 this	 group	 of	 clients,	 who	 make	 up	between	10	and	20%	of	the	total	intake.		As	I	progressed	in	my	doctoral	studies	I	realised	 that	 there	was	 a	 role	 for	health	psychology	 to	both	 inform	 treatment	of	FNSD	and	to	change	the	attitudes	of	some	of	the	health	professionals	that	I	worked	with.	 	 I	 completed	 a	 behaviour	 case	 study	 on	 a	 client	 with	 FNSD	 who	 was	successfully	treated	to	self-manage	her	symptoms	and	reintegrate	in	family,	social	and	work	roles,	and	I	 later	conducted	a	systematic	review	into	the	role	of	 illness	perceptions	 in	 the	management	of	 this	distressing	and	disabling	condition.	 	With	this	 theoretical	 and	 practice-based	 background,	 I	 continued	 to	 develop	 my	therapeutic	skills	working	with	people	with	FNSD	and	I	felt	confident	that	I	could	share	my	expertise	with	my	colleagues.	
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	The	team	had	expressed	a	need	to	understand	the	aetiology	and	background	of	the	diagnosis,	and	to	be	able	to	source	evidence	of	best	management.		Evidence	base	is	important	as	there	are	occasions	when	clients	are	referred	to	us	outside	our	core	contract	criteria	and	their	case	(and	evidence	for	treatment	needs)	is	presented	to	a	 funding	 board.	 	 The	 centre	 is	 also	 developing	 a	 private	 treatment	 arm	 and	 is	required	to	demonstrate	evidence-based	practice	when	marketing	this	service.		A	needs	assessment	was	carried	out	by	informal	contact	with	team	members,	heads	of	 departments	 and	 the	 clinical	 lead,	 and	 identified	 gaps	 in	 knowledge	 about	functional	 symptoms	 and	 in	 management	 efficacy	 (Hauer	 &	 Quill,	 2011).	 The	teaching	plan	was	discussed	with	my	workplace	supervisor	(appendix	1).	I	emailed	the	 team	 to	advertise	 the	date	and	 time	of	 the	 training	and	asked	 if	 any	of	 them	would	like	to	bring	a	case	study	forward	which	could	be	reflected	in	the	last	half	an	hour.		No	case	study	was	suggested	before	the	day.		Because	 our	 staff	 team	 comprised	 highly	 specialist	 professionals,	many	 received	their	 initial	 training	 at	 least	 15	 years	 ago.	 FNSD	 and	 its	 management	 is	 still	 an	emerging	 area	 of	 research,	 with	 the	 involvement	 of	 neurology	 and	 neurological	rehabilitation	only	since	around	the	Millennium.	A	constructivist	teaching	approach	was	adopted,	which	acknowledges	that	the	teacher	only	facilitates	learning,	and	new	knowledge	and	experience	is	incorporated	into	existing	knowledge	and	experience,	which	this	mainly	senior	and	experienced	audience	has	a	wealth	of.				
Deliver	such	training	programmes	I	 discussed	 giving	 a	 presentation	 as	 part	 of	 the	 centre’s	 6-weekly	 education	programme	when	internal	or	external	lecturers	deliver	training	to	the	whole	team	for	an	hour	and	a	half.	My	previous	experience	in	teaching	and	training	was	limited:	I	had	participated	in	co-presentations	but	I	had	never	delivered	teaching	on	my	own.	Initially,	 I	 delivered	 the	 seminar	 on	FNSD	 to	 a	 small	 sub-group	of	 the	 team,	 two	clinical	psychologists	(one	being	my	workplace	supervisor),	a	social	worker	and	an	occupational	therapist.	Their	feedback	was	very	useful	in	adjusting	the	delivery	of	
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my	future	seminars.	It	was	agreed	that	there	was	a	great	deal	of	information	within	the	slides	and	it	was	suggested	to	reduce	the	burden	by	creating	extra	slides.	After,	this	first	seminar,	I	felt	better	prepared	for	the	following	seminars	that	I	facilitated.	I	 delivered	 a	 second	 seminar	 to	 three	 professions	 (two	 physiotherapists,	 three	occupational	therapists	and	one	speech	and	language	therapist).	I	was	approached	after	 the	 second	 lecture	 to	 deliver	 another	 hour-long	 presentation	 to	 two	rehabilitation	assistants,	a	student	OT	and	a	physiotherapist	who	had	been	on	sick-leave	 at	 the	 time	 of	 the	 education	 session.	 	 The	 third	 presentation	 was	 slightly	altered	 as	 the	 group	 included	 rehabilitation	 assistants	 who	 have	 not	 had	 the	academic	training	of	the	other	professions,	and	the	presentation	was	limited	to	just	one	 hour.	 I	 therefore	 decided	 to	 only	 describe	 functional	 symptoms	 using	 the	Cognitive	Behavioural	Model	and	remove	the	slide	on	the	Common-Sense	Model.		I	also	included	an	explicit	mention	of	the	role	of	rehabilitation	assistants	within	the	treating	team	–	as	all	members	need	to	foster	the	trusting	environment	necessary	for	people	with	FNSD.			In	all	there	were	three	training	sessions,	two	15	days	apart	in	November	2016	and	one	in	March	2017,	and	the	content	of	each	presentation	was	developed	to	suit	the	audience	and	the	allocated	time.		To	encourage	the	learner	(in	this	case,	fellow	health	professional)	to	be	an	active	contributor,	I	decided	to	involve	them	from	the	start	in	sharing	their	anxiety	about	this	patient	group.		Some	of	the	team	revealed	that	they	were	not	even	sure	if	they	had	 treated	 people	with	 FNSD,	 as	 a	 straightforward	 diagnosis	 is	 rarely	made	 by	neurologists.	 	 Some	 also	 expressed	 concern	 about	 the	 sub-group	 of	 people	who	present	with	post-concussion	syndrome	and	queried	their	 inclusion	 in	 functional	syndromes.		This	illustrates	the	problem	of	nomenclature	and	nosology	that	is	still	not	 resolved	 within	 this	 field	 but	 should	 be	 clarified	 by	 the	 publication	 of	 the	International	Classification	of	Diseases	–	11	which	is	due	for	publication	in	2018.		Kaufman	(2003)	discusses	how,	in	a	constructivist	view	of	facilitating	learning,	it	is	important	 for	 the	 teacher	 to	expose	 the	 learners’	 inconsistencies	 in	 their	current	understanding	 and	 then	 engage	 them	 to	 learn	 in	 an	 active,	 experiential	 way.		
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Creating	a	cognitive	dissonance	with	their	existing	understanding	of	FNSD	aetiology	was	important	as	this	would	allow	for	new	information	to	be	assimilated	in	a	more	coherent	way.	The	presentation	began	by	discussing	how	uncomfortable	dealing	with	people	with	FNSD	can	be	-	a	flip-chart	was	used	to	write	down	what	the	team	thought	when	faced	with	functional	clients,	and	comments	ranged	from	“heart-sink”	to	“challenging”.		Adult	learners	are	motivated	to	learn	when	they	feel	they	can	express	themselves	in	a	 safe	 place,	 diagnose	 their	 own	 learning	needs	 and	 evaluate	 their	 own	 learning	(Kaufman,	2003).	The	information	presented	was	contextualised	to	real	practice	by	looking	at	best	management	evidence	and	by	examining	the	role	the	centre	could	have	in	becoming	more	confident	in	their	expertise	in	this	field.	I	tried	to	involve	most	of	the	professions:		I	attempted	to	examine	research	about	how	people	with	FNSD’s	 families	 influence	 outcome,	 to	 include	 the	 social	 worker	 who	 has	responsibility	for	supporting	the	loved	ones	of	people	receiving	rehabilitation,	but	I	unfortunately	had	to	highlight	the	lack	of	evidence	in	family	work	in	this	area.	The	roles	of	physiotherapy,	occupational	therapy	and	psychology	were	clarified,	and	the	role	of	rehabilitation	assistants	was	included	in	the	third	presentation.		Discussion	was	encouraged	by	making	time	between	slides,	in	the	second	lecture	for	instance	a	speech	and	language	therapist	recounted	her	experience	of	functional	dysphonia.		Treatment	 for	 FNSD	 involves	 behaviour	 change,	 particularly	 boom-and-bust	behaviour,	 and	 requires	 commitment	 and	 self-efficacy	 on	 the	 part	 of	 client	 and	therapist.		Self-efficacy	theory	(Bandura,	1986)	posits	that	if	people	feel	they	have	succeeded	 in	 a	 task	 (in	 this	 case	 treating	 a	 person	 with	 functional	 neurological	symptoms)	they	will	feel	more	confident	in	repeating	it.		The	success	rate	in	FNSD	treatment	is	low,	around	one	in	four	severely	affected	will	improve	(Stone,	2010)	and	the	literature	on	management	is	scarce,	however	there	is	increasing	acceptance	that	 multi-disciplinary	 interventions	 involving	 at	 minimum	 physiotherapy	 and	psychology	 increase	 patient	 engagement	 and	 promote	 better	 functioning.	 	 A	successful	case	study	was	included	in	the	presentation	to	reinforce	the	message	that	as	a	team	we	were	already	making	a	difference	to	people	with	FNSD.	
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		It	was	also	emphasised	that	the	centre	and	its	staff	were	ideally	placed	to	provide	a	service	for	this	population	both	as	a	core	service	and	as	private	providers,	further	increasing	self-efficacy.		A	PowerPoint	presentation	was	used	as	an	effective	way	to	communicate;	colourful	and	 animated	 text,	 vivid	 images	 and	 linear	 models	 were	 used	 to	 aid	 learning.	Kosslyn	 et	 al	 (2012)	 describe	 eight	 cognitive	 communication	 principles,	 two	 of	which,	 discriminability	 and	 salience	 of	 the	 visual	 information,	 are	 increased	 by	colour	and	movement.		Clear	labelling	of	graphs	and	time	to	process	the	information	also	aids	learning.	With	the	first	group,	handouts	were	distributed	at	the	outset,	but	it	 was	 noticeable	 that	 people	 spent	 a	 lot	 of	 time	 writing	 and	 reading	 them.	 	 In	subsequent	presentations,	the	slides	were	later	emailed	to	the	attendees,	which	also	minimised	paper	wastage.		
Reflexivity:		The	training	was	delivered	using	the	main	meeting	room,	and	on	each	occasion	the	audience	sat	around	the	central	table	and	I	presented	from	my	chair	at	right	angles	to	them	and	the	screen.	 	 I	used	my	own	laptop	connected	to	the	projector,	which	being	familiar,	lessened	my	anxiety.		I	had	also	asked	for	help	in	the	lunch	hour	the	day	before	the	first	presentation	to	ensure	I	was	competent	with	the	technology.				I	used	cognitive	behavioural	skills	(Williams	&	Chellingsworth,	2010)	on	myself	–	I	rationalised	unhelpful,	catastrophic	thinking;	I	also	used	reframing	–	my	somatised	anxiety	about	presenting	“became”	the	expression	of	my	excitement	at	delivering	a	learning	opportunity	to	familiar	colleagues	who	wanted	to	share	in	my	passion	for	developing	an	effective	treatment	for	this	distressed	client	group!		The	information	about	FNSD	is	highly	complex	and	time	to	explain	the	slides	was	limited,	but	I	was	aware	that	I	occasionally	included	too	much	data	to	process	easily	on	slides,	in	the	hope	that	slides	would	be	revisited	in	the	attendee’s	own	time.		In	future	 I	would	 create	 two	 documents,	 one	with	 the	 slides	 and	 another	with	 the	
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additional	material	and	reading	suggestions,	which	would	retain	the	clarity	of	the	presentation			
Plan	and	implement	assessment	procedures	for	such	training	programmes.	The	training	programme	was	evaluated	by	the	questionnaires	that	every	attendee	completed	 before	 and	 after	 the	 presentations,	 asking	 them	 to	 rate	 their	 level	 of	understanding	 of	 FNSD	 and	 their	 confidence	 in	 treating	 people	with	 FNSD,	 both	before	and	after	each	presentation	(appendices	3	and	4).		
Unit	4.4	Evaluate	such	training	programmes	All	groups	reported	having	greater	understanding	of	FNSD	and	more	confidence	in	treating	this	client	group	after	the	presentations	(understanding	increased	by	48%	in	 group	 1,	 by	 20%	 in	 group	 2	 and	 by	 45%	 in	 group	 3.	 treatment	 confidence	increased	by	75%,	9%	and	50%	in	groups	1,2	and	3	respectively).		It	is	interesting	to	note	that	the	second	group	included	a	senior	physiotherapist	who	reported	being	less	confident	and	having	less	understanding	after	the	presentation.		She	wrote	on	her	initial	rating	“I	may	be	confident	but	not	happy	working	with	people	with	FNSD”	and	her	post-presentation	 rating	was	 lower	 than	at	 the	beginning.	 She	has	 since	asked	 for	 some	 one-to-one	 teaching	 in	 FNSD.	 	 More	 importantly,	 the	 seminars	fostered	ongoing	discussions	about	presentation	and	management,	including	how	to	support	people	with	FNSD	in	receiving	benefits,	or	returning	to	work,	and	how	to	market	the	interdisciplinary	team	as	experts	in	FNSD	rehabilitation.			However,	this	was	a	very	general	overview	of	a	very	complex	area,	and	further	sessions	on	specific	sub-groups	 of	 FNSD	 such	 as	 post-concussion	 syndrome	 including	 further	 case	reflection	would	increase	competency	within	the	team.	
	Repeating	and	refining	these	presentations	and	answering	questions	from	different	viewpoints	has	helped	me	consolidate	my	knowledge	and	developed	my	ability	to	focus	on	the	more	salient	points.		I	hope	that	I	have	stimulated	a	discussion	within	the	team	about	both	the	need	to	develop	our	management	skills	for	FNSD	clients,	and	for	the	role	of	Health	Psychology	within	that	team.		
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Appendix	C1.		Teaching	and	Training	I	
	
	
Teaching	plan	for	professionals.		 1. 	Acknowledge	this	topic	is	controversial	and	difficult	–	perhaps	provoking	an	emotional	response.		 2. Explain	difficulty	in	nomenclature	(but	be	prepared	to	not	be	definite.)		 3. Answer	the	questions.		 4. Involve	the	audience:		words	used	by	staff	members	themselves		 5. Some	history	of	how	FNSD	is	now	managed	by	neurology.		 6. Involve	all	main	professions		 7. Use	a	successful	case	study	to	underline	that	we	already	have	a	lot	of	the	skills	needed	to	manage	these	cases.		 8. Look	at	how	the	centre	fits	into	national	guidelines	on	treating	FNSD																					
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Appendix	C2	
FUNCTIONAL NEUROLOGICAL SYMPTOMS DISORDER 
 
Wednesday 3rd November 2016 
 
Please complete this side of the sheet before the presentation begins. 
 
1. How confident are you that you understand Functional Neurological 
Symptom Disorder (FNSD)? 
 
 
 
  1  2  3  4  5  
 
      not at all         very confident 
 
 
2. How confident are you in your practice with people with FNSD?  
 
 
  1  2  3  4  5  
 
    not at all         very confident 
 
 
NOTES 
 
  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
At the end of the presentation, please turn over and complete the  
form. 
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1. How confident are you now that you understand Functional 
Neurological Symptom Disorder (FNSD)? 
 
 
 
  1  2  3  4  5  
 
      not at all         very confident 
 
 
2. How confident are you now in your practice with people with FNSD?  
 
 
  1  2  3  4  5  
 
      not at all         very confident 
 
 
3. Are there areas of FNSD management in a MDT that need further 
explanation in order to increase your confidence in treating a client 
with this diagnosis? 
 
 
 
 
 
 
 
4. Would further training on FNSD management be useful? 
 
 
 
 
5. (Optional) What is your profession? 
 
 
 
6. (Optional) Name 
 
 
 
THANK YOU! 	
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Appendix	C3			Subjective	ratings	of	understanding	and	treatment	confidence			
Mean	
understanding	
pre-presentation	
Mean	
understanding	 post-
presentation	
Mean	treatment	
confidence	 pre-
presentation	
Mean	treatment	
confidence	post-
presentation	
All	three	presentations:	(n=15)	
2.8	 3.8	 2.5	 3.4	
Presentation	1	(n=4)	2.7	 4.0	 2.0	 3.5	
Presentation	2	(n=6)	3.4	 4.1	 3.3	 3.6	
Presentation	3	(n=5)	2.2	 3.2	 2.0	 3.0		
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Case	Study:	Teaching	and	Training	Part	II	–	General	Public	
A	Lecture	on	Functional	Symptoms	(Medically	Unexplained	
Symptoms)	to	MSc	Students		
	
Background	In	2016	I	was	invited	to	give	a	guest	lecture	on	“Medically	Unexplained	Symptoms”	(MUS)	for	Health	Psychology	MSc	students	as	part	of	the	module	Understanding	and	Managing	Long-term	Conditions.		I	have	completed	a	systematic	review	on	the	role	of	Illness	Perceptions	in	Functional	Neurological	Symptom	Disorder	(FNSD)	and	a	case	 study,	 and	 I	 work	 clinically	 with	 people	 with	 FNSD	 as	 a	 Trainee	 Health	Psychologist.	 I	 have	 also	 read	 extensively	 about	 models	 that	 may	 explain	 the	aetiology	and	potential	therapy	targets	of	MUS.			
Plan	 and	 design	 training	 programmes	 that	 enable	 students	 to	 learn	 about	
psychological	knowledge,	skills,	and	practices.	The	module	leader	had	emailed	me	some	feedback	from	a	Staff	and	Student	Liaison	Committee	meeting	where	the	students	requested	that	lectures	incorporate	real-life	cases,	with	qualitative	narratives	and	quantitative	data,	and	opportunities	for	group	exercises.		The	importance	of	cultural	context	was	also	mentioned	because	of	their	own	diverse	backgrounds.  
  This	follows	one	of	Kaufman’s	(2003)	principles	–	that	real-life	problems	are	best	for	engaging	adult	learners.		I	researched	what	Health	Psychology	theory	had	been	covered	in	previous	lectures,	so	that	mentioning	the	Common-Sense	Model	would	not	be	a	new	concept	in	an	already	complex	subject	area.		The	first	half	of	the	lecture’s	focus	was	a	biopsychosocial	explanation	for	functional	or	persistent	physical	 symptoms,	 including	 the	controversial	and	emotive	debate	around	aetiology,	and	incorporating	a	generic	Cognitive	Behavioural	Model	(Deary	et	 al,	 2007),	 the	 Common-Sense	Model	 (Leventhal	 et	 al,	 2016;	 Cameron	 &	 Jago,	2008),	and	research	evidence	from	Irritable	Bowel	and	Chronic	Fatigue	Syndromes.		
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The	 second	 half	 on	 FNSD	 examined	 in	 greater	 depth	 how	 factors	 contribute	 to	symptomology,	and	a	case	study	of	a	successful	multi-disciplinary	rehabilitation	of	an	anonymised	client	with	FNSD.			Two	group	exercises	were	incorporated	within	each	half	of	the	lecture,	to	break	up	any	 passivity	 and	 promote	 active	 learning	 (Hauer	 &	 Quill,	 2011).	 	 Cultural	differences	in	attitudes	and	management	of	functional	disorders	was	also	included	in	 the	 presentation,	 in	 line	with	 the	 learner-centred	 teaching	model	 (Dennick	 &	Exley,	2004)	where	the	students’	own	experiences	are	valued.		Equipment	 needs	were	 ascertained	with	 the	module	 leader	who	 provided	 a	 flip	chart	 and	 pens,	 and	 the	 maximum	 attendance	 confirmed	 as	 14.	 	 	 Slides	 were	prepared	for	projection	with	Powerpoint	and	handouts	(Appendix	1)	were	later	put	on	the	University	intranet.		
Reflection:	I	had	only	 limited	presentation	experience	at	my	workplace.	 I	used	my	cognitive	behavioural	therapy	skills	to	reframe	my	anxiety	symptoms	as	excitement,	and	to	reduce	catastrophic	thinking	by	rationalising	and	thoroughly	preparing	for	as	many	eventualities	as	possible.		
Deliver	such	training	programmes	I	arrived	early	to	ensure	familiarity	with	the	room	and	technology.		I	tried	to	reduce	my	anxiety	about	delivering	my	lecture	by	having	a	water	bottle	and	running	order	(Appendix	2)	to	hand,	and	by	stretching	while	the	room	was	empty.	
		Seven	students	out	of	a	possible	14	attended	–	and	two	of	these	were	20	minutes	late.		This	was	disruptive	and	concerning,	as	they	missed	my	personal	introduction	and	discussion	about	the	potential	controversy	and	emotional	nature	of	this	illness.				During	 the	break,	 I	ensured	 that	 I	 spoke	 to	every	member	of	 the	group	–	no	one	worked	 in	 a	 clinical	 setting	 and	 only	 three	 appeared	 very	 engaged	 with	 Health	
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Psychology	theory	and	practice.		The	latecomers	revealed	that	they	felt	distanced	by	the	way	other	group	members	dominated	discussions	every	week.		The	two	participants	who	sat	directly	in	front	of	me	were	the	most	knowledgeable,	one	revealing	that	they	had	severe	symptoms	that	involved	many	interactions	with	medical	staff	who	had	not	been	able	to	give	them	either	a	satisfactory	diagnosis	or	treatment.		This	student	appeared	to	be	highly	critical	of	the	stance	of	the	lecture	-	I	repeated	the	complexity	and	controversy	surrounding	the	diagnosis	and	treatment	and	asked	them	to	be	open	to	a	biopsychosocial	explanation.				
Reflection:		It	was	challenging	to	include	the	quieter	group	members,	and	I	perhaps	did	not	give	them	enough	time,	nor	did	I	draw	them	into	conversations	enough.	With	hindsight,	I	would	separate	the	two	dominant	members	 in	both	group	exercises	to	 increase	engagement	and	I	should	have	included	a	reversal	of	the	task	in	exercise	1	giving	all	the	students	a	chance	to	experience	both	perspectives.	 	Neither	exercise	felt	very	successful,	and	I	should	not	have	assumed	that	the	students	had	clinical	experience	as	in	my	own	MSc	cohort.		I	did	feel	that	I	engaged	with	the	more	active	students:	people	with	FNSD	have	been	shown	to	be	defensive	and	frustrated	by	the	inclusion	of	 psychological	 causation	 in	 their	 symptoms	 (Stone	 et	 al,	 2010)	 but	 biological	evidence	helped	make	my	lecture	more	acceptable.		I	also	described	another	case,	to	emphasis	my	empathy	for	the	distress	of	people	with	functional	symptoms.		
Plan	and	implement	assessment	procedures	for	such	training	programmes	This	lecture	was	part	of	the	MSc	in	Health	Psychology,	and	my	role	was	to	introduce	an	emerging	area	of	health	research	and	practice	to	potential	Health	Psychologists.		I	 hoped	 to	 stimulate	 their	 interest	 but	 it	was	 not	my	 role	 to	 formally	 assess	 the	students’	learning	outcomes.						
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Evaluate	such	training	programmes	A	 student	 feedback	 form	 (Appendix	 3)	was	 designed	 to	 evaluate	 how	useful	 the	students	 found	 the	 lecture,	 the	 content	 and	 group	 exercises,	 the	 amount	 of	 time	allowed	for	questions	and	open-ended	questions	asking	for	suggestions.				The	students’	feedback	(Appendix	4)	and	personal	conversations	revealed	that	the	majority	found	the	subject	stimulating.	 	The	mean	ratings	for	usefulness,	delivery	and	time	for	questions	were	over	8	out	of	10	and	for	the	group	exercises,	6.9.		One	person’s	feedback	was	negative,	rating	the	group	exercises	and	question	time	at	2	out	 of	 10,	 and	 stating	 a	 lack	 of	 encouragement	 for	 group	 discussion.	 	 Having	overcome	the	initial	feelings	of	failure,	I	feel	this	generated	useful	reflection	on	how	to	improve	further	teaching	sessions:	I	had	found	it	difficult	to	include	the	quieter	members	and	in	future	I	would	make	more	effort	to	scan	the	audience.		999	words		
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Appendix	C4	
Supervisor’s	feedback	on	teaching	
	
Date	of	the	Lecture:	23.02.2017	
Title	of	the	lecture:	Functional	Symptoms	(Medical	Unexplained	Symptoms)		
Lecturer:	Anne	Coxon	
Observer:	Dr	Angeliki	Bogosian	
Attendees:	7	MSc	Health	Psychology	students		Anne	delivered	a	very	engaging	and	informative	lecture	on	medically	unexplained	symptoms.	The	lecture	was	very	interactive,	but	Anne	could	have	assessed	students’	understanding	more	regularly	throughout	the	lecture.	Anne	did	a	good	job	giving	clinical	 examples	 from	 her	 work	 and	 linking	 her	 examples	 with	 the	 theoretical	models	 she	 was	 presenting.	 The	 biopsychosocial	 model	 to	 explain	 functional	symptoms	were	described	concisely	and	accurately.		The	information	given	was	up-to-date.	She	used	a	mix	of	different	teaching	modalities,	i.e.	slides,	group	activities,	reflections	to	facilitate	learning.	The	slides	were	at	times	busy	with	text.	Using	3-4	bullet	points	with	3-5	words	in	each	bullet	point	in	each	slide,	adding	more	pictures	and	diagrams	could	have	made	 them	easier	 to	read	during	 the	 lecture.	However,	Anne	talked	around	the	slides	well	and	presented	everything	that	was	on	the	slides.		Only	two	slides	could	have	been	explained	better.	The	slide	on	emotional	stimuli	and	alexithymia	could	have	been	explained	further	since	the	constructs	presented	are	not	commonly	used	in	health	psychology.	The	slide	with	the	compassionate	scale	needed	more	explaining,	i.e.	that	lower	scores	meant	more	compassion	otherwise	it	did	 not	make	 sense.	 The	 case	 study	 presented	 in	 the	 second	 half	 of	 the	 lecture	facilitated	learning	and	linked	the	theoretical	models	presented	earlier	with	a	real	life	 example.	 The	 group	 activity	 after	 the	 case	 presentation	 facilitated	 student	engagement,	but	it	could	have	been	better	to	allow	more	time	for	discussion	with	the	students	and	also	find	ways	to	engage	the	students	who	remained	silent	during	the	lecture.	Even	though,	I	understand	why	students’	questions	when	they	referred	to	 part	 of	 the	 lecture	 that	 would	 come	 later	 on	 in	 the	 presentation,	 were	 not	addressed.	It	might	have	helped	to		increase	students’	participation	if	diversions	of	
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the	content	were	allowed.	Sometimes	discussion	that	arises	from	questions	can	be	used	as	an	opportunity	to	make	teaching	points.	Usually,	students	remember	better	when	teaching	emerges	from	their	queries	and	arrive	at	the	realisation	rather	than	listening	 to	a	 lecture.	Anne	was	professional	and	 friendly	during	 the	session	and	managed	to	put	everyone	at	ease.	Overall,	I	found	the	lecture	very	informative	and	I	was	impressed	with	how	knowledgeable	Anne	is.																																								
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Case	Study:	Consultancy		
	
A	systematic	review	of	the	inclusion	of	people	with	severe	mental	
illness	in	trials	of	structured	educational	interventions	for	self-
management	of	type	2	diabetes	mellitUS	
	
Assessment	of	requests	for	consultancy	The	 initial	 request	 for	 consultancy	 came	 from	 a	 member	 of	 the	 postgraduate	teaching	staff	who	is	also	part	of	a	team	of	two	Research	Fellows	at	City,	University	of	London,	partly	funded	by	the	East	London	Foundation	Trust,	to	develop	research	into	 long-term	health	conditions.	 	She	offered	a	selection	of	possible	consultancy	projects	 to	 Trainee	 Health	 Psychologists	 who	 are	 required	 to	 demonstrate	competency	as	a	consultant	working	in	a	relevant	area.				The	project	 that	was	of	 interest	 to	me	was	described	as	assisting	 in	a	systematic	review	of	the	literature	examining	the	inclusion	of	people	with	Severe	Mental	Illness	(SMI)	 trials	 of	 type	 2	 diabetes	 mellitus	 (T2DM)	 self-management	 interventions.		People	with	SMI	are	at	a	higher	 risk	of	developing	T2DM	partly	because	of	 their	medication	and	lifestyle	(Osborn	et	al,	2008).	 I	am	interested	 in	how	people	self-manage	 long-term	 conditions	 and	 I	 was	 beginning	 to	 plan	 undertaking	my	 own	systematic	 review	 requirement	 for	my	 Doctorate,	 and	 I	 thought	 that	 this	would	provide	me	with	good	database	training.		I	was	also	keen	to	have	the	opportunity	of	working	with	an	established	research	team	and	to	be	a	co-author	on	any	resulting	publication. I	discussed	the	potential	project	with	my	supervisor	and	applied	to	be	considered	for	the	consultancy.	
 This	consultancy	was	based	on	Schein’s	(1978)	Expert	Model	of	Consultancy,	with	the	client	retaining	control	and	guiding	the	consultant	towards	the	tasks	that	need	undertaking.	During	the	initial	meeting	between	the	clients	and	the	consultant,	the	outline	of	the	project	was	discussed.		The	goal	of	the	project	was	to	look	for	evidence	that	people	with	SMI	were	not	being	 included	 in	diabetes	education	trials,	which	
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would	 result	 in	 a	 guidance	 informing	 interventions	 specifically	 aimed	 at	 this	vulnerable	population.	McKibben	et	 al	 (2006)	had	 shown	 that	 older	people	with	schizophrenia	 and	 T2DM	 could	 benefit	 from	 a	 tailored	 self-management	intervention,	but	this	study	appeared	to	be	unique.	It	was	hoped	that	the	proposed	systematic	review	would	lead	to	funding	for	a	larger	study	that	would	address	this	health	 service	 deficit.	 However,	 as	 no	 budget	 was	 available	 for	 the	 systematic	review,	 the	 clients	 were	 looking	 for	 someone	 to	 undertake	 this	 work	 without	payment	as	part	of	 their	doctoral	 studies,	 and	who	 in	 return	would	benefit	 from	working	collaboratively	with	an	experienced	team	and	being	named	as	a	co-author	on	any	resulting	paper.		The	clients	explained	that	some	of	the	searchings	had	already	been	completed	and	uploaded	to	a	Refman	database	by	an	A-level	student	undertaking	work	experience.		There	was	now	need	to	assess	the	abstracts	of	1245	studies	for	eligibility	in	the	final	review	of	inclusion	of	people	with	SMI.	If	the	study	was	not	explicit	in	stating	the	inclusion	or	exclusion	criteria,	the	consultant	was	to	contact	the	author	by	email	and	request	more	details.	 	 A	 protocol	 of	 the	 review	had	 already	been	written	by	 the	clients	and	was	emailed	to	the	consultant	following	the	initial	meeting,	to	enable	a	contract	to	be	drawn	up.		The	final	contract	was	signed	by	the	consultant	and	clients	on	2nd	March	2015	(see	Appendix	1).		It	 became	 evident	 at	 the	 second	meeting	 held	with	 the	 clients	 that	 the	 software	package,	Refman,	on	which	the	database	was	stored,	was	not	compatible	with	my	MacBook.	 	 I	had	 to	arrange	 to	borrow	another	 laptop	on	which	 to	download	 the	software	and	 the	database	 files.	 	Having	done	 this,	 it	 then	became	clear	 that	 this	software	was	not	supported	by	City	University	and	there	were	no	tutorials	available	from	 the	 library	 staff.	 	 However,	 I	 was	 able	 to	 gain	 some	 training	 from	 an	experienced	colleague	at	my	workplace.		
Reflection:	My	 lack	 of	 Information	 Technology	 experience	 became	 apparent	 both	 with	 the	unfamiliar	database	software	and	use	of	online	file	sharing.		It	was	very	confidence	
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lowering	–	and	I	felt	unprofessional	having	to	admit	that	I	did	not	understand	some	of	the	technological	terms	or	how	to	upload	data	–	but	the	university	help	desk	staff	were	very	good	at	explaining	the	methodology	of	file	sharing.		I	have	since	become	more	 familiar	with	all	 the	available	online	 tools,	 I	 enrolled	 in	a	database	 tutorial	session	and	attended	a	one-to-one	session	at	the	university	library	to	increase	my	IT	 competency.	 	 More	 importantly,	 I	 have	 learned	 to	 accept	 that	 requesting	assistance	early	on	is	a	more	efficient	way	of	working	collaboratively.			
Plan	consultancy	A	protocol	for	the	systematic	review	had	already	been	written	by	the	clients	and	was	emailed	to	me	to	aid	planning.		This	systematic	review	was	not	going	to	follow	all	the	accepted	research	stages	(Moher	et	al,	2010);	for	instance,	the	emphasis	was	not	on	examining	the	quality	of	the	papers	that	would	be	included	in	the	review,	but	to	obtain	 the	percentage	of	study	participants	who	had	a	diagnosis	of	SMI.	 	Further	definition	of	terms	like	SMI	was	necessary.			Although	the	protocol	contained	some	of	 the	 criteria	 determining	 whether	 studies	 were	 eligible	 for	 the	 review	 (eg	population),	 more	 detail	 was	 required	 in	 order	 to	 filter	 the	 studies	 and	 further	exclusion	categories	were	added	as	filtering	progressed.		Aims:	1. To	 demonstrate	 the	 level	 of	 inclusivity	 of	 people	 with	 SMI	 in	 trials	 of	structured	education	for	self-management	of	Type	2	Diabetes	Mellitus.	2. To	publish	a	relevant	paper	in	a	peer-reviewed	journal.		Objectives:		1. Filter	1245	abstracts	(already	uploaded	to	Refman	database).	2. Filter	the	full-text	articles	of	the	papers	remaining	from	the	first	step.	3. Tabulate	the	included	papers	into	exclusion	or	inclusion	of	people	with	SMI.	4. Contact	authors	of	papers	where	it	was	not	specified	if	people	with	SMI	were	included	or	excluded.	
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5. Collate	the	data	to	demonstrate	the	level	of	inclusion	of	people	with	SMI	in	trials	 of	 self-management	 interventions	 for	 people	 with	 Type	 2	 Diabetes	Mellitus.		The	 time	 frame	agreed	was	5	months,	with	 an	 estimate	of	 30	hours	 for	 the	 first	objective,	 and	 65	 hours	 in	 total	 for	 objectives	 2-5.	 	 I	 estimated	 this	 by	 piloting	(categorizing	a	few	abstracts	as	eligible	or	not	for	the	systematic	review)	and	also	through	a	direct	enquiry	to	the	clients	as	to	how	feasible	the	time	scale	was.		I	had	completed	a	restricted	systematic	review	as	part	of	my	Masters	(MSc)	level	of	the	Health	 Psychology	 Stage	 1	 training some	 years	 previously,	 and	 so	 had	 limited	experience	of	undertaking	a	task	of	this	size.				Schein	(1979)	describes	the	Expert	Model	of	Consultation	where	the	client	retains	control	and	effectively	purchases	the	services	of	the	consultant	to	undertake	a	piece	of	work	using	specific	skills	to	solve	the	problem.		(This	is	in	contrast	to	the	Doctor-Patient	Model	where	the	consultant	is	required	to	diagnose	the	problem).	 	In	this	project,	 the	 clients	 “purchased”	 the	 consultant’s	willingness	 to	 learn	 and	 expand	their	knowledge	base,	their	existing	research	skills	and	their	time	commitment	to	fulfilling	 the	 doctoral	 requirements.	 	 Schein	 identifies	 that	 for	 this	 model	 to	 be	successful	the	client	must	have	made	a	correct	diagnosis	of	their	own	problem,	has	to	have	correctly	identified	the	ability	of	the	consultant	to	solve	the	problem,	and	has	to	have	correctly	communicated	the	problem.		Schein	also	emphasizes	that	the	client	must	be	committed	to	using	the	consultant’s	help,	as	the	end	product	must	be	both	achievable	and	desirable.				Where	 the	 problem	 is	 more	 complex,	 Schein	 (1978)	 proposes	 the	 Process	Consultation	Model	-	the	client	retains	control	but	the	consultant	is	involved	in	the	process	of	diagnosing	and	solving	the	problem.	In	this	case,	the	client	and	consultant	worked	 together	 on	 how	 best	 to	 obtain	 the	 missing	 abstracts,	 full	 papers	 and	updated	author	emails,	how	to	categorise	the	abstracts,	what	data	extraction	was	feasible	within	 the	 time	 constraints,	 and	 finally,	 how	 to	write	up	 the	 results.	 	As	
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outlined	in	the	PRISMA	guidelines	(Moher	et	al,	2010),	one	of	the	clients	acted	as	the	second	reviewer	for	the	full	papers.				
Reflection	Both	the	clients	and	I	believed	that	the	abstracts	and	the	full	papers	had	already	been	accessed	and	were	readily	available.		However,	it	did	not	become	apparent	until	later	that	many	were	missing	and	considerable	time	would	be	needed	to	obtain	this	data.	Schein	talks	about	accessing	your	ignorance	–		“You	cannot	determine	what	is	the	current	reality	if	you	do	not	get	in	touch	with	what	you	don't	know	about	the	situation	and	have	the	wisdom	and	the	courage	to	ask	about	it.”		(page	7,	Schein	1997).			This	was	something	I	struggled	with	throughout	the	project	–	it	was	not	easy	to	determine	which	skills	I	was	expected	to	have,	and	which	I	needed	to	develop	further.	
	
Establish,	develop	and	maintain	working	relationships	with	clients	As	so	much	of	this	project	was	collaborative,	close	working	ties	between	the	clients	and	the	consultant	were	essential.		The	consultant	lives	and	works	100	miles	from	the	clients’	base,	so	physical	meetings	were	limited,	totalling	9	throughout	the	19	months	of	consultancy.		However,	there	were	2	telephone	meetings	and	12	emailed	progress	reports	(examples	in	appendices	2	and	3),	shared	database	files	with	both	parties	having	access	on	line,	and	final	paper	revisions	which	were	easily	discussed	by	email.				As	the	clients	were	not	budgeted	to	complete	this	work,	they	had	limited	time	to	respond	to	queries	and	collaborate	with	problem-solving.		One	of	the	clients	was	on	maternity	leave	for	much	of	the	project,	and	there	were	inevitable	gaps	in	access	to	the	other	client	because	of	annual	leave.		However,	the	overall	contact	between	the	clients	and	consultant	was	good.		
Reflection	
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I	felt	I	had	a	good	working	relationship	with	the	client	who	was	not	on	maternity	leave,	and	with	whom	I	had	most	contact.		As	the	contract	revision	in	August	2015	required,	 she	 provided	 supervision	 in	 guiding	 me	 throughout	 the	 processes	 of	filtering	the	data,	and	was	able	to	access	interlibrary	loans	and	update	emails	for	authors	when	required.		It	felt	frustrating	at	times	when	certain	tasks	were	added	to	my	workload,	 for	 instance	having	to	search	for	20%	of	the	1245	abstracts	and	47%	of	the	585	full	text	papers,	and	when	a	table	of	results	was	later	added	to	the	online	 journal	 submission.	 However,	 I	 felt	 we	 developed	 enough	 of	 a	 trusting	relationship	that	they	would	support	me	to	finish	the	task.		
Conduct	consultancy	Meetings	between	the	consultant	and	the	clients	were	used	to	discuss	studies	that	were	difficult	 to	 categorise,	 for	 instance	defining	 the	 term	self-management,	 and	discussing	US	studies	where	Diabetes	was	rarely	defined	as	Type	2.	There	continued	to	be	exclusion	changes	throughout	the	main	screening	–	for	instance	pilot	studies	were	only	included	in	the	review	in	September	2015	following	a	discussion.		In	April	2016	 it	 became	 clear	 that	 one	 of	 the	 exclusion	 criterion	 (studies	 that	 only	 had	participants	with	SMI)	was	not	what	the	clients	had	intended	and	needed	reviewing,	which	 led	 to	 screening	 another	 seven	 papers	 and	 including	 one	 of	 them	 in	 the	review.		At	the	meetings,	the	clients	had	the	experience	of	having	conducted	both	systematic	 and	 Cochrane	 reviews,	 whilst	 the	 consultant	 had	 more	 detailed	knowledge	of	the	studies	being	included	in	this	review,	and	brought	the	queries	to	the	table.		This	fits	well	with	the	process	consultation	model	–	the	consultant	is	the	facilitator	and	the	client	provides	the	relevant	expertise	(Schein	1990).		
	
Reflection:	The	clients	were	at	all	times	respectful	of	my	points	of	view,	but	ultimately	there	was	always	an	awareness	that	they	retained	the	expert	role	in	this	project.	 	They	were	always	supportive	and	showed	understanding	of	my	work	load.				
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Monitor	the	process	of	consultancy	I	maintained	 a	 diary	 that	 recorded	 the	 project’s	 progress	 and	 also	 recorded	 the	hours	 of	 work	 involved.	 	 Despite	 the	 time-consuming	 nature	 of	 producing	 a	systematic	review,	there	is	a	lot	of	pressure	to	finish	as	soon	as	possible:	if	there	is	too	long	a	gap	between	searching	the	literature	and	completion,	newly	published	research	could	render	the	work	obsolete.		The	 original	 contract	 had	 stated	 that	 the	 project	 was	 to	 be	 completed	 by	 the	beginning	of	August	2015.	By	July	it	became	clear	that	the	estimated	time	involved	(95	hours)	had	already	been	exceeded	by	100%.		I	was	under	pressure	to	complete	other	doctoral	projects,	as	well	as	working	at	my	voluntary	placement.	 	I	decided	that	too	much	had	already	been	invested	in	the	consultancy	project	to	stop,	and	at	the	 next	 progress	 meeting	 with	 the	 client,	 I	 proposed	 that	 time	 spent	 on	 the	consultancy	after	August	1st	2015	should	be	considered	as	supervised	practice	and	go	 towards	 that	 requirement	of	 the	doctoral	 studies.	 	 I	 had	already	obtained	my	academic	supervisor’s	agreement,	and	I	was	keen	to	complete	this	task	and	publish	the	paper.		A	revision	to	the	original	contract	was	drawn	up	and	agreed	by	the	clients	(see	Appendix	4).		Factors	that	were	identified	as	causing	major	delays	in	producing	the	review	were	missing	 abstracts,	missing	 full	 papers	 and	waiting	 for	 email	 responses	 to	 author	enquiries.		In	order	to	speed	up	the	process,	I	identified	two	solutions:		the	first	was	to	spend	more	time	on	the	consultancy	project.	In	January	2016	I	proposed	taking	annual	leave	from	my	workplace	to	increase	the	number	of	days	that	could	count	towards	 supervised	 practice.	 	 Secondly,	 the	 amount	 of	 data	 extraction	 was	streamlined:	 the	 clients	had	 requested	 that	 I	 collect	demographic	data	about	 the	participants	 in	all	 the	included	studies	(age,	race	and	gender).	 	This	proved	to	be	very	time	consuming;	the	heterogeneity	of	the	papers’	publication	meant	that	this	information	was	not	always	in	the	results	section	and	could	not	be	easily	copied	and	pasted	 into	 the	 spreadsheet.	 	 I	 suggested	 that	 it	 would	 be	 more	 efficient	 to	concentrate	on	including	the	participants’	mental	health	co-morbidity	information,	
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in	order	to	fulfil	the	objective	of	the	review.		The	clients	confirmed	their	agreement	to	both	these	proposals.		
Reflection:	Time	pressure	provoked	a	lot	of	anxiety	in	me.		I	was	eager	to	complete	one	of	the	competencies	of	my	doctorate,	whilst	working	4	days	a	week	in	a	clinical	setting.		At	the	 same	 time,	 I	 completed	my	 own	 systematic	 review,	 using	 different	 database	software,	and	the	total	amount	of	information	processing	often	felt	overwhelming.	Knowing	that	the	time	spent	on	this	project	was	contributing	to	my	total	supervised	practice	for	my	doctorate	was	encouraging	(Appendix	5).		My	motivation	to	finish	was	 to	 be	 able	 to	 publish	 a	 completed	 paper	 which	 I	 hope	 will	 contribute	 to	reversing	the	inequality	in	health	care	faced	by	people	with	SMI,	but	the	process	was	often	uncomfortable.			
Evaluate	the	impact	of	the	consultancy	Appelbaum	and	Steed	(2003)	suggest	that	the	consultant	and	the	clients	are	jointly	accountable	for	the	result	of	the	project.	 	They	propose	that	successful	consulting	engagements	 include	 consultancy	 competency,	 clear	 expectations,	 consultant	flexibility	to	client	needs,	partnership	between	consultant	and	client,	and	inclusion	of	the	consultant	from	the	start	of	the	project.	 	The	latter	was	not	possible	in	this	project	 as	 some	 of	 the	 work	 had	 already	 been	 put	 in	 place,	 including	 the	 basic	database,	and	whilst	the	level	of	consultant	competency	and	expectations	were	not	very	 clear	 at	 the	 start	 of	 the	 project,	 there	was	 good	 flexibility	 on	 both	 sides	 as	obstacles	occurred	because	of	the	good	communication	that	was	fostered	between	the	consultant	and	the	clients.		The	clients	completed	a	simple	questionnaire	(see	Appendix	6)	which	asked	them	to	evaluate	the	consultant’s	 input	to	the	project,	and	they	replied	very	positively.		The	resulting	short	report	on	the	review	(the	main	objective	of	 the	consultancy),	was	 submitted	 to	 the	 British	 Journal	 of	 Psychiatry,	 with	 a	 view	 to	 reach	 the	readership	most	likely	to	be	responsible	for	the	health	of	people	with	SMI	and	T2DM.	However,	after	rejection	from	this	very	competitive	journal,	and	feedback	from	the	
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reviewers,	the	clients	encouraged	me	to	rewrite	the	paper	looking	at	the	inclusion	(rather	 than	exclusion)	of	people	with	SMI	 in	T2DM	and	 to	submit	 this	article	 to	BioMed	Central	Psychiatry	(Coxon	et	al,	submitted	June	2017).			Unfortunately,	this	revised	paper	was	also	rejected,			
Reflection	Being	rejected	by	a	journal	for	the	first	time	can	feel	personally	wounding	and	I	was	glad	 to	 be	 guided	 towards	 rewriting	 and	 resubmission	by	 the	more	 experienced	clients.	This	extended	an	already	lengthy	consultation	period,	and	at	times	I	often	doubted	my	ability	to	complete	this	work.	I	have	learnt	that	much	more	questioning	at	the	initial	preparation	stage	would	have	allowed	me	to	better	assess	the	scope	of	this	task.	However,	it	was	a	very	good	opportunity	to	work	collaboratively	within	a	team	of	experienced	researchers	who	were	generous	with	 their	 time,	knowledge	and	patience.		I	now	feel	more	competent	in	conducting	a	research	project,	better	able	to	identify	my	own	learning	needs,	and	more	confident	 in	negotiating	future	consultancies.		2787	words			
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Appendix	C5.	Consultancy	contract		
CONSULTANCY CONTRACT 
 
 
This Consultant Agreement is made and effective from 2nd March 2015 
 
 
BETWEEN: Anne Coxon, Trainee Health Psychologist at City University 
London (the “Consultant”) 
 
AND: Dr Kathleen Mulligan, Senior Research Fellow and Dr Hayley 
McBain, Research Fellow at City University London (the Client). 
 
The Consultant has been asked to assist with a project that involves contributing to a 
systematic review of the literature examining the inclusion of people with severe  
mental illness (SMI) in self-management interventions for people with  type 2 diabetes.  
The parties hereto agree as follows: 
 
1. Consultation services: 
The consultancy involves delivery of the following:  
1.  Filter approximately 1245 abstracts describing trials of diabetes self-
management interventions already identified are appropriate for inclusion in the 
review. 
2. Filter full text articles of the papers remaining from first step 1 of the 
consultancy. 
3. Tabulation of the included papers according to whether they exclude or include 
people with severe mental illness. 
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4. Making contact with the authors of papers if people with severe mental illness 
are not specified in the article, to ascertain whether they were included in the 
study. 
5. Collation of the data to demonstrate the level of inclusion of people with severe 
mental illness in trials of self-management interventions for people with type 2 
diabetes. 
 
2.  Terms of agreement 
This agreement will begin on 2nd March 2015 and end on 1st August 2015 or upon the 
completion of the agreed deliverables if sooner.  Either party may cancel this agreement 
on 7 days’ notice to the other party in writing.  
 
3. Resources 
The consultant will not receive payment for their services.  The client will ensure that 
the consultant is equipped to conduct the project effectively.  The consultant will be 
named as a co-author on any publication of this work. 
 
4. Time devoted by consultant and contact arrangements 
The following time is anticipated: 
• Deliverable 1 - filtering abstracts - approximately 30 hours, and will be 
delivered by the end of April 2015. 
• Deliverables 2, 3, 4 and 5 are estimated to take 65 hours and will be delivered by 
the end of July 2015.  
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The consultant will communicate regularly with the client via email and monthly face-
to-face meetings to review the progress of the consultancy and deliverables. 
 
5. Changes to the contract 
Changes to the deliverables and timeline of this contract may be undertaken if necessary 
with agreement from both parties. 
 
6. Disputes 
If any controversy, dispute or claim arises between the parties with respect to this 
agreement, the parties will make good faith efforts to resolve such disputes informally. 
 
7. Signatures 
Consultant Name: 
Mrs Anne Coxon 
Consultant Signature: 
 
 
-------------------------------------- 
 
Client Name:                                                      Client Name: 
Dr Hayley McBain                                               Dr Kathleen Mulligan 
Client Signature:                                                Client Signature: 
 
--------------------------------------------                      ------------------------------------------- 	
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Appendix	C6		
PR	=	Progress	Report	by	email							
 
TABLE	1.	Timeline	of	Consultancy	project.		
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Appendix	C7			Examples	of	Progress	Reports		
 
 
 
 
PROGRESS	REPORT	ON	CONSULTANCY	18th	October	2015		Anne	Coxon	for	Dr	Kathleen	Mulligan	Dr	Hayley	McBain		 1. Missing	full	text	papers	–	total	1	–				
	 2. Full	text	papers				 Originally	581	references	identified	by	abstract	and	by	title	to	need	full	text	screening.		Then	4	pilots	identified	as	RCTs	so	included.		So	now	total	is	585.		 Database	name	in	Reference	Manager,	New	Folder	 No	of	references	Inclexcl_ftextscreenneededAC	 347	Inclexcl_fulltextmissingAC	 1	Inclexcl_ftexts_onlySMI.AC	 7	Inclexcl_fulltext_dupl.AC	 2	Inclexcl_foreignlangAC	 11	Inclexcl_fulltext_followupAC	 31	Inclexcl_fulltext_notEducAC	 18	Inclexcl_fulltext_notType2AC	 28	Inclexcl_fulltext_notRTCac	 92	Inclexcl_notpaperAC	 48	
Grand	Total	 585		 		Meeting	on	Monday	19th	October	at	11.30	at	City	University.				
6974	 King,	AB	Wrong	paper	originally	d/loaded	
Evaluation	of	a	patient	
education	booklet	
(SIMPLESTART)	effect	
on	postprandial	
glucose	control	in	type	
2	diabetes	
Not	on	Researchgate	 Diabetes	Technol	Ther.	2007	Jun;9(3):241-5		
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PROGRESS	REPORT	ON	SR	of	SMI	in	T2D	-		14th	December	2015		Anne	Coxon	for	Dr	Kathleen	Mulligan	Dr	Hayley	McBain		
1. Full	text	screening:	Please	see	the	Excel	worksheet	on	OneDrive	for	data	extraction		so	far	–	92	studies	have	been	processed	(76	have	data).	RefMan	changes	shown	below:	Database	name	in	Reference	Manager,	New	Folder	 No	of	ref	at	October	2015	 No	of	ref	as	of	14	Dec	2015	Inclexcl_ftextscreenneededAC	 348	 255	Inclexcl_ftextscompletAC	 	 76	Inclexcl_fulltextmissingAC	 0	 0	Inclexcl_ftexts_onlySMI.AC	 7	 7	Inclexcl_fulltext_dupl.AC	 2	 3	Inclexcl_foreignlangAC	 11	 11	Inclexcl_fulltext_followupAC	 31	 36	Inclexcl_fulltext_notEducAC	 18	 20	Inclexcl_fulltext_notType2AC	 28	 29	Inclexcl_fulltext_notRTCac	 92	 97	Inclexcl_notpaperAC	 48	 51	
Grand	Total	 585	 585		
2. Time:	I	have	spent	the	following	time	on	the	SR	(1	day	equivalent	to	7	hours)		September	2015		 4	days	October	2015		 	2	days	November	2015	 2.5	days	December	2015	 5	1/3	days		As	you	can	see,	progress	is	slow,	the	full	text	screen	and	data	extraction		is	just	over	¼	done	and	has	taken	over	9	days	so	far.		I	have	managed	to		take	some	extra	days	off	work	in	January	and	should	be	able	to	give		another	8	days	before	the	end	of	January.		One	of	the	most	time-	consuming	factors	in	data	extraction	are	participant	age/gender/race	which	are	often	in	table	form	and	cannot	be	cut	and		pasted.	Would	it	be	feasible	to	not	collect	this	any	further	to	speed	up	the	process?			 3. Mailing	authors.			I	have	started	mailing	authors.		Some	email	addresses	have	already	returned		as	unknown.		Will	chase	on	Research	Gate.				 			
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Meeting	Notes	18th	August	2015		Anne	Coxon	Dr	Hayley	McBain	Dr	Kathleen	Mulligan		At	City	University,	London		 1. Contract.			The	initial	consultancy	contract	has	reached	the	agreed	time	limit,	and	the	systematic	review	 is	not	yet	complete,	mainly	because	of	 the	number	of	full	 papers	 that	 needed	 to	 be	 found.	 	 It	 has	 been	 agreed	 that	 the	consultant,	 Anne	 Coxon,	 will	 continue	 to	 work	 one	 full	 day	 a	 week	 (8	hours)	on	the	Systematic	Review	until	January	1st	2016	when	the	contract	will	be	reviewed.	In	 return	 for	 this	 work,	 the	 Clients,	 Dr	 McBain	 and	 Dr	 Mulligan,	 will	endorse	that	these	hours	are	supervised	hours	that	contribute	to	the	total	supervised	 hours	 for	 the	 Generic	 Competency	 of	 the	 Professional	Doctorate	in	Health	Psychology.	The	Consultant	will	 continue	 to	provide	progress	 reports	 and	will	meet	with	the	Clients	face	to	face	on	a	monthly	basis.		2. Work	to	do:	
• Re-check	all	pilots	for	inclusion/exclusion		
• Make	up	an	excel	sheet	for	the	data	extraction,	copy	and	paste			
o inclusion/exclusion	criteria	
o country/gender/age/race	
o study	type	
o author(s)	names	and	email	
o date	of	email	asking	for	more	detail		 	
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Appendix	C8	Time	sheet	
	
 
 
Anne Coxon Trainee Health Psychologist  Supervised Practice:  Conducting a Systematic Review of the inclusion of people with Severe Mental Illness in trials of type II diabetes self-management education.  Time spent:     Month No of Days (=7 hours) 2015 September 4  October 2  November 2.5  December  5.5 2016 January 8.5  February 3  March  1 TOTAL  26.5   Monthly email progress reports.  Face to face meetings:  19th October 2015, 10th November 2015, 14th December 2015 and 7th March 2016. Telephone meeting: 25th January 2016.    This is to confirm that Anne Coxon, the consultant, undertook the work detailed above:   Client name:  Dr Hayley McBain     
 Signature:  Date: 26th April 2016   Client name: Dr Kathleen Mulligan 
 Signature:   Date: 26th April 2016 
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Appendix	C9	
	
	
	
	
Consultancy	Evaluation	–	Anne	Coxon	
	
A	systematic	review	of	the	inclusion	of	people	with	severe	mental	illness	in	
self-management	interventions	for	people	with	type	2	diabetes.			
1. Please	describe	your	experience	of	working	with	the	consultant.	My	experience	of	working	with	Anne	has	been	excellent.	She	has	been	organized	and	systematic	in	her	work,	has	completed	all	tasks	efficiently,	communicated	progress	effectively	and	required	very	little	supervision.	It	has	been	a	pleasure	to	work	with	Anne.	
	
2. Were	all	the	agreed	tasks	described	in	the	contract	carried	out?	Yes,	all	of	the	agreed	tasks	were	completed.			
3. Were	the	tasks	carried	out	to	the	expected	standard?	The	tasks	were	carried	out	to	an	excellent	standard.	Anne	exceeded	expectations	by	continuing	the	work	and	drafting	a	manuscript	for	submission	to	an	academic	journal.	
	
4. Did	the	consultant	keep	you	adequately	updated	on	progress?	We	had	regular	meetings	and	Anne	also	provided	clear	progress	reports	on	the	work.		
	
5. How	could	the	consultant	improve	their	practice?	Anne	worked	very	well	and	I	do	not	have	any	suggestions	to	improve	her	practice.		
6. Would	you	consider	employing	the	consultant	for	future	projects?	Yes,	I	would	definitely	consider	employing	Anne	for	future	projects.			I	was	very	impressed	with	Anne’s	consultancy	work	on	this	project.			Best	wishes,		Kathleen	Mulligan			
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Case	Study:	Behaviour	Change		
Changing	the	perpetuating	behaviours	in	Functional	Neurological	
Symptom	Disorder	
INTRODUCTION	
Functional	 Neurological	 Symptom	 Disorder	 (FNSD)	 (Conversion	 Disorder)	describes	 patients	 who	 present	 with	 neurological	 symptoms	 but	 in	 whom	 no	organic	or	structural	changes	can	be	 found.	However,	 the	patient’s	 functioning	 is	severely	impaired,	they	are	distressed	and	concerned,	and	were	until	recently	given	the	 non-positive	 diagnosis	 of	 medically	 unexplained	 symptoms,	 without	 a	 clear	prognosis	or	treatment	plan.	
Stone	et	al.	(2010)	found	that	5.6%	of	new	neurology	outpatients	could	be	classified	as	 having	 Conversion	Disorder.	 Despite	 this	 level	 of	 incidence,	 research	 into	 the	predisposing,	 precipitating	 and	 perpetuating	 factors	 in	 the	 development	 and	maintenance	of	FNSD,	and	its	treatment,	has	been	limited	until	recently.	
People	 with	 FNSD	 are	 not	 feigning	 their	 motor,	 cognitive	 or	 communication	weaknesses,	 and	 very	 often	 a	 physical	 trauma	 such	 as	 severe	 illness	 or	 injury	precedes	the	onset	of	symptoms,	but	the	consequential	symptoms	are	excessive,	and	in	the	case	of	functional	weakness,	there	are	positive	signs	(such	as	distraction)	that	demonstrate	that	motor	function	remains	intact.	
Also,	 often	 present	 at	 onset	 is	 psychological	 trauma	 or	 overload;	 historically,	Conversion	Disorder	or	“hysteria”	was	explained	as	the	physical	manifestation	of	psychological	 distress.	 	 Recent	 advances	 in	 neuroscience	 have	 led	 to	biopsychosocial	explanations	of	how	FNSD	develops	and	is	maintained	(Edwards,	Adams,	Brown,	Parees	&	Friston	(2012)	and	Carson	et	al.	(2012).	
Recommended	 treatment	 for	 FNSD	 includes	 graded	 exercise	 and	 Cognitive	Behavioural	Therapy	(Stone,	J.,	2011).		Jon	Stone	states	that	a	positive	diagnosis,	an	
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explanation	of	the	potential	reversibility	of	the	condition	and	an	endorsement	of	the	patient’s	genuine	distress	and	disability	are	the	foundations	of	successful	treatment.		Treatment	 is	 rehabilitative,	 and	 follows	 a	 similar	 pathway	 to	 that	 of	 structural	neurological	events	such	as	stroke.		However,	the	extent	of	symptom	reversibility	is	not	 predictable	 and	 there	 is	 probably	 a	 tendency	 for	 the	 patient	 to	 always	 be	vulnerable	to	further	episodes	of	FNSD.			Wilson’s	 (2007)	 account	 of	 neuropsychological	 rehabilitation	 -	 a	 complex,	collaborative,	 goal-setting	 pathway	 that	 addresses	 the	 cognitive,	 social	 and	emotional	 aspects	 of	 reducing	 disability	 and	 achieving	 optimum	 well-being	 -	describes	 the	 trajectory	 of	 brain-injured	 people.	 People	 with	 FNSD	may	 also	 be	understood	by	a	chronic	 illness	model	of	adjustment	–	their	symptoms	may	have	already	endured	for	several	years	and	their	recovery	may	be	fluctuating	and	uneven	and	by	their	own	beliefs,	unachievable.	 	Moss-Morris	(2013)	proposes	a	working	model	 of	 adjustment	 to	 chronic	 illness	 that	 describes	 the	 multiple	 contributory	factors	(personal,	social	and	environmental,	as	well	as	key	critical	events)	that	lead	to	a	disruption	of	emotional	equilibrium	and	quality	of	life.			The	 pursuit	 of	 equilibrium	 is	 also	 central	 to	 Leventhal’s	 Common-Sense	 Model	(Leventhal	&	Diefenbach,	1991)	of	the	parallel	processes	of	managing	a	health	threat	(fig.1).		This	model	can	explain	how	a	person	with	FNSD,	who	may	have	attentional	bias	to	threat	cues	(Hou	et	al,	2014),	and	be	hyper-vigilant	and	hypersensitive	to	the	physical	symptoms	of	anxiety	(Dimartini	et	al,	2014),	develops	avoidant	behaviours,	which	are	both	disabling	and	distressing.				
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Figure	21.	The	Common-Sense	Model	of	the	Processes	of	Managing	a	Health	
Threat	(Leventhal	&	Diefenbach,	1991)		
As	symptom	perception	is	central	to	understanding	FNSD,	interventions	that	aim	to	help	people	with	FNDS	return	to	more	productive	and	independent	lives,	and	lessen	their	distress,	should	target	Illness	Perceptions.	
	Cognitive	behavioural	models	of	other	functional	disorders	(for	instance,	chronic	fatigue)	have	described	the	predisposition	to,	and	perpetuation	of,	the	symptoms	as	being	 mediated	 by	 Illness	 Perceptions	 and	 “boom-and-bust	 behaviour”,	 and	successful	interventions	have	focused	on	these.	(Castell,	Kazantzis,	&	Moss-Morris,	2011).		While	the	trigger	for	the	FNSD	patient’s	condition	is	not	always	identifiable,	there	are	behaviours	that	maintain	the	level	of	disability	and	which	are	barriers	to	reversing	the	effects	of	the	symptoms.			
	
THE	CONTEXT	OF	THE	BEHAVIOUR	CHANGE	INTERVENTION	
The	 setting:	 	 a	multidisciplinary	 outpatient	 community	 rehabilitation	 centre	 for	post-acute	acquired	brain	injury	clients.	This	case	study	was	conducted	according	to	 the	 British	 Psychological	 Code	 of	 Ethics;	 all	 notes	 were	 retained	 securely;	 to	
Leventhal)et)al)(1984))Common)Sense)
Model)
Ellipse)=social)context)
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protect	 the	 client’s	 confidentiality,	 a	 pseudonym	 has	 been	 used	 and	 some	 non-essential	demographic	characteristics	have	been	altered.		The	client	gave	informed	consent	in	writing.		
The	Case:	Susan	(S),	aged	around	40,	collapsed	and	was	admitted	to	hospital	with	stroke-like	symptoms.	Her	husband	had	recently	been	diagnosed	with	aggressive	cancer	and	she	had	been	promoted	at	work	a	month	earlier	to	a	senior	management	position.	 	 For	 several	 days,	 she	was	 unable	 to	move	 her	 left	 side	 or	 speak.	 	 She	gradually	 became	more	mobile,	 and	 communication	 improved	 by	 discharge	 two	weeks	later,	but	she	and	her	husband	remained	concerned	by	the	lack	of	definitive	diagnosis,	 as	 all	 the	 imaging	 showed	 no	 structural	 changes.	 She	 was	 eventually	referred	 to	 a	 psychiatrist	 who	 found	 no	 underlying	 psychopathology,	 and	 who	suggested	functional	disorder,	later	confirmed	by	a	neurologist.			
About	 18	 months	 after	 this	 crisis,	 she	 used	 a	 stick	 for	 walking,	 reported	 poor	memory	and	executive	functioning	and	slurred	speech.		She	avoided	social	contact	and	 described	 extremes	 of	 activity:	 either	 being	 bedbound	 and	 exhausted,	 or	chaotically	 working	 in	 her	 domestic	 environment	 and	 having	 to	 repeat	 tasks	because	of	memory	problems.		Susan	continued	to	seek	help	through	her	GP	for	her	symptoms,	and	was	referred	to	the	Brain	Injury	Centre,	in	line	with	National	Health	Service	recommendations	for	Functional	Symptoms	(NHS,	July	2015).	
Once	 funding	 for	 treatment	was	 secured,	 Susan	was	 assessed	 and	 treated	 by	 an	inter-disciplinary	 team	 comprising	 a	 Specialist	 Occupational	 Therapist,	 a	 Speech	and	Language	Therapist	and	a	Specialist	Physiotherapist,	alongside	the	Psychology	team.	A	collaborative	planning	meeting	with	Susan	and	her	husband,	identified	that	Susan	would	benefit	from	greater	understanding	of	her	disorder,	from	cognitive	and	physical	 retraining,	 and	 lifestyle	 changes	 to	 promote	 better	 social	 engagement,	symptom	self-management	and	health	outcomes.	 	A	Trainee	Health	Psychologist,	under	the	close	supervision	of	a	Consultant	Clinical	Psychologist,	was	assigned	to	assess	and	deliver	the	psychological	intervention.	
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BASELINE	ASSESSMENT	Clients	with	FNSD	may	be	resistant	to	the	idea	of	psychological	therapy.		They	avoid	any	suggestion	that	their	symptoms	are	“all	in	the	mind”	and	that	they	can	control	them.	 Including	 a	 physiological	 explanation	 for	 functional	 conditions	 may	 help	engage	clients	in	psychological	therapy	(Castell,	et	al.	2011).	 	The	Common-sense	Model	was	used	to	describe	to	Susan	the	parallel	emotional	and	cognitive	processes	of	dealing	with	any	health	threat.			Because	 Susan	 had	 revealed	 a	 great	 deal	 of	 self-criticism	 and	 shame	 about	 her	condition	at	assessment,	 the	psychology	 team	believed	 that	Compassion	Focused	Therapy	 (CFT)	 (Gilbert,	 (2014),	 a	 collaborative,	 non-judgmental,	 third-wave	therapy	that	has	been	shown	to	improve	psychological	well-being	in	patients	with	traumatic	brain	injury	(Ashworth,	F.,	Gracey,	F.	&	Gilbert,	P.,	2011,	and	Ashworth,	F.,	Clarke,	A.,	Jones,	L.,	Jennings,	C.,	&	Longworth,	C.,	2015)	would	be	appropriate.			Gilbert	(2014)	posits	that	the	evolved	brain	is	potentially	problematic	because	of	the	conflict	between	primitive	drives	and	our	evolved	cognitive	competencies.		CFT	is	 designed	 to	 develop	 people’s	 inner	 compassion	 to	 improve	 resilience	 and	functioning	through	Compassion	Mind	Training	(CMT)	–	developing	skills	such	as	mindful	awareness	and	identifying	values,	while	at	the	same	time	using	traditional	CBT	interventions	such	as	graded	exposure	practice	and	reducing	safety	behaviours.		Barriers	 to	 following	 self-management	 of	 symptoms	advice	 are	not	 addressed	 in	traditional	patient	education	programmes,	and	exploring	an	individual’s	beliefs	and	understanding	 is	 recommended	 before	 tailoring	 an	 intervention	 to	 change	behaviours.	 (Mulligan,	 Steed	&	Newman,	 2010).	 It	was	 decided	 to	 use	 the	Brief	
Illness	 Perception	 Questionnaire	 (Brief	 IPQ)	 (Broadbent,	 Petrie,	 Main	 &	Weinman,	 2006)	 to	 elicit	 Susan’s	 beliefs	 about	 her	 symptomology	 and	 disorder	causation.		The	Brief	IPQ	was	designed	to	rapidly	assess	in	8	simple	items	the	main	dimensions	of	the	Illness	Perception	Questionnaire-Revised	(IPQ-R)	(Moss-Morris,	Weinman,	 Petrie,	 Horne,	 Cameron,	 &	 Buick,	 2002)	 as	 well	 as	 assessing	 causal	perceptions.		The	wording	of	the	questions	was	altered	to	reflect	the	biopsychosocial	
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nature	of	Susan’s	disorder	(see	appendix	1).	The	Brief	IPQ	also	gave	a	baseline	for	the	 intervention,	which	 aimed	at	 altering	 Susan’s	 Illness	Perceptions	 to	promote	changes	in	behaviour,	reduce	her	distress,	manage	her	symptoms	more	effectively,	and	enable	her	to	self-soothe	and	reduce	the	effect	of	her	threat	system.		
The	Hospital	Anxiety	and	Depression	Scale	(HADS)	(Zigmond	&	Snaith,	1983)	is	a	14-item	self-report	measure,	designed	for	people	with	physical	health	conditions,	and	is	routinely	used	to	assess	mood	at	the	Brain	Injury	Centre.		The	scale	comprises	two	sub-scales	measuring	Anxiety	and	Depression	with	a	score	of	8	or	higher	out	of	21	in	either	representing	significant	symptomology.		
The	Fears	of	Compassion	Scale	(FCS)	(Gilbert,	McEwan,	Matos	&	Rivis,	2011)	was	developed	 to	 assess	 how	 resistant	 a	 person	 may	 be	 to	 showing	 compassion	 to	others,	showing	compassion	to	themselves,	or	receiving	compassion.		As	the	Scale	has	no	published	norms,	it	was	used	for	before	and	after	intervention	comparison	and	as	an	interview	schedule	to	begin	a	dialogue	about	the	client’s	personal	meaning	of	compassion.		
FORMULATION	
Establishing	a	therapeutic	relationship	is	essential	to	any	intervention,	but	perhaps	more	 so	 in	 FNSD	 because	 of	 the	 repeated	 perceived	 rejections	 of	 the	 validity	 of	Susan’s	symptoms	by	clinicians,	family	members	and	colleagues.		Liaising	with	the	interdisciplinary	 team	 is	 also	 essential:	 Physiotherapists	 have	 traditionally	 been	trained	 to	 regard	 inconsistent	 neurological	 behaviours	 as	 indications	 of	 feigning	(Edwards,	Stone	and	Nielson,	2012).	Assessment	comprised	the	first	4	sessions,	as	suggested	 by	 Gilbert,	 but	 was	 ongoing	 throughout	 treatment,	 building	 up	 a	collaborative	formulation.	
																																	
Formulation	–	Compassion	focused:	Once	it	was	established	that	CFT	was	an	appropriate	approach	to	take	with	Susan,	the	 assessment	 continued	 with	 an	 explanation	 of	 the	 3	 circles	 model	 and	 the	emotional	 regulation	 system	 (Gilbert,	 2010)	 and	with	 Susan	 identifying	 that	 she	
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herself	fitted	into	the	model	(see	figure	2).		The	3	circles	provided	a	way	of	eliciting	information	that	then	contributed	to	a	more	detailed	formulation	that	described	her	safety/defensive	 behaviours,	 and	 allowed	 her	 to	 express	 and	 explore	 the	unintended	 consequences	 and	 self-to-self	 relating	 that	 became	 the	 focus	 of	 the	intervention.	 	The	compassion	 formulation	maps	well	onto	Leventhal’s	Common-sense	Model	 of	 health	 threat	 as	well	 as	 to	Moss-Morris’	model	 of	 adjustment	 to	chronic	illness,	which	emphasizes	the	need	to	identify	the	historical	influences	on	how	people	cope	with	changes	to	their	wellbeing.		Susan	 was	 asked	 to	 complete	 a	 3	 circles	 template	 (downloaded	 from	http://psychology.tools/)	 at	 home	 and	 bring	 it	 to	 the	 next	 session.	 	 Further	exploration	 of	 her	 historical	 influences,	 relationships	 and	 understanding	 of	 her	diagnosis	 continued	 for	 the	 next	 3	 sessions.	 	 A	 trusting	 therapeutic	 relationship	developed	that	enabled	her	to	share	her	perceived	shame	memories,	her	feelings	of	guilt	at	being	unwell	and	the	subsequent	loss	of	job	role,	and	her	difficulties	in	being	able	to	share	her	symptoms	and	diagnosis	with	other people. 
 
 
 
 
 
 
 
 
 
 
 
 
Figure	22.	Emotional	Regulation	System	(adapted	from	Gilbert,	P.	(2005)		
Soothing System 
Purpose: to manage distress & promote 
 bonding 
“I don’t know what nurturing myself looks 
 like-I have always nurtured my mother  
and sister.I can’t monitor my 
 tiredness” 
Drive System 
Purpose: to motivate us towards 
resources 
“I feel proud of my drive system, what I 
have achieved in my career, family, 
home”. 
 
 
Threat System 
Purpose: Threat detection and protection 
“My husband’s illness, 
 relationship with my father. 
I feel angry at myself, scared. 
I feel lonely”. 
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1.	Historical	influences:	 	A	critical	mother,	who	continues	to	be	very	dependent,	along	with	Susan’s	sister.	Her	father	is	not	reliable;	dominant	and	very	aggressive	in	the	past	 and	now	estranged.	 	Her	husband,	 always	 	 “a	 rock”,	 now	 threatened	by	serious	illness.	
2.	Key	fears:		
External:	Susan	feels	very	sensitive	to	other	people’s	perceptions.	
Internal:	feeling	alone,	exhausted	with	struggling	to	pretend	to	feel	emotions.		
3.	Safety/defensive	behaviours:		
External:	always	nurturing	others,	focusing	on	other,	boom	and	bust	behaviour.	
Internal:	 “choking”	 when	 feeling	 emotions.	 	 Terrified	 about	 becoming	 tearful,	avoiding	having	the	time	to	be	emotional	(so	either	busy	or	asleep).		
4.	Unintended	Consequences:				
External	–	feels	used	by	family	and	friends.	
Internal:	 identity	loss	–	no	longer	the	career	woman,	nor	running	the	family	and	home.	
Self-attacking:		weak	–	reverts	to	safety/defensive	behaviours.	
	
OUTCOME	OF	ASSESSMENT	AND	FORMULATION	The	assessment	and	collaborative	formulation	identified	beliefs	and	behaviours	that	were	barriers	to	Susan	recovering	from	her	potentially	reversible	symptoms.	
	The	Brief	IPQ	revealed	that	Susan	felt	that	she	had	no	personal	control,	and	only	moderate	 faith	 in	 any	 treatment	 control.	 	 	 She	 had	 numerous	 symptoms,	 high	concern	and	low	coherence.		She	felt	very	angry	and	believed	that	these	symptoms	would	 continue	 forever.	 The	 HADS	 showed	 moderate	 levels	 of	 depression	 and	normal	levels	of	anxiety,	whilst	the	FCS	gave	insight	into	Susan’s	fears	of	expressing	compassion	 for	 others,	 for	 responding	 to	 compassion	 and	 her	 difficulties	 in	expressing	compassion	and	kindness	to	herself.	
Information	about	FNSD	was	discussed	with	Susan	to	enable	her	to	feel	confident	in	
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explaining	her	diagnosis	to	her	husband,	thus	increasing	her	coherence	about	her	symptoms,	 their	 biopsychosocial	 aetiology	 and	 potential	 reversibility.	 	 Her	symptoms	and	diagnosis	were	validated	and	normalised	by	signposting	her	to	the	FNS	 website	 (www.neurosymptoms.org.uk)	 and	 by	 the	 team	 approach	 to	 her	rehabilitation.	
The	 role	 of	 the	 Trainee	 Health	 Psychologist	 in	 designing	 and	 planning	 an	intervention	 to	address	 the	barriers	 to	Susan’s	rehabilitation	 included	explaining	the	formulation	to	the	interdisciplinary	team,	and	collaborating	on	therapeutic	goal	setting,	understanding	each	team	members’	role	in	the	delivery	of	interventions.		
DESIGN,	PLAN,	IMPLEMENTATION	AND	DELIVERY	OF	INTERVENTION	The	 primary	 behaviour	 change	 identified	 was	 to	 stop	 the	 boom	 and	 bust	 cycle:		Susan	described	a	chaotic	lifestyle,	of	not	being	able	to	sit	down	and	relax,	of	not	allowing	herself	physical	pleasure	(even	using	her	shower-time	to	clean	the	tiles),	not	knowing	what	the	time	was	and	having	bad	days	when	she	was	unable	to	get	out	of	bed.	This	perceived	lack	of	ability	to	self-regulate	her	activity	levels	was	causing	her	severe	distress.				Motivational	 Interviewing	(MI)	 techniques	 (Rollnick,	Miller	&	Butler,	2008)	were	used	to	elicit	which	behaviours	should	be	targeted	first:		activating	the	client’s	own	motivation	for	change	is	one	of	four	guiding	principles	of	MI,	and	the	client	is	more	likely	to	commit	to	change	if	they	verbalise	the	process	themselves	rather	than	be	directed	by	 the	 therapist.	 	 Susan	 identified	 that	 sleep	disturbance	was	a	primary	issue,	as	was	her	inability	to	“feel	emotions”.			The	first	few	sessions	therefore,	included	exploring	better	sleep	hygiene	(reducing	caffeine	intake,	regulating	bedtimes,	curtailing	the	use	of	her	I-pad	in	the	bedroom).		The	Occupational	Therapist	supported	the	practical	changes	that	implemented	this	behaviour	change,	and	the	Physiotherapist	engaged	Susan	in	graded	exercise	that	improved	her	stamina	and	helped	regulate	her	body	clock.	At	the	same	time,	CMT	was	 practiced	 to	 re-activate	 Susan’s	 self-soothing	 system	 and	 reduce	 the	 safety	behaviours	 she	 used	 to	 avoid	 situations	 that	 could	 trigger	 extreme	 emotional	reactions,	 such	 as	 the	 feelings	 she	 experienced	 when	 her	 husband	 was	 first	diagnosed,	just	before	her	collapse.		The	simple	body	scan	and	relaxation	exercise	
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from	Gilbert	(2010)	was	practiced	at	every	session	and	Susan	developed	her	own,	very	 rapid	 exhalation	 exercise	 to	 use	when	 she	 felt	 overwhelmed	 by	 sensory	 or	cognitive	stress.		Compassion	under	the	Duvet,	The	Perfect	Nurturer	(Gilbert	2010),	and	 other	 exercises	 that	 promoted	 self-compassion	 and	 encouraged	 thought	defusion	were	expanded	to	include	reattributing	some	of	her	symptomology	to	the	physical	sensations	of	anxiety.	Over	20	sessions	in	a	time	frame	of	6	months,	a	variety	of	psychological	techniques	were	used	in	cognitive,	behavioural	and	emotional	interventions	(see	Appendix	2	for	a	table	of	psychological	intervention	techniques).		
OUTCOME	OF	BEHAVIOUR	CHANGE	INTERVENTION	Michie	&	Abraham	(2004)	recommend	caution	in	measuring	success	of	behaviour	change	 –	 outcome	 measures	 should	 measure	 the	 targeted	 health	 outcome	 (not	adherence	per	se	for	instance).	The	targeted	behaviour	change	in	this	case	was	to	stop	 the	 cycle	 of	 boom-and-bust	 and	 for	 Susan	 to	 gain	 an	 understanding	 of	 her	symptoms,	 to	 manage	 her	 symptoms	 so	 that	 she	 could	 function	 physically	 and	emotionally,	and	develop	skills	to	prevent	relapses.			The	 Brief	 IPQ	 has	 demonstrated	 that	 higher	 perceived	 consequences,	 identity,	emotional	 response	and	 concern	are	associated	with	worse	psychological,	 social,	and	physical	functioning,	and	worse	health	outcomes.		Higher	perceived	control	is	associated	 with	 better	 psychological,	 social	 and	 physical	 functioning	 and	 better	health	 outcomes	 and	 longer	 perceived	 timeline	 is	 associated	 with	 worse	psychological	 outcomes	 and	 quality	 of	 life.	 	 (Broadbent,	 Wilkes,	 Koschwanez,	Weinman,	Norton	and	Petrie,	2015).	The	radar	chart	shows	the	change	in	each	of	the	IPQ	items:	
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Figure	 23.	 The	 Brief	 Illness	 Perception	 Questionnaire	 –	 before	 and	 after	intervention		Changes	 in	 Susan’s	 self-report	 levels	 of	 anxiety	 and	 depression	 and	 fears	 of	compassion	can	be	seen	in	the	following	charts:		
		
Figure	24.	Anxiety	and	Depression	–	before	and	after	intervention	
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Figure	25:	Fears	of	Compassion	Scales	
These	positive	outcome	measures	were	 shared	with	Susan,	her	husband	and	 the	treating	team,	and	she	contributed	her	own	evaluation:	“Although	I	know	I	have	a	little	way	to	go	before	I’m	happy	with	the	me	I	am	now,	I	have	accepted	and	learnt	to	embrace	the	change	and	now	look	forward.”		Susan’s	re-found	ability	to	interact	socially	 and	 her	 success	 in	 setting	 up	 a	 new	 home-craft	 business	were	 concrete	evidence	of	the	reduction	in	the	disabling	effects	that	FNSD	had	on	her	life	after	her	interdisciplinary	intervention.	A	report	with	these	results	was	shared	with	the	Care	Commissioning	Group.	
It	is	not	normal	practice	at	the	Centre	to	contact	clients	after	discharge,	so	it	has	not	been	possible	to	follow-up	Susan’s	progress	without	ethical	approval.	
REFLECTION	This	case	was	my	first	intervention	in	FNSD	as	a	Trainee	Health	Psychologist.		I	was	extremely	 well	 supported	 by	 a	 Consultant	 Clinical	 Psychologist	 with	 fortnightly	formal	supervision	and	access	to	the	psychology	team	whenever	needed.		One	of	the	greatest	challenges	was	to	engage	the	other	disciplines	 in	acknowledging	Susan’s	
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diagnosis	of	FNSD,	which	remains	stigmatized	among	health	professionals.	 	Some	team	members	saw	FNSD	as	a	negative	diagnosis,	others	found	it	difficult	to	accept	it	was	not	a	case	of	malingering.		Recent	evidence-based	research	was	shared	and	discussed	amongst	the	team	(including	Carson,	A.	J.,	Stone,	J.,	Warlow,	C.,	&	Sharpe,	M.,	 2004;	 Edwards	 et	 al,	 2012),	 however,	 it	 was	 daunting	 to	 put	 forward	 this	protocol	 and	 lead	 a	 senior	 team	 as	 a	 trainee,	 and	 I	 felt	 quite	 isolated	 at	 times.		Focusing	on	 the	 client’s	 distress	 and	 the	positive	behaviour	 changes,	 and	not	 on	aetiology,	 was	 more	 motivating	 for	 fellow	 professionals.	 	 Engaging	 people	 with	FNSD	is	challenging	–	but	also,	as	in	this	successful	case	–very	rewarding.	2996	words	
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Appendix	C10.	Modified	B-IPQ	
The Brief Functional Neurological Symptom Perception Questionnaire 
For the following questions, please circle the number that best corresponds to your views 
(Adapted from The Brief Illness Perception Questionnaire, Broadbent, E., Petrie, K. J., Main, J., & Weinman, J. 
(2006)) 
 
How much does your condition affect your life? 
 
        0             1             2             3             4             5             6             7             8             9             10  
no affect                                                                                                                              severely  affects my life      
at all                                                                                                                                                                                      
 
How long do you think your condition will continue? 
 
        0             1             2             3             4             5             6             7             8             9             10  
a very                                                                                                                                                          forever                           
short time 
How much control do you feel you have over your condition? 
 
        0             1             2             3             4             5             6             7             8             9             10  
absolutely                                                                                                                                                                            
no control                                                                                                                    extreme amount of control 
                                    
 
How do you think your treatment can help your condition? 
 
        0             1             2             3             4             5             6             7             8             9             10  
not at all                                                                                                                                      extremely  helpful   
              
How much do you experience symptoms from your condition? 
 
        0             1             2             3             4             5             6             7             8             9             10  
no symptoms                                                                                                                                                                           
at all                                                                                                                                    many severe  symptoms  
                                                             
How concerned are you about your condition? 
 
        0             1             2             3             4             5             6             7             8             9             10  
not at all                                                                                                                                                                                
concerned                                                                                                                             extremely concerned                                                 
 
How well do you feel you understand your condition? 
 
        0             1             2             3             4             5             6             7             8             9             10  
don’t understand                                                                                                             understand very clearly                                              
at all                                                                                                                                                                                           
How much does your condition affect you emotionally? (e.g. does it make you angry, scared, upset or 
depressed?) 
 
        0             1             2             3             4             5             6             7             8             9             10  
not at all affected                                                                                                                                                              
emotionally                                                                                                       extremely affected emotionally 
Please list in rank-order the three most important factors that you believe caused your condition: the 
most important causes for me: - 
 
1. __________________________________________________________________ 
 
2. __________________________________________________________________ 
 
3. __________________________________________________________________ 
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Appendix	C11.	Interventions	for	behaviour	change	
PSYCHOLOGICAL	
INTERVENTION	
TECHNIQUES	
DEFINITION	 CASE	EXAMPLE	 LIKELY	MECHANISMS	
TARGETED	
Assessment,	formulation	and	engagement	techniques	Information	about	functional	neurological	symptom	disorder	
Elicit	from	S	her	understanding	of	her	condition.		Collaboratively	identify	areas	that	she	would	like	to	work	on.		Using	S’s	own	language,	reflect	information,	encouraging	a	therapeutic	relationship.	
Directing	S	to	neurosymptoms.org	written	by	a	neurologist	specializing	in	FNSD.	(Stone,	2015)	
Inaccurate	illness	beliefs,	treatment	outcome	expectancies,	coherence.	
Explanation	of	parallel	processing	of	health	information	and	coping	(Common	Sense	Model)	
Collaboratively	develop	a	formulation	of	the	case,	using	elicited	information,	and	identify	goals	and	agenda	for	therapeutic	sessions.	
Showing	diagram	of	Common-Sense	Model	(CSM).	Collaborating	on	mapping	threat/perceptions	(cognitive	and	emotional)/appraisal	onto	CSM.	
Adjustment	behaviour		Building	trust	between	therapist	and	client.	
Cognitions	Acceptance	 Supporting	S	in	accepting	the	diagnosis	of	FNSD	in	collaboration	with	other	disciplines	(OT,	PT,	SLT,	SW),	demonstrating	positive	symptomology.		Validating	the	reality	of	the	symptoms.	Socratic	questioning	to	increase	self	-reflection	and	awareness	of	
Reducing	the	anxiety	about	disease.		Fostering	possibility	of	symptoms	being	reversible.			Providing	an	explanation	of	primitive	brain	drives	are	difficult	to	control,	as	well	as	possible	biological	aetiology	for	vulnerability	to	FNSD.	
Addressing	shame	and	self-criticism.	
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coping	styles.	Explaining	the	evolved	brain	theory	of	3	drives,	and	the	regulatory	effect	of	soothing	on	the	threat	system.	Attention		 Mindfulness-based	exercise	to	promote	present	moment	awareness,	to	relax	and	reduce	attention	to	symptoms.	Demonstrating	that	distraction	can	allow	normal	functioning.		Including	cognitive	ability.		Link	from	anxiety	levels	to	attention	to	function	explored.	
Body	scan	exercise	undertaken	at	every	session.			 Cognitions/illness	beliefs	Self-efficacy	
Behaviours	Activity	Monitoring	 Diary	of	good	days	and	bad	days	to	examine	self-management	of	time	and	stamina.		Guide	S	towards	activity	scheduling	taking	responsibility	for	pacing.	
Using	a	watch,	sitting	and	crocheting/watching	a	film.	
Behavioural	
	
Boom	and	bust	situations	
Assertiveness	skills	training	 Graded	exposure	of	being	able	to	tell	people	about	FNSD,	or	its	effects.	
Explaining	symptoms	to	her	husband,	her	family,	withdrawing	for	short	periods	when	overloaded.	Having	a	script.		
Increasing	social	support	through	explanation.	Encouraging	independence	from	family	members	who	may	also	be	maintaining		the	unhelpful	
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behaviours.	Graded	exposure	 Collaborate	on	a	fear	hierarchy	for	social	situations	and	increase	exposure	in	a	graded	way.	
Talking	face	to	face	with	her	clients	instead	of	internet,	delivering	to	her	clients,	answering	the	phone,	being	with	members	of	the	extended	family,	going	to	pilates.	
Behavioural	avoidance/social	situations	
Problem	focused	strategies	 Identifying	problems,	eliciting	solutions	from	the	client.	
Caffeine	intake,	relaxing	with	crochet,	relaxing	in	bath.	 Behavioural.		Not	avoiding.		Increasing	mastery	and	activation.	
Physical	symptoms	Emotional	expression	 Providing	S	opportunities	to	experience	the	physical	responses	of	anxiety	or	sadness	in	a	safe	environment	so	as	to	be	able	to	begin	to	identify	the	symptoms	in	a	less	threatening	way.			
Talking	about	emotional	situations	in	the	past,	or	emotional	triggers	in	films	etc.	Drawing	cupboard	with	emotions.	Listing	all	the	emotions.	
Exposure	to	physical	symptoms	of	emotional	origin.	Identifying	emotions	
Sleep	routines	 To	encourage	routine	and	prevent	boom	and	bust	cycle.	
Reduction	in	use	of	caffeine,	ipad	at	bedtime.	Using	a	watch	to	monitor	time.	
Self-management		
Anxiety	management	 Skill	training	in	anxiety	reduction	techniques:	collaborating	on	safe	place	guided	imagery,	breathing	practice.	
Using	the	Whoosh	when	overwhelmed.	Technique	shared	with	OT	for	situations	requiring	executive	functioning.	
Self-management	
Compassionate	mind	training	Being	kind	to	 Graded	 	Happy	place	imagery,	 Developing	soothing	
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oneself	exercises	 exposure	to	pleasurable	emotions.		
Compassion	under	the	duvet:				
Perfect	nurturer:	
bath.	Repeating	to	herself	every	morning:	I	am	warm	and	wise.	Imagining	what	a	perfect	nurturer/friend	would	say:	for	Susan	that	was	someone	just	like	her,	being	kind	to	herself.	
system	(Gilbert,	2000)	
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Case	Study	-	Generic	Professional	Skills		
	
Background	I	had	been	working	at	a	community	outpatient	acquired	brain	injury	service	for	8	years	 as	 both	 a	 volunteer	 and	 later	 as	 an	 assistant	 psychologist,	 while	 also	completing	a	Master’s	 in	Health	Psychology.	 	Volunteering	as	an	Epilepsy	Society	information	 officer,	 at	 Addenbrooke’s	 Hospital	 first	 seizure	 clinic,	 and	 as	 an	assistant	 at	 Headway	 in	 Suffolk,	 expanded	 my	 understanding	 of	 complex	neurological	 conditions,	 and	enhanced	my	 interaction	with	people	at	 challenging	times	in	their	lives.					However,	I	realised	I	needed	to	complete	Stage	2	of	training	to	become	a	Health	and	Care	Professions	Council	(HCPC)	registered,	chartered	psychologist,	both	in	order	to	further	my	career	and	also	to	advance	my	own	competency	as	a	therapist	and	as	an	 applied	 psychologist.	 	 I	 completed	 all	 my	 supervised	 practice	 at	 the	 same	acquired	 brain	 injury	 centre,	 with	 excellent	 workplace	 supervision	 from	 a	consultant	psychologist	who	specialised	in	neuropsychology,	and	with	support	from	a	highly	specialist	interdisciplinary	therapy	team.				I	 applied	 for	 a	 clinical	 psychology	 position	 in	 neuro-rehab	 and	 stroke	 unit	 in	 a	general	hospital	and	I	have	now	been	in	post	for	over	a	year.		I	work	therapeutically	with	people	on	the	acute	stroke	ward	as	well	as	with	acquired	brain	injury	and	all	neurological	diagnoses,	 including	 functional	 symptoms,	 in	outpatients.	 	 I	 conduct	neuropsychological	 assessment	when	 appropriate,	 I	 am	 involved	 in	 group	work,	staff	 education,	 onward	 referrals,	 family	 support,	 and	 liaising	 with	 consultants,	therapy	teams	and	rehabilitation	assistants.		
Implement	and	maintain	systems	for	legal,	ethical	and	professional	standards	
in	applied	psychology	All	 patient	 information	 must	 be	 treated	 securely	 (British	 Psychological	 Society	(BPS)	 Code	 of	 Ethics	 and	 Conduct,	 2009)	 and	 practitioner	 psychologists	 have	 a	responsibility	to	ensure	that	paper	and	electronic	data	are	securely	stored	and	only	shared	 with	 other	 professionals	 when	 in	 the	 patient’s	 best	 interests	 (HCPC	
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Standards	of	Conduct,	Performance	and	Ethics,	2016)	and	when	patient	consent	has	been	 obtained	 (Information	 Governance	 Alliance,	 2018).	 	 Record	 keeping	 is	maintained	to	a	high	standard	with	locked	filing	cabinets	and	password	protected	electronic	 records.	 Information	 sharing	 is	 essential	 when	 working	 in	 a	 multi-disciplinary	 team	 to	 ensure	 timely	 and	 accurate	 understanding	 of	 the	 patient’s	emotional	 and	 cognitive	 status	 to	 enable	 engagement	 in	 rehabilitation,	 and	 is	facilitated	 through	 encrypted	 email,	 and	 prompt	 updating	 of	 continuous	 notes.	Assessment	and	discharge	reports	and	letters	are	shared	with	other	clinicians,	and	as	a	trainee,	countersigned	by	a	supervisor.			Patients	are	told	at	first	meeting	that	I	am	a	health	psychologist	in	training,	that	I	do	share	 information	with	my	 supervisor	and	 team	members	 if	 required,	 and	 that	 I	follow	a	protocol	that	if	there	is	disclosure	of	potential	self-harm,	or	harm	to	others,	other	agencies,	including	their	General	Practitioner,	the	mental	health	crisis	team	or	the	police,	may	be	contacted.			Patient-therapist	 boundaries	 are	 always	 respected,	 especially	 important	 when	living	in	the	same	community	as	the	population	I	am	treating,	and	I	try	and		balance	being	naturally	friendly	and	empathetic	with	a	professional	stance.		For	example,	I	now	work	within	a	multi-disciplinary	 team,	seeing	patients	 in	a	busy	outpatients	clinic	with	rooms	allocated	to	me	on	an	ad	hoc	basis,	which	occasionally	have	not	been	fit	for	purpose,	as	they	lack	sufficient	soundproofing	to	enable	the	patient	to	speak	freely	without	the	possibility	of	being	overheard,	and	indeed,	being	able	to	hear	other	clinicians.		Through	discussions	with	other	therapies,	administration	and	other	 psychologists	 about	 the	 need	 to	 maintain	 client	 privacy	 and	 to	 foster	 an	environment	 that	 promotes	 trust	 between	 therapist	 and	 patient,	 our	 room	allocation	has	become	more	therapy-friendly.							Some	brain-injured	patients	may	have	erratic	and	potentially	dangerous	behaviour,	and,	following	risk	assessment,	the	initial	session	may	be	carried	out	with	another	member	of	staff	present.		Where	there	is	suspicion	of	abuse	or	neglect,	either	of	the	patient,	 and	 the	 people	 they	 live	 with,	 or	 perpetrated	 by	 them,	 the	 hospital	
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safeguarding	 team	 are	 contacted	 to	 investigate	 further	 (HCPC,	 2012).	 	 If	 the	presenting	 problem	 is	 predominantly	 mental	 health,	 	 or	 if	 there	 is	 suspicion	 of	dementia,	rather	than	adjustment	to	a	neurological	diagnosis	or	an	acquired	brain	injury,	the	patient	is	referred	to	the	appropriate	services.		Ensuring	that	referring	consultants,	GPs	and	external	 services	are	aware	of	our	acceptance	 criteria	 is	 an	ongoing	task.			
Contribute	 to	 the	 continuing	 development	 of	 self	 as	 a	 professional	 applied	
psychologist	I	 have	been	a	member	of	 the	BPS	 since	my	undergraduate	psychology	degree	 in	2002,	and	of	the	DHP	since	starting	my	Master’s.	I	have	familiarised	myself	with,	and	follow,	 the	 legal,	 ethical	 and	 professional	 requirements,	 	 and	 I	 ensure	 that	 any	assistants	or	trainees	for	whom	I	have	had	responsibility	have	also	followed	good	practice.		I	have	kept	logs	of	all	my	activity	during	the	doctorate,	and	I	have	regularly	reflected	upon	my	development	as	a	health	psychologist	in	training.		Looking	back	on	nearly	four	years	of	training,	I	can	see	how	I	have	developed	in	my	approach	to	some	of	the	early	interventions	I	undertook.			I	attended	all	the	core	workshops	for	the	doctorate	in	the	first	year,	and	the	Division	of	Health	Psychology	 conferences	 in	2014,	2015	and	2016.	 	 I	 have	 improved	my	therapeutic	skills	through	external	courses	on	health	psychology	clinical	practice,	mindfulness-based	 interventions	 for	 health	 psychologists,	 acceptance	 and	commitment	 therapy	 for	 physical	 health	 problems	 and	 cognitive	 behavioural	therapy	for	health	psychologists.		I	continue	to	develop	my	competencies	and	I	am	registered	 to	 attend	 a	 three-day	 workshop	 on	 compassion-focused	 therapy,	delivered	by	the	developer,	Paul	Gilbert,	in	November	2018.		The	most	challenging	skills	 training	has	been	the	8	week	mindfulness	course	(and	day	retreat)	which	I	initially	undertook	to	understand	the	participant	experience	in	the	mediation	study	for	my	thesis,	but	which	has	 fundamentally	 impacted	my	perspective	on	 life,	and	thus	 the	 way	 I	 have	 developed	 as	 an	 applied	 psychologist.	 	 As	 an	 example,	 by	learning	 to	decenter,	 to	be	 less	 reactive,	 I	 feel	 that	 I	have	 improved	my	 listening	skills,	not	only	with	patients	but	also	with	fellow	professionals.				
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I	have	also	undertaken	research	skills	training:	a	workshop	on	single	case	studies	and	case	series	was	attended	in	my	first	year	of	the	doctorate	as	I	had	initially	been	contemplating	writing	a	thesis	on	smoking	cessation	for	post-stroke	patients,	who	have	difficulty	accessing	services	because	of	cognitive,	mobility	and	communication	difficulties.	 	 Unfortunately,	 the	 centre	 where	 I	 worked	 would	 not	 support	 this	intervention	as	it	was	felt	that	smoking	cessation	services	were	already	available	in	the	community.				I	have	also	attended	symposia	on	medically	unexplained	symptoms	and	behaviour	change	in	practice,	both	giving	me	greater	insight	into	how	different	disciplines	and	cultures	view	functional	symptoms,	and	how	health	psychology	can	be	applied	in	public	health.		Two	inspiring	events	that	I	attended	in	March	2017	and	March	2018	were	 the	1st	 and	2nd	Annual	Practitioner	Applied	Health	Psychology	Conferences	convened	 by	 SCCH,	which	 provided	 opportunities	 to	 network	 and	which	 greatly	enhanced	my		confidence	in	becoming	an	applied	health	psychologist.		After	 each	 learning	opportunity,	 I	 have	been	 able	 to	 feed	back	 to	my	 colleagues,	whether	 at	 workplace	 psychology	 department	 meetings,	 or	 multidisciplinary	groups,	helping	to	consolidate	my	learning,	and	enabling	me	to	consider	how	this	new	knowledge	can	be	applied	to	benefit	the	particular	patient	group	I	work	with.	Writing	 reflective	 journals	 about	 my	 learning	 experiences	 has	 also	 helped	 me	evaluate	how	I	am	developing.				Academic	 supervision	 has	 been	 undertaken	 regularly	 and	 formal	 agendas	 and	minutes	have	been	recorded.		Work	commitments	and	distance	from	the	university	has	meant	I	had	to	occasionally	participate	by	video-conference,	and	this	required	me	 to	 become	 extremely	 organised	 in	 	 what	 documents	 were	 sent	 ahead	 and	signposted	during	the	discussions.		Peer	supervision	within	my	doctoral	cohort	has	also	been	extremely	beneficial,	both	the	supportive	group	effect	and	having	access	to	 consultation	 when	 faced	 with	 obstacles,	 either	 at	 work,	 academically	 or	practically	in	completing	competency	requirements.		
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Annual	 reviews	 provide	 a	 useful	 opportunity	 to	 reflect	 on	 progress	 in	 all	 the	competencies,	 and	 to	 receive	 feedback	 from	a	 supervisory	panel	 and,	 informally,	from	peers.		Listening	to	fellow	doctoral	students	tackling	the	course	requirements	in	very	diverse	employment	settings	has	been	both	inspiring	and	also	reassuring,	demonstrating	 the	 shared	 hurdles,	 in	 particular	 the	 extreme	 time	 pressure	 of	combining	study,	work	commitments	and	life!		I	 continue	 to	 be	 a	 lay	 member	 of	 the	 Scientific	 advisory	 committee	 of	 Epilepsy	Research	 UK,	 evaluating	 grant	 proposals	 and	 I	 have	 twice	 sat	 on	 fellowship	interview	 panels.	 	 I	 have	 recently	 been	 invited	 to	 join	 the	 Programme	 Steering	Committee	 (as	 an	 independent	member)	 of	 a	 development,	 trial	 and	 qualitative	evaluation	of	a	modular	mental	health	treatment	in	children	and	young	people	with	epilepsy	(NIHR	PGfAR:	RP-PG-0616-20007).		Being	involved	in	high	level	research	has	made	me	much	more	aware	of	the	complexities	of	large	scale	trials	and	the	need	for	excellent	 communication	between	 research	 teams,	 funders,	 and	personal	 and	public		involvement.		My	role	is	to	represent	consumers	of	the	research	outcomes,	as	well	as	the	potential	trial	participants,	and	having	almost	completed	my	doctorate	in	Health	Psychology,	 I	 feel	 I	now	have	a	more	 rounded	view	of	 applied	medical	research,	with	greater	understanding	of	the	difficulties	faced	by	research	teams,	the	pressure	 from	 funders	 for	 results,	 and	 the	 value	 patients	 and	 families	 place	 on	research	that	not	only	addresses	pure	science,	but	also	the	psychological	and	social	aspects	of	living	with	long-term	conditions.				I	have	been	able	to	incorporate	much	of	my	training	into	my	everyday	work.		I	am	enthusiastic	 about	 promoting	 health	 psychology	 theory	 and	 practice	 in	 a	 health	setting	that	has	traditionally	been	focused	on	clinical	psychology	interventions.	 	 I	have	given	several	presentations	to	team	members	at	both	of	my	work	placements	based	on	the	common	sense	model	(CSM,	Leventhal,	Diefenbach,	&	Leventhal,	1992)	to	engage	staff	in	better	communication	with	patients	and	improve	understanding	of	how	patients	and	families	appraise	and	cope	with	health	threats.		I	frequently	use	the	 Brief	 Illness	 Perceptions	 Questionnaire	 (B-IPQ,	 Broadbent,	 Petrie,	 Main,	 &	Weinman,	2006)	with	my	patients	to	explore	their	beliefs,	and	I	find	this	a	useful	
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way	to	structure	early	sessions.		I	conducted	the	systematic	review	on	the	utility	of	illness	 perceptions	 to	 see	 if	 there	 was	 evidence	 that	 could	 be	 useful	 in	 the	management	of	people	with	functional	neurological	symptom	disorder,	a	condition	that	presents	in	about	a	third	of	my	outpatient	caseload.				While	undertaking	my	supervised	practice,	 I	received	at	 least	an	hour	a	 fortnight	(usually	 weekly)	 of	 supervision	 from	 an	 HCPC	 registered,	 consultant	 clinical	psychologist,	as	well	as	ad	hoc	supervision	from	the	interdisciplinary	team.	In	my	most	recent	position,	my	supervisor	and	line-manager	left	the	service	three	months	after	I	joined,	and	I	had	to	recruit	an	HCPC	registered,	practitioner	psychologist	from	another	 trust	 to	provide	supervision	to	me	and	the	assistant	psychologist	 I	work	with.	 	 At	 the	 same	 time,	 I	 instigated	 peer	 supervision	 sessions	with	 an	 assistant	psychologist	 for	 mutual	 support	 with	 our	 case	 load.	 The	 Division	 of	 Health	Psychology	 guidelines	 for	 applied	 	 trainees	 only	 states	 that	 adequate	 clinical	supervision	 should	 be	 given	 (BPS,	 DHP,	 2018),	 however,	 the	 division	 of	 Clinical	Psychology	recommends	that	trainees		receive	a	minimum	of	one	hour	supervision	a	week	(BPS,	2010).	Attempts	to	publish	my	work	in	peer	reviewed	journals	have	been	challenging	and	so	 far,	 unsuccessful:	 I	 have	 submitted	 a	 systematic	 review	 (with	 two	 of	 my	supervisors	as	co-authors)	as	well	as		the	systematic	review	I	conducted	as	part	of	my	consultation	competency	with	a	research	team.			The	latter	paper	was	revised	following	 rejection	 and	 subsequently	 rejected	 again	 by	 a	 second	 journal.	 	While	initially	it	is	extremely	disappointing,	the	reviewers	in	each	case	have	been	thorough	and	made	helpful	comments	–	both	papers	will	be	resubmitted	in	the	near	future.		I	have	also	submitted		an	article	to	the	Health	Psychology	Update	journal,	detailing	the	contribution	health	psychology	theory	and	practice	can	make	within	neurology,	and	 critiquing	 the	 availability	 of	 formal	 neuro-psychometric	 training	 for	 health	psychologists;	this	is	awaiting	review.		I	 presented	 a	 poster	 of	 my	 systematic	 review	 at	 the	 2016	 Health	 psychology	conference	in	London,	as	a	work	in	progress,	and	found	that	comments	made	by	the	other	 presenters	 and	 viewers	 were	 encouraging	 and	 helpful.	 	 A	 poster	entitled	 	“Rehabilitation	 of	 Functional	 Neurological	 Symptom	 Disorder:		 A	 Case	
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Study	 describing	 the	 Central	 Role	 of	 Psychology	 in	 an	 Interdisciplinary	 Team	Intervention”	was	accepted	at	the	2nd	International	Case	Management	Conference.			My	teaching	and	training	competency	undoubtedly	took	me	out	of	my	comfort	zone,	as	I	had	previously	very	little	experience	in	presenting	to	audiences,	however,	I	feel	I	 have	 gained	 in	 confidence	 and	 grown	 in	 self-efficacy	 and	 I	 now	 take	 up	 every	opportunity	available	to	share	my	knowledge	with	others.	For	instance,	I	had	two	invitations	 in	 2017	 to	 present	 to	 health	 psychology	 Masters’	 students	 at	 City,	University	 of	 London,	 on	 my	 experience	 of	 working	 within	 a	 neurological	 field.	Feedback	has	helped	me	reflect	on	the	audience’s	perspective	which	I	now	bear	in	mind	when	preparing	a	presentation,	and	I	am	also	more	conscious	of	how	other	people	present	information	when	attending	workshops.		
Provide	psychological	advice	and	guidance	to	others	My	supervised	practice	placement	involved	assessing	the	emotional	and	cognitive	status	of	patients	with	acquired	brain	injuries,	informing	the	multidisciplinary	team,	formulating	a	joint	plan	for	rehabilitation,	and	if	necessary,	conducting	therapy	with	that	patient.		I	was	able	to	have	nearly	300	face-to-face	hours	with	patients	with	a	variety	of	presentations,	 from	different	 cultural	and	socioeconomic	backgrounds,	ranging	in	age	from	18	to	late	70s.	Neurological	conditions	almost	always	lead	to	some	 cognitive	deficit,	 and	 this	 needs	 to	 be	 assessed	before	 treatment	 can	 start.	Therapy	ranged	from	cognitive	behavioural	therapy,	motivational	interviewing	to	compassion	focused	therapy,	and	took	place	both	in	the	patient’s	residence	(either	their	own	home	or	a	nursing	home)	or	at	the	centre.		These	sessions	gave	me	the	opportunity	to	develop		a	therapeutic	relationship	based	on	empathy	and	trust,	in	order	 to	 then	 help	 patients	 identify	 goals.	 	Where	 I	 lacked	 knowledge	 in	 health	conditions,	 I	 undertook	 literature	 reviews,	 I	 sought	 information	 from	 health	professionals,	 including	 sitting	 in	 on	 consultant	 clinics,	 and	 from	 the	 very	experienced	and	highly	specialist	multi-disciplinary	team	that	I	worked	with.		I	also	believe	that	patients	and	their	families	are	their	own	experts,	and	listening	to	their	experiences,	understanding	their	beliefs	about	their	health	condition	and	treatment,	is	crucial	to	successful	interventions.		Formulations	need	to	be	as	collaborative	as	
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possible,	and	should	be	shared,	 if	confidentiality	allows,	 	with	all	members	of	the	team	working	with	the	patient.				I	have	worked	in	client	areas	that	are	extremely	sensitive	–	people	with	acquired	brain	injury	may	also	have	comorbid,	visible	injuries,	but	many	patients	live	with	invisible	 damage,	 high-level	 cognitive	 difficulties	 from	 different	 aetiologies,	including	 functional	 cognitive	 deficits,	 that	 require	 rehabilitation	 	 but	which	 the	patient	may	not	wish	to	advertise,	for	career,	relationship	and	social	reasons.		As	a	practitioner	 psychologist,	 helping	 someone	 to	 feel	 confident	 about	 their	 new	identity	(Gracey,	Evans	&	Malley,	2007)	and	also	respecting	their	right	to	privacy	can	 sometimes	 feel	 conflicting,	 but	 in	 time,	 using	 cognitive	 and	 behavioural	interventions	 to	 promote	 social	 interaction,	 and	 working	 within	 a	 compassion	focused	 therapeutic	 framework	 (Gilbert,	 2009)	 and	 towards	 a	 value-driven	 life,	some	patients	can	find	positive	changes	(post-traumatic	growth	-	Grace,	Kinsella,	Muldoon	&	Fortune,	2015).		I	also	provide	psychological	advice	to	fellow	clinicians.		For	instance,	brain-injured	patients	are	frequently	assessed	for	basic	cognitive	function	in	the	acute	phase,	by	specialist	 nurses	 or	 by	 occupational	 therapists,	 and	 I	 am	 called	 upon	 to	 help	interpret	the	results,	or	conduct	more	in-depth	testing,	in	order	to	refer	the	patient	on	 to	 the	 most	 appropriate	 rehabilitation.	 	 The	 patient’s	 emotional	 state,	 their	potential	natural	cognitive	recovery,	and	their	emotional	support	are	all	considered	when	recommending	referral.	 	Occasionally,	further	cognitive	testing	is	not	in	the	patient’s	best	interests	at	that	time,	and	more	qualitative	and	objective	assessments	of	 their	 psychological	 state	 may	 be	 more	 helpful,	 and	 I	 have	 to	 manage	 other	clinicians’	expectations	that	formal	testing	is	necessary.				
Provide	feedback	to	clients	Feedback	to	my	clients,	both	patients	and	colleagues	within	the	teams,	needs	to	be	tailored	to	their	needs.		In	a	multi-disciplinary	team	meeting,	attended	by	therapists,	social	workers,	nursing	staff	and	consultants,	and	occasionally	family	members,	my	contributions	have	to	be	concise	–	I	may	recommend	the	patient	is	prescribed	anti-depressants,	or	behavioural	activation	with	occupational	therapists	–	I	am	often	the	
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only	person	in	the	room	who	has	been	able	to	spend	time	exploring	that	person’s	motivation,	 cognition	 and	 emotional	 state,	 and	 I	 have	 to	 advocate	 for	 them,	 for	instance	as	to	where	they	are	going	to	be	discharged.		Feedback	 to	patients	 requires	 careful	 tailoring,	 taking	 into	account	any	cognitive	and	 sensory	 deficits,	 and	materials	 should	 be	 adjusted	 accordingly,	 for	 instance	including	pictorial	aids	and	using	speech	and	language	therapists	or	interpreters	if	there	are	language	barriers.		The	patient’s	rehabilitation	capacity,	or	the	progress	of	the	 neurological	 disease,	 is	 also	 considered	 .	 	 Explaining	 to	 a	 patient	 with	Parkinson’s	 or	motor	neurone	disease	 that	 they	have	mild	 cognitive	 impairment	may	help	them	prepare	for	future	cognitive	decline	and	allow	them	to	state	their	wishes	before	that	eventuality.		It	may	also	give	the	family	greater	understanding	of	some	of	their	loved	one’s	behaviours.		However,		care	needs	to	be	taken	so	as	not	to	demotivate	that	patient	from	continuing	with	maintaining	their	skills.		An	accessibly	written	 report	 for	 the	 patient	 and	 their	 family	 following	 feedback	 is	 always	provided,	enabling	them	to	have	clear	and	coherent	record	of	how	their	treatment	has	been	carried	out	with	recommendations	to	maintain	their	wellbeing.			In	my	present	role,	when	providing	therapy	to	outpatients,	feedback	is	mutual:	at	the	beginning	of	each	session	patients	are	invited	to	comment	on	how	they	felt	their	last	 session	 contributed	 to	 (or	 not)	 to	 a	 previously	 agreed	plan,	whether	 it	 is	 to	identify	 and	 work	 towards	 a	 value-led	 life,	 or	 to	 become	 more	 active	 in	 self-management,	or	to	feel	more	able	to	integrate	socially.					
Conclusion	The	four	years	I	have	spent	as	a	health	psychologist	in	training	have	been	extremely	fulfilling.		I	have	grown	in	confidence,	and	gained	knowledge	and	skills,	and	I	now	feel	better	able	to	translate	theoretical	work	to	my	applied	work	as	a	practitioner.		This	is	especially	evident	in	the	work	I	do	with	people	with	functional	neurological	disorder,	a	challenging	but	potential	rewarding	area	of	multidisciplinary	work	that	until	very	recently	has	been	shunned	by	clinicians	 from	many	disciplines.	 	 I	very	much	hope	to	expand	this	interest	once	I	achieve	chartership.			
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The	Role	of	 Illness	Perceptions	 in	the	Management	of	Functional	
Neurological	 Symptom	 Disorder	 –	 A	 Systematic	 Review	 of	 the	
Literature.	
	
Abstract:			While	Functional	Neurological	Symptom	Disorder	(FNSD)	is	prevalent	in	primary	and	 secondary	 care,	 there	 is	 scant	 evidence	 for	 treatment	efficacy.	 Illness	beliefs	have	been	shown	to	inform	people’s	health	behaviours	across	a	variety	of	illness	and	may	 be	 considered	 a	 potential	 therapeutic	 target	 for	 people	 with	 FNSD.	 This	systematic	review	examined	the	role	of	 illness	perceptions	in	the	management	of	FNSD.		EBSCO	CINAHL,	PsycINFO,	Ovid	EMBASE,	MEDLINE	and	ISI	Web	of	Science	electronic	databases	were	 searched	 in	2016,	 and	updated	 in	2018.	 	Nine	 studies	were	included	with	a	total	of	2161	participants	(FNSD	patients	n=253).		One	paper	was	 rated	 as	 medium	 quality,	 eight	 as	 good.	 	 The	 results	 showed	 that	 illness	perceptions	 were	 associated	 with	 psychological	 well-being	 and	 symptom	management	 for	 people	 with	 FNSD,	 and	 that	 illness	 perception	 scales	 could	 be	useful	in	guiding	interventions	to	improve	health	outcomes	for	people	with	FNSD,	and	 could	 help	 identify	 those	 patients	 who	 would	 most	 benefit	 from	 intensive	multidisciplinary	rehabilitation.		
Background:	
	Functional	Neurological	Symptom	Disorder	(FNSD)	belongs	to	a	complex	umbrella	group	of	Somatic	Symptom	and	Related	Disorders	(The	Diagnostic	and	Statistical	Manual	 for	Mental	Disorders-5	 (American	Psychiatric	Association,	2013)	but	has	previously	 been	 variously	 labelled	 as	 Somatization,	 Medically	 Unexplained	(Physical)	Symptoms,	Psychogenic	and	Psychosomatic	Symptoms,	Hysteria.		Around	30%	of	neurology	outpatients	have	a	functional	disorder,	even	if	it	is	not	their	main	presentation,	and	5%	of	neurology	patients	can	be	diagnosed	with	FNSD	(Stone	et	al.,	2010).		
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Along	with	Non-Epileptic	Attacks,	Functional	Weakness	is	the	main	presentation	of	FNSD,	but	other	symptoms	include	motor,	memory,	speech	and	executive	function	difficulties.	The	prevalence	of	FW	is	estimated	to	be	close	to	that	of	multiple	sclerosis	(Stone,	Warlow	&	Sharpe,	2011),	and	on	self-report	it	is	perceived	to	be	as	disabling	and	 as	 distressing	 as	 stroke	 (Stone	 et	 al.,	 2010).	 	 	 Spontaneous	 remission	 of	symptoms	occurs	in	about	30%	of	cases,	however	most	people	with	FNSD	will	have	symptoms	long-term	(Stone,	Sharpe,	Rothwell,	&	Warlow,	2003;	Sharpe	et	al.,	2010).		In	 the	 last	 decade,	 a	 minority	 of	 people	 with	 FNSD	 have	 reported	 improved	symptomology	following	intensive	inpatient	treatment	centres	by	multidisciplinary	teams	(Saifee	et	al.,		2012;	Demartini,	Batla,	Petrochilos,	Fisher,	Edwards,	&	Joyce,	2014;	Nielsen	et	al,	2016).	The	Department	of	Health	(2014)	has	recommended	a	step-wise	 approach	 to	 treatment	 (usually	 graded	 exercise	 and	 psychological	therapy)	for	all	functional	syndromes,	and	suggests	treatment	should	be	embedded	within	 the	 clinical	 speciality	 of	 the	 organic	 disease	 equivalent	 to	 increase	engagement.	 	They	 recommend	 that	patients’	 illness	beliefs	 are	elicited	 from	 the	primary	care	 stage.	 In	 fact,	 the	 cognitive	behavioural	model	of	 somatic	 symptom	disorders	 (Deary,	 Chalder	&	 Sharpe,	 2007)	 proposes	 that	 the	 patient’s	 symptom	interpretation	 and	 subsequent	 deconditioning	 contribute	 to	 a	 self-perpetuating	pattern	of	illness	behaviour.			Illness	 perceptions	 are	 central	 to	 the	 Common-Sense	 Model	 (CSM)	 (Leventhal,	Phillips	&	Burns,	 2016)–	 a	 dynamic	model	 that	 describes	 how	 a	 health	 threat	 is	interpreted	both	cognitively	and	emotionally,	incorporating	existing	health-related	prototypes	 into	 activated	 representations	 of	 both	 the	 threat	 and	 treatment,	 and	informing	continuous	assessment	of	coping	performance	and	outcome	(see	Figure	2).	 	 The	 resulting	 personal	 illness	 perceptions	 of	 symptom	 identity,	 cause,	chronicity,	controllability	and	what	this	means	to	the	individual	emotionally,	can	be	examined	and	measured	through	questionnaires	and	have	been	shown	to	predict	health	outcome	(Hagger	&	Orbell,	2003;	Frostholm	et	al.,	2007),	and	interventions	can	be	targeted	to	improve	coping	and	outcome	(Jones,	Smith	&	Llewellyn,	2015).		
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The	 CSM	 has	 been	 used	 to	 explain	 coping	 style	 and	 adjustment	 to	 a	 number	 of	somatic	symptom	disorders.	For	example,	in	chronic	fatigue	syndrome,	attribution	of	symptoms	to	“overdoing	it”	and	to	external	factors	leads	to	a	maladaptive	cycle	of	complete	 rest	 and	 bouts	 of	 excessive	 activity,	 exacerbating	 the	 symptoms	 and	resulting	in	chronic	disability	(Moss-Morris	&	Wrapson,	2003).	A	systematic	review	of	treatment	for	chronic	fatigue	syndrome	has	reported	that	interventions	that	are	directed	at	beliefs	are	the	most	effective,	and	that	cognitive	change,	including	less	negativity	 about	 symptoms	 and	 higher	 sense	 of	 symptom	 controllability,	contributes	more	to	outcome	than	behavioural	change	(Knoop,	Prins,	Moss-Morris,	&	 Bleijenberg,	 2010).	 Further,	 increased	 personal	 control	 has	 been	 shown	 to	mediate	 the	 effect	 in	 CBT	 interventions	 in	 severe	 somatic	 symptom	 disorders	(Christensen,	Frostholm,	Ørnbøl,	&	Schröder,	2015).							As	 well	 as	 cognitive	 misinterpretation	 of	 symptoms,	 studies	 in	 other	 somatic	symptom	disorders	have	found	differences	in	the	way	people	emotionally	process	health	 threats	 (Rimes,	 Ashcroft,	 Bryan	 &	 Chalder,	 2016).	 	 Monitoring	 of	 threat-related	 stimuli	 and	 levels	 of	 attention	 paid	 to	 the	 threat	 are	 regulated	 by	 the	emotional	 arm	 of	 the	 elaborated	 CSM	 (Cameron	 &	 Jago,	 2008),	 and	 this	 may	contribute	to	the	development	of	functional	symptoms	in	people	whose	emotional	processing	overpowers	the	cognitive	arm	of	symptom	recognition,	coping	strategy	and	 appraisal;	 for	 instance	 	 not	 recognising	 symptoms	 as	 being	 physical	manifestations	 of	 emotions	may	be	 the	 result	 of	 overwhelming	 fear,	 anxiety	 and	worry,	 maladaptive	 emotional	 coping	 and	 appraisal	 of	 coping.	 Beliefs	 about	 the	unacceptability	of	emotional	expression	have	also	been	demonstrated	to	mediate	in	the	relationship	between	emotional	suppression	and	quality	of	life	in	people	with	Irritable	Bowel	Syndrome	(Bowers	&	Wroe,	2016).		It	has	been	reported	that	people	with	FNSD	have	higher	levels	of	alexithymia	(an	inability	to	recognise	emotions)	and	are	threat	hypervigilant	(Demartini,	Petrochilos,	Ricciardi,	Price,	Edwards,	&	Joyce,	2014).	A	pilot	study	of	an	emotional	regulation	training	extension	to	a	traditional	CBT	 intervention	 for	 people	 with	 multiple	 somatic	 symptom	 disorders	 was	encouraging	(Gottschalk,	Berking	&	Rief,	2015).		
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Exploring	both	the	cognitive	and	emotional	representations	and	coping	strategies	of	people	with	FNSD	may	lead	to	identifying	modifiable	factors.	Given	their	likely	important	 role,	 a	 review	 of	 the	 current	 literature	 exploring	 the	 role	 of	 illness	perceptions	in	the	management	of	FNSD	has	therefore	been	undertaken.		
Figure	26. Adapted	from	Cameron	&	Jago,	2008.	The	common-sense	model	of	the	self-regulation	of	illness	behaviour,	with	the	elaboration	of	emotion-focused	coping.	
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Objectives:	1. Examine	 whether	 illness	 perceptions,	 as	 defined	 by	 the	 Common-Sense	Model	(cause,	identity,	control,	time-line	and	consequences)	are	associated	with	 psychological	well-being	 and	 symptom	management	 for	 people	with	FNSD.		2. Review	the	evidence	for	the	effectiveness	of	changing	illness	perceptions	for	people	with	FNSD.					
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METHODS	
Search	strategy	The	 procedures	were	 informed	 by	 standardised	 systematic	 reviewing	 guidelines	(Centre	 for	 Reviews	 and	 Dissemination,	 2009)	 and	 a	 PRISMA	 checklist	 was	completed	(Appendix	A). 
 The	EBSCO	CINAHL	and	PsycINFO,	Ovid	EMBASE,	MEDLINE	and	ISI	Web	of	Science	electronic	 databases	were	 searched	 from	 1996	 to	 August	 2015	 (1996	 being	 the	publication	year	of	the	original	Illness	Perception	Questionnaire)	(see	Appendix	B).			Given	 the	 plethora	 of	 terms	 used	 to	 describe	 patients	with	 FNSD,	 the	 electronic	search	 strategy	 included	 the	 exploded	 MeSH	 terms:	 conversion	 disorder,	dissociative	disorder,	medically	unexplained,	somatoform	disorder,	and	key	words	“hysteri*”,	 “functional	 neurological	 symp*”,	 “functional	 motor”,	 “functional	weakness”	 and	 “psychogenic”.	 These	were	 combined	with	 exploded	MeSH	 term:	illness	 perception,	 and	 key	 word	 “IPQ”.	 	 Papers	 were	 screened	 for	 neurological	content.	 	 The	 Cochrane	 Database	 of	 Systematic	 Reviews	 was	 searched	 for	appropriate	primary	studies.	 	Grey	 literature	searching	 included	OPEN	and	BASE	search	engines.		References	of	papers	were	hand	searched	and	the	patient	websites	www.neurosymptoms.org	and	www.fndhope.org	were	also	searched.		The	 search	was	 limited	 to	English	 language	 empirical	 studies	 published	 in	 peer-reviewed	 journals	 and	 conducted	during	September	2015	 (see	 figure	3	 for	 flow-chart	diagram).		
Selection	strategy:	Studies	were	included	if	they	met	the	following	criteria:	the	participants	were	over	18	years	old	and	were	diagnosed	with	Functional	Neurological	Symptom	Disorder	or	Conversion	Disorder	(but	not	solely	Non-Epileptic	Attack	Disorder)	or	Functional	Weakness,	 as	 described	 in	 DSM-5;	 the	 participants	 could	 be	 recruited	 through	primary	 or	 secondary	 care,	 or	 through	 community	 services	 or	 charities	 and	 the	study	was	undertaken	with	 the	aim	of	understanding	 the	perpetuating	 factors	 in	
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FNSD	 and/or	 improving	 outcome	 for	 people	with	 FNSD.	 Studies	 included	 illness	perception	 domains	 (cause,	 identity,	 timeline,	 chronicity,	 control)	 assessed	 by	validated	illness	perception	measures	(Illness	Perception	Questionnaire	(Weinman,	Petrie,	 Moss-Morris,	 &	 Horne,	 1996),	 	 Illness	 Perception	 Questionnaire-	 Revised	(Moss-Morris,	Weinman,	Petrie,	Horne,	Cameron,	&	Buick,	2002)	or	the	Brief	Illness	Perception	Questionnaire	(Broadbent,	Petrie,	Main,	&	Weinman,	2006),	from	single	items	 to	 entire	 questionnaires.	 	 Studies	 also	 had	 to	 include	 some	 measure	 of	psychological	 variables	 as	 a	 primary	 or	 secondary	 outcome	 (e.g.	 psychological	distress,	quality	of	life,	anxiety	or	depression.)		Studies	were	 excluded	 if	 they	 only	 included	 participants	with	 only	 non-epileptic	seizure	disorder	(NESD),	or	only	chronic	pain,	or	only	fibromyalgia,	or	only	other	somatic	illness	that	is	not	FNSD.		This	review	focused	on	FNSD	but	excluded	Non-Epileptic	Seizures,	for	which	there	is	a	growing	and	separate	body	of	research.				
Quality	assessment	of	studies:	To	assess	the	methodological	quality	and	reporting	of	studies,	a	quality	assessment	tool	was	adapted	from	Ariëns,	van	Mechelen,	Bongers,	Bouter,	&	van	der	Wal	(2001)	(see	Appendix	A),	which	has	been	used	in	previous	reviews	(Harrison,	McCracken,	Bogosian,	&	Moss-Morris,	2014)	and	is	an	objective	checklist	to	identify	biases.	The	quality	of	all	studies	was	assessed	by	the	lead	author	(AC).		To	improve	the	accuracy	of	this	assessment	a	sub-section	(n=3,	37.5%)	of	papers	was	randomly	selected	and	rated	 by	 an	 independent	 researcher.	 Fourteen	 items	 in	 eight	 categories	 were	independently	rated	as	either	present	or	not	applicable	 (1)	or	not	present	 (0)	 to	provide	a	total	positive	score	for	three	of	the	studies.		Scores	were	classified	as	poor	(0-8),	medium	(9-11)	and	good	(12-14).	No	discrepancy	was	found	between	the	two	raters.				
Search	results:	Using	 the	 search	 criteria	 described,	 237	 studies	 were	 identified	 for	 possible	inclusion.		Of	these,	48	duplicate	studies	were	excluded,	and	after	a	screening	of	title	and	abstract,	a	further	174	were	excluded	(see	Figure	3).		The	full	texts	of	15	studies	
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were	accessed	to	determine	eligibility	by	the	first	author,	and	seven	of	these	did	not	have	a	separate	analysis	of	FNSD	within	their	results.	The	remaining	eight	studies	were	 reviewed	 for	 study	 design,	 participant	 characteristics,	 intervention	 and	outcomes	by	two	researchers	(see	Table	1).		
Search	update:	A	 further	 search	was	 conducted	 in	 June	 2018	 before	 journal	 submission	 but	 no	papers	were	found	that	met	the	inclusion	criteria.		However,	a	reviewer	identified	a	missing	study	(Nielsen	et	al,	2016)	and	this	has	been	included	in	the	review.	
	
Data	synthesis		Meta-analysis	of	these	studies	was	attempted,	but	the	heterogeneity	of	participants,	study	 type,	 outcome	 measures,	 and	 follow-up	 periods	 prevented	 a	 meaningful	synthesis	of	the	data.		The	studies	are	discussed	in	narrative	review	(Popay	et	al.,	2006),	and	where	available,	effect	sizes	are	presented	(Table	2).				
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Figure	27.	Flow	diagram	for	identification	of	studies	using	Illness	Perceptions	in	populations	of	FNSD	or	conversion	disorder,	excluding	studies	that	focused	only	on	non-epileptic	seizures.																										*	NESD	=	non-epileptic	seizure	disorder	
	
Records	identified	through	database	searching	(n	=233)	 Additional	records	identified	through	other	sources:	BASE,	Open	Grey,	patient	websites,	hand-searching,	etc.	(n	=	4)	
Records	after	duplicates	removed	(n	=	186)	
Records	(abstracts)	screened	(n	=	186)	
Records	excluded:	(n	=	174)	1.	Not	neurological	symptoms	(n	=	96)	2.	Only	NESD*								(n=	10)										3.	No	Illness	Perceptions	(n	=	35)	4.	Not	English	(n	=	6)	5.	Paediatric		(n	=	5)	6.	Not	empirical	(n	=	22)	
- 	 	Full-text	articles	assessed	for	eligibility	(n	=	15)	 Full-text	articles	excluded,	participants	with	MUS	not	defined	as	FNSD	or	conversion	for	analysis	(n	=	7)			Studies	included	in	qualitative	synthesis	(n	=	8)	
Study	identified	by	journal	reviewer	(n=1)	added	to	review		(n=9)		
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RESULTS	
Description	of	the	included	studies:	All	the	studies	(n=9)	included	were	conducted	in	the	United	Kingdom:	 	three	were	based	 in	 London	 and	 three	 in	 Scotland.	 A	 further	 two	 had	 Functional	 Weakness	participants	 from	 Scotland	 and	 Non-Epileptic	 Seizure	 participants	 or	 participants	with	epilepsy	from	Sheffield.			One	study	recruited	in	Manchester.				Four	 studies	 were	 cross-sectional	 (Jackson,	 Kincey,	 Fiddler,	 Creed,	 &	 Tomenson,	2004;	Stone,	Warlow,	&	Sharpe,	2010;	Ludwig,	Whitehead,	Sharpe,	Reuber,	&	Stone,	2015;		Whitehead,	Stone,	Norman,	Sharpe,	&	Reuber,	2015),	one	was	a	randomised	controlled	trial	(Sharpe	et	al.,	2011),	one	a	randomised	feasibility	study	(Nielsen	et	al,	2016),	two	were	prospective	one-year	cohort	studies	(Sharpe	et	al.,	2010;	Demartini,	Petrochilos	 et	 al.,	 2014),	 and	one	a	 two-year	 retrospective	 follow-up	 (Saifee	 et	 al.,	2012).	 	 Eight	 of	 the	 studies	 were	 assessed	 to	 be	 of	 good	 quality,	 one	 study	 was	assessed	to	be	of	medium	quality	(Demartini,	Petrochilos	et	al.,	2014)	because	of	the	absence	of	a	control	group	when	evaluating	the	 intervention.	 	Study	quality	scores	were	not	 reduced	by	 the	use	of	only	single	 items	 from,	or	partial	use	of,	validated	illness	perception	questionnaires.	
 Three	papers	included	in	this	review	used	the	same	cohort	of	107	people	who	had	functional	weakness.	Originally	recruited	by	Stone	et	al	(2010)	in	a	case-controlled	study	 examining	 the	 differences	 between	 people	 with	 functional	 weakness	 and	neurological	weakness,	 this	same	population	was	also	used	in	Ludwig	et	al,	2015’s	study	comparing	illness	perceptions	in	functional	weakness	and	non-epileptic	seizure	patients,	 and	 in	 Whitehead	 et	 al,	 2015’s	 study	 of	 illness	 perceptions	 in	 both	 the	patients	and	their	relatives.			Researchers	in	the	field	of	FNSD	appear	to	be	restricted	to	a	small	group:	of	the	eight	papers	included	in	this	review,	one	author	(Sharpe)	contributed	to	six	studies,	one	author	 (Stone)	 to	 five	 studies,	 and	 five	 other	 authors,	 (Warlow,	 Walker,	 Carson,	Whitehead	and	Reuber)	to	two	studies.		
 249 
Illness	perception	measures	were	either	the	IPQ,	the	IPQ-R,	or	in	one	case	the	Brief	Illness	Perception	Questionnaire	(B-IPQ,	Broadbent,	Petrie,	Main	et	al,	2006)	but	six	out	of	the	eight	studies	adapted	the	measures	to	increase	the	neurological	focus	of	the	questions	or	only	used	a	few,	or	one,	of	the	questionnaire	components.	The	one	study	that	used	the	B-IPQ	(Nielsen	et	al,	2016)	only	reported	the	total	score.			
 The	identity	element	of	either	the	IPQ	or	the	IPQ-R	was	only	included	in	three	out	of	the	 eight	 studies	 and	 specifically	 excluded	 in	 one	 study	 (Whitehead	 et	 al.,	 2015)	because	 the	 authors	 did	 not	 consider	 the	 list	 relevant	 to	 functional	 neurological	symptom	 disorder	 or	 neurological	 disease,	 despite	 the	 IPQ-R	 being	 adaptable	 to	specific	conditions.			Included	studies	used	illness	perceptions	as	predictive	tools	(Demartini,	Batla	et	al,	2014;	Sharpe	et	al.,	2010),	as	measures	of	 intervention	effectiveness	(Sharpe	et	al,	2011;	 Demartini,	 Petrochilos	 et	 al,	 2014;	 Nielsen	 et	 al,	 2016),	 as	 ways	 to	 inform	treatment	 (Jackson	 et	 al,	 2004;	 Stone	 et	 al,	 2010;	 Saifee	 et	 al,	 2012;	 Ludwig	 et	 al,	2015).	 
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Table	16.		Summary	of	the	role	of	Illness	Perceptions	(IP)	in	studies	of	functional	neurological	symptom	disorder	(presented	in	chronological	
order	of	publication).	
Study	 Participants	 Design		 Study	Aim	 IP	measures		 Other	
outcome	
measures	
Are	IPs	
associated	with	
psychological	
wellbeing?	
Contribution	of	IPs	to	Study	
	
Jackson	 et	
al.	(2004)	
New	neurology	(n=112)	and	cardiology	(n=60)	of	whom	MUS	neurology	(n=25)	and	MUS	cardiology	(n=16).	
Cross	sectional	 Assess	differences	in	satisfaction	in	two	outpatient	clinics	and	relationship	of	satisfaction	with	emotional	distress	and	illness	perceptions.		MUS	diagnosis	post	6	months.	
IPQ	 The	Satisfaction	Questionnaire	at	2	weeks	post	consultation	HADS	and	HAQ	before	first	consultation		
No	difference	in	IPs	or	HADS	between	clinic	groups,	but	MUS	overall	had	lower	mood	
No	difference	in	IPs	or	HADS	between	clinic	 groups,	 but	 MUS	 overall	 had	lower	mood.	Significant	correlation	between	cause,	consequences,	 timeline,	 cure	 and	control,	 and	 satisfaction	 with	 health.	Significant	 correlation	 between	 IPQ	consequences	 and	 satisfaction	 with	information.	 Higher	 number	 of	symptoms	 (Identity)	 associated	 with	lower	 satisfaction.	 But	 no	 differences	between	MUS	and	the	organic	disease	groups.			
Sharpe	 et	
al.	(2010)	
Neurology	outpatients	(n=1144)	 1	year	prospective	cohort	study.	
To	determine	which	patient	characteristics	predicted	poor	1	year	outcome										
IPQ	adapted:	Only	timeline	and	psychological	causality.	
HADS,	Medical	Outcomes	Study,	PHQ,	Whitely	Index	(health	anxiety),	Clinical	Global	improvement.	Improvement	in	Presenting	Symptoms.			
Yes.	Poor	self-rated	outcome	best	predicted	by	IP	belief	about	recovery	and	non-attribution	to	psychological	factors.		(also	by	receipt	of	health	related	financial	benefits.)	HADS	did	not	predict	poor	outcome.	
IPs	 (the	 two	 measured)	 were	 strong	predictors	 of	 outcome	 along	 with	social	factors.	(receipt	of	benefits).		Demonstrated	 to	 be	 predictors	 of	outcome.	
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Stone,	
Warlow	 &	
Sharpe.	
(2010)	
Neurology	
outpatients	with	
FW	(n=107)	and	
outpatients	with	
Neurological	
Disease	
(ND)(n=46)	
Cross-
sectional	
Comparing	FW	cases	
and	ND	controls.		
IPQ	adapted:	
plus	more	
causes,	
specifically	
neurological	
causes.	
SF-36	–	health	
status.	HADS.		
Within	 case	
analysis	 showed	
that	 higher	 belief	
in	stress	as	a	cause	
was	 associated	
with	having	higher	
HADS	 and	 less	
physical	 disability	
on	SF-36.	
Cases	 LESS	 likely	 than	 controls	 to	
believe	 that	 illness	 permanent.	
Cases	much	more	 likely	 to	 believe	
that	 illness	 was	 a	 mystery.	 Cases	
less	 likely	 to	 agree	 that	 stress	 a	
cause.	 	Cases	 less	 likely	 to	endorse	
all	 causes.	 Cases	 less	 likely	 to	
choose	psychological	cause.	
Differentiates	 between	 FNSD	 and	
non	FNSDS.	Better	understanding	of	
how	people	with	FNSD	believe	and	
also	 possibly	 diagnostic	 and	 help	
interventions	
Sharpe	 et	
al.	(2011)	
Neurology	FNSD	outpatients,	usual	care	(n=63)	usual	care	+CBT	based	Guided	Self-help	(n=63).	
2-arm	parallel	group	randomized	controlled	trial	
Comparing	usual	 care	for	 FNSD	 and	 usual	care	 plus	 CBT	 based	Guided	 self-help.	Measured	at	3m	and	at	6m.		
IPQ	 adapted:	Only	timeline/con-sequences	 and	coherence.	
PHQ,	Medical	Outcomes	Short	form	Scale,	HADS,	Whiteley	Index	(partial)	
No	 intervention	effects	 on	 IP	 at	 3	months,	 at	 6	 m	consequences	difference	significant.	
The	intervention	aimed	at	changing	how	people	with	FNSD	view	their	condition,	so	surprising	that	a	full	assessment	of	IP	not	undertaken.	Did	not	use	IP	very	effectively		
Saifee	et	al.	
(2012)	
Patients	with	FNSD	(n=32)											
2-year	retrospective	 self-report	follow	up	
Long	term	effect	of	inpatient	treatment		 IPQ	adapted:	Only	cause	component		 Work	and	Social	Adjustment	Scale,	info	questionnaire,		
Yes.	 	 Significant	correlation	 between	those	 who	 agreed	that	 emotional	 state	and	 stress	 were	causative	 and	 those	who	 reported	 a	benefit	 from	 the	inpatient	programme.	
Non-attribution	 of	 symptoms	 to	psychological	 factors	 was	 correlated	with	 poor	 outcome.	 May	 be	 useful	 in	allocating	 expensive	 and	 rationed	inpatient	resources.	
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Demartini,	
Batla	 et	 al.	
(2014)	
Inpatients	at	a	
multidisciplinar
y	treatment	
centre	for	FNSD	
(n=61).	
Prospecti
ve	short	
and	long	
term	
evaluatio
n	of	an	
inpatient	
intervent
ion.	
Aim	 to	 determine	
short	 and	 long	 term	
efficacy	of	treatment	
and	 determine	
predictors	 of	 good	
outcome.	Admission,	
Discharge	 and	 12-
months	post.	
IPQ-R	 Clinician	
rated:	HoNOS,	
COPM.	
Patient:		
HADS,	Fear	
Questionnaire
,	PHQ-15,	CGI,		
	
Significant	changes	
between	
admission	 and	
discharge	 on	
timeline	
acute/chronic,	
illness	 coherence,	
and	 emotional	
representations	
and	 consequences.	
(significant	
changes	 on	
emotional	 but	
small	effect	–	same	
for	 HADS).	 After	 a	
year,	 timeline	
acute/chronic,	
coherence	 and	
emotional	 rep.	
changes	 still	
significant	 with	
smaller	effect.	
	
IPQ-R:	 admission	 to	 discharge	
(n=61):	 timeline	 acute/chronic,	
consequences,	 coherence,	
emotional	 representation,	 all	
significantly	improved.	
IPQ-R:	admission	to	12-month	post	
discharge(n=36),	 coherence	 and	
emotional	 representation	
significantly	improved.	
	
IP	 did	 not	 predict	 outcome.	 (only	
HoNOS	did).		No	measures	predicted	
which	patients	would	benefit.	
	
Ludwig	 et	
al.	(2015)	
Patients	with	FW	(n=107)	and	neurological	disease	(n=46)	compared	with	each	other	and	with	patients	with	epilepsy	(n=34)	and	non-epileptic	seizures	(n=40)	
Cross	sectional	 Differences	 in	 IPs	between	patients	with	NES	and	FW	 IPQ-R	adapted	-excluding	the	Identity	subscale	and	adding	18	possible	causes).	
HADS	 No.	No	differences	in	HADS	 between	 two	groups	 (functional	and	 organic).	 Both	functional	 groups	tended	 to	 reject	psychological	causes,	 but	more	 so	in	FW.			
IPs	 can	 inform	 interventions,	highlighting	 differences	 in	acceptability	 of	 psychological	causation	between	FW	and	NES.	
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Whitehead	
et	al	
(2015)	
112	pairs	of	
FNSD	patients	
and	their	
relatives	and	60	
pairs	of	ND	
patients	and	
relatives.	
Cross	
sectional	
Differences	in	
relatives’	and	
patients’	IPs	in	FNSD	
compared	to	
neurological	
disease.	
IPQ-R	adapted	
-excluding	
coherence	
subscale	and	
identity	
subscale.		
HADS	 Both	relatives	of	
FNSD	and	ND	felt	
condition	had	
>emotional	impact	
on	patient	than	
patient	did.		
FNSD	 relatives	 see	 psychological	
factors	 as	 more	 relevant	 than	 the	
patients	 do.	 Could	 contribute	 to	
FNSD	treatment	planning	by	getting	
relatives	 on	 board	 first	 as	 more	
open	to	psychological	causation.	
Nielsen	 et	
al	(2016)	
29	functional	motor	symptoms	participants	and	28	functional	motor	symptoms	controls	(TAU)	
Randomised	controlled	feasibility	study	
Determine	feasibility	of	specialist	physiotherapy	intervention	
B-IPQ	total	score	(causality	not	described)	 HADS;	SF36;	WSAS	 Participants	excluded	if	clinically	depressed	or	anxious.		No	significant	change	in	psychological	outcomes	but	intervention	group	reported	>good	outcome.	
Used	as	a	measure	of	health	threat,	the	intervention	group’s	total	B-IPQ	score	change	 suggests	 that	 this	intervention’s	 effect	 on	 patients’	understanding	and	movement	control	is	mediated	by	illness	perceptions.	
	
Abbreviations:			B-IPQ:	Brief	Illness	Perceptions	Questionnaire;	CBT:	cognitive	behavioural	therapy;	CGI:	Clinical	Global	Impressions	Questionnaire;	COPM:	Canadian	Occupational	Performance	Measure;	FNSD:	functional	neurological	symptoms	disorder;	HADS:	Hospital	Anxiety	and	Depression	Scale;	HAQ:	Health	Assessment	Questionnaire;	HoNOS:	Health	of	the	Nation	Outcome	Scales;	IPQ:	Illness	Perception	Questionnaire;	IPQ-R:	Illness	Perception	Questionnaire	Revised;	MUS:	medically	unexplained	symptoms;	ND:	neurological	disease;	PHQ-15:	Patient	Health	Questionnaire;	SF-36:	Short	Form	Health	Survey;		WSAS:		Work	and	Social	Adjustment	Scale
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Table	17.	The	Role	of	Illness	Perceptions	in	included	studies	
	 Study	aim	 Effectiveness	 Effect	
(only	significant	results	reported)	
				IPs	used	as:																									Predictive	tools	Demartini,	Batla	et	al,	2014	 Comparing	outcome	from	admission,	discharge	and	1	year	follow	up	(55%)	of	an	inpatient	multidisciplinary	intervention.	
	Mood	improvement,	and	general	health	rating	was	improved	long	term.	Only	HoNos	was	predictive	of	outcome.	No	self-report	measure	predicted	who	would	benefit	from	treatment	
		
Sharpe	et	al,	2010	 To	find	predictors	of	outcome	in	new	neurology	outpatients	whose	symptoms	were	not	at	all	or	only	somewhat	explained	by	disease.		
Beliefs	-	two	items	from	IPQ:	1:	permanence	of	symptoms	question	and	2:	Non-attribution	of	symptoms	to	psychological	factors	were	strong	independent	predictors	of	outcome.				
1:	p<.001;	Adjusted	OR	for	poor	outcome	(95%)	=2.04	(1.40-2.96)	p<0.001	2:	(95%)	=	2.22	(1.51-3.26)	<0.001	
																																																				Measures	of	intervention	effectiveness	Sharpe	et	al,	2011	 Comparing	CBT	guided	self-help	intervention	to	usual	care	for	functional	neurological	symptoms.	 Beliefs,	two	items	from	the	IPQ;	1:	symptoms	are	permanent	and	2:	symptoms	are	a	mystery.	 No	significant	difference	between	the	groups	at	3	months,	but	at	6-months	intervention	group	had	significant	less	belief	that	symptoms	were	permanent.	Demartini,	Batla	et	al,	2014	 Comparing	outcome	from	admission,	discharge	and	1	year	follow	up	(55%)	of	an	inpatient	multidisciplinary	intervention.		Shows	intervention	can	have	long-term	effect.						
IPQ-R	-	Comparing	admission	and	discharge	scores	–	significant	results	shown	in:	1.	IPQ-R	timeline	acute/chronic;	2.	IPQ-R	consequences;	3.	IPQ-R	illness	coherence;	4.	IPQ-R	emotional	representation	After	1	year	follow	up:	significant	effect	found	for:	5.	Timeline	acute/chronic;	6.	Illness	coherence;	7.	Emotional	representation.	
Effect	size	(Cohen’s	d)	1:d=0.51,p<0.001,medium	effect	2:	d=0.26,	p=0.02,	small	effect	3:	d=0.84,	p<0.001,	large	effect	4:	d=0.32,	p=0.009,	large	effect	Effect	size	(partial	eta	squared)	5:	0.13,	p=0.01,	small	effect	6:	0.32,	p<0.001,	medium	effect	7.	0.11,	p=0.03,	small	effect			
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																																																Ways	to	inform	treatment	Jackson	et	al,		2004	 Looking	at	differences	in	satisfaction,	emotional	distress	and	IP	between	physical	disease	and	MUS	in	cardiology	and	neurology	clinics.	
Small	effect	sizes	for	any	significant	correlations	between	satisfaction	scores	and	illness	perceptions.		1:	IPQ	consequences	with	total	satisfaction	score;	2:	IPQ	consequences	and	satisfaction	with	health;	3:	IPQ	consequences	and	satisfaction	with	information;	4.	IPQ	cure	and	satisfaction	with	health.)	No	overall	differences	in	satisfaction	between	the	two	groups	(MUS	and	organic).	No	direct	relationship	between	satisfaction	of	information	and	IP.			
1:	R=0.28,	p<0.001,	small	effect	2:	R=0.39,	p=0.005,	small	effect	3.	R=0.23,	p=0.006,	small	effect	4.	R=-0.24,	p=0.004,	small	effect	
Stone,	Warlow,	&	Sharpe,	2010	 Comparison	of	FW	cases	and	neurological	controls.	 Differences	between	cases	and	controls:	1:	cases	less	likely	to	believe	that	illness	permanent;	2:	cases	more	likely	to	believe	that	illness	was	a	mystery.	Analysis	between	distress	and	IP:	3:	more	likely	to	believe	that	stress	is	a	cause	and	higher	scores	on	HADS,	4:	less	physical	disability	on	SF-36	
Median	 scores	 cases,	 controls,	 (95%)	confidence	intervals,	p;	1:	60,	77,	(-23	to	-10),	p<0.0001;	2:	40,	60,	(-28	to	-16),	p<0.0001	3:	r=0.24,	p=0.02,	small	effect	4:	r=0.38;	p=0.001,	small	effect	Saifee	et	al,	2012	 Long	term	follow	up	to	an	inpatient	multidisciplinary	intervention	for	people	with	functional	motor	symptoms.	 Significant	correlation	between	patients	who	agreed	that	1:	emotional	state	2:	and	stress	were	causative,	and	those	that	reported	benefit	from	the	intervention.		 1:	r=	.40,	p	=	.03,	small	effect	2:	r=	.37,	p	=	.04,	small	effect	Ludwig	et	al,	2015	 Looking	at	differences	in	IP	between	NES	and	FW,	and	neurological	disease	and	epilepsy.		Demonstrates	that	there	are	differences	in	how	receptive	FW	and	NES	groups	may	be	in	accepting	any	psychological	basis	to	cause	and	therefore	treatment.	
Effect	sizes	calculated	where	there	were	significant	differences	between	groups.	1:	The	FW	group	was	more	likely	than	NES	group	to	reject	psychological	causes.	2:	The	FW	group	was	less	likely	to	see	stress	as	being	a	factor.	3:	FW	reported	lower	consequences	on	themselves	and	their	families.	4:	FW	endorsed	lower	treatment	effectiveness	than	NES.	p<0.01.		
1.	d=0.49,	p<.01,	medium	effect	2.	d=0.56,	p<.01,	medium	effect	3.	d=0.44,	p<0.01,	small	effect.	4.	d=0.52,	p<0.01,	medium	effect.			
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Whitehead	et	al,	2015	 Compare	IP	of	FNSD	and	IP	of	their	relatives,	and	control	pairs	of	neurological	disease.	And	subgroups	between	weakness	and	seizures.	
Only	in	FNSD	pairs	did	relatives	endorse	1:	psychological	or	2:	stress	cause	more	than	patients.				
1:	t=-4.1314,	p<0.001	2:	t=-3.944,	p<0.001	
Nielsen	et	al,	2016	 To	assess	feasibility	of	physiotherapy	intervention	 Trial	was	effective:	large	treatment	effect	reported.	1.	SF36	physical	function.	2.	CGI	collapsed	score	72%	in	intervention	reported	improved	or	much	improved	(18%	in	the	control	group).		
1.	d=.70,	large	effect		
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THE	ROLE	OF	 ILLNESS	PERCEPTIONS	 IN	STUDIES	 INCLUDING	PEOPLE	WITH	
FNSD	
	Three	 papers	 had	 illness	 perceptions	 as	 the	 primary	 outcome	measure	 for	 their	studies	(Jackson	et	al,	2004;	Ludwig	et	al,	2015;	Whitehead	et	al,	2015).	Four	good	quality	 papers	 examined	 the	 causal	 beliefs	 of	 people	with	 functional	 symptoms:	Saifee	 et	 al	 (2012)	 found	 that	 not	 attributing	 symptoms	 to	 psychological	 factors	(emotional	state	and	stress)	was	negatively	correlated	to	patient-reported	benefit	following	an	inpatient	intervention.		Stone	et	al	(2010)	found	that	functional	cases	were	less	likely	to	endorse	psychological	factors	as	a	cause	and	were	less	likely	to	endorse	any	of	the	suggested	causes,	in	keeping	with	the	belief	that	their	condition	was	a	mystery.		Ludwig’s	study	found	that	people	with	functional	weakness	had	a	greater	tendency	to	 reject	 psychological	 causation	 than	 people	 with	 non-epileptic	 seizures.	 The	results	of	Whitehead’s	study	challenge	the	stereotype	that	relatives	of	people	with	functional	disorders	are	barriers	 to	change.	 	Using	 the	 IPQ-R,	 they	demonstrated	that	whilst	relatives	of	people	with	FNSD	were	in	the	most	part	reluctant	to	endorse	psychological	causality	for	the	symptoms,	they	were	significantly	less	reluctant	than	the	FNSD	patients.		
	
Using	illness	perceptions	to	differentiate	between	clinical	groups:	No	significant	differences	in	IP	were	found	between	FNSD	and	organic	neurological	disease	groups	in	Jackson	et	al	(2004),	but	Stone,	Warlow,	&	Sharpe	(2010)	found	that	 people	with	 FNSD	were	 less	 likely	 than	people	with	diagnosed	neurological	disease	to	believe	that	their	illness	was	permanent,	and	they	also	were	more	likely	to	endorse	that	their	illness	was	a	mystery.	 	Stone	and	colleagues	also	found	that	people	 with	 FNSD	 were	 less	 likely	 to	 endorse	 any	 of	 the	 suggested	 causes	 (i.e.	environmental)	and	especially	less	likely	to	endorse	causes	that	were	psychological.				Ludwig	et	al	(2015)	also	found	that	people	with	Functional	Weakness	were	more	likely	 to	 reject	 psychological	 causes	 and	 stress	 factors,	 and	were	more	 likely	 to	
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report	 lower	 consequences	 of	 their	 condition	 and	 lower	 treatment	 effectiveness,	than	people	with	non-epileptic	seizures.	
 
Illness	perceptions	predicting	outcome	of	psychological	interventions:	In	a	 long-term	follow-up	of	an	inpatient	multidisciplinary	intervention	for	people	with	FNSD,	Saifee	et	al	(2012)	found	a	significant	correlation	between	patients	who	agreed	 that	 their	 emotional	 state	 and	 stress	were	 causative	 and	 those	who	 later	reported	 benefit	 from	 the	 intervention.	 However,	 illness	 perceptions	 were	 not	predictive	of	patient-rated	improvement	in	Demartini,	Batla	et	al’s	(2014)	study	of	a	group	undergoing	intensive	intervention.	In	this	medium	quality	paper,	the	only	predictive	measure	was	the	clinician-rated	outcome	scale.		Demartini	and	colleagues	do	 not	 report	 analysis	 of	 the	 causality	 factor	 in	 the	 IPQ-R,	 and	 their	 group’s	endorsement	of	psychological	 causation	 is	not	known.	 Sharpe	et	 al	 (2010)	 study	investigating	patient	characteristics	demonstrated	that	timeline	and	psychological	causality	beliefs	were	predictive	of	outcome,	along	with	receipt	of	benefits.			
Changes	in	illness	perceptions	after	intervention:	Sharpe	 et	 al	 (2011)	 compared	 a	 Cognitive	 Behavioural	 Therapy	 guided	 self-help	intervention	to	usual	care	for	FNSD	and	found	no	significant	differences	in	timeline	and	 coherence	 at	 3	 months,	 but	 significantly	 lower	 belief	 in	 permanence	 at	 6	months.	 	 Demartini,	 Batla	 et	 al	 (2014)	 demonstrated	 significant	 differences	 on	discharge	 from	 their	 multidisciplinary	 inpatient	 intervention	 in	 IPQ-R	 timeline	acute/chronic,	consequences,	illness	coherence	and	emotional	representation.		The	1-year	 follow-up	 showed	 continued	 significant	 effect	 on	 timeline	 acute/chronic,	illness	coherence	and	emotional	representation.		The	composite	score	of	the	B-IPQ	was	used	to	measure	the	level	of	threat	patients’	attached	to	their	health	condition	and	 showed	 medium	 effect	 size	 change	 following	 a	 five	 day	 physiotherapy	intervention	compared	to	a	treatment	as	usual	control	(Nielsen	et	al,	2016).			
DISCUSSION	The	 studies	 included	 in	 this	 review	 have	 shown	 that	 some	 domains	 of	 illness	perceptions	in	FNSD	can	be	predictive	of	outcome	(Sharpe	et	al,	2010),	can	measure	
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intervention	effectiveness	(Sharpe	et	al,	2011;	Demartini,	Batla	et	al,	2014),	and	can	inform	treatment	(Jackson	et	al,	2004;	Stone	et	al,	2010;	Saifee	et	al,	2012;	Ludwig	et	al,	2015,	Whitehead	et	al,	2015).	Changes	to	illness	perceptions	were	shown	to	be	associated	 with	 improved	 psychological	 well-being;	 illness	 perceptions	 were	demonstrated	to	be	modifiable	following	intervention,	and	may	also	be	predictive	of	outcome	after	intervention.		Illness	perceptions	may	also	mediate	in	the	causal	chain	between	trial	arm	and	outcome.		These	results	are	important	as	there	is	a	lack	of	evidence	to	guide	treatment	that	can	improve	the	lives	of	people	living	with	the	disorder,	and	their	families,	and	reduce	the	 resulting	health	 cost	 and	 social	 burden	 that	 FNSD	 carries.	 	 	 	 One	 small-scale	intervention	 (Demartini,	 Batla	 et	 al,	 2014)	 targeting	 illness	 perceptions,	demonstrated	 that	 beliefs	 in	 FNSD	 can	 be	 modified	 with	 perceived	 long-term	benefits	 for	 the	 person	 living	 with	 FNSD.	 However,	 this	 resource-intensive	intervention	 targeted	 people	who	were	 already	more	 accepting	 of	 psychological	aetiology,	 and	 too	 costly	 to	 be	 scalable	 to	 the	 general	 population	 of	 people	with	FNSD.		While	a	CBT	intervention	for	people	with	irritable	bowel	syndrome	demonstrated	that	changes	in	cognitions	rather	than	changes	in	anxiety	and	depression	mediated	the	intervention	effect	on	symptom	severity	and	social	adjustment	at	six	months’	follow-up	 (Chilcot	 &	 Moss-Morris,	 2013),	 emotional	 expression	 may	 require	intervention	 before	mood	 and	 cognitive	 beliefs	 are	 addressed	 (Cameron	&	 Jago,	2008;	Bowers	&	Wroe,	2016).				Despite	the	introduction	of	the	IPQ-R	(Moss-Morris	et	al.,	2002),	which	expanded	the	original	questionnaire	to	include	emotional	representations,	five	out	of	the	eight	studies	in	this	review	had	the	IPQ	as	a	measure	and	only	one	study	used	the	full	IPQ-R.	The	original	IPQ	cannot	be	a	useful	measure	in	a	disorder	that	has	at	least	partial	psychological	aetiology	-	as	FNSD	has	been	shown	to	frequently	be	associated	with	emotional	 trauma	 (whether	 concurrent	 with	 the	 onset	 of	 symptoms	 or	 in	 the	patient’s	 past),	 emotional	 processing	 dysfunction,	 and	 aversion	 to	 acceptance	 of	
   260 
psychological	 causation,	 so	 examining	 only	 cognitive-based	 illness	 perceptions	would	 not	 encompass	 the	 breadth	 of	 the	 patient’s	 perceptions	 about	 their	symptoms.		Jackson	et	al.’s	2004	study	discussed	the	introduction	of	the		IPQ-R	but	persisted	 in	using	 the	original	 questionnaire	 in	 their	 study	 looking	 at	 IP,	 patient	satisfaction	and	emotional	distress.		The	identity	element	of	the	IPQ-R	was	only	used	in	Demartini’s	intervention	study,	and	 showed	 no	 significant	 change.	 	 It	 would	 have	 been	 interesting	 to	 examine	differences	 between	 the	 identity	 scores	 of	 people	 with	 FNSD	 and	 neurological	disease	in	future	studies	to	evaluate	any	discriminatory	value	in	this	domain,	and	to	inform	 interventions	 aimed	 at	 reducing	 the	 health	 care	 demands	 of	 people	with	FNSD.	 Fiddler,	 Jackson,	 Kapur,	Wells,	 &	 Creed	 (2004)	 found	 that	 the	 number	 of	bodily	symptoms	(identity)	in	people	with	Somatic	Symptom	Disorder	mediated	the	association	 between	 self-reported	 childhood	 adversity	 and	 frequent	 medical	consultations.				There	may	also	be	diagnostic	value	in	using	the	IPQ-R	or	B-IPQ	by	looking	more	at	what	is	not	endorsed	as	a	cause	rather	than	what	is.	As	shown	in	the	studies	included	in	 this	 review,	 people	 with	 FNSD	 have	 tended	 to	 not	 endorse	 psychological	causation,	and	people	with	Functional	Weakness	even	less	than	people	with	Non-Epileptic	Seizures.	Perhaps	the	marker	of	functional	symptoms	might	lie	more	in	the	way	any	psychological	causation	is	denied	by	the	patient	–	this	has	been	shown	to	differentiate	 the	FNSD	patient	 from	 the	neurological	disease	patient	 (Stone	et	 al,	2010).	 The	 stigma	 of	 mental	 health	 and	 the	 cumulative	 experience	 of	 suspicion	amongst	clinicians	over	the	genuineness	of	the	symptoms	contribute	to	the	patient’s	reluctance	to	admit	to	stress	contributing	to	their	disability	(Stone	et	al,	2011).		However,	if	people	with	FNSD	tend	to	misinterpret	their	symptoms,	their	evaluation	of	their	coping	and	treatment	outcome	will	also	be	compromised.	The	question	must	also	be	asked	if	people	with	FNSD	can	consciously	identify	their	beliefs.	Self-report	of	illness	perceptions	may	not	be	straight	forward	for	people	with	FNSD.		The	clue	may	be	in	the	word	perception	–	people	with	FNSD	are	experiencing symptoms	at	a	
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different	level	of	consciousness	and	thus	perceive	their	symptoms	differently.		It	is	interesting	 to	 note	 that	 the	 clinician-rated	 HoNOS	 	 (Wing,	 Beevor,	 Curtis,	 Park,	Hadden,	&	Burns,	1998)	was	the	only	measure	in	Demartini’s	longitudinal	study	that	was	predictive	of	outcome.			Another	route	to	perhaps	clarifying	and	influencing	the	illness	perceptions	of	people	with	FNSD	was	highlighted	by	Whitehead	et	al’s	(2015)	study	of	IPs	in	FNSD	and	neurological	disease	patient	and	relative	pairs,	positing	the	possibility	of	engaging	relatives	 of	 FNSD	 early	 on	 in	 treatment	 plans	 because	 the	 IPQ-R	 identified	 their	greater	acceptance	of	psychological	factors	in	causation.			
Limitations:	The	difficulty	with	nomenclature	and	nosology	of	Functional	Neurological	Symptom	disorder	means	that	this	systematic	review	may	not	have	captured	all	the	studies	that	 describe	 FNSD	 and	 illness	 perceptions.	 This	 review	 included	 five	 studies	conducted	before	the	publication	of	DSM-5	(2013)	so	some	of	the	included	patients	with	Medically	Unexplained	Symptoms	(Sharpe,	Jackson)	would	probably	not	meet	the	modern	criteria	of	functional	neurological	symptoms.			Despite	a	growing	interest	in	this	area,	there	continues	to	be	a	lack	of	evidence	for	treatment	–	as	illustrated	by	the	total	number	of	participants	with	FNSD	(excluding	Non-Epileptic	Seizures)	included	in	this	review	(n=253)	and	the	limited	number	of	researchers	investigating	this	common	disorder.				
Conclusion:	Illness	 perceptions	 may	 play	 a	 role	 in	 the	 aetiology,	 onset	 and	 maintenance	 of	symptoms	 in	 Functional	 Neurological	 Symptom	 Disorder,	 and	 this	 review	 has	demonstrated	that	they	can	be	useful	diagnostic	markers,	that	they	are	indicative	of	rehabilitation	potential,	they	may	mediate	the	effects	of	interventions,	and	they	may	be	 intervention	targets	 to	 increase	patient	engagement.	 	 Illness	perceptions	have	been	shown	to	be	associated	with	wellbeing	outcomes	and	symptom	management.		This	systematic	review	has	highlighted	the	paucity	of	FNSD	studies	 that	examine	
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illness	perceptions,	in	particular	randomised	controlled	studies,	and	more	studies	need	to	investigate	the	full	range	of	 illness	perceptions	to	evaluate	if	people	with	FNSD	 hold	 significantly	 different	 beliefs,	 and	 if	 they	 report	 these	 perceptions	differently	to	people	without	their	condition.				If	 the	Common-Sense	Model	 adds	 to	 the	understanding	of	FNSD,	 then	examining	individual	illness	perceptions	domains	should	further	inform	management	of	this	complex	disorder,	which	 is	 distressing	 and	disabling	 for	 the	 individual	 and	 their	families,	demanding	on	limited	healthcare	resources,	and	perplexing	for	the	people	responsible	for	their	treatment.				5914	words			
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Appendix	D1		SEARCH	STRATEGIES		Cochrane,	Embase,	Medline,	CINAHL,	PsychInfo	&	Web	of	Science	August	2015		FNSD	search	terms:	1. functional	neurological	2. functional	n3	neuro*	3. functional	neurological	symptom*	4. functional	somatic	symptom*	5. functional	somatic	syndrome	6. “functional	weakness”	7. functional	motor	8. functional	psychogenic	movement	disorder	9. psychogenic	movement	disorder	10. dissociative	motor	disease	11. conversion	disorder	12. hysteria	13. medically	unexplained	symptoms		Illness	perception	search	terms:	1. IPQ	2. Illness	perception*	3. Illness	belief*	4. Illness	representation*	5. Health	belief*/	6. Perception/				
Appendix	C:	Sample	Search		
Embase			Time	limit	1996	(publication	of	original	Illness	Perception	Questionnaire)	until	present	day	(August	22,	2015).		
Search	1	 	 	 	 =	4	papers	appropriate	for	title	screening	1. Health	belief	2. Functional	neurological	symp*.af.	3. Illness	(adj	3	perception).ab.	4. 1	or	3	5. 2	and	4																																																																																																										
	
Search	2	 	 	 	 =	0	papers	appropriate	(1	rejected)	1. illness	rep*	=	456	papers	2. functional	weakness	=	0	3. functional	somatic	syndrome	=	106	4. 1	and	3	=	0	5. illness	(adj	3)	perception	=1314	
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6. combined	3	and	5	=	0	7. Health	beliefs	=	2265	8. Combined	3	and	7	=		1	
	
Search	3																																																								=	45	papers	appropriate	(10	rejected)	1. conversion	disorder	=	35	2. conversion	disorder	and	illness	perception	=	2	3. conversion	disorder	and	IPQ	=	0	4. dissociative	motor	disease	and	Illness	perception	=	0	5. dissociative	(adj	3)	motor	and	illness	perception	=	0	6. medically	unexplained	and	illness	perception	=	13	7. medically	unexplained	and	IPQ	=	5	8. psychogenic	movement	disorder	and	illness	perception	=	0	9. psychogenic	movement	and	IPQ	=	0																																																						Electronic	searching	resulted	in	total	of		Medline	=	131	CINHAL	=	226	PsychINFO	=	465	Web	of	Science	=	16	Cochrane	=	3		Total	=	841		After	title	screen	by	1	researcher			237	abstracts	reviewed																	
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Appendix	D2	
Quality	Assessment		
Study	Author/date:																																									Rater	name:	
Date:	
	(All	Items	scores	as	0	=	not	present	or	1	=	present)	Scoring	0-15:	≤8	(53%)	Poor;	9-12	(≥60-≤80%)	Medium;	13-15	(≥86.6%)	Good.		Rationale	-Aims	 1.	Positive	if	the	objective	of	the	study	was	sufficiently	described.	 	Demographic	variables	 2.	Positive	if	information	was	reported	on	participants’	gender,	age,	diagnosis,	comorbidities	(at	least	3	of	these).	 	Suitability	of	the	design	to	answer	the	research	question	 3.	Positive	if	appropriate	research	design	was	used,	eg.	Ie	controls,	correlations,	qualitative.	4.	Positive	if	control	group	was	equivalent	in	age,	sex,	and	socioeconomic	status.	
	
The	Sample	 5.	Positive	if	the	source	of	the	participant	is	stated.	6.	Positive	if	response/participation	rate	relative	to	non-participation	was	stated	(ie	how	many	responded	to	questionnaires).	7.	Positive	if	sample	size	was	justified	in	relation	to	a	power/calculation	and/or	the	number	of	independent	variables	utilised	(a	recognised	rule	of	thumb	is	10	times	the	number	of	IVs	within	a	regression	analysis:	including	control	and	psychological	factors).		
	
Statistical	analysis	 8:	Positive	if	appropriate	statistical	methods	of	analysis	were	used	for	the	data	(specific	to	the	context	of	the	studies	aims).																																																																							9.	Positive	if	an	appropriate	statistical	adjustment	was	performed	on	confounders.																																																																																																																																10.	Positive	if	the	authors	stated	if	normality	distributions	were	met,	and	if	not,	whether	data	transformation	was	conducted	prior	to	analysis	(if	required).	
	
Presentation	of	the	analysis	 11:	Positive	if	the	graphs	and	tables	were	easy	to	understand,	e.g.	presenting	a	table	for	regression	analyses	including	R2	values	and	β	weights.																																		12:	Positive	if	confidence	intervals	or	p	values	were	given	for	the	main	results.	
	
Measures	used	 13:	Positive	if	all	the	questionnaires	used	were	standardized,	defined	as	questionnaires	that	had	been	validated	and	published	or	psychometric	properties	of	new	measures	were	presented.		Single	items	from	or	partial	questionnaires	permitted.			
	
Conclusions	 14:	Positive	if	the	conclusions	were	justified	based	on	the	research	findings		 	
Total	Score	and	
Quality	Range	
	 	
Quality	tool	adapted	from	Mechelen,	v.,	W,	Ariens,	G.	A.	M.,	Bongers,	P.	M.,	Bouter,	L.	M.,	&	Wal,	v.	d.,	G.	(2001).	Psychosocial	risk	factors	for	neck	pain:	A	systematic	review.	American	Journal	of	
Industrial	Medicine,	39(2),	180-193.	doi:10.1002/1097-0274(200102)39:2<180::AID-AJIM1005>3.0.CO;2-	
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